<SEC-DOCUMENT>0001477932-24-002689.txt : 20240510
<SEC-HEADER>0001477932-24-002689.hdr.sgml : 20240510
<ACCEPTANCE-DATETIME>20240510161553
ACCESSION NUMBER:		0001477932-24-002689
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20240331
FILED AS OF DATE:		20240510
DATE AS OF CHANGE:		20240510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGHTBRIDGE Corp
		CENTRAL INDEX KEY:			0001084554
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				911975651
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34487
		FILM NUMBER:		24935083

	BUSINESS ADDRESS:	
		STREET 1:		11710 PLAZA AMERICA DRIVE
		STREET 2:		SUITE 2000
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190
		BUSINESS PHONE:		571 730 1200

	MAIL ADDRESS:	
		STREET 1:		11710 PLAZA AMERICA DRIVE
		STREET 2:		SUITE 2000
		CITY:			RESTON
		STATE:			VA
		ZIP:			20190

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Thorium Power, Ltd
		DATE OF NAME CHANGE:	20061011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVASTAR RESOURCES LTD.
		DATE OF NAME CHANGE:	20051011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVASTAR RESOURCES LTD
		DATE OF NAME CHANGE:	20050829
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ltbr_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ltbr="http://ltbr.com/20240331"><head><title>ltbr_10q.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-01-01to2024-03-31" id="ixv-5821">0001084554</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-01-01to2024-03-31" format="ixt:booleanfalse" id="ixv-5822">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2024-01-01to2024-03-31" id="ixv-5823">--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2024-01-01to2024-03-31" id="ixv-5824">Q1</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="From2024-01-01to2024-03-31" id="ixv-5825">2024</ix:nonNumeric><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" unitRef="USDPShares" decimals="INF" id="ixv-5826">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" unitRef="Shares" decimals="0" id="ixv-5827">10000000</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" unitRef="Shares" decimals="0" id="ixv-5828">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-03-31" unitRef="Shares" decimals="0" id="ixv-5829">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" unitRef="Shares" decimals="0" id="ixv-5830">0</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" unitRef="USDPShares" decimals="INF" id="ixv-5831">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" unitRef="Shares" decimals="0" id="ixv-5832">25000000</ix:nonFraction><ix:nonFraction name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2023-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" unitRef="USD" decimals="0" id="ixv-5833">500000.0</ix:nonFraction><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-01-01to2023-03-31" unitRef="USD" decimals="0" id="ixv-5834">24000</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-01-01to2023-03-31" unitRef="Pure" decimals="INF" id="ixv-5835">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-01to2023-03-31" unitRef="Pure" decimals="INF" id="ixv-5836">0</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardActivityMember" unitRef="Shares" decimals="0" id="ixv-5837">557688</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31_ltbr_RestrictedStockAwardActivityMember" unitRef="Shares" decimals="0" id="ixv-5838">557688</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31_ltbr_RestrictedStockAwardActivityMember" unitRef="Shares" decimals="0" id="ixv-5839">557688</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-03-31_ltbr_CommonShareIssuancesMember" unitRef="Shares" decimals="0" id="ixv-5840">3750</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareIssuancesMember" unitRef="USD" decimals="0" id="ixv-5841">15000</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ltbr-20240331.xsd"/></ix:references><ix:resources><xbrli:context id="From2024-01-01to2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-04-01to2024-04-19_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-05-01to2024-05-08_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-03-31_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_AvailableForSaleSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-15_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-03-01to2021-03-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_RestrictedStockAwardActivityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-03-31_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_CommonShareIssuancesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_ltbr_RestrictedStockAwardActivityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_RestrictedStockAwardActivityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_ConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-12-01to2022-12-15_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseForFeedStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseRatenIcnMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseINLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseINLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_RATENICNMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:RATENICNMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:StrategicPartnershipProjectAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-12-31_ltbr_CentrusEnergyFEEDStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CentrusEnergyFEEDStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-12-31_ltbr_RomaniaFeasibilityStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RomaniaFeasibilityStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-12-31_ltbr_INLProjectMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:INLProjectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_CentrusEnergyFEEDStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CentrusEnergyFEEDStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_RomaniaFeasibilityStudyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RomaniaFeasibilityStudyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_INLProjectMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:INLProjectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_TreasuryBillsLevelThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_TreasuryBillsLevelTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_TreasuryBillsLevelOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_ltbr_CommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_ltbr_CommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_ltbr_CommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-03-31_ltbr_CommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31_ltbr_CommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-12-31_ltbr_CommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2023-01-01to2023-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-05-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001084554</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2024-01-01to2024-03-31" id="ixv-6446">10-Q</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Mark One)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:DocumentQuarterlyReport" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:boolballotbox" id="ixv-6447">&#9746;</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">For the quarterly period ended: <strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2024-01-01to2024-03-31" format="ixt:datemonthdayyearen" id="ixv-6448">March 31, 2024</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:DocumentTransitionReport" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:boolballotbox" id="ixv-6449">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">For the transition period from _____________ to _____________</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Commission File Number: <strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2024-01-01to2024-03-31" id="ixv-6450">001-34487</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2024-01-01to2024-03-31" id="ixv-6451">LIGHTBRIDGE CORPORATION</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:stateprovnameen" id="ixv-6452">Nevada</ix:nonNumeric></strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2024-01-01to2024-03-31" id="ixv-6453">91-1975651</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(State or other jurisdiction of incorporation or organization)</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(I.R.S. Employer Identification No.)</em></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2024-01-01to2024-03-31" id="ixv-6454">11710 Plaza America Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="From2024-01-01to2024-03-31" id="ixv-6455">Suite 2000</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2024-01-01to2024-03-31" id="ixv-6456">Reston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2024-01-01to2024-03-31" id="ixv-6457">VA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2024-01-01to2024-03-31" id="ixv-6458">20190</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Address of principal executive offices, Zip Code)</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2024-01-01to2024-03-31" id="ixv-6459">571</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2024-01-01to2024-03-31" id="ixv-6460">730-1200</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Registrant&#8217;s telephone number, including area code)</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of Each Class:</p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s):</p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of Each Exchange on Which Registered:</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:Security12bTitle" contextRef="From2024-01-01to2024-03-31" id="ixv-6461">Common Stock, $0.001 par value</ix:nonNumeric></strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:TradingSymbol" contextRef="From2024-01-01to2024-03-31" id="ixv-6462">LTBR</ix:nonNumeric></strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>The <ix:nonNumeric name="dei:SecurityExchangeName" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:exchnameen" id="ixv-6463">Nasdaq</ix:nonNumeric> Capital Market</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" contextRef="From2024-01-01to2024-03-31" id="ixv-6464">Yes</ix:nonNumeric> &#9746; No &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" contextRef="From2024-01-01to2024-03-31" id="ixv-6465">Yes</ix:nonNumeric> &#9746; No &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Large Accelerated Filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accelerated Filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:EntityFilerCategory" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:entityfilercategoryen" id="ixv-6466">Non- accelerated Filer</ix:nonNumeric></p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9746;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Smaller reporting company</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:boolballotbox" id="ixv-6467">&#9746;</ix:nonNumeric></p></td></tr><tr style="height:15px"><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:boolballotbox" id="ixv-6468">&#9744;</ix:nonNumeric></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <ix:nonNumeric name="dei:EntityShellCompany" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:boolballotbox" id="ixv-6469">&#9744;</ix:nonNumeric> No &#9746;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The number of shares outstanding of the issuer&#8217;s common stock, as of May 10, 2024 is as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Class of Securities</p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Shares Outstanding</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock, $0.001 par value </strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-05-10" format="ixt:numdotdecimal" unitRef="Shares" decimals="INF" id="ixv-6470">14,434,480</ix:nonFraction></strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LI</strong><span class="atag" style="display: inline" id="toc"><strong>GHTBRI</strong></span><strong>DGE CORPORATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FORM 10-Q</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>MARCH 31, 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Page</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><a href="#p1">PART I - FINANCIAL INFORMATION </a></strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1">Item 1.</a></p></td><td style="vertical-align:top;"><a href="#i1">Condensed Consolidated Financial Statements (unaudited)</a></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#bs">Unaudited Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#sop">Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and 2023</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#stock">Unaudited Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity for the Three Months Ended March 31, 2024 and 2023</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#cf">Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#notes">Notes to Condensed Consolidated Financial Statements (unaudited)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">7</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#forw">Forward-Looking Statements </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">14&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i2">Item 2. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i2">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">15</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i3">Item 3.</a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i3">Quantitative and Qualitative Disclosures About Market Risk</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">21</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i4">Item 4.</a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i4">Controls and Procedures</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">21</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><a href="#p2">PART II - OTHER INFORMATION</a></strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1n">Item 1. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1n">Legal Proceedings</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">23</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1a">Item 1A. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i1a">Risk Factors</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">23</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i2n">Item 2. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i2n">Unregistered Sales of Equity Securities and Use of Proceeds</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i3n">Item 3. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i3n">Defaults Upon Senior Securities</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i4n">Item 4. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i4n">Mine Safety Disclosures</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i5n">Item 5. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i5n">Other Information</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">24</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i6">Item 6. </a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#i6">Exhibits</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#sin">SIGNATURES</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">26</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p1">PART I-FINANCIAL INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i1">ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="bs">LIGHTBRIDGE CORPORATION </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="8" style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ASSETS</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1415" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">27,942,421</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1416" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,598,445</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Prepaid expenses and other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1417" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">401,859</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1418" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">207,063</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 22.5pt; text-align:justify;">Total Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1419" name="us-gaap:AssetsCurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,344,280</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1420" name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,805,508</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Prepaid project costs and other long-term assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1422" name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">479,625</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1423" name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">483,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Trademarks</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1424" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">108,865</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1425" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">108,865</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total Assets </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1426" name="us-gaap:Assets" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,932,770</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1427" name="us-gaap:Assets" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,397,373</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </strong></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1429" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">907,421</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1430" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">486,326</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 22.5pt; text-align:justify;">Total Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1431" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">907,421</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1432" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">486,326</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Commitments and contingencies - Note 5</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stockholders&#8217; Equity </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Preferred stock, $<ix:nonFraction id="fid_1449" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.001</ix:nonFraction> par value, <ix:nonFraction id="fid_1451" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">10,000,000</ix:nonFraction> authorized shares, <ix:nonFraction id="fid_1453" name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">0</ix:nonFraction> shares issued and outstanding at March 31, 2024 and December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1435" name="us-gaap:PreferredStockValue" contextRef="AsOf2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1436" name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Common stock, $<ix:nonFraction id="fid_1457" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.001</ix:nonFraction> par value, <ix:nonFraction id="fid_1459" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">25,000,000</ix:nonFraction> authorized, <ix:nonFraction id="fid_1460" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,189,780</ix:nonFraction> shares and <ix:nonFraction id="fid_1461" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,698,274</ix:nonFraction> shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1437" name="us-gaap:CommonStockValue" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,190</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1438" name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">13,698</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additional paid-in capital </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1439" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,228,519</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1440" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">181,295,125</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accumulated deficit </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1441" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">155,217,360</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1442" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">152,397,776</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 22.5pt; text-align:justify;">Total Stockholders&#8217; Equity </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1443" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,025,349</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1444" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,911,047</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total Liabilities and Stockholders&#8217; Equity </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1445" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,932,770</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1446" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,397,373</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="sop">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>March</strong><strong> 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.6pt; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1464" name="us-gaap:Revenues" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1465" name="us-gaap:Revenues" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1467" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,157,745</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1468" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,865,929</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1469" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,023,823</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1470" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">448,044</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1471" name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,181,568</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1472" name="us-gaap:OperatingExpenses" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,313,973</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Operating Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Contributed services - research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1474" name="ltbr:ContributedServicesResearchAndDevelopment" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1475" name="ltbr:ContributedServicesResearchAndDevelopment" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">31,028</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Other Operating Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1476" name="us-gaap:OtherOperatingIncome" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1477" name="us-gaap:OtherOperatingIncome" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">31,028</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1478" name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,181,568</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1479" name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,282,945</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1481" name="us-gaap:InterestIncomeOther" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">361,984</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1482" name="us-gaap:InterestIncomeOther" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">256,365</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Other Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1483" name="us-gaap:OtherIncome" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">361,984</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1484" name="us-gaap:OtherIncome" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">256,365</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss Before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1485" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,819,584</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1486" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,026,580</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1487" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1488" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1489" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,819,584</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1490" name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,026,580</ix:nonFraction> </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss Per Common Share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Basic and diluted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1492" name="ltbr:EarningsPerSharesBasicAndDiluted" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.21</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1493" name="ltbr:EarningsPerSharesBasicAndDiluted" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.17</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted Average Number of Common Shares Outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1494" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,491,954</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1495" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">11,673,736</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="stock">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2024</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - January 1, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1532" name="us-gaap:SharesIssued" contextRef="AsOf2022-12-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">11,900,217</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1533" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,900</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1534" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">173,595,385</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1535" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">144,489,130</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1536" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,118,155</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1537" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">169,978</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1538" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">170</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1539" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">730,882</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1540" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1541" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">731,052</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultant &amp; directors for services </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1542" name="ltbr:SharesIssuedToConsultantDirectorsForServicesShares" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">55,835</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1543" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">56</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1544" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">214,944</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1545" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1546" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">215,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1547" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1548" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">284,360</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1549" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1550" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">284,360</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the three months ended March 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1551" name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1552" name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1553" name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,026,580</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1554" name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,026,580</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - March 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1555" name="us-gaap:SharesIssued" contextRef="AsOf2023-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,126,030</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1556" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,126</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1557" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">174,825,571</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1558" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">146,515,710</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1559" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,321,987</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - January 1, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1560" name="us-gaap:SharesIssued" contextRef="AsOf2023-12-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,698,274</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1561" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">13,698</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1562" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">181,295,125</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1563" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">152,397,776</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1564" name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,911,047</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued - registered offerings - net of offering costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1565" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">427,300</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1566" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">428</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1567" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,221,554</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1568" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1569" name="ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,221,982</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares issued to consultant &amp; directors for services </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1570" name="ltbr:SharesIssuedToConsultantDirectorsForServicesShares" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">64,206</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1571" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">64</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1572" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">254,936</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1573" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1574" name="ltbr:SharesIssuedToConsultantDirectorsForServicesAmount" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">255,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1575" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1576" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">456,904</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1577" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1578" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">456,904</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss for the three months ended March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1579" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1580" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1581" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,819,584</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1582" name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,819,584</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance - March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1583" name="us-gaap:SharesIssued" contextRef="AsOf2024-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,189,780</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1584" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_ltbr_CommonShareMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,190</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1585" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,228,519</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1586" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">155,217,360</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1587" name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,025,349</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="cf">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1497" name="us-gaap:ProfitLoss" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,819,584</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1498" name="us-gaap:ProfitLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,026,580</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adjustments to reconcile net loss to net cash used in operating activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1499" name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">456,904</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1500" name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">284,360</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Changes in operating assets and liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid expenses and other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1502" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">194,796</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1503" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">278,173</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid project costs and other long-term assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1504" name="ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,375</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1505" name="ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts payable and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1506" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">676,095</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1507" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">440,647</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1508" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,878,006</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1509" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,579,746</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1510" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1511" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net proceeds from the issuances of common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1513" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,221,982</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1514" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">731,052</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Provided by Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1515" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,221,982</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1516" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">731,052</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Decrease in Cash and Cash Equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1517" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">656,024</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1518" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">848,694</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and Cash Equivalents, Beginning of Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1519" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,598,445</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1520" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,899,997</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and Cash Equivalents, End of Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1521" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">27,942,421</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1522" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,051,303</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Supplemental Disclosure of Cash Flow Information</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid during the period:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest paid</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1525" name="us-gaap:InterestPaidNet" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1526" name="us-gaap:InterestPaidNet" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Income taxes paid</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1527" name="us-gaap:IncomeTaxesPaidNet" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1528" name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-Cash Financing Activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Payment of accrued liabilities with common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1530" name="ltbr:PaymentOfAccruedLiabilitiesWithCommonStock" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">255,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1531" name="ltbr:PaymentOfAccruedLiabilitiesWithCommonStock" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">215,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="notes">LIGHTBRIDGE CORPORATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_292" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true" continuedAt="cont_756eca"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Nature of Operations and Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in these notes, the terms &#8220;Lightbridge&#8221;, &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its next generation nuclear fuel technology. These condensed consolidated financial statements include the accounts of the Company and the Company&#8217;s wholly-owned subsidiaries, TPI, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America, including a summary of the Company&#8217;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 4, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three-month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Summary of Significant Accounting Policies</em></strong><em>&#160;</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair Value of Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1117" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="From2024-01-01to2024-03-31" escape="true" continuedAt="cont_830729"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities are classified in their entirety in the fair value hierarchy level based on the lowest level of input that is significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement within the fair value hierarchy levels.</p></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_756eca"><ix:continuation id="cont_830729"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of&#160;&#160;accounts payable and accrued liabilities are considered to be a Level 1 measurement, representative of their respective fair values because of the short-term nature of those instruments.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes the valuation of the Company&#8217;s cash equivalents (in millions) that fall within the fair value hierarchy at March 31, 2024. There were no cash equivalents at December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1143" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assets</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Treasury Bills</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1211" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-03-31_ltbr_TreasuryBillsLevelOneMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.5</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1212" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-03-31_ltbr_TreasuryBillsLevelTwoMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">17.5</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1213" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-03-31_ltbr_TreasuryBillsLevelThreeMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Certain Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1118" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="From2024-01-01to2024-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and /or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of our nuclear fuel, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Recent Accounting Pronouncements </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1130" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which expands on the required disclosure of incremental segment information. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect this guidance to have a material impact on its consolidated financial statements and related disclosures. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires companies to annually disclose categories in the effective tax rate reconciliation and additional information about income taxes paid. The new guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company expects the new standard to have an immaterial effect on its consolidated financial statements and related disclosures upon adoption.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In August 2020, the FASB issued&#160;ASU 2020-06,&#160;<em>Debt-Debt with Conversion and Other Options&#160;</em>(Subtopic 470-20)<em>&#160;and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity&#160;</em>(Subtopic 815-40), which simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in&#160;ASC 470-20,&#160;<em>Debt: Debt with Conversion and Other Options</em>, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in&#160;Subtopic 815-40&#160;for freestanding financial instruments and embedded features that are both indexed to the issuer&#8217;s own stock and classified in stockholders&#8217; equity, by removing certain criteria required for equity classification; and (3) revises the guidance in&#160;ASC 260,&#160;<em>Earnings Per Share</em>, to require entities to calculate diluted earnings per share for convertible instruments by using the if-converted method.&#160;ASU 2020-06&#160;is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Adoption is either through a modified retrospective method or a full retrospective method of transition. The Company adopted this guidance on January 1, 2024 and the adoption did not have a material impact on its results of operations, financial position, and disclosures because the Company does not have any transactions or instruments to which this standard applies. If in the future, the Company issues new convertible debt, warrants or other instruments, the standard may have a material effect, but it cannot be determined at this time.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and do not believe the future adoption of any such standards will have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</p></ix:nonNumeric></ix:continuation><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><ix:nonNumeric id="fid_293" name="us-gaap:EarningsPerShareTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2. Net Loss Per Share</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2024 and 2023, as they would have been anti-dilutive due to the Company&#8217;s losses at March 31, 2024 and 2023 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_310" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1588" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">555,582</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1589" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">525,903</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1590" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">557,688</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1591" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">416,316</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1592" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,113,270</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1593" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">942,219</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_294" name="ltbr:PrepaidProjectCostsDisclosureTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3. Prepaid Project Costs and Other Long-term Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company entered into two agreements with Idaho National Laboratory (INL), in collaboration with the United States Department of Energy (DOE), to support the development of Lightbridge Fuel&#8482;. At the time of signing, the Company made advanced payments for future project work totaling $<ix:nonFraction id="fid_1594" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million to Battelle Energy Alliance, LLC (BEA), DOE&#8217;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing and increasing the advanced payments by $<ix:nonFraction id="fid_1599" name="ltbr:PrepaidProjectCostsAddition" contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MinimumMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million to $<ix:nonFraction id="fid_1600" name="ltbr:PrepaidProjectCostsAddition" contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MaximumMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction> million. The prepaid project costs were $<ix:nonFraction id="fid_1595" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="AsOf2024-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction> million as of March 31, 2024 and December 31, 2023, recorded under Other Assets - Prepaid project costs and other long-term assets.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_295" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4. Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities consisted of the following (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_311" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1238" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1237" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued legal and consulting expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1240" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1239" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1372" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1373" name="us-gaap:AccruedBonusesCurrentAndNoncurrent" contextRef="AsOf2023-12-31" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1242" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.9</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1241" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_296" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true" continuedAt="cont_e1029a"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Commitments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024 and December 31, 2023, the Company had total contractual commitments for R&amp;D work for the following three R&amp;D projects (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1412" name="ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong>&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1603" name="ltbr:ContractualCommitments" contextRef="From2024-01-01to2024-03-31_ltbr_INLProjectMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1607" name="ltbr:ContractualCommitments" contextRef="From2023-01-01to2023-12-31_ltbr_INLProjectMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.9</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1604" name="ltbr:ContractualCommitments" contextRef="From2024-01-01to2024-03-31_ltbr_RomaniaFeasibilityStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1608" name="ltbr:ContractualCommitments" contextRef="From2023-01-01to2023-12-31_ltbr_RomaniaFeasibilityStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1605" name="ltbr:ContractualCommitments" contextRef="From2024-01-01to2024-03-31_ltbr_CentrusEnergyFEEDStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1609" name="ltbr:ContractualCommitments" contextRef="From2023-01-01to2023-12-31_ltbr_CentrusEnergyFEEDStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1602" name="ltbr:ContractualCommitments" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1606" name="ltbr:ContractualCommitments" contextRef="From2023-01-01to2023-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.6</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Project Task Statements - INL</span></em><span style="text-decoration:underline"> </span><em><span style="text-decoration:underline">Project</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 26, 2024, the Company and BEA entered into Modification No. 2 (&#8220;Modification No. 2&#8221;) to the project task statement (PTS) under the Strategic Partnership Project Agreement (SPPA), dated December 9, 2022, as amended on May 23, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 2, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $<ix:nonFraction id="fid_1618" name="ltbr:IncreasedExpensesAmountForProjectTask" contextRef="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.6</ix:nonFraction> million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $<ix:nonFraction id="fid_1619" name="ltbr:TotalCostAmountForProject" contextRef="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.7</ix:nonFraction> million.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_e1029a"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for Modification No. 2, total cash payments from the Company to BEA under both Agreements were estimated at approximately $<ix:nonFraction id="fid_1620" name="us-gaap:PaymentsForFees" contextRef="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">4.3</ix:nonFraction> million (excluding project contingencies) on a cost reimbursable basis over the performance periods under the initial releases. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, the Company had approximately $<ix:nonFraction id="fid_1614" name="ltbr:ProjectTaskTatementPostemploymentObligations" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">3.1</ix:nonFraction> million in outstanding PTS commitments to BEA relating to the R&amp;D work being conducted under the SPPA and &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA) at INL. Performance of work under these agreements may be terminated at any time by either party, without any liability, after the effective date of termination, upon giving a thirty-day written notice under the SPPA and a sixty-day written notice under the CRADA, to the other party. In the event of termination, the Company shall be responsible for BEA&#8217;s costs (including the closeout costs), through the effective date of termination, but in no event shall the Company&#8217;s cost responsibility exceed the total estimated cost stated in each PTS and any subsequent modification to the PTS.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Romania Feasibility Study of Lightbridge Fuel&#8482; for use in CANDU reactors</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in CANDU reactors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, the Company had approximately $<ix:nonFraction id="fid_1616" name="ltbr:RemainingOutstandingProject" contextRef="AsOf2024-03-31_ltbr_RATENICNMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million in remaining outstanding project commitments to RATEN ICN.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy Corp. (Centrus Energy) to conduct a front-end engineering and design (FEED) study to construct a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) to manufacture Lightbridge Fuel&#8482; using high-assay low-enriched uranium (HALEU) at the American Centrifuge Plant in Piketon. The work is expected to be completed in 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These Agreements can be terminated by either Party by giving thirty calendar days' prior written notice of termination to the other Party.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Operating Leases</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leased office space for a <ix:nonNumeric id="fid_1615" name="ltbr:LesseeOperatingLeaseTerm" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:durmonth">12</ix:nonNumeric>-month term from January 1, 2024 through December 31, 2024 with a monthly payment of approximately $<ix:nonFraction id="fid_1612" name="us-gaap:OperatingLeasePayments" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">8,000</ix:nonFraction>. The future minimum lease payments required under the non-cancellable operating leases for 2024 total approximately $<ix:nonFraction id="fid_1613" name="ltbr:LeasePaymentUnderNonCancellableOperatingLeases" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million. Total rent expense for the three months ended March 31, 2024 and 2023 was approximately $<ix:nonFraction id="fid_1611" name="us-gaap:OperatingLeaseExpense" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction>.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_300" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true" continuedAt="cont_c0566d"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6. Research and Development Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">INL Project</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#8482;. These framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; SPPA and an &#8220;umbrella&#8221; CRADA, with an initial duration of seven years. Throughout the duration of these umbrella agreements, all research and development (R&amp;D) work contracted with BEA is through the issuance of PTSs. The initial phase of work under the two agreements will culminate in irradiation testing in the Advanced Test Reactor (ATR) of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. The data, which will be obtained during post-irradiation examination work, will support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#8482;. For the three months ended March 31, 2024 and 2023, the Company recorded $<ix:nonFraction id="fid_1396" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million and $<ix:nonFraction id="fid_1397" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction> million in R&amp;D expenses associated with INL, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Romania Feasibility Study</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged RATEN ICN in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in CANDU reactors. The total price of approximately $<ix:nonFraction id="fid_1399" name="ltbr:ResearchAndDevelopmentExpenseAmountForProject" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction> million is payable in three installments, including an advance payment of $<ix:nonFraction id="fid_1400" name="ltbr:AdvancePaymentForResearchAndDevelopmentExpenseAmount" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million and an interim milestone payment and final payment totaling approximately $<ix:nonFraction id="fid_1401" name="ltbr:InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million. For the three months ended March 31, 2024, the Company recorded $<ix:nonFraction id="fid_1398" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million in R&amp;D expenses associated with RATEN ICN. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_c0566d"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Centrus Energy FEED Study</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a FEED study to add a dedicated LPFFF at the American Centrifuge Plant in Piketon, Ohio. As of the date hereof, Centrus Energy has completed the initial phase of the FEED study and issued a preliminary report. For the three months ended March 31, 2024, the Company recorded $<ix:nonFraction id="fid_1402" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction> million in R&amp;D expenses associated with this FEED study. After reviewing the preliminary report, the Company will decide whether to proceed to the final phase of the FEED study. If the Company decides to move forward with the final phase of the FEED study, the remaining work is expected to be completed in 2024 at an additional fixed price cost of approximately $<ix:nonFraction id="fid_1403" name="ltbr:ResearchAndDevelopmentEstimatedExpenses" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction> million. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents the total R&amp;D expenses for the three months ended March 31, 2024 and 2023 (rounded to millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><ix:nonNumeric id="fid_1411" name="ltbr:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong>&#160;&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1385" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1246" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1386" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1387" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1388" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1389" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1390" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.2</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1391" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1392" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1393" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1394" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.0</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1395" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1110" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true" continuedAt="cont_978495"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7. Stockholders&#8217; Equity and Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2024, the Company had <ix:nonFraction id="fid_1641" name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,189,780</ix:nonFraction> common shares outstanding (including outstanding RSAs totaling <ix:nonFraction id="fid_1637" name="ltbr:OutstandingRestrictedStockAwards" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">557,688</ix:nonFraction> shares). Also outstanding were stock options relating to <ix:nonFraction id="fid_1656" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">555,582</ix:nonFraction> shares of common stock (of which <ix:nonFraction id="fid_1665" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">542,972</ix:nonFraction> stock options were vested), all totaling <ix:nonFraction id="fid_1654" name="ltbr:CommonStockAndAllCommonStockEquivalents" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,745,362</ix:nonFraction> shares of common stock and all common stock equivalents, potentially outstanding at March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2023, the Company had <ix:nonFraction id="fid_1642" name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">13,698,274</ix:nonFraction> common shares outstanding (including outstanding RSAs totaling <ix:nonFraction id="fid_1638" name="ltbr:OutstandingRestrictedStockAwards" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">557,688</ix:nonFraction> shares). Also outstanding were stock options relating to <ix:nonFraction id="fid_1657" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" contextRef="From2023-01-01to2023-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">510,787</ix:nonFraction> shares of common stock (of which <ix:nonFraction id="fid_1666" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2023-01-01to2023-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">498,177</ix:nonFraction> stock options were vested), all totaling <ix:nonFraction id="fid_1655" name="ltbr:CommonStockAndAllCommonStockEquivalents" contextRef="AsOf2023-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,209,061</ix:nonFraction> shares of common stock and all common stock equivalents, outstanding at December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock Equity Offerings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>At-the-Market (ATM) Offerings</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024 (the &#8220;ATM Agreement&#8221;), pursuant to which the Company may issue and sell shares of its common stock from time to time through Stifel as the Company&#8217;s sales agent. Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party. Sales of the Company&#8217;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933. <ix:nonNumeric id="fid_1658" name="ltbr:AtTheMarketOfferingsDisclosureDescription" contextRef="From2021-03-01to2021-03-25">On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#8217;s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024</ix:nonNumeric>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 29, 2024, the Company filed a new shelf registration statement on Form S-3, registering the sale of up to $<ix:nonFraction id="fid_1680" name="ltbr:ProceedFromSaleOfAvailableForSaleSecurities" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">75.0</ix:nonFraction> million of the Company&#8217;s securities, which registration statement was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $<ix:nonFraction id="fid_1679" name="ltbr:ProceedsFromSaleOfAvailableForSaleSecuritiesB8" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">6.6</ix:nonFraction> million from time to time through its ATM.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records its ATM sales on a settlement date basis. The Company sold <ix:nonFraction id="fid_1662" name="ltbr:SharesSoldUnderAtmSettlement" contextRef="AsOf2024-03-31_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">427,300</ix:nonFraction> shares under the ATM for the three months ended March 31, 2024 resulting in net proceeds of $<ix:nonFraction id="fid_1663" name="ltbr:ProceedsFromSharesSoldUnderTheAtm" contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.2</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_1664" name="ltbr:StockIssuedDuringPeriodAmount" contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction> million). The Company sold approximately <ix:nonFraction id="fid_1667" name="ltbr:SharesSoldUnderAtmSettlement" contextRef="AsOf2023-03-31_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">169,978</ix:nonFraction> shares under the ATM for the three months ended March 31, 2023 resulting in net proceeds of $<ix:nonFraction id="fid_1668" name="ltbr:ProceedsFromSharesSoldUnderTheAtm" contextRef="From2023-01-01to2023-03-31_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.7</ix:nonFraction> million (stock issuance costs were approximately $<ix:nonFraction id="fid_1669" name="ltbr:StockIssuedDuringPeriodAmount" contextRef="From2023-01-01to2023-03-31_ltbr_AvailableForSaleSecuritiesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,000</ix:nonFraction>). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>2020 Equity Incentive Plan </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 9, 2020, the Board of Directors adopted the Company&#8217;s 2020 Omnibus Incentive Plan (the 2020 Plan). On September 3, 2020, the shareholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. The total number of shares of common stock available for issuance under the 2020 Plan is <ix:nonFraction id="fid_1682" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,800,000</ix:nonFraction> shares with <ix:nonFraction id="fid_1648" name="ltbr:FutureIssuanceOfShare" contextRef="From2024-01-01to2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">758,672</ix:nonFraction> shares available for future issuance at March 31, 2024.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:continuation id="cont_978495"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Stock Options</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024 and 2023, the number of stock options the Company granted to a consultant was <ix:nonFraction id="fid_1670" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2024-01-01to2024-03-31_ltbr_ConsultantMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">58,309</ix:nonFraction> and <ix:nonFraction id="fid_1671" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2023-01-01to2023-03-31_ltbr_ConsultantMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">0</ix:nonFraction>, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Common Stock</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Consultants&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2024 and 2023, the Company issued <ix:nonFraction id="fid_1672" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-03-31_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,750</ix:nonFraction> shares (with stock prices at $<ix:nonFraction id="fid_1649" name="ltbr:StockOptionExercisePrice" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">4.00</ix:nonFraction>&#160;per share) to its investor relations firm for services provided during the quarter, recorded to general and administrative expenses. The total stock-based compensation expense recorded for these share issuances was $<ix:nonFraction id="fid_1650" name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,000</ix:nonFraction> for each quarter with a weighted average grant date fair value of $<ix:nonFraction id="fid_1651" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">4.00</ix:nonFraction> per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Directors&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2023, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_1639" name="ltbr:CommonSharesIssuancesEquityGrant" contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">240,000</ix:nonFraction> in total to its six directors, which resulted in granting a total of <ix:nonFraction id="fid_1660" name="ltbr:AdditionalCommonShare" contextRef="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">60,456</ix:nonFraction> shares of common stock, valued on the grant date at $<ix:nonFraction id="fid_1652" name="ltbr:CommonSharesEquityGrantPricePerShares" contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">3.97</ix:nonFraction> per share, which vested on January 2, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 15, 2022, the Board of Directors approved an equity grant valued at $<ix:nonFraction id="fid_1640" name="ltbr:CommonSharesIssuancesEquityGrant" contextRef="From2022-12-01to2022-12-15_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">200,000</ix:nonFraction> in total to its five independent directors, recorded in general and administrative expenses, which resulted in granting a total of <ix:nonFraction id="fid_1661" name="ltbr:AdditionalCommonShare" contextRef="AsOf2022-12-15_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">52,085</ix:nonFraction> shares of common stock to the five independent directors, valued on the grant date at $<ix:nonFraction id="fid_1653" name="ltbr:CommonSharesEquityGrantPricePerShares" contextRef="From2022-12-01to2022-12-15_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">3.84</ix:nonFraction> per share, which vested on January 3, 2023. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Restricted Stock Awards</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024 and December 31, 2023, there were <ix:nonFraction id="fid_1673" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardActivityMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">557,688</ix:nonFraction> restricted stock awards (RSAs) included in the total issued and outstanding common stock. A total of $<ix:nonFraction id="fid_1677" name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction> million and $<ix:nonFraction id="fid_1678" name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-01to2023-03-31_ltbr_RestrictedStockAwardActivityMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction> million of compensation expense was recorded for the three months ended March 31, 2024 and 2023, respectively. Compensation expense is recognized in a straight line over the three-year vesting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, total unrecognized compensation cost related to restricted stock units was $<ix:nonFraction id="fid_1643" name="ltbr:UnrecongnizedCompensationCostRestrictedStockUnit" contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">2.2</ix:nonFraction> million, which is expected to be recognized over a remaining weighted-average vesting period of <ix:nonNumeric id="fid_1659" name="us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember" format="ixt-sec:duryear">1.9</ix:nonNumeric> years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expense</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Stock Options</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted during the three months ended March 31, 2024 and 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1135" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1629" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-01-01to2024-03-31" unitRef="Pure" decimals="INF" scale="-2">75.36</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1627" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-01-01to2024-03-31" unitRef="Pure" decimals="INF" scale="-2">4.54</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1621" name="us-gaap:OtherInterestAndDividendIncome" contextRef="From2024-01-01to2024-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1622" name="us-gaap:OtherInterestAndDividendIncome" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected term </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonNumeric id="fid_1623" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2024-01-01to2024-03-31" format="ixt-sec:duryear">2</ix:nonNumeric> years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share &#8211; common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1625" name="us-gaap:SharePrice" contextRef="AsOf2024-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.62</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1626" name="us-gaap:SharePrice" contextRef="AsOf2023-03-31" format="ixt:zerodash" unitRef="USDPShares" decimals="INF">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total non-cash stock-based compensation expense recorded related to options granted and restricted stock awards included in the Company&#8217;s unaudited condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 are as follows (rounded in millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1140" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1631" name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.1</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1632" name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:zerodash" unitRef="USD" decimals="-6" scale="6">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1633" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.4</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1634" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1635" name="us-gaap:DividendsSharebasedCompensationStock" contextRef="From2024-01-01to2024-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.5</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1636" name="us-gaap:DividendsSharebasedCompensationStock" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.3</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><ix:nonNumeric id="fid_297" name="us-gaap:SubsequentEventsTextBlock" contextRef="From2024-01-01to2024-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Amendment to At-the-Market Equity Offering Sales Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 8, 2024, the Company entered into an amendment (the "Amendment") to its&#160;at-the-market equity offering sales agreement, dated May 28, 2019 and as amended on April 9, 2021, with Stifel, Nicolaus &amp; Company, Incorporated (&#8220;Stifel&#8221;) to (i) replace certain references to the Company&#8217;s expired shelf registration statement on Form S-3 (File No. 333-254702) filed on March 25, 2021 with the Securities and Exchange Commission (&#8220;SEC&#8221;) and declared effective April 5, 2021, with reference to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-278388), filed on March 29, 2024 with the SEC and declared effective on April 19, 2024 (the &#8220;Registration Statement&#8221;), (ii) update public float calculations included therein and (iii) <ix:nonNumeric id="fid_1404" name="ltbr:CommissionRateDescription" contextRef="From2024-05-01to2024-05-08_us-gaap_SubsequentEventMember">reduce the commission rate for fees owed to Stifel from 4.0% of the gross sales price per share sold to 3.0% of the gross sales price per share sold</ix:nonNumeric>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>ATM Sales</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of common stock under the ATM from April 1, 2024 to May 10, 2024 amounted to approximately <ix:nonFraction id="fid_1407" name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="-5" scale="6">0.2</ix:nonFraction> million shares, which resulted in total net proceeds of approximately $<ix:nonFraction id="fid_1406" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">0.7</ix:nonFraction> million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Amendment to 2020 Equity Incentive Plan</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2024, the <ix:nonNumeric id="fid_1410" name="ltbr:EquityIncentivePlanDescription" contextRef="From2024-04-01to2024-04-19_us-gaap_SubsequentEventMember">Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Equity Incentive Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#8217; annual meeting on April 19, 2024</ix:nonNumeric>.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="forw">FORWARD-LOOKING STATEMENTS</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to historical information, thisQuarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. We use words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;plan,&#8221; &#8220;optimistic,&#8221; &#8220;intend,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; or similar expressions, which are intended to identify forward-looking statements. Such statements include, among others:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">those concerning market and business segment growth, demand, and acceptance of our nuclear fuel technology and other steps toward the commercialization of Lightbridge Fuel&#8482;;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any projections of sales, earnings, revenue, margins, or other financial items;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any statements of the plans, strategies, and objectives of management for future operations and the timing and outcome of the development of our nuclear fuel technology;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any statements regarding future economic conditions or performance;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any statements about future financings and liquidity;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company&#8217;s anticipated financial resources and position; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">all assumptions, expectations, predictions, intentions, or beliefs about future events and other statements that are not historical facts.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">You are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, as well as assumptions that if they were to ever materialize or prove incorrect, could cause the results of the Company to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties, among others, include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to commercialize our nuclear fuel technology, including risks related to the design and testing of nuclear fuel incorporating our technology and the degree of market adoption of the Company&#8217;s product and service offerings;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">dependence on strategic partners;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any adverse changes to our agreements or relationship with the U.S. government and its national laboratories;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to fund our future operations, including general corporate overhead and outside research and development (R&amp;D) expenses, and continue as a going concern;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the future market and demand for our fuel for nuclear reactors and our ability to attract customers;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to manage the business effectively in a rapidly evolving market;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our ability to employ and retain qualified employees and consultants that have experience in the nuclear industry;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">competition and competitive factors in the markets in which we compete, including from accident tolerant fuels;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the availability of nuclear test reactors and the risks associated with unexpected changes in our nuclear fuel development timeline;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the increased costs associated with metallization of our nuclear fuel;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">uncertainties related to conducting business in foreign countries;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">public perception of nuclear energy generally;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">changes in laws, rules, and regulations governing our business;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">changes in the political environment;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">development and utilization of, and challenges to, our intellectual property domestically and abroad;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">the trading price of our securities is likely to be volatile, and purchasers of our securities could incur substantial losses; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">the other risks and uncertainties identified in Item 1A. Risk Factors included in our Annual Report on Form 10-K for the year ended December 31, 2023.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Most of these factors are beyond our ability to predict or control and you should not put undue reliance on any forward-looking statement. Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward-looking statements. Forward-looking statements speak only as of the date on which they are made. The Company assumes no obligation and does not intend to update these forward-looking statements for any reason after the date of the filing of this report, to conform these statements to actual results or to changes in our expectations, except as required by law.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i2">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, or MD&amp;A, is intended to help the reader understand Lightbridge Corporation, our operations, and our present business environment. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our condensed consolidated financial statements and the accompanying notes thereto contained in Part I, Item 1 of this report, as well as those included in our Annual Report on Form 10-K for the year ended December 31, 2023. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This MD&amp;A consists of the following sections:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Overview of Our Business and Development of Lightbridge Fuel&#8482; - a general overview of our business and updates;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Critical Accounting Estimates - a discussion of critical judgments and estimates;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operations Review - an analysis of our consolidated results of operations for the periods presented in our condensed consolidated financial statements; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Liquidity, Capital Resources, and Financial Position - an analysis of our cash flows and an overview of our financial position.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As discussed in more detail under &#8220;Forward-Looking Statements&#8221; preceding this MD&amp;A, the following discussion contains forward-looking statements that are based on our management&#8217;s current expectations, estimates, and projections, which are subject to a number of risks and uncertainties. Our actual results may differ materially from those discussed in these forward-looking statements because of the risks and uncertainties inherent in future event<em>s, including those set forth under &#8220;Forward-Looking Statements&#8221; and Part II. Item 1A. Risk Factors included herein</em>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">OVERVIEW OF OUR BUSINESS AND DEVELOPMENT OF LIGHTBRIDGE FUEL</span></strong><strong><span style="text-decoration:underline"><sup style="vertical-align:super">TM</sup></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in this Quarterly Report on Form 10-Q, the terms &#8220;Lightbridge&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221;, and &#8220;us&#8221; refer to Lightbridge Corporation together with its wholly-owned subsidiaries Lightbridge International Holding LLC and Thorium Power Inc. Lightbridge&#8217;s principal executive offices are located at 11710 Plaza America Drive, Suite 2000, Reston, Virginia 20190 USA.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Our Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At Lightbridge, we are developing next generation nuclear fuel for water-cooled reactors that could significantly improve the economics and safety of existing and new nuclear power plants, large and small, and enhance proliferation resistance of spent nuclear fuel while supplying clean energy to the electric grid. We project that the world&#8217;s energy and climate needs can only be met if nuclear power&#8217;s share of the energy-generating mix grows substantially in the coming decades. We believe Lightbridge can benefit from a growing nuclear power industry, and that our nuclear fuel can help enable that growth to happen. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We believe our metallic fuel will offer significant economic and safety benefits over traditional nuclear fuel, primarily because of the superior heat transfer properties and the resulting lower operating temperature of all-metal fuel. We also believe that uprating a reactor with Lightbridge Fuel&#8482; will add incremental electricity at a lower levelized cost than any other means of generating baseload electric power, including any renewable, fossil, or hydroelectric energy source, or any traditional nuclear fuel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging nuclear technologies include small modular reactors (SMRs), which are now in the development and licensing phases. We expect that Lightbridge Fuel&#8482; can provide water-cooled SMRs with the same benefits our technology brings to large reactors, with such benefits being even more meaningful to the economic case for deployment of SMRs, including potential load following capability when included on a virtually zero-carbon electric grid with renewable energy sources. We expect Lightbridge Fuel&#8482; to generate more power in SMRs than traditional nuclear fuels. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have built a significant portfolio of patents, and we anticipate testing our nuclear fuel through third-party vendors and others, including the United States Department of Energy&#8217;s (DOE) national laboratories. Currently, we are performing the majority of our R&amp;D activities within and in collaboration with the DOE&#8217;s national laboratories. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Recent Developments </strong></em>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, we entered into an agreement with Centrus Energy Corp. (Centrus Energy) to conduct a front-end engineering and design (FEED) study for a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) to manufacture Lightbridge Fuel&#8482; using high-assay low-enriched uranium (HALEU) at the American Centrifuge Plant in Piketon, Ohio. The FEED study&#8217;s objective is to identify infrastructure and licensing requirements as well as the estimated cost and construction schedule for the LPFFF. Centrus Energy&#8217;s wholly-owned subsidiary, American Centrifuge Operating, LLC, is leading the study. As of the date hereof, Centrus Energy has completed the initial phase of the FEED study and issued a preliminary report. The Company has expensed approximately $0.2 million in connection with the work that has been completed by Centrus Energy. After reviewing the preliminary report, we will decide whether to proceed to the final phase of the FEED study. If we decide to move forward with the final phase of the FEED study, the remaining work is expected to be completed in 2024 at an additional fixed price cost of approximately $0.3 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Romania Feasibility Study of Lightbridge Fuel&#8482; for use in CANDU reactors</span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, we engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in CANDU reactors. This assessment covers key areas including mechanical design, neutronics analysis, and thermal and thermal-hydraulic evaluations. The findings from this engineering study will play an important role in guiding future economic evaluations and navigating potential regulatory licensing-related issues for potential use of Lightbridge Fuel&#8482; in CANDU reactors. The remaining work is expected to be completed in 2024 at an additional fixed price of approximately $0.1 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Idaho National Laboratory Agreements </span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2022, Lightbridge entered into agreements with Battelle Energy Alliance, LLC (BEA), the DOE&#8217;s operating contractor for Idaho National Laboratory (INL), to support the development of Lightbridge Fuel&#8482;. The framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; Strategic Partnership Project Agreement (SPPA) and an &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA), each with BEA, with an initial duration of seven years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that the initial phase of work under the two agreements that has been released will culminate in casting and extrusion of unclad fuel material samples using enriched uranium supplied by the DOE that will subsequently be inserted for irradiation testing in the Advanced Test Reactor (ATR) at INL. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. The data will support fuel performance modeling and regulatory licensing efforts for commercial deployment of Lightbridge Fuel&#8482;.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that subsequent phases of work under the two umbrella agreements that have not yet been released may include post-irradiation examination of the irradiated fuel material coupons, loop irradiation testing in the ATR, and post-irradiation examination of one or more uranium-zirconium fuel rodlets, as well as transient experiments in the Transient Reactor Test Facility at INL.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2023, we worked with INL to complete and issue a Quality Implementation Plan (QIP) for our collaborative project at INL which was an essential first step to ensure all future work performed at INL on the project would meet the U.S. nuclear industry quality assurance requirements. Additionally, we worked with INL to demonstrate casting of delta-phase uranium-zirconium ingots with depleted uranium using existing INL equipment. As part of that effort, we cast several laboratory-scale ingots using depleted uranium and zirconium alloy materials. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2024, we announced a successful extrusion demonstration at INL of a billet into an unclad cylindrical rod, made of depleted uranium and zirconium alloy using the same composition of uranium and zirconium elements in the alloy as what is planned to be ultimately used in Lightbridge Fuel&#8482;. We will work with INL to analyze the extruded rod to confirm the extrusion process parameters prior to producing future fuel samples using enriched uranium for irradiation testing in the ATR.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 26, 2024, the Company and BEA entered into Modification No. 2 (&#8220;Modification No. 2&#8221;) to the project task statement (PTS) under the SPPA, dated December 9, 2022, as amended on May 23, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 2, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $1.7 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After Modification No. 2, total cash payments from the Company to BEA under both agreements were estimated at approximately $4.3 million (excluding project contingencies) on a cost reimbursable basis over the performance periods under the initial releases. As of March 31, 2024, the Company had approximately $3.1 million in outstanding PTS commitments to BEA.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Nuclear Energy University Program Awards </span>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Texas A&amp;M University (TAMU), NuScale Power, and Structural Integrity Associates are working on a 3-year study of our nuclear fuel, led by TAMU. In mid-2023, TAMU was awarded $1 million by the DOE&#8217;s Nuclear Energy University Program (NEUP) R&amp;D Awards to conduct this study. The project entails a characterization of the performance of the Lightbridge Fuel&#8482; Helical Cruciform advanced fuel design, which will generate sets of experimental data on friction factor, flow, and heat transfer behavior under NuScale&#8217;s SMR simulated normal and off-normal conditions. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We previously announced the ongoing NEUP project with the Massachusetts Institute of Technology (MIT). The study led by MIT and funded by DOE relates to evaluation of accident tolerant fuels in various SMRs. The project aims to simulate the fuel and safety performance of Lightbridge Fuel&#8482; for the NuScale SMR and provide scoping analysis to improve the safety and economics of water-cooled SMRs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not have any contractual obligations with the collaboration teams working on the above-mentioned projects and will not receive any revenue or record any economic benefits from these awards.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Future Steps Toward Our Fuel Development and Timeline For The Commercialization of Our Nuclear Fuel Assemblies</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate fuel development milestones for Lightbridge Fuel&#8482; over the next 2-3 years will consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">continue to execute SPPA/CRADA work at INL leading to casting and extrusion of unclad fuel material samples using enriched uranium and their subsequent insertion for irradiation testing in the ATR.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">complete a feasibility study for the use of our nuclear fuel in CANDU heavy water reactors.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">complete a FEED study for a LPFFF in collaboration with Centrus Energy.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">commence manufacturing efforts relating to co-extrusion of cladded rodlets for loop irradiation testing.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The long-term milestones towards development and commercialization of nuclear fuel assemblies include, among other things, irradiating nuclear material samples and prototype fuel rods with enriched uranium in test reactors, conducting post-irradiation examination of irradiated material samples and/or prototype fuel rods, performing thermal-hydraulic experiments, performing seismic and other out-of-reactor experiments, performing advanced computer modeling and simulations to support fuel qualification, designing a lead test assembly (LTA), entering into a lead test rod/assembly agreement(s) with a host reactor(s), demonstrating the production of lead test rods and/or lead test assemblies at a pilot-scale fuel fabrication facility and demonstrating the operation of lead test rods and/or lead test assemblies in commercial reactors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There are inherent uncertainties in the cost and outcomes of the many steps needed for successful deployment of our fuel in commercial nuclear reactors, which makes it difficult to accurately predict the timing of the commercialization of our nuclear fuel technology. However, based on our best estimate and assuming adequate R&amp;D funding levels, we expect to begin demonstration of lead test rods (LTRs) and/or possibly LTAs with our metallic fuel in commercial reactors in the 2030s and begin receiving purchase orders for initial fuel reload batches from utilities 15-20 years from now, with deployment of our nuclear fuel in the first reload batch in a commercial reactor taking place approximately two years thereafter. We are exploring ways of shortening this timeframe that may include securing access to expanded irradiation test loop capacity in existing or new research reactor facilities. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Future Potential Collaborations and Other Opportunities</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the ordinary course of business, we engage in periodic reviews of opportunities to invest in or acquire companies or units within companies to leverage operational synergies and/or establish new streams of revenue. We will be opportunistic in this regard. We may also partner or contract with entities that could be synergistic to our fuel business or present an attractive stable business and/or growth opportunity in the nuclear space.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">CRITICAL ACCOUNTING ESTIMATES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make a variety of estimates and assumptions that affect (i) the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and (ii) the reported amounts of revenues and expenses during the reporting periods covered by the financial statements. For a discussion of the accounting judgments and estimates that we have identified as critical in the preparation of our financial statements, please see &#8220;Critical Accounting Estimates&#8221; under Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 4, 2024. There have been no significant changes in our critical accounting policies and estimates during the three months ended March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management expects to make judgments and estimates about the effect of matters that are inherently uncertain. As the number of variables and assumptions affecting the future resolution of the uncertainties increase, these judgments become even more subjective and complex. Although we believe that our estimates and assumptions are reasonable, actual results may differ significantly from these estimates. Changes in estimates and assumptions based upon actual results may have a material impact on our results of operations and/or financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">OPERATIONS REVIEW</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial information is included in Part I, Item 1 of this Quarterly Report on Form 10-Q. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Condensed Consolidated Results of Operations - Three Months Ended March 31, 2024 and 2023</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our historical operating results and the change in amounts for the periods indicated (rounded to millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Increase</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Decrease)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Change %</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7.3pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7.3pt">Research and development </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">150</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">39</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3.2 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2.3 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">39</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 9pt">Other Income </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">33</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss before Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2.8 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2.0 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(2.0 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.8</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">40</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Operating Expenses</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">General and Administrative </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General and administrative expenses consist mostly of compensation and related costs for personnel and facilities, stock-based compensation, finance, human resources, information technology, and fees for consulting and other professional services. Professional services are principally comprised of legal, audit, strategic advisory services, and outsourcing services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total general and administrative expenses increased by $0.3 million for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023. The increase of $0.3 million was primarily due to an increase in employee compensation and employee benefits and directors&#8217; fee of $0.1 million, due to increases in compensation, an increase in postage and recruitment expenses of $0.1 million due to our SEC proxy mailings to shareholders and recruitment fees for new R&amp;D employees and an increase in stock-based compensation of $0.1 million, due to the stock-based compensation amortization of RSAs issued in November 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total stock-based compensation included in general and administrative expenses was $0.4 million and $0.3 million for three months ended March 31, 2024 and March 31, 2023, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research and Development </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">R&amp;D expenses consist primarily of costs associated with our CRADA and SPPA with INL for the R&amp;D of our fuel, employee compensation and related fringe benefits including stock-based compensation and related allocable overhead costs for the R&amp;D of our fuel. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents our total R&amp;D expenses, including internal costs and other outside R&amp;D costs, for the three months ended March 31, 2024 and 2023 (rounded to millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total R&amp;D expenses increased by $0.6 million for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023 due to the increase in R&amp;D activities related to the development of our fuel. This increase primarily consisted of an increase in INL project labor costs and outside R&amp;D expenses of $0.5 million, and an increase in allocated employee compensation and employee benefits of $0.1 million. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We currently project investing approximately $8 million to $9 million in the R&amp;D of our nuclear fuel over the next 12 to 15 months. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the nature of our R&amp;D expenditures, future costs and schedule estimates are inherently uncertain and can vary significantly as new information and the outcome of these R&amp;D activities become available. Our future business operations are dependent on budgetary constraints due primarily to market conditions and the uncertainty of future liquidity and capital resources available to us to conduct our future R&amp;D activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Other Income </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There was an increase in other income of $0.1 million due to rising interest rates over the past year, which resulted in an increase in interest income earned from the purchase of treasury bills and from our bank savings account for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">LIQUIDITY, CAPITAL RESOURCES, AND FINANCIAL POSITION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Liquidity Outlook </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We measure liquidity in terms of our ability to fund the cash requirements of our R&amp;D activities and our general and administrative expenses, including our contractual obligations and other commitments. We believe that based on our current level of operating expenses and currently available cash resources, we will have sufficient funds available to cover our business activities and operating cash needs for the next 12 months. Our long-term cash requirements for R&amp;D are currently estimated to be an average of $10.0 million of outside or third-party R&amp;D expenditures per year over the next 10-15 years. In order to meet these long-term cash requirements for future planned operations to develop and commercialize our nuclear fuel, including any additional expenditures that may result from unexpected developments, it will be necessary for our project to receive direct or indirect funding and/or in-kind support from government and/or strategic partners and/or other third-party sources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2024, we had cash and cash equivalents of $27.9 million, as compared to $28.6 million at December 31, 2023, a decrease of $0.7 million. We raised net proceeds of $1.2 million from the sale of approximately 0.4 million shares of common stock during the three months ended March 31, 2024. Our net cash used in operating activities for the three months ended March 31, 2024 was $1.9 million and our cash flow projections indicate that we will have continued negative cash flows for the foreseeable future. We currently do not anticipate any incoming cash flows, other than the sale of common stock through our ATM offering. We are not profitable, and we cannot provide any assurance that we will become profitable in the future. We will continue to incur losses because we are in the early development stage of commercializing our nuclear fuel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have approximately $27.6 million of working capital as of the date of this filing. We currently project a negative cash flow from our operations for both our general and administrative and R&amp;D expenses, resulting in total expected expenditures of approximately $16.2 million for the next 12 months. Our R&amp;D expenses are expected to increase over the next 12-15 months. Our cash balance at March 31, 2024 and as of the date of this filing exceeds our anticipated cash requirements for the next 12 months. There are inherent uncertainties in forecasting the R&amp;D and other expenditures that will be required in the future. Once other anticipated agreements are finalized or other future R&amp;D agreements are entered into and the future R&amp;D expenses are known, we expect to incur a significantly higher level of future required R&amp;D expenses and higher negative monthly cash flows from operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If sufficient funding becomes available to us, our R&amp;D activities may significantly increase in the future. This funding is needed to continue our nuclear fuel development project and to achieve our future R&amp;D milestones. The actual amount of cash we will need to operate is subject to many factors, including, but not limited to, the timing, design and conduct of the R&amp;D work at the DOE&#8217;s national laboratories for our fuel along with the cost to commercialize our nuclear fuel. Accordingly, there is high potential for budget variances in the current cost projections and fuel development timelines of our current planned operations over the fuel development period. We will continue to utilize our ATM to finance our future R&amp;D and corporate activities. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We will need to receive substantial funding and in-kind support from government, strategic partners and/or other third-party sources throughout our nuclear fuel R&amp;D development period in order to fund our ongoing R&amp;D efforts in the future. If we are unable to obtain such funding and/or in-kind support that meets our future R&amp;D cash requirements, we will need to seek other funding, which may include the issuance of additional shares of the Company&#8217;s common stock, if available. This will result in dilution to our existing stockholders. If we can raise additional funds through the issuance of preferred stock, other equity or convertible securities, these securities could have rights or preferences senior to those of our common stock and could contain covenants that restrict our operations in the future. There can be no assurance that we will be able to obtain additional equity or debt financing on terms acceptable to us, if at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our current source of cash available to us for the next 12 months, in addition to cash and cash equivalents on hand, is the potential funding from equity issuances pursuant to the at-the-market equity offering sales agreement, as amended, with Stifel, Nicolaus &amp; Company, Incorporated. The Company previously had an effective shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission, or SEC, on March 25, 2021, registering the sale of up to $75 million of the Company&#8217;s securities which was declared effective on April 5, 2021. We filed a prospectus supplement, dated April 4, 2023, with the SEC pursuant to which we may offer and sell shares of common stock having an aggregate offering price of up to $17.9 million from time to time, through the ATM. We filed a new shelf registration statement on Form S-3 on March 29, 2024 and that became effective on April 19, 2024. We filed a prospectus supplement, dated May 10, 2024, with the SEC pursuant to which we may offer and sell shares of common stock having an aggregate offering price of up to $6.6 million from time to time, through the ATM.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under current SEC regulations set forth under General Instruction I.B.6. of Form S-3, if at any time our public float is less than $75.0 million, and for so long as our public float remains less than $75.0 million, the amount we can raise through primary public offerings of securities in any twelve-month period using shelf registration statements is limited to an aggregate of one-third of our public float, which is referred to as the baby shelf rules. As of the date of this filing, we are subject to the baby shelf rules for any offerings conducted on our current shelf registration statement, and therefore may be limited on the amount of funding available under this Form S-3 shelf registration statement in the future. Although we expect this ATM facility to continue to be a source of working capital for the Company in 2024, there is no assurance that an ATM financing arrangement will be available to us in the future. See Note 7. Stockholders&#8217; Equity and Stock-Based Compensation of the Notes to our condensed consolidated financial statements included in Part I. Item 1. <em>Financial Statements,</em> of this Quarterly Report on Form 10-Q for information regarding our prior equity financings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have no debt or lines of credit and we have financed our operations to date through the sale of our preferred stock and common stock. Management believes that public or private equity investments may be available in the future; however, adverse market conditions, in our common stock price and trading volume, as well as other factors could substantially impair our ability to raise capital in the future and continue developing our nuclear fuel. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Short-Term and Long-Term Liquidity Sources</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our current source of liquidity is cash raised from our ATM facility.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As discussed above, we will seek new financing in order to bring us additional sources of capital, depending on the capital market conditions of our common stock. There can be no assurance that these additional sources of capital will be made available on terms acceptable to us, or at all. The primary potential sources of cash that may be available to us are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">equity or debt investment from third-party investors in Lightbridge;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">collaboration with potential industry partners; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">strategic investment and/or government funding to support the remaining R&amp;D activities required to continue the development of our fuel products and move them to a commercial stage.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In support of our long-term business with respect to our fuel technology business, we endeavor to create strategic alliances with other parties to support the remaining R&amp;D activities that are required to further enhance and complete the development of our fuel products to a commercial stage. We may be unable to form such strategic alliances on terms acceptable to us or at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">See Note 7. Stockholders&#8217; Equity and Stock-Based Compensation of the Notes to our condensed consolidated financial statements included in Part I. Item 1. <em>Financial Statements,</em> of this Quarterly Report on Form 10-Q for information regarding our prior equity financings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table provides detailed information about our net cash flows for the three months ended March 31, 2024 and 2023 (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Cash Flows</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Operating Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1.9 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1.5 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Used in Investing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Provided by Financing Activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.7</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash Outflow</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.7 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(0.8 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Operating Activities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our net cash used in operating activities increased by $0.4 million for the three months ended March 31, 2024 as compared to the three months ended March 31, 2023. This increase was primarily due to increased spending on R&amp;D and general and administrative expenses. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Financing Activities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our net cash provided by financing activities increased by $0.5 million for the three months ended March 31, 2024 as compared to the three months ended March 31, 2023. This increase was due to an increase in the net proceeds received from the issuance of common stock under our at-the-market (ATM) facility.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash provided by our ATM facility was $1.2 million (sale of approximately 0.4 million common shares) and $0.7 million (sale of approximately 0.2 million common shares) for the three months ended March 31, 2024 and 2023, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Off Balance Sheet Arrangements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity or capital expenditures or capital resources that is material to an investor in our securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Inflation </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business, revenues, and operating results have not been affected in any material way by inflation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i3">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is not required to provide the information required by this Item as it is a &#8220;smaller reporting company,&#8221; as defined in Rule 12b-2 of the Exchange Act. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i4">ITEM 4. CONTROLS AND PROCEDURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Evaluation of Disclosure Controls and Procedures</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is (a) recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms, and (b) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating such controls and procedures, the Company recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 31, 2024 due to the material weakness in internal control over financial reporting described below.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. As previously disclosed in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2023, in management&#8217;s assessment of the effectiveness of internal control over financial reporting as of December 31, 2023, management determined that there was a material weakness related to the design of our information technology general controls (ITGC) over logical access to key information systems used in the financial reporting process, resulting in certain segregation of duties conflicts. Additionally, certain business process controls that are dependent on information from these systems were also not effective. Notwithstanding the material weakness, there were no restatements of prior period finance statements, and no changes in previously released financial results were required as a result of the material weakness.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Ongoing Remediation of Previously Identified Material Weakness</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s management, under the oversight of the Audit Committee, has undertaken measures to remediate these deficiencies. This includes enhancing the design of logical access controls to ensure appropriate segregation of duties through improved internal documentation and monitoring activities. Management began to implement these remedial steps during the fourth quarter of fiscal 2023 by removing privileged access to accounting software. The material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are designed and operating effectively. The Company may also identify additional measures that may be required to remediate the material weaknesses in the Company&#8217;s internal control over financial reporting, necessitating further action.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Changes in Internal Control Over Financial Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Except as noted above, there were no changes in the Company&#8217;s internal control over financial reporting during the first quarter of 2024 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="p2">PART II-OTHER INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i1n">ITEM 1. LEGAL PROCEEDINGS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i1a">ITEM 1A. RISK FACTORS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other than as set forth below, there have been no other material changes to our risk factors from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Acquisition activity presents certain risks to our business, operations and financial condition, and we may not realize the financial and strategic goals contemplated at the time of a transaction.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We expect that acquisitions will be an important part of our long-term growth strategy. Successful execution following the closing of an acquisition is essential to achieving the anticipated benefits of the transaction. We may make acquisitions to support our growth and our acquisition strategy depends on our ability to complete and integrate the acquisitions. Mergers and acquisitions are inherently risky, and any mergers and acquisitions that we complete may not be successful. The process of integrating an acquired company's business into our operations is challenging and may result in expected or unexpected operating or compliance challenges, which may require significant expenditures and a significant amount of our management's attention that would otherwise be focused on the ongoing operation of our business. The potential difficulties or risks of integrating an acquired company's business include, among others:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the effect of any potential acquisition on our financial and strategic positions and our reputation,</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">risk that we fail to successfully implement our business plan for the combined business,</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">risk that we are unable to obtain the anticipated benefits of any potential acquisition, including synergies or economies of scale,</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">challenges in reconciling business practices or in integrating activities, logistics or information technology and other systems,</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">challenges in reconciling accounting issues, especially if an acquired company utilizes accounting principles different from those we use,</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">retention risk with respect to key collaborators and employees and challenges in retaining, assimilating and training new employees,</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">potential failure of the due diligence processes to identify significant problems, liabilities or other shortcomings or challenges of an acquired company, which could result in unexpected litigation, regulatory exposure, financial contingencies and known and unknown liabilities, and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">challenges in complying with newly applicable laws and regulations, including obtaining or retaining required approvals, licenses and permits.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any potential acquisitions may also result in the expenditure of available cash and amortization of expenses any of which could have a material adverse effect on our results of operations or financial condition. Investments in immature businesses with unproven track records have an especially high degree of risk, with the possibility that we may lose the value of our entire investments or incur additional unexpected liabilities. Large or costly acquisitions or investments may also diminish our capital resources and liquidity or limit our ability to engage in additional transactions for a period of time. All of the foregoing risks may be magnified as the cost, size or complexity of a potential acquisition or acquired company increases, or where the acquired company's market or business are materially different from ours, or where more than one integration is occurring simultaneously or within a concentrated period of time.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, in the future we may require significant financing to complete an acquisition or investment, whether through bank loans, raising of debt, issuance of equity securities or otherwise. We cannot assure you that such financing options will be available to us on reasonable terms, or at all. If we are not able to obtain such necessary financing, it could have an impact on our ability to consummate any potential acquisition or investment and execute our growth strategy. The issuance of a significant number of shares as consideration for any potential acquisition would have a dilutive effect on our existing stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i2n">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES OR USE OF PROCEEDS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">None</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i3n">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not Applicable</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i4n">ITEM 4. MINE SAFETY DISCLOSURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not Applicable</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i5n">ITEM 5. OTHER INFORMATION </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, no director or officer of the Company adopted or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as each term is defined in Item&#160;408(a)&#160;of&#160;Regulation S-K.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Amendment to At-the-Market Equity Offering Sales Agreement</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 8, 2024, the Company entered into an amendment (the "Amendment") to its&#160;at-the-market equity offering sales agreement, dated May 28, 2019 and as amended on April 9, 2021, with Stifel, Nicolaus &amp; Company, Incorporated (&#8220;Stifel&#8221;) to (i) replace certain references to the Company&#8217;s expired shelf registration statement on Form S-3 (File No. 333-254702) filed on March 25, 2021 with the Securities and Exchange Commission (&#8220;SEC&#8221;) and declared effective April 5, 2021, with reference to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-278388), filed on March 29, 2024 with the SEC and declared effective on April 19, 2024 (the &#8220;Registration Statement&#8221;), (ii) update public float calculations included therein and (iii) reduce the commission rate for fees owed to Stifel from 4.0% of the gross sales price per share sold to 3.0% of the gross sales price per share sold.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of the Company&#8217;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, pursuant to the Company&#8217;s Registration Statement, the base prospectus filed as part of such registration statement, and the prospectus supplement dated May 10, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The foregoing summary of the&#160;Amendment&#160;does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached as Exhibit 1.1 to this Quarterly Report on Form 10-Q and incorporated herein by reference.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This Quarterly Report on Form 10-Q shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="i6">ITEM 6. EXHIBITS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>EXHIBIT INDEX - </strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exhibit</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Number</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Description </strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex11.htm">1.1*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex11.htm">Amendment No. 2 to the At-the-Market Equity Offering Sales Agreement, dated May 8, 2024, by and between Lightbridge Corporation and Stifel, Nicolaus &amp; Company, Incorporated.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex51.htm">5.1*</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="ltbr_ex51.htm">Opinion of Gary R. Henrie, Esq.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex101.htm">10.1&#9650;*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex101.htm">Modification No. 2 to the Project Task Statement, dated March 25, 2024, under the Strategic Partnership Project Agreement, dated December 9, 2022, as amended on May 23, 2023, by and between Lightbridge Corporation and Battelle Energy Alliance, LLC.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td>&#160;&#160;</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">23.1*</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consent of Gary R. Henrie, Esq. (included in Exhibit 5.1).</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex311.htm">31.1*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex311.htm">Rule 13a-14(a)/15d-14(a) Certification - Principal Executive Officer.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex312.htm">31.2*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex312.htm">Rule 13a-14(a)/15d-14(a) Certification - Principal Financial Accounting Officer.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex32.htm">32*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="ltbr_ex32.htm">Section 1350 Certifications.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Interactive data files pursuant to Rule 405 of Regulation S-T.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.INS</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.SCH</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Schema Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.CAL</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.DEF</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.LAB</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Labels Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">101.PRE</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">104</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">* Filed or furnished herewith </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9650; Certain portions of this Exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish supplementally an unredacted copy of this Exhibit to the SEC upon request.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="sin">SIGNATURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>LIGHTBRIDGE CORPORATION </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: May 10, 2024</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name: </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Seth Grae </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">President, Chief Executive Officer and Director </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Executive Officer) </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman </em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name:</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Larry Goldman </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Financial Officer </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Financial Officer and Principal Accounting Officer) </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">26</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ltbr_ex11.htm
<DESCRIPTION>MARKET EQUITY OFFERING SALES AGREEMENT
<TEXT>
<html><head><title>ltbr_ex11.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 1.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>AMENDMENT NO. 2 TO AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">May 8, 2024</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">STIFEL, NICOLAUS &amp; COMPANY, INCORPORATED</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One South Street, 15th Floor</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Baltimore, Maryland 21202</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Ladies and Gentlemen:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lightbridge Corporation (the &#8220;<u>Company</u>&#8221;) and Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;<u>Agent</u>&#8221;) are parties to that certain At-the-Market Equity Offering Sales Agreement dated May 28, 2019, as amended by Amendment No. 1 to At-the-Market Equity Offering Sales Agreement dated April 9, 2021 (as amended, the &#8220;<u>Original Agreement</u>&#8221;). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The parties, intending to be legally bound, hereby amend the Original Agreement as follows:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">1. Reference to the &#8220;Registration Statement&#8221; in the Original Agreement shall refer to the registration statement on Form S-3 (File No. 333-278388), originally filed with the Securities and Exchange Commission on March 29, 2024 and declared effective by the Securities and Exchange Commission on April 19, 2024.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">2. Section 6(k) of the Original Agreement is hereby deleted and replaced with:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&#8220;<u>S-3 Eligibility</u>. At the time the Registration Statement was or will be declared effective, and at the time the Company&#8217;s most recent Annual Report on Form 10-K was filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form S-3 under the Securities Act, including, but not limited to, General Instruction I.B.6 of Form S-3, if applicable. As of the close of trading on the Exchange on March 28, 2024, the aggregate market value of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Rule 144 of the Securities Act, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common control with, the Company) (the &#8220;<u>Non-Affiliate Shares</u>&#8221;), was approximately $43.1 million (calculated by multiplying (x) the price at which the common equity of the Company was last sold on the Exchange on March 18, 2024 times (y) the number of Non-Affiliate Shares).<sup style="vertical-align:super"> </sup>The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in General Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">3. All references to &#8220;May 28, 2019&#8221; set forth in Schedule 1 and Exhibit 7(m) of the Original Agreement are revised to read &#8220;May 8, 2024 (as amended by Amendment No. 1 to At-the-Market Equity Offering Sales Agreement, dated April 9, 2021 and Amendment No. 2 to At-the-Market Equity Offering Sales Agreement, dated May 8, 2024)&#8221;.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4. The reference to &#8220;up to 4%&#8221; set forth in Schedule 2 of the Original Agreement is hereby revised to read &#8220;equal to 3%&#8221;.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5. In addition to the requirements under Section 9 of the Original Agreement, the Company agrees to pay the reasonable fees and disbursements of counsel to the Agent in an amount not to exceed $50,000 in connection with this Amendment No. 2 to At-the-Market Offering Sales Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">6. Except as specifically set forth herein, all other provisions of the Original Agreement shall remain in full force and effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">7. <u>Entire Agreement; Amendment; Severability</u>. This Amendment No. 2 to the Original Agreement together with the Original Agreement (including all schedules and exhibits attached hereto and thereto and Placement Notices issued pursuant hereto and thereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. All references in the Original Agreement to the &#8220;Agreement&#8221; shall mean the Original Agreement as amended by this Amendment No. 2; <em>provided, however</em>, that all references to &#8220;date of this Agreement&#8221; in the Original Agreement shall continue to refer to the date of the Original Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">8. <u>Applicable Law; Consent to Jurisdiction</u>. This amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such party at the address in effect for notices to it under this amendment and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">9. <u>Waiver of Jury Trial</u>. The Company and the Agent each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this amendment or any transaction contemplated hereby.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">10. <u>Counterparts</u>. This amendment may be executed in counterparts, each of which shall be deemed an original, but both of which together shall constitute one and the same instrument. Delivery of an executed amendment by one party to the other may be made by facsimile transmission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>[Remainder of Page Intentionally Blank]</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">If the foregoing correctly sets forth the understanding among the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding amendment to the Original Agreement between the Company and the Agent.&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Very truly yours,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>LIGHTBRIDGE CORPORATION</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:50%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="width:5%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><em>/s/ Larry Goldman</em></p></td> <td style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Name:</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Larry Goldman</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Title:</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Chief Financial Officer </p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>STIFEL, NICOLAUS &amp; COMPANY, </strong><strong>INCORPORATED</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><em>/s/ Lewis Chia</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Name:</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Lewis Chia</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Title:</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Managing Director</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ltbr_ex51.htm
<DESCRIPTION>OPINION
<TEXT>
<html><head><title>ltbr_ex51.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>&nbsp;EXHIBIT 5.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Gary R. Henrie </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Attorney at Law</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Licensed in the States of Utah and Nevada</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">619 South 1040 East</p></td> <td style="width:50%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Telephone: 307-200-9415</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">American Fork, UT 84003</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">e-mail: grhlaw@hotmail.com</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">May 10, 2024</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lightbridge Corporation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">11710 Plaza America Drive, Suite 2000</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Reston, VA 20190</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Re:</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Registration Statement on Form S-3</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Ladies and Gentlemen:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We are acting as special Nevada counsel for Lightbridge Corporation, a Nevada corporation (the &#8220;<strong>Company</strong>&#8221;), in connection with the sale from time to time by the Company of shares of its common stock, par value $0.001 per share (the &#8220;<strong>Shares</strong>&#8221;), having an aggregate offering price of up to $6,560,000 through Stifel, Nicolaus &amp; Company, Incorporated (&#8220;<strong>Stifel</strong>&#8221;), as the sales agent, to be issued pursuant to a registration statement on Form S-3 (File No. 333-278288) filed by the Company with the Securities and Exchange Commission (the &#8220;<strong>Commission</strong>&#8221;) on March 29, 2024 (the &#8220;<strong>Registration Statement</strong>&#8221;), the base prospectus included in the Registration Statement (the &#8220;<strong>Base Prospectus</strong>&#8221;), the prospectus supplement dated May 10, 2024 (with the Base Prospectus, the &#8220;<strong>Prospectus</strong>&#8221;), and that certain At-the-Market Equity Offering Sales Agreement, dated as of May 28, 2019, and as amended on April 9, 2021 and May 8, 2024, by and between the Company and Stifel (the &#8220;<strong>Sales Agreement</strong>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have reviewed and are familiar with such corporate proceedings and other matters as we have deemed necessary for this opinion.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In rendering the opinion set forth below, we have assumed that (i) all information contained in all documents reviewed by us is true and correct; (ii) all signatures on all documents examined by us are genuine; (iii) all documents submitted to us as originals are authentic and all documents submitted to us as copies conform to the originals of those documents; and (iv) each natural person signing any document reviewed by us had the legal capacity to do so.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based upon, subject to and limited by the foregoing, we are of the opinion that, as of the date hereof, the Shares have been duly authorized by all necessary corporate action on the part of the Company and, following (i) issuance and delivery of the Shares in the manner contemplated by the Sales Agreement, and (ii) receipt by the Company of the consideration for the Shares specified in the resolutions of the Board of Directors of the Company and the Pricing Committee of such Board, the Shares will be validly issued, fully paid, and nonassessable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In providing this opinion, we have relied as to certain matters on information obtained from public officials and officers or agents of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is limited to matters governed by the Nevada Revised Statutes (including the statutory provisions and reported judicial decisions interpreting such law) and the laws of the State of Nevada. We disclaim any obligation to update this opinion or otherwise advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or the opinion set forth herein, nor do we deliver any opinion as to the extent to which any laws other than the laws of the State of Nevada apply or the effect of any such other laws should they apply.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This opinion letter has been prepared for use in connection with the Quarterly Report on Form 10-Q to be filed by the Company on May 10, 2024. We assume no obligation to advise you of any changes in the foregoing subsequent to the effective date of this opinion letter.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We hereby consent to the filing of this opinion as Exhibit 5.1 to the Company&#8217;s Quarterly Report on Form 10-Q and to the use of our name under the caption &#8220;Legal Matters&#8221; in the Registration Statement and in the Prospectus and any supplement thereto. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission promulgated thereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sincerely,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">/s/ Gary R. Henrie</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Gary R. Henrie</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">2</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ltbr_ex101.htm
<DESCRIPTION>MODIFICATION NO. 2 TO THE PROJECT TASK STATEMENT
<TEXT>
<html><head><title>ltbr_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>*** Certain identified information has been excluded from this exhibit because it </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>is both not material and the type the registrant treats as private or&nbsp;confidential</strong>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img19.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img20.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img21.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img22.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img23.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img24.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img25.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img26.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="ltbr_ex101img27.jpg">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;">&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ltbr_ex311.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex311.htm</title><!--Document created using EDGARMaster--></head><body style="COLOR: #000000; TEXT-ALIGN: justify; FONT: 10pt Times New Roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="MARGIN: 0px; text-align:right;"><strong>EXHIBIT 31.1</strong></p> <p style="MARGIN: 0px; text-align:center;"><strong></strong>&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Certification of Principal Executive Officer</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">I, Seth Grae, certify that: </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">I have reviewed this Quarterly Report on Form 10-Q of Lightbridge Corporation;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">d.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">5.</p></td> <td colspan="2" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: May 10, 2024</p></td> <td style="width:3%;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae </em></p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Seth Grae</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">Principal Executive Officer </p></td> <td></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ltbr_ex312.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex312.htm</title><!--Document created using EDGARMaster--></head><body style="COLOR: #000000; TEXT-ALIGN: justify; FONT: 10pt Times New Roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="MARGIN: 0px; text-align:right;"><strong>EXHIBIT 31.2</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:center;"><strong>Certification of Principal Financial Officer</strong></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">I, Larry Goldman, certify that: </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">I have reviewed this Quarterly Report on Form 10-Q of Lightbridge Corporation;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">d.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">5.</p></td> <td colspan="2" style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">a.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: May 10, 2024</p></td> <td style="width:3%;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman </em></p></td> <td style="width:12%;"></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">Larry Goldman</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="MARGIN: 0px; text-align:justify;">Chief Financial Officer </p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td> <p style="margin:0px">(Principal Financial and Principal Accounting Officer)</p></td> <td></td></tr></table></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>ltbr_ex32.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>ltbr_ex32.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 32</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Section 1350 Certifications</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>STATEMENT FURNISHED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The undersigned, the Chief Executive Officer and Chief Financial Officer of Lightbridge Corporation, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"></td> <td style="width:4%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">1. </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">The Quarterly Report on Form 10-Q of Lightbridge Corporation for the quarter ended March 31, 2024, filed on the date hereof with the Securities and Exchange Commission (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">2. </p></td> <td> <p style="MARGIN: 0px; text-align:justify;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Lightbridge Corporation.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="MARGIN: 0px; text-align:justify;">Date: May 10, 2024</p></td> <td style="width:5%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Seth Grae</em></p></td> <td style="width:10%;"></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Name: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Seth Grae</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Title: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">President, Chief Executive Officer and Director</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">(Principal Executive Officer)</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">By:</p></td> <td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;"><em>/s/ Larry Goldman</em></p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Name: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Larry Goldman</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Title: </p></td> <td style="vertical-align:top;"> <p style="MARGIN: 0px; text-align:justify;">Chief Financial Officer</p></td> <td></td></tr> <tr style="height:15px"> <td></td> <td></td> <td style="vertical-align:top;"> <p style="margin:0px">(Principal Financial Officer and Principal Accounting Officer)</p></td> <td></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>ltbr-20240331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/10/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ltbr="http://ltbr.com/20240331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://ltbr.com/20240331">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://ltbr.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" id="UnauditedCondensedConsolidatedBalanceSheets">
        <link:definition>000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" id="UnauditedCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" id="UnauditedCondensedConsolidatedStatementsOfOperations">
        <link:definition>000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" id="UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity">
        <link:definition>000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="UnauditedCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements">
        <link:definition>000007 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShare" id="NetLossPerShare">
        <link:definition>000008 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" id="PrepaidProjectCostsAndOtherLongTermAssets">
        <link:definition>000009 - Disclosure - Prepaid Project Costs and Other Long-term Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
        <link:definition>000010 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>000011 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" id="ResearchAndDevelopmentCosts">
        <link:definition>000012 - Disclosure - Research and Development Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" id="StockholdersEquityAndStockBasedCompensation">
        <link:definition>000013 - Disclosure - Stockholders Equity and Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>000014 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies">
        <link:definition>000015 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables">
        <link:definition>000016 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShareTables" id="NetLossPerShareTables">
        <link:definition>000017 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
        <link:definition>000018 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
        <link:definition>000019 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" id="ResearchAndDevelopmentCostsTables">
        <link:definition>000020 - Disclosure - Research and Development Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" id="StockholdersEquityAndStockbasedCompensationTables">
        <link:definition>000021 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" id="NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails">
        <link:definition>000022 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/NetLossPerShareDetails" id="NetLossPerShareDetails">
        <link:definition>000023 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" id="PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative">
        <link:definition>000024 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilitiesDetails">
        <link:definition>000025 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
        <link:definition>000026 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
        <link:definition>000027 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" id="ResearchAndDevelopmentCostsDetails">
        <link:definition>000028 - Disclosure - Research and Development Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" id="ResearchAndDevelopmentCostsDetailsNarrative">
        <link:definition>000029 - Disclosure - Research and Development Costs (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" id="StockholdersEquityAndStockbasedCompensationDetails">
        <link:definition>000030 - Disclosure - Stockholders Equity and StockBased Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" id="StockholdersEquityAndStockbasedCompensationDetails1">
        <link:definition>000031 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" id="StockholdersEquityAndStockbasedCompensationDetailsNarrative">
        <link:definition>000032 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
        <link:definition>000033 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20240331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20240331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20240331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ltbr-20240331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <import namespace="http://fasb.org/srt-roles/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd" />
  <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <import namespace="http://fasb.org/us-roles/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd" />
  <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <element id="ltbr_OtherOperatingIncomeAbstract" name="OtherOperatingIncomeAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ContributedServicesResearchAndDevelopment" name="ContributedServicesResearchAndDevelopment" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_EarningsPerSharesBasicAndDiluted" name="EarningsPerSharesBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" name="SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" name="SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedToConsultantDirectorsForServicesShares" name="SharesIssuedToConsultantDirectorsForServicesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesIssuedToConsultantDirectorsForServicesAmount" name="SharesIssuedToConsultantDirectorsForServicesAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" name="IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CashPaidDuringThePeriodAbstract" name="CashPaidDuringThePeriodAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" name="PaymentOfAccruedLiabilitiesWithCommonStock" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidProjectCostsDisclosureTextBlock" name="PrepaidProjectCostsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" name="ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" name="ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidProjectCostsAddition" name="PrepaidProjectCostsAddition" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ContractualCommitments" name="ContractualCommitments" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_IncreasedExpensesAmountForProjectTask" name="IncreasedExpensesAmountForProjectTask" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_TotalCostAmountForProject" name="TotalCostAmountForProject" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" name="LeasePaymentUnderNonCancellableOperatingLeases" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProjectTaskTatementPostemploymentObligations" name="ProjectTaskTatementPostemploymentObligations" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_LesseeOperatingLeaseTerm" name="LesseeOperatingLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_RemainingOutstandingProject" name="RemainingOutstandingProject" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentExpenseAmountForProject" name="ResearchAndDevelopmentExpenseAmountForProject" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount" name="AdvancePaymentForResearchAndDevelopmentExpenseAmount" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" name="InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ResearchAndDevelopmentEstimatedExpenses" name="ResearchAndDevelopmentEstimatedExpenses" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_OutstandingRestrictedStockAwards" name="OutstandingRestrictedStockAwards" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonSharesIssuancesEquityGrant" name="CommonSharesIssuancesEquityGrant" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_UnrecongnizedCompensationCostRestrictedStockUnit" name="UnrecongnizedCompensationCostRestrictedStockUnit" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_FutureIssuanceOfShare" name="FutureIssuanceOfShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_StockOptionExercisePrice" name="StockOptionExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonSharesEquityGrantPricePerShares" name="CommonSharesEquityGrantPricePerShares" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommonStockAndAllCommonStockEquivalents" name="CommonStockAndAllCommonStockEquivalents" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_AtTheMarketOfferingsDisclosureDescription" name="AtTheMarketOfferingsDisclosureDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_AdditionalCommonShare" name="AdditionalCommonShare" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_SharesSoldUnderAtmSettlement" name="SharesSoldUnderAtmSettlement" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8" name="ProceedsFromSaleOfAvailableForSaleSecuritiesB8" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProceedFromSaleOfAvailableForSaleSecurities" name="ProceedFromSaleOfAvailableForSaleSecurities" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_ProceedsFromSharesSoldUnderTheAtm" name="ProceedsFromSharesSoldUnderTheAtm" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_StockIssuedDuringPeriodAmount" name="StockIssuedDuringPeriodAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_CommissionRateDescription" name="CommissionRateDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_EquityIncentivePlanDescription" name="EquityIncentivePlanDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" name="PrepaidExpensesCurrentAndLongTermAssetsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element name="RATENICNMember" id="ltbr_RATENICNMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CommonShareMember" id="ltbr_CommonShareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BattelleEnergyAllianceLLCMember" id="ltbr_BattelleEnergyAllianceLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseRatenIcnMember" id="ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwoThousandTwentyEquityIncentivePlanMember" id="ltbr_TwoThousandTwentyEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CommonShareIssuancesMember" id="ltbr_CommonShareIssuancesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockAwardActivityMember" id="ltbr_RestrictedStockAwardActivityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelOneMember" id="ltbr_TreasuryBillsLevelOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelTwoMember" id="ltbr_TreasuryBillsLevelTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreasuryBillsLevelThreeMember" id="ltbr_TreasuryBillsLevelThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="AvailableForSaleSecuritiesMember" id="ltbr_AvailableForSaleSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" id="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" id="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" id="ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" id="ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseINLMember" id="ltbr_ResearchAndDevelopmentExpenseINLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ResearchAndDevelopmentExpenseForFeedStudyMember" id="ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="INLProjectMember" id="ltbr_INLProjectMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RomaniaFeasibilityStudyMember" id="ltbr_RomaniaFeasibilityStudyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="CentrusEnergyFEEDStudyMember" id="ltbr_CentrusEnergyFEEDStudyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="StrategicPartnershipProjectAgreementMember" id="ltbr_StrategicPartnershipProjectAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ConsultantMember" id="ltbr_ConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ltbr-20240331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/10/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl_49de2a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl_49de2a" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl_a4b759" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl_a4b759" xml:lang="en-US">ASSETS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl_4ebb9a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl_4ebb9a" xml:lang="en-US">Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_f6db64" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_f6db64" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_c14882" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl_c14882" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_40dd53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl_40dd53" xml:lang="en-US">Total Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl_6" xml:lang="en-US">[Assets, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl_f183f9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl_f183f9" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl_b17251" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl_b17251" xml:lang="en-US">Prepaid project costs and other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_999028" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_999028" xml:lang="en-US">Trademarks</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_0b3626" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl_0b3626" xml:lang="en-US">Total Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl_10" xml:lang="en-US">[Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl_4db2ed" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl_4db2ed" xml:lang="en-US">Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_114b31" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_114b31" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_4fd81d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl_4fd81d" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl_13" xml:lang="en-US">[Liabilities, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_8fd74d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_8fd74d" xml:lang="en-US">Commitments and contingencies - Note 5</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl_5d6062" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl_5d6062" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl_23a0f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl_23a0f5" xml:lang="en-US">Preferred stock, $0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at March 31, 2024 and December 31, 2023</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl_6bf825" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl_6bf825" xml:lang="en-US">Common stock, $0.001 par value, 25,000,000 authorized, 14,189,780 shares and 13,698,274 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl_2bd9cf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl_2bd9cf" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_4c149c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_4c149c" xml:lang="en-US">Accumulated deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_814668" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl_814668" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl_20" xml:lang="en-US">[Stockholders' Equity Attributable to Parent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_8b924d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_8b924d" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_21" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_21" xml:lang="en-US">[Liabilities and Equity]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl_1ff72a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl_1ff72a" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl_2" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_3c5d0b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_3c5d0b" xml:lang="en-US">Preferred Stock, Shares Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl_f8036c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl_f8036c" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl_8d3650" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl_8d3650" xml:lang="en-US">Preferred Stock, Shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl_c43d8c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl_c43d8c" xml:lang="en-US">Preferred Stock, Shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl_ddae23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl_ddae23" xml:lang="en-US">Common Stock, Shares Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_ed5028" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_ed5028" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_590e8f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl_590e8f" xml:lang="en-US">Common Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_96e06b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_96e06b" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl_f1f9ef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl_f1f9ef" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_2a8969" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl_2a8969" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl_39d2fb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl_39d2fb" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_4c8be3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_4c8be3" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_128e24" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_128e24" xml:lang="en-US">Research and development</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_dbd502" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl_dbd502" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl_6" xml:lang="en-US">[Operating Expenses]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_OtherOperatingIncomeAbstract" xlink:label="ltbr_OtherOperatingIncomeAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OtherOperatingIncomeAbstract" xlink:to="ltbr_OtherOperatingIncomeAbstract_lbl_eb0450" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OtherOperatingIncomeAbstract_lbl_eb0450" xml:lang="en-US">Other Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ContributedServicesResearchAndDevelopment" xlink:label="ltbr_ContributedServicesResearchAndDevelopment" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ContributedServicesResearchAndDevelopment" xlink:to="ltbr_ContributedServicesResearchAndDevelopment_lbl_c64dd9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ContributedServicesResearchAndDevelopment_lbl_c64dd9" xml:lang="en-US">Contributed services - research and development</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl_099892" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherOperatingIncome_lbl_099892" xml:lang="en-US">Total Other Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_lbl_9" xml:lang="en-US">[Other Operating Income]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_a720fe" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl_a720fe" xml:lang="en-US">Operating Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl_10" xml:lang="en-US">[Operating Income (Loss)]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAbstract" xlink:label="us-gaap_OtherIncomeAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeAbstract_lbl_6992d8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAbstract_lbl_6992d8" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl_44563e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl_44563e" xml:lang="en-US">Interest income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl_db9bd9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherIncome_lbl_db9bd9" xml:lang="en-US">Total Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl_13" xml:lang="en-US">[Other Income]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_a45515" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_a45515" xml:lang="en-US">Net Loss Before Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_14" xml:lang="en-US">[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl_86af80" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl_86af80" xml:lang="en-US">Income taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_1d67cf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_1d67cf" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl_16" xml:lang="en-US">[Net Income (Loss) Attributable to Parent]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl_926698" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl_926698" xml:lang="en-US">Net Loss Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_EarningsPerSharesBasicAndDiluted" xlink:label="ltbr_EarningsPerSharesBasicAndDiluted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_EarningsPerSharesBasicAndDiluted" xlink:to="ltbr_EarningsPerSharesBasicAndDiluted_lbl_e7f3c0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_EarningsPerSharesBasicAndDiluted_lbl_e7f3c0" xml:lang="en-US">Basic and diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_5bf78d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_5bf78d" xml:lang="en-US">Weighted Average Number of Common Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl_704873" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl_704873" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl_ec9d8f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl_ec9d8f" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl_b5c091" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl_b5c091" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl_236973" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl_236973" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl_d5b66d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl_d5b66d" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl_cd21c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl_cd21c4" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonShareMember" xlink:label="ltbr_CommonShareMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonShareMember" xlink:to="ltbr_CommonShareMember_lbl_b9692e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonShareMember_lbl_b9692e" xml:lang="en-US">Common Stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_6ec204" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl_6ec204" xml:lang="en-US">Balance, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl_2" xml:lang="en-US">[Shares, Issued]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_0ec832" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl_0ec832" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" xlink:to="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares_lbl_f7cb5f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares_lbl_f7cb5f" xml:lang="en-US">Shares issued - registered offerings - net of offering costs, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" xlink:to="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount_lbl_0a0792" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount_lbl_0a0792" xml:lang="en-US">Shares issued - registered offerings - net of offering costs, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedToConsultantDirectorsForServicesShares" xlink:label="ltbr_SharesIssuedToConsultantDirectorsForServicesShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedToConsultantDirectorsForServicesShares" xlink:to="ltbr_SharesIssuedToConsultantDirectorsForServicesShares_lbl_a392a4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedToConsultantDirectorsForServicesShares_lbl_a392a4" xml:lang="en-US">Shares issued to consultant &amp; directors for services, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedToConsultantDirectorsForServicesAmount" xlink:label="ltbr_SharesIssuedToConsultantDirectorsForServicesAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesIssuedToConsultantDirectorsForServicesAmount" xlink:to="ltbr_SharesIssuedToConsultantDirectorsForServicesAmount_lbl_587b35" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesIssuedToConsultantDirectorsForServicesAmount_lbl_587b35" xml:lang="en-US">Shares issued to consultant &amp; directors for services, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl_ff05c0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl_ff05c0" xml:lang="en-US">Stock-based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_2faf3b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_2faf3b" xml:lang="en-US">Net loss for the three months ended March 31, 2023</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_33b7d1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl_33b7d1" xml:lang="en-US">Balance, shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_52c0c7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl_52c0c7" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl_8f2ee3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl_8f2ee3" xml:lang="en-US">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_07537e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_07537e" xml:lang="en-US">Operating Activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl_17532c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl_17532c" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl_3" xml:lang="en-US">[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_331296" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_331296" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl_4" xml:lang="en-US">[Share-Based Payment Arrangement, Noncash Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_cba1ef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_cba1ef" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_224526" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_224526" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl_6" xml:lang="en-US">[Increase (Decrease) in Prepaid Expenses, Other]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:to="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_1cb993" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_1cb993" xml:lang="en-US">Prepaid project costs and other long-term assets</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:to="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_lbl_7" xml:lang="en-US">[Prepaid project costs and other long-term assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_3c8d79" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_3c8d79" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_8" xml:lang="en-US">[Increase (Decrease) in Accounts Payable and Accrued Liabilities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_0c0ab7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_0c0ab7" xml:lang="en-US">Net Cash Used in Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_9" xml:lang="en-US">[Net Cash Provided by (Used in) Operating Activities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_985e58" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_985e58" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_ca316e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_ca316e" xml:lang="en-US">Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_ff4f60" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_ff4f60" xml:lang="en-US">Net proceeds from the issuances of common stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_238222" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_238222" xml:lang="en-US">Net Cash Provided by Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_13" xml:lang="en-US">[Net Cash Provided by (Used in) Financing Activities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_cf8e7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_cf8e7f" xml:lang="en-US">Net Decrease in Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_14" xml:lang="en-US">[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_bb4a24" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_bb4a24" xml:lang="en-US">Cash and Cash Equivalents, Beginning of Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_4f4659" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_4f4659" xml:lang="en-US">Cash and Cash Equivalents, End of Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl_6cb412" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl_6cb412" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CashPaidDuringThePeriodAbstract" xlink:label="ltbr_CashPaidDuringThePeriodAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CashPaidDuringThePeriodAbstract" xlink:to="ltbr_CashPaidDuringThePeriodAbstract_lbl_efefba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CashPaidDuringThePeriodAbstract_lbl_efefba" xml:lang="en-US">Cash paid during the period:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl_cbc8b5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl_cbc8b5" xml:lang="en-US">Interest paid</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl_06442f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl_06442f" xml:lang="en-US">Income taxes paid</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_34bab3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_34bab3" xml:lang="en-US">Non-Cash Financing Activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:label="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:to="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock_lbl_fe3c69" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PaymentOfAccruedLiabilitiesWithCommonStock_lbl_fe3c69" xml:lang="en-US">Payment of accrued liabilities with common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl_f1ca5f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl_f1ca5f" xml:lang="en-US">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_46a9bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_46a9bc" xml:lang="en-US">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl_2" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl_d482ae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl_d482ae" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl_16e4ae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl_16e4ae" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl_2" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:to="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract_lbl_43f824" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract_lbl_43f824" xml:lang="en-US">Prepaid Project Costs and Other Long-term Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:to="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_82448e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_82448e" xml:lang="en-US">Prepaid Project Costs and Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:to="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidProjectCostsDisclosureTextBlock_lbl_2" xml:lang="en-US">[Prepaid Project Costs and Other Long-term Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl_a60af9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl_a60af9" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_a62f02" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_a62f02" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl_2" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_e9a0d9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_e9a0d9" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl_45d2df" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl_45d2df" xml:lang="en-US">Research and Development Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_719f3f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_719f3f" xml:lang="en-US">Research and Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl_2" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl_668cd3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl_668cd3" xml:lang="en-US">Stockholders Equity and Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_799b3a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_799b3a" xml:lang="en-US">Stockholders' Equity and Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl_71a11d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl_71a11d" xml:lang="en-US">Subsequent Events</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_feb2f8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_feb2f8" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_2" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_78223f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_78223f" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl_d59d11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl_d59d11" xml:lang="en-US">Certain Risks and Uncertainties</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_f9eb90" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_f9eb90" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock_lbl_72fbce" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock_lbl_72fbce" xml:lang="en-US">Schedule of fair value of treasury bill</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl_422911" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl_422911" xml:lang="en-US">Summary of outstanding securities excluded from diluted weighted shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl_0bc2de" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl_0bc2de" xml:lang="en-US">Schedule of accounts payable and accrued liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" xlink:label="ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" xlink:to="ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock_lbl_49d89f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock_lbl_49d89f" xml:lang="en-US">Schedule Of commitments and contingencies R and D works</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:label="ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:to="ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_lbl_e56713" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock_lbl_e56713" xml:lang="en-US">Schedule of research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_0400d6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_0400d6" xml:lang="en-US">Schedule of share-based compensation, stock options, activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl_0fb300" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl_0fb300" xml:lang="en-US">Schedule of stock based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl_780d74" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl_780d74" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="ltbr_TreasuryBillsLevelOneMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelOneMember" xlink:to="ltbr_TreasuryBillsLevelOneMember_lbl_4b4f9c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelOneMember_lbl_4b4f9c" xml:lang="en-US">Level I</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="ltbr_TreasuryBillsLevelTwoMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelTwoMember" xlink:to="ltbr_TreasuryBillsLevelTwoMember_lbl_af4c2c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelTwoMember_lbl_af4c2c" xml:lang="en-US">Level II</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="ltbr_TreasuryBillsLevelThreeMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TreasuryBillsLevelThreeMember" xlink:to="ltbr_TreasuryBillsLevelThreeMember_lbl_67e5eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TreasuryBillsLevelThreeMember_lbl_67e5eb" xml:lang="en-US">Level III</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl_889e5a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl_889e5a" xml:lang="en-US">Treasury Bills</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_1ccd20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_1ccd20" xml:lang="en-US">Stock options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_7fbb76" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_lbl_7fbb76" xml:lang="en-US">Restricted stock awards outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_fc2eb3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_fc2eb3" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl_4" xml:lang="en-US">[Weighted Average Number of Shares Outstanding, Diluted, Adjustment]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_8715c1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_8715c1" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl_235d53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl_235d53" xml:lang="en-US">Balance Sheet Location Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl_453284" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl_453284" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="ltbr_BattelleEnergyAllianceLLCMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_BattelleEnergyAllianceLLCMember" xlink:to="ltbr_BattelleEnergyAllianceLLCMember_lbl_d24b79" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_BattelleEnergyAllianceLLCMember_lbl_d24b79" xml:lang="en-US">Battelle Energy Alliance, LLC (BEA) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl_d2c287" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_lbl_d2c287" xml:lang="en-US">Prepaid Expenses - Current and Long-term Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl_218922" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl_218922" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl_987a04" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl_987a04" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="us-gaap_PrepaidExpenseNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseNoncurrent" xlink:to="us-gaap_PrepaidExpenseNoncurrent_lbl_164d96" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseNoncurrent_lbl_164d96" xml:lang="en-US">Prepaid project costs</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidProjectCostsAddition" xlink:label="ltbr_PrepaidProjectCostsAddition" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_PrepaidProjectCostsAddition" xlink:to="ltbr_PrepaidProjectCostsAddition_lbl_a514e2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_PrepaidProjectCostsAddition_lbl_a514e2" xml:lang="en-US">Prepaid project costs- addition</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableTradeCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableTradeCurrentAndNoncurrent_lbl_b97b53" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrentAndNoncurrent_lbl_b97b53" xml:lang="en-US">Trade payables</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl_b159dc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl_b159dc" xml:lang="en-US">Accrued legal and consulting expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl_75bd2f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl_75bd2f" xml:lang="en-US">Accrued bonus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_177b18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_177b18" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl_5" xml:lang="en-US">[Accounts Payable and Accrued Liabilities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl_9a3ce9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl_9a3ce9" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_INLProjectMember" xlink:label="ltbr_INLProjectMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_INLProjectMember" xlink:to="ltbr_INLProjectMember_lbl_145443" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_INLProjectMember_lbl_145443" xml:lang="en-US">INL Project [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RomaniaFeasibilityStudyMember" xlink:label="ltbr_RomaniaFeasibilityStudyMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RomaniaFeasibilityStudyMember" xlink:to="ltbr_RomaniaFeasibilityStudyMember_lbl_c7157b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RomaniaFeasibilityStudyMember_lbl_c7157b" xml:lang="en-US">Romania Feasibility Study [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CentrusEnergyFEEDStudyMember" xlink:label="ltbr_CentrusEnergyFEEDStudyMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CentrusEnergyFEEDStudyMember" xlink:to="ltbr_CentrusEnergyFEEDStudyMember_lbl_418623" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CentrusEnergyFEEDStudyMember_lbl_418623" xml:lang="en-US">Centrus Energy FEED Study [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ContractualCommitments" xlink:label="ltbr_ContractualCommitments" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ContractualCommitments" xlink:to="ltbr_ContractualCommitments_lbl_9267a5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ContractualCommitments_lbl_9267a5" xml:lang="en-US">Total contractual commitments</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RATENICNMember" xlink:label="ltbr_RATENICNMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RATENICNMember" xlink:to="ltbr_RATENICNMember_lbl_ade83c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RATENICNMember_lbl_ade83c" xml:lang="en-US">RATEN ICN. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="ltbr_StrategicPartnershipProjectAgreementMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_StrategicPartnershipProjectAgreementMember" xlink:to="ltbr_StrategicPartnershipProjectAgreementMember_lbl_4e1985" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_StrategicPartnershipProjectAgreementMember_lbl_4e1985" xml:lang="en-US">Strategic Partnership Project Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl_d5535d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl_d5535d" xml:lang="en-US">Total Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_IncreasedExpensesAmountForProjectTask" xlink:label="ltbr_IncreasedExpensesAmountForProjectTask" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_IncreasedExpensesAmountForProjectTask" xlink:to="ltbr_IncreasedExpensesAmountForProjectTask_lbl_b96443" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_IncreasedExpensesAmountForProjectTask_lbl_b96443" xml:lang="en-US">Increased expenses amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TotalCostAmountForProject" xlink:label="ltbr_TotalCostAmountForProject" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TotalCostAmountForProject" xlink:to="ltbr_TotalCostAmountForProject_lbl_90e4f6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TotalCostAmountForProject_lbl_90e4f6" xml:lang="en-US">Total cost amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl_ea320b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForFees_lbl_ea320b" xml:lang="en-US">Total cash payments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl_70e824" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl_70e824" xml:lang="en-US">Operating Lease Monthly Payment</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:to="ltbr_LeasePaymentUnderNonCancellableOperatingLeases_lbl_ba6917" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_LeasePaymentUnderNonCancellableOperatingLeases_lbl_ba6917" xml:lang="en-US">Future minimum lease payments required under the non-cancellable operating leases</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProjectTaskTatementPostemploymentObligations" xlink:label="ltbr_ProjectTaskTatementPostemploymentObligations" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProjectTaskTatementPostemploymentObligations" xlink:to="ltbr_ProjectTaskTatementPostemploymentObligations_lbl_8f727e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProjectTaskTatementPostemploymentObligations_lbl_8f727e" xml:lang="en-US">Project Task Statements (Purchase Orders)</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="ltbr_LesseeOperatingLeaseTerm" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_LesseeOperatingLeaseTerm" xlink:to="ltbr_LesseeOperatingLeaseTerm_lbl_15372a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_LesseeOperatingLeaseTerm_lbl_15372a" xml:lang="en-US">Operating Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RemainingOutstandingProject" xlink:label="ltbr_RemainingOutstandingProject" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RemainingOutstandingProject" xlink:to="ltbr_RemainingOutstandingProject_lbl_d6d70c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RemainingOutstandingProject_lbl_d6d70c" xml:lang="en-US">Remaining outstanding project commitments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl_6863d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl_6863d0" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember_lbl_e1cb71" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember_lbl_e1cb71" xml:lang="en-US">Romania Feasibility Study [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember_lbl_22" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember_lbl_22" xml:lang="en-US">[Romania Feasibility Study [Member]]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember_lbl_535974" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember_lbl_535974" xml:lang="en-US">Centrus Energy FEED Study [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember_lbl_23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember_lbl_23" xml:lang="en-US">[Centrus Energy FEED Study [Member]]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember_lbl_d52b6c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember_lbl_d52b6c" xml:lang="en-US">Allocated employee compensation and stock-based compensation expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember_lbl_2cbaf8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember_lbl_2cbaf8" xml:lang="en-US">Other outside R&amp;D expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl_ec5d7b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl_ec5d7b" xml:lang="en-US">Research And Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseINLMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseINLMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseINLMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseINLMember_lbl_5693ae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseINLMember_lbl_5693ae" xml:lang="en-US">INL [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_2fb5df" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_2fb5df" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseRatenIcnMember_lbl_06c504" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseRatenIcnMember_lbl_06c504" xml:lang="en-US">RATEN ICN [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" xlink:label="ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" xlink:to="ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember_lbl_8dcd2f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember_lbl_8dcd2f" xml:lang="en-US">Feed Study [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_7331f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_7331f5" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseAmountForProject" xlink:label="ltbr_ResearchAndDevelopmentExpenseAmountForProject" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentExpenseAmountForProject" xlink:to="ltbr_ResearchAndDevelopmentExpenseAmountForProject_lbl_3e1c7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentExpenseAmountForProject_lbl_3e1c7f" xml:lang="en-US">Research and development expenses total amount</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount" xlink:label="ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount" xlink:to="ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount_lbl_b759e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount_lbl_b759e1" xml:lang="en-US">Research and development expenses advance payment</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" xlink:label="ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" xlink:to="ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount_lbl_b0d0c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount_lbl_b0d0c2" xml:lang="en-US">Research and development expenses interim milestone payment and final payment</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentEstimatedExpenses" xlink:label="ltbr_ResearchAndDevelopmentEstimatedExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ResearchAndDevelopmentEstimatedExpenses" xlink:to="ltbr_ResearchAndDevelopmentEstimatedExpenses_lbl_da5a07" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ResearchAndDevelopmentEstimatedExpenses_lbl_da5a07" xml:lang="en-US">Estimated expenses for research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInterestAndDividendIncome" xlink:label="us-gaap_OtherInterestAndDividendIncome" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInterestAndDividendIncome" xlink:to="us-gaap_OtherInterestAndDividendIncome_lbl_a50dd9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInterestAndDividendIncome_lbl_a50dd9" xml:lang="en-US">Dividend yield rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_8988c8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_8988c8" xml:lang="en-US">Expected volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_21cfc8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_21cfc8" xml:lang="en-US">Risk free interest rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl_a2e4ef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl_a2e4ef" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_2d3444" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_2d3444" xml:lang="en-US">Expected term</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl_c30928" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl_c30928" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl_2" xml:lang="en-US">[Other Research and Development Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_93a89a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl_93a89a" xml:lang="en-US">General and administrative expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsSharebasedCompensationStock" xlink:label="us-gaap_DividendsSharebasedCompensationStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsSharebasedCompensationStock" xlink:to="us-gaap_DividendsSharebasedCompensationStock_lbl_3c673c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsSharebasedCompensationStock_lbl_3c673c" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl_f688a3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl_f688a3" xml:lang="en-US">Information By Category Of Debt Security Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="ltbr_TwoThousandTwentyEquityIncentivePlanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="ltbr_TwoThousandTwentyEquityIncentivePlanMember_lbl_3c0db1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_TwoThousandTwentyEquityIncentivePlanMember_lbl_3c0db1" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonShareIssuancesMember" xlink:label="ltbr_CommonShareIssuancesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonShareIssuancesMember" xlink:to="ltbr_CommonShareIssuancesMember_lbl_df7859" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonShareIssuancesMember_lbl_df7859" xml:lang="en-US">Common Share Issuances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl_ad7fed" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl_ad7fed" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RestrictedStockAwardActivityMember" xlink:label="ltbr_RestrictedStockAwardActivityMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_RestrictedStockAwardActivityMember" xlink:to="ltbr_RestrictedStockAwardActivityMember_lbl_c792f6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_RestrictedStockAwardActivityMember_lbl_c792f6" xml:lang="en-US">Restricted Stock Award Activity Member</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="ltbr_AvailableForSaleSecuritiesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AvailableForSaleSecuritiesMember" xlink:to="ltbr_AvailableForSaleSecuritiesMember_lbl_9a63a5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AvailableForSaleSecuritiesMember_lbl_9a63a5" xml:lang="en-US">Available for sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ConsultantMember" xlink:label="ltbr_ConsultantMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ConsultantMember" xlink:to="ltbr_ConsultantMember_lbl_5e86d3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ConsultantMember_lbl_5e86d3" xml:lang="en-US">Consultant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_OutstandingRestrictedStockAwards" xlink:label="ltbr_OutstandingRestrictedStockAwards" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_OutstandingRestrictedStockAwards" xlink:to="ltbr_OutstandingRestrictedStockAwards_lbl_c6cca3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_OutstandingRestrictedStockAwards_lbl_c6cca3" xml:lang="en-US">Outstanding restricted stock awards</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="ltbr_CommonSharesIssuancesEquityGrant" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonSharesIssuancesEquityGrant" xlink:to="ltbr_CommonSharesIssuancesEquityGrant_lbl_f4524a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonSharesIssuancesEquityGrant_lbl_f4524a" xml:lang="en-US">Common shares issuances equity grant value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl_e19baa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl_e19baa" xml:lang="en-US">Stock options granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_e5d3d1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_e5d3d1" xml:lang="en-US">Common stock, shares, outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_UnrecongnizedCompensationCostRestrictedStockUnit" xlink:label="ltbr_UnrecongnizedCompensationCostRestrictedStockUnit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_UnrecongnizedCompensationCostRestrictedStockUnit" xlink:to="ltbr_UnrecongnizedCompensationCostRestrictedStockUnit_lbl_c6a722" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_UnrecongnizedCompensationCostRestrictedStockUnit_lbl_c6a722" xml:lang="en-US">Unrecognized compensation cost related to restricted stock units</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_7b3148" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl_7b3148" xml:lang="en-US">Shares of common stock issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_0f7613" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_0f7613" xml:lang="en-US">Stock options vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_11ffe3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_11ffe3" xml:lang="en-US">Total number of common stock available for future issuance</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_FutureIssuanceOfShare" xlink:label="ltbr_FutureIssuanceOfShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_FutureIssuanceOfShare" xlink:to="ltbr_FutureIssuanceOfShare_lbl_4a52d3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_FutureIssuanceOfShare_lbl_4a52d3" xml:lang="en-US">Common stock available for future issuance</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StockOptionExercisePrice" xlink:label="ltbr_StockOptionExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_StockOptionExercisePrice" xlink:to="ltbr_StockOptionExercisePrice_lbl_b76fd2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_StockOptionExercisePrice_lbl_b76fd2" xml:lang="en-US">Common stock issuance price</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_a64177" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_a64177" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_774824" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl_774824" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="ltbr_CommonSharesEquityGrantPricePerShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonSharesEquityGrantPricePerShares" xlink:to="ltbr_CommonSharesEquityGrantPricePerShares_lbl_19f25e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonSharesEquityGrantPricePerShares_lbl_19f25e" xml:lang="en-US">Common shares equity grant price per shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonStockAndAllCommonStockEquivalents" xlink:label="ltbr_CommonStockAndAllCommonStockEquivalents" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommonStockAndAllCommonStockEquivalents" xlink:to="ltbr_CommonStockAndAllCommonStockEquivalents_lbl_7fe261" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommonStockAndAllCommonStockEquivalents_lbl_7fe261" xml:lang="en-US">Total common stock and all common stock equivalents</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_ee87d8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_lbl_ee87d8" xml:lang="en-US">Stock options outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AtTheMarketOfferingsDisclosureDescription" xlink:label="ltbr_AtTheMarketOfferingsDisclosureDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AtTheMarketOfferingsDisclosureDescription" xlink:to="ltbr_AtTheMarketOfferingsDisclosureDescription_lbl_8ed7ba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AtTheMarketOfferingsDisclosureDescription_lbl_8ed7ba" xml:lang="en-US">Description related to ATM offerings</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:to="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_lbl_0542ee" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_lbl_0542ee" xml:lang="en-US">Weighted-average period</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AdditionalCommonShare" xlink:label="ltbr_AdditionalCommonShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_AdditionalCommonShare" xlink:to="ltbr_AdditionalCommonShare_lbl_44eeec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_AdditionalCommonShare_lbl_44eeec" xml:lang="en-US">Additional common shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesSoldUnderAtmSettlement" xlink:label="ltbr_SharesSoldUnderAtmSettlement" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_SharesSoldUnderAtmSettlement" xlink:to="ltbr_SharesSoldUnderAtmSettlement_lbl_5dcbeb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_SharesSoldUnderAtmSettlement_lbl_5dcbeb" xml:lang="en-US">Shares sold under the ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8" xlink:label="ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8" xlink:to="ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8_lbl_1f2943" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8_lbl_1f2943" xml:lang="en-US">Shares sale offering price</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedFromSaleOfAvailableForSaleSecurities" xlink:label="ltbr_ProceedFromSaleOfAvailableForSaleSecurities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProceedFromSaleOfAvailableForSaleSecurities" xlink:to="ltbr_ProceedFromSaleOfAvailableForSaleSecurities_lbl_cf8667" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProceedFromSaleOfAvailableForSaleSecurities_lbl_cf8667" xml:lang="en-US">Maximum sale of securities registered</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedsFromSharesSoldUnderTheAtm" xlink:label="ltbr_ProceedsFromSharesSoldUnderTheAtm" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_ProceedsFromSharesSoldUnderTheAtm" xlink:to="ltbr_ProceedsFromSharesSoldUnderTheAtm_lbl_344033" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_ProceedsFromSharesSoldUnderTheAtm_lbl_344033" xml:lang="en-US">Proceeds from shares sold under the ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StockIssuedDuringPeriodAmount" xlink:label="ltbr_StockIssuedDuringPeriodAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_StockIssuedDuringPeriodAmount" xlink:to="ltbr_StockIssuedDuringPeriodAmount_lbl_10d7f0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_StockIssuedDuringPeriodAmount_lbl_10d7f0" xml:lang="en-US">Stock issuence cost</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl_62c321" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl_62c321" xml:lang="en-US">Subsequent Event Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl_3e3082" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl_3e3082" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl_521260" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl_521260" xml:lang="en-US">Net proceeds from sale of common shares</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommissionRateDescription" xlink:label="ltbr_CommissionRateDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_CommissionRateDescription" xlink:to="ltbr_CommissionRateDescription_lbl_a19b39" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_CommissionRateDescription_lbl_a19b39" xml:lang="en-US">Description related to commission rate</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_443cff" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_443cff" xml:lang="en-US">Number of common stock shares, sold</link:label>
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_EquityIncentivePlanDescription" xlink:label="ltbr_EquityIncentivePlanDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ltbr_EquityIncentivePlanDescription" xlink:to="ltbr_EquityIncentivePlanDescription_lbl_4029e0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ltbr_EquityIncentivePlanDescription_lbl_4029e0" xml:lang="en-US">Description related to equity incentive plan</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>ltbr-20240331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/10/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20240331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20240331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" xlink:href="ltbr-20240331.xsd#PrepaidProjectCostsAndOtherLongTermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20240331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20240331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesTables" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20240331.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20240331.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetails" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20240331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ContributedServicesResearchAndDevelopment" xlink:label="loc_ltbrContributedServicesResearchAndDevelopment" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherOperatingIncome" xlink:to="loc_ltbrContributedServicesResearchAndDevelopment" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherIncome" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:title="000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="000007 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="000008 - Disclosure - Net Loss Per Share" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" xlink:title="000009 - Disclosure - Prepaid Project Costs and Other Long-term Assets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="000010 - Disclosure - Accounts Payable and Accrued Liabilities" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="000011 - Disclosure - Commitments and Contingencies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="000012 - Disclosure - Research and Development Costs" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" xlink:title="000013 - Disclosure - Stockholders Equity and Stock-Based Compensation" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="000014 - Disclosure - Subsequent Events" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="000015 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="000016 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="000017 - Disclosure - Net Loss Per Share (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="000018 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesTables" xlink:title="000019 - Disclosure - Commitments and Contingencies (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" xlink:title="000020 - Disclosure - Research and Development Costs (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="000021 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="000022 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="000023 - Disclosure - Net Loss Per Share (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="000024 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="000025 - Disclosure - Accounts Payable and Accrued Liabilities (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetails" xlink:title="000026 - Disclosure - Commitments and Contingencies (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000027 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" xlink:title="000028 - Disclosure - Research and Development Costs (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:title="000029 - Disclosure - Research and Development Costs (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="000030 - Disclosure - Stockholders Equity and StockBased Compensation (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="000031 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="000032 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="000033 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>ltbr-20240331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/10/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20240331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20240331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" xlink:href="ltbr-20240331.xsd#PrepaidProjectCostsAndOtherLongTermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20240331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20240331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesTables" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20240331.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20240331.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetails" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20240331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract_295f05" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_f99455" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract_295f05" xlink:to="loc_us-gaapAssetsAbstract_f99455" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_dcbb8d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract_f99455" xlink:to="loc_us-gaapAssetsCurrentAbstract_dcbb8d" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc954f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_dcbb8d" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc954f" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_17aa5b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_dcbb8d" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_17aa5b" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_dea8ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_dcbb8d" xlink:to="loc_us-gaapAssetsCurrent_dea8ab" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract_2e1c73" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_dcbb8d" xlink:to="loc_us-gaapOtherAssetsAbstract_2e1c73" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets_042268" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract_2e1c73" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets_042268" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_c065b9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract_2e1c73" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_c065b9" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_b88890" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract_2e1c73" xlink:to="loc_us-gaapAssets_b88890" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_d3faa7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract_2e1c73" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_d3faa7" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_a1ca8a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_d3faa7" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_a1ca8a" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_f303e6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_d3faa7" xlink:to="loc_us-gaapLiabilitiesCurrent_f303e6" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_d90043" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_d3faa7" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_d90043" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_36bd81" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_d90043" xlink:to="loc_us-gaapStockholdersEquityAbstract_36bd81" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_ad500c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_36bd81" xlink:to="loc_us-gaapPreferredStockValue_ad500c" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_22769a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_36bd81" xlink:to="loc_us-gaapCommonStockValue_22769a" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_2724a1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_36bd81" xlink:to="loc_us-gaapAdditionalPaidInCapital_2724a1" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_5b2a1c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_36bd81" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_5b2a1c" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_af4459" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_36bd81" xlink:to="loc_us-gaapStockholdersEquity_af4459" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_f1fa05" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_36bd81" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_f1fa05" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract_acba24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract_acba24" xlink:to="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_4a73c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_4a73c4" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_243a55" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_243a55" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_902adc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapPreferredStockSharesIssued_902adc" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_820501" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_820501" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_23477b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_23477b" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_a6c50b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapCommonStockSharesAuthorized_a6c50b" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_ccfa35" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapCommonStockSharesIssued_ccfa35" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_a9820d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract_a08e59" xlink:to="loc_us-gaapCommonStockSharesOutstanding_a9820d" order="9" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_d61693" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_c53f49" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d61693" xlink:to="loc_us-gaapRevenues_c53f49" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_d704f5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_d61693" xlink:to="loc_us-gaapOperatingExpensesAbstract_d704f5" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_f62ed3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_d704f5" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_f62ed3" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_0d86c6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_d704f5" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_0d86c6" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_5c2a61" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_d704f5" xlink:to="loc_us-gaapOperatingExpenses_5c2a61" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_OtherOperatingIncomeAbstract" xlink:label="loc_ltbrOtherOperatingIncomeAbstract_b7365d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_d704f5" xlink:to="loc_ltbrOtherOperatingIncomeAbstract_b7365d" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ContributedServicesResearchAndDevelopment" xlink:label="loc_ltbrContributedServicesResearchAndDevelopment_54ed45" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrOtherOperatingIncomeAbstract_b7365d" xlink:to="loc_ltbrContributedServicesResearchAndDevelopment_54ed45" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome_c35c32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrOtherOperatingIncomeAbstract_b7365d" xlink:to="loc_us-gaapOtherOperatingIncome_c35c32" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_61a5d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrOtherOperatingIncomeAbstract_b7365d" xlink:to="loc_us-gaapOperatingIncomeLoss_61a5d1" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract_f53655" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrOtherOperatingIncomeAbstract_b7365d" xlink:to="loc_us-gaapOtherIncomeAbstract_f53655" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther_d8b484" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract_f53655" xlink:to="loc_us-gaapInterestIncomeOther_d8b484" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome_2bf9db" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract_f53655" xlink:to="loc_us-gaapOtherIncome_2bf9db" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_894e2d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract_f53655" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_894e2d" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_f5eb62" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract_f53655" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_f5eb62" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_d126a3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract_f53655" xlink:to="loc_us-gaapNetIncomeLoss_d126a3" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_b38fa0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract_f53655" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_b38fa0" order="16" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_EarningsPerSharesBasicAndDiluted" xlink:label="loc_ltbrEarningsPerSharesBasicAndDiluted_35fb09" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_b38fa0" xlink:to="loc_ltbrEarningsPerSharesBasicAndDiluted_35fb09" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_d1d6b0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_b38fa0" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_d1d6b0" order="18" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:title="000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_1931af" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_66acac" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract_1931af" xlink:to="loc_us-gaapStatementTable_66acac" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_39096c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_66acac" xlink:to="loc_us-gaapStatementLineItems_39096c" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_68de4b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_66acac" xlink:to="loc_us-gaapStatementEquityComponentsAxis_68de4b" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_5afa15" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_68de4b" xlink:to="loc_us-gaapEquityComponentDomain_5afa15" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_077a02" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_5afa15" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_077a02" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_bc17c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_5afa15" xlink:to="loc_us-gaapRetainedEarningsMember_bc17c1" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonShareMember" xlink:label="loc_ltbrCommonShareMember_4d979d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_5afa15" xlink:to="loc_ltbrCommonShareMember_4d979d" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_8da5e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_us-gaapSharesIssued_8da5e5" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_7955ea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_us-gaapStockholdersEquity_7955ea" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsShares_f1e6d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsShares_f1e6d7" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount_8d7762" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount_8d7762" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedToConsultantDirectorsForServicesShares" xlink:label="loc_ltbrSharesIssuedToConsultantDirectorsForServicesShares_35c0ca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_ltbrSharesIssuedToConsultantDirectorsForServicesShares_35c0ca" order="5" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedToConsultantDirectorsForServicesAmount" xlink:label="loc_ltbrSharesIssuedToConsultantDirectorsForServicesAmount_397352" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_ltbrSharesIssuedToConsultantDirectorsForServicesAmount_397352" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_5b6f9c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_5b6f9c" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_5192f0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_us-gaapNetIncomeLoss_5192f0" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_1e4261" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_us-gaapSharesIssued_1e4261" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_640271" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_39096c" xlink:to="loc_us-gaapStockholdersEquity_640271" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_e65843" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_a12534" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_e65843" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_a12534" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_74f5ce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_a12534" xlink:to="loc_us-gaapProfitLoss_74f5ce" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_3c3275" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_a12534" xlink:to="loc_us-gaapShareBasedCompensation_3c3275" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_a12534" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_6f392c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_6f392c" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets" xlink:label="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_b2a01a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" xlink:to="loc_ltbrIncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets_b2a01a" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c3237a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c3237a" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_4864cf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_4864cf" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_016b88" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_016b88" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_265822" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_c47689" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_c47689" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_4bf97f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_4bf97f" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_52d7bf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_52d7bf" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c66527" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c66527" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_593f2a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_593f2a" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_52234c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2ad511" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_52234c" order="16" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CashPaidDuringThePeriodAbstract" xlink:label="loc_ltbrCashPaidDuringThePeriodAbstract_ae31a5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_52234c" xlink:to="loc_ltbrCashPaidDuringThePeriodAbstract_ae31a5" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet_872213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCashPaidDuringThePeriodAbstract_ae31a5" xlink:to="loc_us-gaapInterestPaidNet_872213" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet_bb7ddf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCashPaidDuringThePeriodAbstract_ae31a5" xlink:to="loc_us-gaapIncomeTaxesPaidNet_bb7ddf" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_df95af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrCashPaidDuringThePeriodAbstract_ae31a5" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_df95af" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PaymentOfAccruedLiabilitiesWithCommonStock" xlink:label="loc_ltbrPaymentOfAccruedLiabilitiesWithCommonStock_ed3e4b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_df95af" xlink:to="loc_ltbrPaymentOfAccruedLiabilitiesWithCommonStock_ed3e4b" order="21" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="000007 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_dd9388" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_95e2e7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_dd9388" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_95e2e7" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="000008 - Disclosure - Net Loss Per Share">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_36e599" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock_7cc48e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_36e599" xlink:to="loc_us-gaapEarningsPerShareTextBlock_7cc48e" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" xlink:title="000009 - Disclosure - Prepaid Project Costs and Other Long-term Assets">
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_5ef6ef" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidProjectCostsDisclosureTextBlock" xlink:label="loc_ltbrPrepaidProjectCostsDisclosureTextBlock_2933f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_5ef6ef" xlink:to="loc_ltbrPrepaidProjectCostsDisclosureTextBlock_2933f9" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="000010 - Disclosure - Accounts Payable and Accrued Liabilities">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_ba85dc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_0cd0f2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_ba85dc" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_0cd0f2" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="000011 - Disclosure - Commitments and Contingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_03b5b8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_235df7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_03b5b8" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_235df7" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="000012 - Disclosure - Research and Development Costs">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_7af504" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_7fb291" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_7af504" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_7fb291" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" xlink:title="000013 - Disclosure - Stockholders Equity and Stock-Based Compensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_a2c9df" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_b6036c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_a2c9df" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_b6036c" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="000014 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_52ab4d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_915b91" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_52ab4d" xlink:to="loc_us-gaapSubsequentEventsTextBlock_915b91" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="000015 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_60ffba" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_663665" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_60ffba" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_663665" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk_e0af95" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_60ffba" xlink:to="loc_us-gaapConcentrationRiskCreditRisk_e0af95" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_c68fcc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_60ffba" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_c68fcc" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="000016 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_df8f35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="loc_us-gaapScheduleOfTreasuryStockByClassTextBlock_c7d1b5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_df8f35" xlink:to="loc_us-gaapScheduleOfTreasuryStockByClassTextBlock_c7d1b5" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="000017 - Disclosure - Net Loss Per Share (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_0b3cbb" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0bfdde" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_0b3cbb" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0bfdde" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="000018 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_e4f335" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_a6ab29" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_e4f335" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_a6ab29" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesTables" xlink:title="000019 - Disclosure - Commitments and Contingencies (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_beb185" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock" xlink:label="loc_ltbrScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock_77ae13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_beb185" xlink:to="loc_ltbrScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock_77ae13" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" xlink:title="000020 - Disclosure - Research and Development Costs (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_dfb36c" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock" xlink:label="loc_ltbrScheduleOfResearchAndDevelopmentExpensesTableTextBlock_0f9eb7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_dfb36c" xlink:to="loc_ltbrScheduleOfResearchAndDevelopmentExpensesTableTextBlock_0f9eb7" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="000021 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_61062a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2d7897" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_61062a" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2d7897" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_f5f9c9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_61062a" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_f5f9c9" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="000022 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_1805e8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_d6ac92" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_1805e8" xlink:to="loc_us-gaapStatementTable_d6ac92" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_c14e48" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_d6ac92" xlink:to="loc_us-gaapStatementLineItems_c14e48" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_3678b2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_d6ac92" xlink:to="loc_us-gaapStatementClassOfStockAxis_3678b2" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_885919" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_3678b2" xlink:to="loc_us-gaapClassOfStockDomain_885919" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="loc_ltbrTreasuryBillsLevelOneMember_ba0d7d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_885919" xlink:to="loc_ltbrTreasuryBillsLevelOneMember_ba0d7d" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="loc_ltbrTreasuryBillsLevelTwoMember_568fdc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_885919" xlink:to="loc_ltbrTreasuryBillsLevelTwoMember_568fdc" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="loc_ltbrTreasuryBillsLevelThreeMember_2c970a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_885919" xlink:to="loc_ltbrTreasuryBillsLevelThreeMember_2c970a" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_71600b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c14e48" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_71600b" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="000023 - Disclosure - Net Loss Per Share (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_5ac5f3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_e8546e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_5ac5f3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_e8546e" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:label="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c4614d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_5ac5f3" xlink:to="loc_us-gaapRestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_c4614d" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_ddfd24" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract_5ac5f3" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_ddfd24" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="000024 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract" xlink:label="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_1ee177" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_5703ed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ltbrPrepaidExpensesCurrentAndLongTermAssetsAbstract_1ee177" xlink:to="loc_us-gaapStatementTable_5703ed" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_fa4516" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5703ed" xlink:to="loc_us-gaapStatementLineItems_fa4516" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ace8bd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5703ed" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ace8bd" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_ae6ca4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ace8bd" xlink:to="loc_us-gaapRelatedPartyDomain_ae6ca4" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis_e4e075" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5703ed" xlink:to="loc_us-gaapBalanceSheetLocationAxis_e4e075" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_7773bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis_e4e075" xlink:to="loc_us-gaapBalanceSheetLocationDomain_7773bc" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis_46db2c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5703ed" xlink:to="loc_srtRangeAxis_46db2c" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_9a4afe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis_46db2c" xlink:to="loc_srtRangeMember_9a4afe" order="60" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember_c1bceb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_ae6ca4" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember_c1bceb" order="61" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_c441f3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain_7773bc" xlink:to="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember_c441f3" order="62" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_4305a7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember_9a4afe" xlink:to="loc_srtMinimumMember_4305a7" order="63" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_f0146f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember_9a4afe" xlink:to="loc_srtMaximumMember_f0146f" order="64" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseNoncurrent_2e2e58" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_fa4516" xlink:to="loc_us-gaapPrepaidExpenseNoncurrent_2e2e58" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidProjectCostsAddition" xlink:label="loc_ltbrPrepaidProjectCostsAddition_362f51" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_fa4516" xlink:to="loc_ltbrPrepaidProjectCostsAddition_362f51" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="000025 - Disclosure - Accounts Payable and Accrued Liabilities (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_1ee231" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrentAndNoncurrent_dcc369" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_1ee231" xlink:to="loc_us-gaapAccountsPayableTradeCurrentAndNoncurrent_dcc369" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities_686593" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_1ee231" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities_686593" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_6b182e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_1ee231" xlink:to="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_6b182e" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_374340" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_1ee231" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_374340" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetails" xlink:title="000026 - Disclosure - Commitments and Contingencies (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_51bcde" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_85b9e7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_51bcde" xlink:to="loc_us-gaapStatementTable_85b9e7" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_cd0fb8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_85b9e7" xlink:to="loc_us-gaapStatementLineItems_cd0fb8" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_20d1cc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_85b9e7" xlink:to="loc_us-gaapPlanNameAxis_20d1cc" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_80678c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_20d1cc" xlink:to="loc_us-gaapPlanNameDomain_80678c" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_INLProjectMember" xlink:label="loc_ltbrINLProjectMember_20d114" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_80678c" xlink:to="loc_ltbrINLProjectMember_20d114" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RomaniaFeasibilityStudyMember" xlink:label="loc_ltbrRomaniaFeasibilityStudyMember_fcd0b6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_80678c" xlink:to="loc_ltbrRomaniaFeasibilityStudyMember_fcd0b6" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CentrusEnergyFEEDStudyMember" xlink:label="loc_ltbrCentrusEnergyFEEDStudyMember_06e497" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_80678c" xlink:to="loc_ltbrCentrusEnergyFEEDStudyMember_06e497" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ContractualCommitments" xlink:label="loc_ltbrContractualCommitments_20b651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_cd0fb8" xlink:to="loc_ltbrContractualCommitments_20b651" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000027 - Disclosure - Commitments and Contingencies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_dde381" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_fcceb8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_dde381" xlink:to="loc_us-gaapStatementTable_fcceb8" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_33247c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fcceb8" xlink:to="loc_us-gaapStatementLineItems_33247c" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_3761a1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fcceb8" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_3761a1" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_4b08f4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_3761a1" xlink:to="loc_us-gaapRelatedPartyDomain_4b08f4" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_69db94" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fcceb8" xlink:to="loc_us-gaapPlanNameAxis_69db94" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_b7f96c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_69db94" xlink:to="loc_us-gaapPlanNameDomain_b7f96c" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RATENICNMember" xlink:label="loc_ltbrRATENICNMember_7426f1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_4b08f4" xlink:to="loc_ltbrRATENICNMember_7426f1" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="loc_ltbrStrategicPartnershipProjectAgreementMember_53cf8a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_b7f96c" xlink:to="loc_ltbrStrategicPartnershipProjectAgreementMember_53cf8a" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_0e3216" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_us-gaapOperatingLeaseExpense_0e3216" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_IncreasedExpensesAmountForProjectTask" xlink:label="loc_ltbrIncreasedExpensesAmountForProjectTask_2e6f5d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_ltbrIncreasedExpensesAmountForProjectTask_2e6f5d" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TotalCostAmountForProject" xlink:label="loc_ltbrTotalCostAmountForProject_0c7ca1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_ltbrTotalCostAmountForProject_0c7ca1" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForFees" xlink:label="loc_us-gaapPaymentsForFees_10298e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_us-gaapPaymentsForFees_10298e" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_3b9807" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_us-gaapOperatingLeasePayments_3b9807" order="5" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases_a5aa40" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases_a5aa40" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProjectTaskTatementPostemploymentObligations" xlink:label="loc_ltbrProjectTaskTatementPostemploymentObligations_c22066" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_ltbrProjectTaskTatementPostemploymentObligations_c22066" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="loc_ltbrLesseeOperatingLeaseTerm_f879c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_ltbrLesseeOperatingLeaseTerm_f879c7" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RemainingOutstandingProject" xlink:label="loc_ltbrRemainingOutstandingProject_8c02bf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_33247c" xlink:to="loc_ltbrRemainingOutstandingProject_8c02bf" order="9" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" xlink:title="000028 - Disclosure - Research and Development Costs (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_bdac8d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_bf9687" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_bdac8d" xlink:to="loc_us-gaapStatementTable_bf9687" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_97b409" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_bf9687" xlink:to="loc_us-gaapStatementLineItems_97b409" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis_bbea8d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_bf9687" xlink:to="loc_us-gaapIncomeStatementLocationAxis_bbea8d" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_199644" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis_bbea8d" xlink:to="loc_us-gaapIncomeStatementLocationDomain_199644" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember_e7e6ad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_199644" xlink:to="loc_ltbrResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember_e7e6ad" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember_b38899" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_199644" xlink:to="loc_ltbrResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember_b38899" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember_14c345" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_199644" xlink:to="loc_ltbrResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember_14c345" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember_d693b2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_199644" xlink:to="loc_ltbrResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember_d693b2" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_291351" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_199644" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_291351" order="25" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseINLMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseINLMember_a19330" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_199644" xlink:to="loc_ltbrResearchAndDevelopmentExpenseINLMember_a19330" order="26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_90ea62" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_97b409" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_90ea62" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:title="000029 - Disclosure - Research and Development Costs (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaapResearchAndDevelopmentAbstract_724751" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_022e5d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapResearchAndDevelopmentAbstract_724751" xlink:to="loc_us-gaapStatementTable_022e5d" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_c8eaa4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_022e5d" xlink:to="loc_us-gaapStatementLineItems_c8eaa4" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis_27ca32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_022e5d" xlink:to="loc_us-gaapIncomeStatementLocationAxis_27ca32" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_52692e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis_27ca32" xlink:to="loc_us-gaapIncomeStatementLocationDomain_52692e" order="10" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseINLMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseINLMember_c95958" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_52692e" xlink:to="loc_ltbrResearchAndDevelopmentExpenseINLMember_c95958" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseRatenIcnMember_cd29e8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_52692e" xlink:to="loc_ltbrResearchAndDevelopmentExpenseRatenIcnMember_cd29e8" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseForFeedStudyMember_8653ed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain_52692e" xlink:to="loc_ltbrResearchAndDevelopmentExpenseForFeedStudyMember_8653ed" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_9d0814" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c8eaa4" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_9d0814" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseAmountForProject" xlink:label="loc_ltbrResearchAndDevelopmentExpenseAmountForProject_8c559d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c8eaa4" xlink:to="loc_ltbrResearchAndDevelopmentExpenseAmountForProject_8c559d" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount" xlink:label="loc_ltbrAdvancePaymentForResearchAndDevelopmentExpenseAmount_bce298" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c8eaa4" xlink:to="loc_ltbrAdvancePaymentForResearchAndDevelopmentExpenseAmount_bce298" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" xlink:label="loc_ltbrInterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount_6a367e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c8eaa4" xlink:to="loc_ltbrInterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount_6a367e" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentEstimatedExpenses" xlink:label="loc_ltbrResearchAndDevelopmentEstimatedExpenses_7728fd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_c8eaa4" xlink:to="loc_ltbrResearchAndDevelopmentEstimatedExpenses_7728fd" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="000030 - Disclosure - Stockholders Equity and StockBased Compensation (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_81c1a2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInterestAndDividendIncome" xlink:label="loc_us-gaapOtherInterestAndDividendIncome_5d47e0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_81c1a2" xlink:to="loc_us-gaapOtherInterestAndDividendIncome_5d47e0" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9f2a4e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_81c1a2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9f2a4e" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ec4957" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_81c1a2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ec4957" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_256f46" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_81c1a2" xlink:to="loc_us-gaapSharePrice_256f46" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92ee40" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_81c1a2" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92ee40" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="000031 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_4b92f7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense_b48275" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_4b92f7" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense_b48275" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherGeneralAndAdministrativeExpense_d4abfc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_4b92f7" xlink:to="loc_us-gaapOtherGeneralAndAdministrativeExpense_d4abfc" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsSharebasedCompensationStock" xlink:label="loc_us-gaapDividendsSharebasedCompensationStock_f8c424" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_4b92f7" xlink:to="loc_us-gaapDividendsSharebasedCompensationStock_f8c424" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="000032 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_47f8df" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_a48f95" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_47f8df" xlink:to="loc_us-gaapStatementTable_a48f95" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_46817c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a48f95" xlink:to="loc_us-gaapStatementLineItems_46817c" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_d53186" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a48f95" xlink:to="loc_us-gaapPlanNameAxis_d53186" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_0af8d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_d53186" xlink:to="loc_us-gaapPlanNameDomain_0af8d4" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_c5e54e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a48f95" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_c5e54e" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_34fca7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_c5e54e" xlink:to="loc_us-gaapRelatedPartyDomain_34fca7" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_e95e2b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_a48f95" xlink:to="loc_us-gaapFinancialInstrumentAxis_e95e2b" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b7c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_e95e2b" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b7c7" order="40" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember_1d91cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_0af8d4" xlink:to="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember_1d91cb" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonShareIssuancesMember" xlink:label="loc_ltbrCommonShareIssuancesMember_1f2f76" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_0af8d4" xlink:to="loc_ltbrCommonShareIssuancesMember_1f2f76" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_048e53" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_34fca7" xlink:to="loc_srtBoardOfDirectorsChairmanMember_048e53" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RestrictedStockAwardActivityMember" xlink:label="loc_ltbrRestrictedStockAwardActivityMember_8df774" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_0af8d4" xlink:to="loc_ltbrRestrictedStockAwardActivityMember_8df774" order="44" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="loc_ltbrAvailableForSaleSecuritiesMember_86f083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07b7c7" xlink:to="loc_ltbrAvailableForSaleSecuritiesMember_86f083" order="45" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ConsultantMember" xlink:label="loc_ltbrConsultantMember_af1954" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_34fca7" xlink:to="loc_ltbrConsultantMember_af1954" order="46" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_OutstandingRestrictedStockAwards" xlink:label="loc_ltbrOutstandingRestrictedStockAwards_98f902" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrOutstandingRestrictedStockAwards_98f902" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="loc_ltbrCommonSharesIssuancesEquityGrant_bfce02" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrCommonSharesIssuancesEquityGrant_bfce02" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40e25f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40e25f" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2038ef" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2038ef" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_UnrecongnizedCompensationCostRestrictedStockUnit" xlink:label="loc_ltbrUnrecongnizedCompensationCostRestrictedStockUnit_b910c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrUnrecongnizedCompensationCostRestrictedStockUnit_b910c7" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_e0d3ef" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapCommonStockSharesIssued_e0d3ef" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a9e36e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a9e36e" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_d4f183" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_d4f183" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_FutureIssuanceOfShare" xlink:label="loc_ltbrFutureIssuanceOfShare_a7bc18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrFutureIssuanceOfShare_a7bc18" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StockOptionExercisePrice" xlink:label="loc_ltbrStockOptionExercisePrice_3284c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrStockOptionExercisePrice_3284c4" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_0c3cc4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapShareBasedCompensation_0c3cc4" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_f43216" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_f43216" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="loc_ltbrCommonSharesEquityGrantPricePerShares_04777f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrCommonSharesEquityGrantPricePerShares_04777f" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonStockAndAllCommonStockEquivalents" xlink:label="loc_ltbrCommonStockAndAllCommonStockEquivalents_bda8e0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrCommonStockAndAllCommonStockEquivalents_bda8e0" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_ae9fec" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease_ae9fec" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AtTheMarketOfferingsDisclosureDescription" xlink:label="loc_ltbrAtTheMarketOfferingsDisclosureDescription_7c5f6e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrAtTheMarketOfferingsDisclosureDescription_7c5f6e" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:label="loc_us-gaapNetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_095664" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_us-gaapNetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1_095664" order="17" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AdditionalCommonShare" xlink:label="loc_ltbrAdditionalCommonShare_49a6eb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrAdditionalCommonShare_49a6eb" order="18" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesSoldUnderAtmSettlement" xlink:label="loc_ltbrSharesSoldUnderAtmSettlement_f9d525" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrSharesSoldUnderAtmSettlement_f9d525" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8" xlink:label="loc_ltbrProceedsFromSaleOfAvailableForSaleSecuritiesB8_511aee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrProceedsFromSaleOfAvailableForSaleSecuritiesB8_511aee" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedFromSaleOfAvailableForSaleSecurities" xlink:label="loc_ltbrProceedFromSaleOfAvailableForSaleSecurities_bada9d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrProceedFromSaleOfAvailableForSaleSecurities_bada9d" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedsFromSharesSoldUnderTheAtm" xlink:label="loc_ltbrProceedsFromSharesSoldUnderTheAtm_21b371" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrProceedsFromSharesSoldUnderTheAtm_21b371" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StockIssuedDuringPeriodAmount" xlink:label="loc_ltbrStockIssuedDuringPeriodAmount_e6d2ae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_46817c" xlink:to="loc_ltbrStockIssuedDuringPeriodAmount_e6d2ae" order="23" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="000033 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_12dbdd" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_1f31bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_12dbdd" xlink:to="loc_us-gaapStatementTable_1f31bc" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_4c6026" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_1f31bc" xlink:to="loc_us-gaapStatementLineItems_4c6026" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis_5031ca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_1f31bc" xlink:to="loc_us-gaapSubsequentEventTypeAxis_5031ca" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_dfe277" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis_5031ca" xlink:to="loc_us-gaapSubsequentEventTypeDomain_dfe277" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_7458cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain_dfe277" xlink:to="loc_us-gaapSubsequentEventMember_7458cb" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_197a35" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4c6026" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_197a35" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommissionRateDescription" xlink:label="loc_ltbrCommissionRateDescription_fd7ca0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4c6026" xlink:to="loc_ltbrCommissionRateDescription_fd7ca0" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_0f0038" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4c6026" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_0f0038" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_EquityIncentivePlanDescription" xlink:label="loc_ltbrEquityIncentivePlanDescription_210d4f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4c6026" xlink:to="loc_ltbrEquityIncentivePlanDescription_210d4f" order="4" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>ltbr-20240331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/10/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ltbr.com/role/Cover" xlink:href="ltbr-20240331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="ltbr-20240331.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShare" xlink:href="ltbr-20240331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" xlink:href="ltbr-20240331.xsd#PrepaidProjectCostsAndOtherLongTermAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingencies" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCosts" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEvents" xlink:href="ltbr-20240331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareTables" xlink:href="ltbr-20240331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesTables" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ltbr-20240331.xsd#NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/NetLossPerShareDetails" xlink:href="ltbr-20240331.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:href="ltbr-20240331.xsd#PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="ltbr-20240331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetails" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ltbr-20240331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:href="ltbr-20240331.xsd#ResearchAndDevelopmentCostsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:href="ltbr-20240331.xsd#StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:href="ltbr-20240331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:title="000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonShareMember" xlink:label="loc_ltbrCommonShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ltbrCommonShareMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsShares" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" xlink:label="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedToConsultantDirectorsForServicesShares" xlink:label="loc_ltbrSharesIssuedToConsultantDirectorsForServicesShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedToConsultantDirectorsForServicesShares" order="5" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesIssuedToConsultantDirectorsForServicesAmount" xlink:label="loc_ltbrSharesIssuedToConsultantDirectorsForServicesAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesIssuedToConsultantDirectorsForServicesAmount" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="8" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="000007 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShare" xlink:title="000008 - Disclosure - Net Loss Per Share" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets" xlink:title="000009 - Disclosure - Prepaid Project Costs and Other Long-term Assets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="000010 - Disclosure - Accounts Payable and Accrued Liabilities" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingencies" xlink:title="000011 - Disclosure - Commitments and Contingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCosts" xlink:title="000012 - Disclosure - Research and Development Costs" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation" xlink:title="000013 - Disclosure - Stockholders Equity and Stock-Based Compensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEvents" xlink:title="000014 - Disclosure - Subsequent Events" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="000015 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="000016 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareTables" xlink:title="000017 - Disclosure - Net Loss Per Share (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="000018 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesTables" xlink:title="000019 - Disclosure - Commitments and Contingencies (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsTables" xlink:title="000020 - Disclosure - Research and Development Costs (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables" xlink:title="000021 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="000022 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelOneMember" xlink:label="loc_ltbrTreasuryBillsLevelOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelOneMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelTwoMember" xlink:label="loc_ltbrTreasuryBillsLevelTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelTwoMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TreasuryBillsLevelThreeMember" xlink:label="loc_ltbrTreasuryBillsLevelThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ltbrTreasuryBillsLevelThreeMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/NetLossPerShareDetails" xlink:title="000023 - Disclosure - Net Loss Per Share (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative" xlink:title="000024 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" order="80" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_BattelleEnergyAllianceLLCMember" xlink:label="loc_ltbrBattelleEnergyAllianceLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrBattelleEnergyAllianceLLCMember" order="61" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapPrepaidExpensesAndOtherCurrentAssetsMember" order="62" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" order="63" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" order="64" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPrepaidExpenseNoncurrent" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_PrepaidProjectCostsAddition" xlink:label="loc_ltbrPrepaidProjectCostsAddition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrPrepaidProjectCostsAddition" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="000025 - Disclosure - Accounts Payable and Accrued Liabilities (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetails" xlink:title="000026 - Disclosure - Commitments and Contingencies (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_INLProjectMember" xlink:label="loc_ltbrINLProjectMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrINLProjectMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RomaniaFeasibilityStudyMember" xlink:label="loc_ltbrRomaniaFeasibilityStudyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrRomaniaFeasibilityStudyMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CentrusEnergyFEEDStudyMember" xlink:label="loc_ltbrCentrusEnergyFEEDStudyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrCentrusEnergyFEEDStudyMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ContractualCommitments" xlink:label="loc_ltbrContractualCommitments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrContractualCommitments" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000027 - Disclosure - Commitments and Contingencies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RATENICNMember" xlink:label="loc_ltbrRATENICNMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrRATENICNMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StrategicPartnershipProjectAgreementMember" xlink:label="loc_ltbrStrategicPartnershipProjectAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrStrategicPartnershipProjectAgreementMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_IncreasedExpensesAmountForProjectTask" xlink:label="loc_ltbrIncreasedExpensesAmountForProjectTask" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrIncreasedExpensesAmountForProjectTask" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TotalCostAmountForProject" xlink:label="loc_ltbrTotalCostAmountForProject" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrTotalCostAmountForProject" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForFees" xlink:label="loc_us-gaapPaymentsForFees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForFees" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" order="5" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_LeasePaymentUnderNonCancellableOperatingLeases" xlink:label="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrLeasePaymentUnderNonCancellableOperatingLeases" order="6" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProjectTaskTatementPostemploymentObligations" xlink:label="loc_ltbrProjectTaskTatementPostemploymentObligations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProjectTaskTatementPostemploymentObligations" order="7" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_LesseeOperatingLeaseTerm" xlink:label="loc_ltbrLesseeOperatingLeaseTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrLesseeOperatingLeaseTerm" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RemainingOutstandingProject" xlink:label="loc_ltbrRemainingOutstandingProject" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrRemainingOutstandingProject" order="9" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetails" xlink:title="000028 - Disclosure - Research and Development Costs (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" order="25" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseINLMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseINLMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseINLMember" order="26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative" xlink:title="000029 - Disclosure - Research and Development Costs (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseINLMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseINLMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseINLMember" order="11" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseRatenIcnMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseRatenIcnMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseRatenIcnMember" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember" xlink:label="loc_ltbrResearchAndDevelopmentExpenseForFeedStudyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ltbrResearchAndDevelopmentExpenseForFeedStudyMember" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentExpenseAmountForProject" xlink:label="loc_ltbrResearchAndDevelopmentExpenseAmountForProject" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentExpenseAmountForProject" order="2" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount" xlink:label="loc_ltbrAdvancePaymentForResearchAndDevelopmentExpenseAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrAdvancePaymentForResearchAndDevelopmentExpenseAmount" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" xlink:label="loc_ltbrInterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrInterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ResearchAndDevelopmentEstimatedExpenses" xlink:label="loc_ltbrResearchAndDevelopmentEstimatedExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrResearchAndDevelopmentEstimatedExpenses" order="5" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails" xlink:title="000030 - Disclosure - Stockholders Equity and StockBased Compensation (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1" xlink:title="000031 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative" xlink:title="000032 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrTwoThousandTwentyEquityIncentivePlanMember" order="41" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonShareIssuancesMember" xlink:label="loc_ltbrCommonShareIssuancesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrCommonShareIssuancesMember" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" order="43" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_RestrictedStockAwardActivityMember" xlink:label="loc_ltbrRestrictedStockAwardActivityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ltbrRestrictedStockAwardActivityMember" order="44" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AvailableForSaleSecuritiesMember" xlink:label="loc_ltbrAvailableForSaleSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ltbrAvailableForSaleSecuritiesMember" order="45" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ConsultantMember" xlink:label="loc_ltbrConsultantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ltbrConsultantMember" order="46" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_OutstandingRestrictedStockAwards" xlink:label="loc_ltbrOutstandingRestrictedStockAwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrOutstandingRestrictedStockAwards" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonSharesIssuancesEquityGrant" xlink:label="loc_ltbrCommonSharesIssuancesEquityGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonSharesIssuancesEquityGrant" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" order="4" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_UnrecongnizedCompensationCostRestrictedStockUnit" xlink:label="loc_ltbrUnrecongnizedCompensationCostRestrictedStockUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrUnrecongnizedCompensationCostRestrictedStockUnit" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" order="8" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_FutureIssuanceOfShare" xlink:label="loc_ltbrFutureIssuanceOfShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrFutureIssuanceOfShare" order="9" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StockOptionExercisePrice" xlink:label="loc_ltbrStockOptionExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrStockOptionExercisePrice" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="12" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonSharesEquityGrantPricePerShares" xlink:label="loc_ltbrCommonSharesEquityGrantPricePerShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonSharesEquityGrantPricePerShares" order="13" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommonStockAndAllCommonStockEquivalents" xlink:label="loc_ltbrCommonStockAndAllCommonStockEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommonStockAndAllCommonStockEquivalents" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease" order="15" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AtTheMarketOfferingsDisclosureDescription" xlink:label="loc_ltbrAtTheMarketOfferingsDisclosureDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrAtTheMarketOfferingsDisclosureDescription" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" xlink:label="loc_us-gaapNetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1" order="17" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_AdditionalCommonShare" xlink:label="loc_ltbrAdditionalCommonShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrAdditionalCommonShare" order="18" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_SharesSoldUnderAtmSettlement" xlink:label="loc_ltbrSharesSoldUnderAtmSettlement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrSharesSoldUnderAtmSettlement" order="19" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8" xlink:label="loc_ltbrProceedsFromSaleOfAvailableForSaleSecuritiesB8" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProceedsFromSaleOfAvailableForSaleSecuritiesB8" order="20" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedFromSaleOfAvailableForSaleSecurities" xlink:label="loc_ltbrProceedFromSaleOfAvailableForSaleSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProceedFromSaleOfAvailableForSaleSecurities" order="21" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_ProceedsFromSharesSoldUnderTheAtm" xlink:label="loc_ltbrProceedsFromSharesSoldUnderTheAtm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrProceedsFromSharesSoldUnderTheAtm" order="22" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_StockIssuedDuringPeriodAmount" xlink:label="loc_ltbrStockIssuedDuringPeriodAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrStockIssuedDuringPeriodAmount" order="23" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://ltbr.com/role/SubsequentEventsDetailsNarrative" xlink:title="000033 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" order="1" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_CommissionRateDescription" xlink:label="loc_ltbrCommissionRateDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrCommissionRateDescription" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" order="3" />
    <link:loc xlink:type="locator" xlink:href="ltbr-20240331.xsd#ltbr_EquityIncentivePlanDescription" xlink:label="loc_ltbrEquityIncentivePlanDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ltbrEquityIncentivePlanDescription" order="4" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ltbr_ex101img22.jpg
<TEXT>
begin 644 ltbr_ex101img22.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\
M#<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/
M1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W
M/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__
M %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW
M/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]
MF45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[
M_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2
M[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\
M9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K
M?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM
M_P#W/0!]F45\9_\ #<__ %2[_P K?_W/1_PW/_U2[_RM_P#W/0!]F45\9_\
M#<__ %2[_P K?_W/7O?P9^*G_"WO!-YXF_L'^Q3;:@]B+?[5]HW;8XWW[MB8
M_P!9C&.W7F@#U&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "OS._:D_P"3F_%W_;G_ .D<-?IC7YG?M2?\G-^+O^W/_P!(X: /
M&**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K[^_8J_Y(CK/_8P3?^DUO7P#7W]^Q5_R1'6?^Q@F_P#2:WH ^FJ*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK
MF/%?BS3_  G964M\RFXU&[CL+*%G"":X?.U2YX4<$DGL#@$X! .F(XHKSG5O
M&GBS1_"?B35K_P $P)=:%:B[,9U-OL]V@5VD\J80Y)54Z,BDDX(48)P]-^+&
MORZQX?T?5O!MI8W?B?37OM%DCU9IH)W6,2F&9OLZM$P4CD(XYXS2[@>PT5XC
MH?QLU2\TWP?KNN>#8=/T+Q5=_P!GVMW:ZH;F2WN"[(BRQM#'@,4;E6;&.:Z7
MXF>/M6^'>F6NM0^%UUS2WF6&X\B\9+J/.22D7E,L@"J3RZ],>]#TW[V#_*YZ
M717G5SX[OKK4O"+>%M+T[6=$\2Y\K4'U-X&C"QM(Q\L0ON^1#CY@=WRG;UKT
M6G:PD[A17E_QX\2:YX/^!WB#Q+X;OOL&JV?V;R)_+239ON8D;Y7!4Y5F'([U
M\/?\-1_'7_H>O_*99_\ QF@9^F-%?F=_PU'\=?\ H>O_ "F6?_QFC_AJ/XZ_
M]#U_Y3+/_P",T ?IC17YG?\ #4?QU_Z'K_RF6?\ \9H_X:C^.O\ T/7_ )3+
M/_XS0!^F-%?F=_PU'\=?^AZ_\IEG_P#&:/\ AJ/XZ_\ 0]?^4RS_ /C- 'Z8
M4M>$_LS>./%?Q"^%^IZUXNU8ZG?Q:Q+:I+Y,4.V(0PL%Q&JCJ['.,\UW'Q&\
M9:IX%\/6VLZ=H=MK"2WD-I)'/?M:E#+(L:,"(I-PW-STP.F>E+L@.]I >:\B
MC^*'B:3Q=?>!SX%@'BNU,,PA75F:RDM9-V;CSQ!N4*5P08@<D8S4GAGXC>,O
M$5U<R?\ ""V*6=CK3Z)>RV^LR3RPNC!7F6,VJAHP2.=P..2!BD#TW/6Z*\YL
M/B%>Z]'%JWAG0%UOP\]\NGF\AO,3HXG$4DC0;.(UY;.[=@9*A3NKNIF:*-I$
MB><J"1&A +'T&2!D^Y JNEPZV+-+7$^ /&TGCCP]>ZG<:+)HTUGJ$^GR6LDR
MS,K1-M8EE^7KGH2..IK:\1WU[I?AR_U+3[*&]N+2$S+!/<&!)-HR07".5X!Q
M\IYQTZU+=E=A:^G4VSTI<5YS\/\ XI:5X\^&3^-)K?\ L9;02B_MI9=YLS&-
MS9;"Y&S#9P.#3/A/\1+SXE>'[O76\/KHMA'=/:P(UX9IG*'#%T\I1'U7 #-W
MZ8Y?5H6EDSTK%'>C/-<3IOC.2\^*&M>!VT26T_LNS@O4NWG1A<K(S+\J+G:
M5(^8@\= ,$O=V'L=OVHKS7QWX_UKP79ZAKB^#WO_  _I+1B_NS>>3/M;;N>"
M(QD2J@89)=.<@9P:]"AFCN+>.>(YCD4.IZ9!&10M=0+%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*N?_ (Q0!Z=^R1KVGZ)\%;M;]YT%[XFDMHGCMI94$C06RJ'=%*Q@D@ N5!)
MS7I_QZAN[SX=6^EV-CJ]W=3ZE:2*=+L9;J2)(YT=Y/D1PI502-PY(P >E5?@
M/\)=3^&/@6?0_%1TK4;_ /M:34+>:TW2K"&ABCX:1%*M^[;H.A'->U5/;R=P
M.#\,>#-)T'4M1\92:EJNM:QJMO&)K_5$ N!"HW+$L,<48C Z[ @;/7FN;^"L
MUUY/C:&ZTG5]->X\27FH0?VAIMQ:B:"5@8W4RHN<X.5^\.X&17L!Q15=;B\C
MYJU+2;J/Q)IOB3X?^%/$WA'QK?:A$=2TZ.SD_LR\@+_O)+B0KY ^3+9!$F3@
MKN.1[?:P^*[75+J[U76M+NM)"R-':VFDS1W"#.5S)]H<.0."!&"QZ8Z5TU%+
MI8>[N>-?!^^DTWPSXPGU#1]:LMNNWVHJESH]U%)+!+(61HT:,-(2!]U06' (
M&17:Z[K-GJ'PUOM9TY;J]M+JQ<P"WM)I9I-Z[5 B53)G)&1MR.<XP:Z6XMX;
MJVDM[F%)X)%VO'(H97!Z@@\$4L4,5O D$,:QQ1J%1$7"J!P  .@I-)QL"?O7
M/F;2/ _B!K[1(K#3;^U\(>)M)M)/$UO<64T4MO/8JH=/*90^9@HCP%^<!B-P
MQEUG:>*+[X.^,=.T?0==@G;Q1-J-Q8RV%Q9S7VG27.]DA,BIN9HP<J#G'! W
M#/U!BEJM]1>1\O:EX=\3?8?'EU\+_#^K:%X:N["R4:4+*33Y+B<2@W)MH'"-
M&3!E"0!N8\$D9KHOAOIMGI_QPUB\\,?#_5M \.7VBVL<<LVF-80QRH[EU*2;
M6W'('RJ<D%CP=Q]_I,\T=0>JL>5>.M>L-5U1O"&K:1K[:'%LGU"2W\/WUTE]
M@AEMT>*)EVY +MG&,*,Y8KZ/9S27-C!<-:RVIEC5_(F #Q9&=K $@$=#@FM"
MBA:*PPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/&/VH_\ DV3Q=_VY_P#I9#7YG5^F/[4?_)LGB[_MS_\ 2R&OS.H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MV?\ 9;_Y.;\(_P#;Y_Z1S5XQ7L_[+?\ R<WX1_[?/_2.:@#],:*** "BBB@
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MC5Q=% ':?\++\1?] WPK_P"$GI7_ ,C4?\++\1?] WPK_P"$GI7_ ,C5Q=%
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M^$GI7_R-7%T4 =I_PLOQ%_T#?"O_ (2>E?\ R-1_PLOQ%_T#?"O_ (2>E?\
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M -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\
MA07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z\8HH ]G_P"%!?\ 5:?A5_X4
M?_VNC_A07_5:?A5_X4?_ -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^
M%7_A1_\ VNO&** /9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z\8H
MH ]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KKQBB@#V?_ (4%_P!5
MI^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\ A07_ %6GX5?^%'_]KH_X
M4%_U6GX5?^%'_P#:Z\8HH ]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_
M -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\
MA07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z\8HH ]G_P"%!?\ 5:?A5_X4
M?_VNC_A07_5:?A5_X4?_ -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^
M%7_A1_\ VNO&** /9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z\8H
MH ]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KKQBB@#V?_ (4%_P!5
MI^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\ A07_ %6GX5?^%'_]KH_X
M4%_U6GX5?^%'_P#:Z\8HH ]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_
M -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\
MA07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z\8HH ]G_P"%!?\ 5:?A5_X4
M?_VNC_A07_5:?A5_X4?_ -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^
M%7_A1_\ VNO&** /9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z\8H
MH ]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KKQBB@#V?_ (4%_P!5
MI^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\ A07_ %6GX5?^%'_]KH_X
M4%_U6GX5?^%'_P#:Z\8HH ]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_
M -KKQBB@#V?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VNO&** /9_\
MA07_ %6GX5?^%'_]KKJ=+_9'\=:WI46J:)XN\':E83Y\NZM-0FFBDPQ4[76
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M  )U7_Y-H_X3+P[_ -$G\*_^!.J__)M '&45V?\ PF7AW_HD_A7_ ,"=5_\
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MZ)/X5_\  G5?_DVC_A,O#O\ T2?PK_X$ZK_\FT <9179_P#"9>'?^B3^%?\
MP)U7_P"3:/\ A,O#O_1)_"O_ ($ZK_\ )M '&45V?_"9>'?^B3^%?_ G5?\
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MJ_\ R;0!QE%=G_PF7AW_ *)/X5_\"=5_^3:/^$R\._\ 1)_"O_@3JO\ \FT
M<9179_\ "9>'?^B3^%?_  )U7_Y-H_X3+P[_ -$G\*_^!.J__)M '&45V?\
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M&U/BE_T /"O_ ("W/_Q^C_AM3XI?] #PK_X"W/\ \?H ^_J*^ ?^&U/BE_T
M/"O_ ("W/_Q^OOZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** /&/VH_P#DV3Q=_P!N?_I9#7YG5^I'QX\-ZYXP^!WB#PUX<L?MVJWGV;R+
M?S$CW[+F)V^9R%&%5CR>U?#W_#+GQU_Z$7_RIV?_ ,>H \8HKV?_ (9<^.O_
M $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3L_\
MX]1_PRY\=?\ H1?_ "IV?_QZ@#QBBO9_^&7/CK_T(O\ Y4[/_P"/4?\ #+GQ
MU_Z$7_RIV?\ \>H \8HKV?\ X9<^.O\ T(O_ )4[/_X]1_PRY\=?^A%_\J=G
M_P#'J /&**]G_P"&7/CK_P!"+_Y4[/\ ^/4?\,N?'7_H1?\ RIV?_P >H \8
MHKV?_AESXZ_]"+_Y4[/_ ./4?\,N?'7_ *$7_P J=G_\>H \8HKV?_AESXZ_
M]"+_ .5.S_\ CU'_  RY\=?^A%_\J=G_ /'J /&**]G_ .&7/CK_ -"+_P"5
M.S_^/4?\,N?'7_H1?_*G9_\ QZ@#QBBO9_\ AESXZ_\ 0B_^5.S_ /CU'_#+
MGQU_Z$7_ ,J=G_\ 'J /&**]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\
M*G9__'J /&**]G_X9<^.O_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZ@#Q
MBBO9_P#AESXZ_P#0B_\ E3L__CU'_#+GQU_Z$7_RIV?_ ,>H \8HKV?_ (9<
M^.O_ $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3
ML_\ X]1_PRY\=?\ H1?_ "IV?_QZ@#QBBO9_^&7/CK_T(O\ Y4[/_P"/4?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M% ':?VA\+/\ H3?%7_A36W_R!1_:'PL_Z$WQ5_X4UM_\@5Q=% ':?VA\+/\
MH3?%7_A36W_R!1_:'PL_Z$WQ5_X4UM_\@5Q=% ':?VA\+/\ H3?%7_A36W_R
M!1_:'PL_Z$WQ5_X4UM_\@5Q=% ':?VA\+/\ H3?%7_A36W_R!1_:'PL_Z$WQ
M5_X4UM_\@5Q=% ':?VA\+/\ H3?%7_A36W_R!7IWP9^'?PO^+WC6[\-?V7XJ
MT7[-I[WWVC^VK:XW;9(TV;?L:8_UF<Y[=.:^?:^FOV*_^2VZS_V+\W_I3;T
M>R_\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"
MW_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_
M  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%
M'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_
MZ#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*
MMO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7T
MS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\
M,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/
M^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *M
MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%
M7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_B
MK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\
MXQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!
M\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"
MW_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_
M  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%
M'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_
MZ#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*
MMO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7T
MS10!\S?\,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\
M,5?"W_H/^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/
M^*O_  *MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *M
MO_C%'_#%7PM_Z#_BK_P*MO\ XQ7TS10!\S?\,5?"W_H/^*O_  *MO_C%>C_"
MOX,^%OA!_:__  C6H:I=C5O)\_\ M&6-]OE;]NW9&F/]8V<YZ#I7J5% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML<=< ^E?;U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 'W_ /\ #:OPM_Z 'BK_ ,!;;_X_1_PVK\+?^@!XJ_\  6V_^/U\ 44 ??\
M_P -J_"W_H >*O\ P%MO_C]'_#:OPM_Z 'BK_P !;;_X_7P!10!]_P#_  VK
M\+?^@!XJ_P# 6V_^/T?\-J_"W_H >*O_  %MO_C]? %% 'W_ /\ #:OPM_Z
M'BK_ ,!;;_X_1_PVK\+?^@!XJ_\  6V_^/U\ 44 ??\ _P -J_"W_H >*O\
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M+?X#_P"Q@L/_ $I2OU0T_3K?38I8;>2ZD$LS3,;FZEN&#,<D R,Q5?11A1V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
M&:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QFOS.HH _3
M'_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QFOS.HH _3'_AJ+X%?]#U
M_P"4R\_^,T?\-1? K_H>O_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-
M'_#47P*_Z'K_ ,IEY_\ &:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\
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MO_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
M&:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QFOS.HH _3
M'_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QFOS.HH _3'_AJ+X%?]#U
M_P"4R\_^,T?\-1? K_H>O_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-
M'_#47P*_Z'K_ ,IEY_\ &:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\
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MO_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
M&:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QFOS.HH _3
M'_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QFOS.HH _3'_AJ+X%?]#U
M_P"4R\_^,T?\-1? K_H>O_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-
M'_#47P*_Z'K_ ,IEY_\ &:_,ZB@#],?^&HO@5_T/7_E,O/\ XS71>#?C)\.O
MB%K<VA^$?$7]IW\,#74D7V.XAVQ!E4MF2-1U=1C.>:_*ROIK]BO_ )+;K/\
MV+\W_I3;T ??U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7XB_Z!OA7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\
MPD]*_P#D:C_A9?B+_H&^%?\ PD]*_P#D:@#BZ*[3_A9?B+_H&^%?_"3TK_Y&
MH_X67XB_Z!OA7_PD]*_^1J .+HKM/^%E^(O^@;X5_P#"3TK_ .1J/^%E^(O^
M@;X5_P#"3TK_ .1J .+HKM/^%E^(O^@;X5_\)/2O_D:C_A9?B+_H&^%?_"3T
MK_Y&H XNBNT_X67XB_Z!OA7_ ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\ Y&H
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MQBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\
M5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KH \8HKV?_ (4%_P!5I^%7_A1__:Z/
M^%!?]5I^%7_A1_\ VN@#QBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'
M_P#:Z /&**]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KH \8HKV?_
M (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VN@#QBBO9_\ A07_ %6GX5?^
M%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:
M?A5_X4?_ -KH \8HKV?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VN@#
MQBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\
M5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KH \8HKV?_ (4%_P!5I^%7_A1__:Z/
M^%!?]5I^%7_A1_\ VN@#QBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'
M_P#:Z /&**]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KH \8HKV?_
M (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VN@#QBBO9_\ A07_ %6GX5?^
M%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:
M?A5_X4?_ -KH \8HKV?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VN@#
MQBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\
M5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KH \8HKV?_ (4%_P!5I^%7_A1__:Z/
M^%!?]5I^%7_A1_\ VN@#QBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'
M_P#:Z /&**]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:?A5_X4?_ -KH \8HKV?_
M (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VN@#QBBO9_\ A07_ %6GX5?^
M%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\ 5:?A5_X4?_VNC_A07_5:
M?A5_X4?_ -KH \8HKV?_ (4%_P!5I^%7_A1__:Z/^%!?]5I^%7_A1_\ VN@#
MQBBO9_\ A07_ %6GX5?^%'_]KH_X4%_U6GX5?^%'_P#:Z /&**]G_P"%!?\
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M +<__2R&OS.K],?VH_\ DV3Q=_VY_P#I9#7YG4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?37[%?_);
M=9_[%^;_ -*;>OOZO@']BO\ Y+;K/_8OS?\ I3;U]_4 %%%% !1110 4444
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MZ)/X5_\  G5?_DVC_A,O#O\ T2?PK_X$ZK_\FUQE% '9_P#"9>'?^B3^%?\
MP)U7_P"3:/\ A,O#O_1)_"O_ ($ZK_\ )M<910!V?_"9>'?^B3^%?_ G5?\
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ME% '9_\ "9>'?^B3^%?_  )U7_Y-H_X3+P[_ -$G\*_^!.J__)M<910!V?\
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M\_\ CU>ST4 >,?\ #+GP+_Z$;_RIWG_QZC_AESX%_P#0C?\ E3O/_CU>ST4
M>=>#?@W\.OA[K<VN>$?#O]F7\T#6LDOVRXFW1%E8KB21AU13G&>*]%HHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R']HC3KG5OV>_$V
MGVTEI%--]EVM=W45M$,7<+'=+*RHO XRPR< <D"OSY_X5IXB_P"@EX5_\*S2
MO_DFOOW]J/\ Y-D\7?\ ;G_Z60U^9U ':?\ "M/$7_02\*_^%9I7_P DT?\
M"M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\
M02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^
M%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_
M\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=%
M ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\
M"M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\
M02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^
M%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_
M\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\
M"M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\
M02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^
M%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_
M\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=%
M ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\
M"M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\
M02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^
M%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_
M\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\
M"M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\
M02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^
M%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_
M\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=%
M ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\
M"M/$7_02\*_^%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\
M02\*_P#A6:5_\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^
M%9I7_P DT?\ "M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_
M\DT?\*T\1?\ 02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DT?\
M"M/$7_02\*_^%9I7_P DUQ=% ':?\*T\1?\ 02\*_P#A6:5_\DT?\*T\1?\
M02\*_P#A6:5_\DUQ=% ':?\ "M/$7_02\*_^%9I7_P DULZ+\%_'GB6^?3_#
MMKHNL74<9F:&P\1:=<2*@(!8JEP2!EE&>F2/6O,J^FOV*_\ DMNL_P#8OS?^
ME-O0!3^'_P"SM\8-#^*'A/6M4\&_9K#3]8L[JYF_M"U?RXDF1G;"RDG !. "
M:_0JBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLW_"P_@3_P!&Z_\ EW7G_P 31_PL/X$_]&Z_^7=>?_$T >,T5[-_PL/X$_\
M1NO_ )=UY_\ $T?\+#^!/_1NO_EW7G_Q- 'C-%>S?\+#^!/_ $;K_P"7=>?_
M !-'_"P_@3_T;K_Y=UY_\30!XS17LW_"P_@3_P!&Z_\ EW7G_P 31_PL/X$_
M]&Z_^7=>?_$T >,T5[-_PL/X$_\ 1NO_ )=UY_\ $T?\+#^!/_1NO_EW7G_Q
M- 'C-%>S?\+#^!/_ $;K_P"7=>?_ !-'_"P_@3_T;K_Y=UY_\30!XS17LW_"
MP_@3_P!&Z_\ EW7G_P 31_PL/X$_]&Z_^7=>?_$T >,T5[-_PL/X$_\ 1NO_
M )=UY_\ $T?\+#^!/_1NO_EW7G_Q- 'C-%>S?\+#^!/_ $;K_P"7=>?_ !-'
M_"P_@3_T;K_Y=UY_\30!XS17LW_"P_@3_P!&Z_\ EW7G_P 31_PL/X$_]&Z_
M^7=>?_$T >,T5[-_PL/X$_\ 1NO_ )=UY_\ $T?\+#^!/_1NO_EW7G_Q- 'C
M-%>S?\+#^!/_ $;K_P"7=>?_ !-'_"P_@3_T;K_Y=UY_\30!XS17LW_"P_@3
M_P!&Z_\ EW7G_P 31_PL/X$_]&Z_^7=>?_$T >,T5[-_PL/X$_\ 1NO_ )=U
MY_\ $T?\+#^!/_1NO_EW7G_Q- 'C-%>S?\+#^!/_ $;K_P"7=>?_ !-'_"P_
M@3_T;K_Y=UY_\30!XS17LW_"P_@3_P!&Z_\ EW7G_P 31_PL/X$_]&Z_^7=>
M?_$T >,T5[-_PL/X$_\ 1NO_ )=UY_\ $T?\+#^!/_1NO_EW7G_Q- 'C-%>S
M?\+#^!/_ $;K_P"7=>?_ !-'_"P_@3_T;K_Y=UY_\30!XS17LW_"P_@3_P!&
MZ_\ EW7G_P 31_PL/X$_]&Z_^7=>?_$T >,T5[-_PL/X$_\ 1NO_ )=UY_\
M$T?\+#^!/_1NO_EW7G_Q- 'C-%>S?\+#^!/_ $;K_P"7=>?_ !-'_"P_@3_T
M;K_Y=UY_\30!XS7TU^Q7_P EMUG_ +%^;_TIMZXO_A8?P)_Z-U_\NZ\_^)KI
M_!OQ\^''P_UV76_!_P #_P"S+^:W:UDE_P"$FN)=T196*XDC8=44YQGB@#]"
MZ*^,_P#AN?\ ZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>@#[,HKXS_ .&Y_P#J
MEW_E;_\ N>C_ (;G_P"J7?\ E;_^YZ /LRBOC/\ X;G_ .J7?^5O_P"YZ/\
MAN?_ *I=_P"5O_[GH ^S**^?O@O^T7_PMSQO>>&O^$/_ +%^SV#WWVC^T/M&
M[;)&FS;Y28_UF<Y[=.:^@: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH \8_:C_ .39/%W_ &Y_^ED-?F=7Z=_M#Z3JFN?L]^*-+T?3+K4[
M^?[+Y=K9PM-+)BZA8[44$G !)P.@)K\^/^%3_%+_ *)IXJ_\$US_ /$4 <71
M7:?\*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?
MXI?]$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$US_\ $4 <717:?\*G^*7_ $33
MQ5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_
M^(H_X5/\4O\ HFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_
M !2_Z)IXJ_\ !-<__$4 <717:?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>
M*O\ P37/_P 10!Q=%=I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-
M<_\ Q% '%T5VG_"I_BE_T33Q5_X)KG_XBC_A4_Q2_P"B:>*O_!-<_P#Q% '%
MT5VG_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\10!Q=%=I_P *
MG^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$
MT\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$4 <717:?\*G^*7_1-/%7_@FN
M?_B*/^%3_%+_ *)IXJ_\$US_ /$4 <717:?\*G^*7_1-/%7_ ()KG_XBC_A4
M_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HF
MGBK_ ,$US_\ $4 <717:?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P
M37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!
MQ=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4 <717:?\
M"I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\ P37/_P 10!Q=%=I_PJ?XI?\
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MS_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\
MA,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1
M_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O
M%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\
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M&";_ -)K>@#C?^&&/^JH_P#E$_\ NBC_ (88_P"JH_\ E$_^Z*^S** /C/\
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M (NC_A;'Q2_Z*7XJ_P#!S<__ != '%T5VG_"V/BE_P!%+\5?^#FY_P#BZ/\
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M_P"#FY_^+H_X6Q\4O^BE^*O_  <W/_Q= '%T5VG_  MCXI?]%+\5?^#FY_\
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M?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\ \70!Q=%=I_PMCXI?]%+\5?\
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M4 >,T5[-_P *\^!/_1Q7_EHWG_Q5'_"O/@3_ -'%?^6C>?\ Q5 'C-%>S?\
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M^&HO@5_T/7_E,O/_ (S1_P -1? K_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\
ME,O/_C-'_#47P*_Z'K_RF7G_ ,9H ]GHKDO!?CSPK\0-"FUKP?JG]IV$-PUM
M)+Y$L.)0JL5Q(JGHZG.,<UUM !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'C'[4?_ ";)XN_[<_\ TLAK\SJ_3']J/_DV3Q=_VY_^
MED-?F=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\
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MBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\
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MBZ* .T_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1JXNB@#M/\
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M\)EX=_Z)/X5_\"=5_P#DVC_A,O#O_1)_"O\ X$ZK_P#)M '&45V?_"9>'?\
MHD_A7_P)U7_Y-H_X3+P[_P!$G\*_^!.J_P#R;0!QE%=G_P )EX=_Z)/X5_\
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MD_A7_P "=5_^3:/^$R\._P#1)_"O_@3JO_R;0!QE%=G_ ,)EX=_Z)/X5_P#
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MQE%=G_PF7AW_ *)/X5_\"=5_^3:/^$R\._\ 1)_"O_@3JO\ \FT <9179_\
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M .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\ QZ@#QBBO9_\ AESXZ_\
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M /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\ QZ@#QBBO9_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*O\ P*MO_C%?3-% 'S-_PQ5\+?\ H/\ BK_P*MO_ (Q1_P ,5?"W_H/^*O\
MP*MO_C%?3-% 'S-_PQ5\+?\ H/\ BK_P*MO_ (Q1_P ,5?"W_H/^*O\ P*MO
M_C%?3-% 'S-_PQ5\+?\ H/\ BK_P*MO_ (Q1_P ,5?"W_H/^*O\ P*MO_C%?
M3-% 'S-_PQ5\+?\ H/\ BK_P*MO_ (Q1_P ,5?"W_H/^*O\ P*MO_C%?3-%
M'S-_PQ5\+?\ H/\ BK_P*MO_ (Q1_P ,5?"W_H/^*O\ P*MO_C%?3-% 'S-_
MPQ5\+?\ H/\ BK_P*MO_ (Q7;_#7]G_P;\*?$USXB\.ZEK-U=7-HUDR7TT3Q
M[&=') 2)3G,:]\8SQ7L5% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7ZR44 ?DW_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$5^LE%
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M7ZR44 ?DW_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$5^LE%
M'Y-_\*G^*7_1-/%7_@FN?_B*_0?]GC2=4T/]GOPOI>L:9=:9?P?:O,M;R%H9
M8\W4S#<C $9!!&1T(->NT4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '#?$SQRWPU^&&K^-&TO^U?[.\G_1//\ )\SS
M)DB^_M;&-^>AZ8]Z^;/^&Y_^J7?^5O\ ^YZ]E_:C_P"39/%W_;G_ .ED-?F=
M0!]F?\-S_P#5+O\ RM__ '/1_P -S_\ 5+O_ "M__<]?&=% 'V9_PW/_ -4N
M_P#*W_\ <]'_  W/_P!4N_\ *W_]SU\9T4 ?9G_#<_\ U2[_ ,K?_P!ST?\
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M_P#*W_\ <]'_  W/_P!4N_\ *W_]SU\9T4 ?9G_#<_\ U2[_ ,K?_P!ST?\
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M_P#*W_\ <]'_  W/_P!4N_\ *W_]SU\9T4 ?9G_#<_\ U2[_ ,K?_P!ST?\
M#<__ %2[_P K?_W/7QG10!]F?\-S_P#5+O\ RM__ '/7TG\,_'+?$KX8:1XT
M72_[*_M'SO\ 1//\[R_+F>+[^U<YV9Z#KCWK\H*_3']ES_DV3PC_ -OG_I9-
M0![/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >,?M1_\FR>+O\ MS_]+(:_,ZOV8HH _&>BOV8HH _&>BOV8HH
M_&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH
M_&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH
M_&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH _&>BOV8HH
M_&>BOV8HH _&>OTQ_9<_Y-D\(_\ ;Y_Z635[/10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\!_">I:Q#J$^H:IY5OHO]@0V1^SR01VH3:,"2%F+AOG#%B=P';BNT\/^%?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,#Q1XHT/P?X:N_$GB*^^PZ7:;/.N/*>39O
M=47Y4!8Y9E' [UYO_P -1? K_H>O_*9>?_&:/VH_^39/%W_;G_Z60U^9U 'Z
M8_\ #47P*_Z'K_RF7G_QFC_AJ+X%?]#U_P"4R\_^,U^9U% 'Z8_\-1? K_H>
MO_*9>?\ QFC_ (:B^!7_ $/7_E,O/_C-?F=10!^F/_#47P*_Z'K_ ,IEY_\
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M9U% 'Z8_\-1? K_H>O\ RF7G_P 9H_X:B^!7_0]?^4R\_P#C-?F=10!^F/\
MPU%\"O\ H>O_ "F7G_QFC_AJ+X%?]#U_Y3+S_P",U^9U% 'Z8_\ #47P*_Z'
MK_RF7G_QFC_AJ+X%?]#U_P"4R\_^,U^9U% 'Z8_\-1? K_H>O_*9>?\ QFC_
M (:B^!7_ $/7_E,O/_C-?F=10!^F/_#47P*_Z'K_ ,IEY_\ &:/^&HO@5_T/
M7_E,O/\ XS7YG44 ?IC_ ,-1? K_ *'K_P IEY_\9H_X:B^!7_0]?^4R\_\
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M*_Z'K_RF7G_QFC_AJ+X%?]#U_P"4R\_^,U^9U% 'Z8_\-1? K_H>O_*9>?\
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M7XB_Z!OA7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\
MPD]*_P#D:C_A9?B+_H&^%?\ PD]*_P#D:@#BZ*[3_A9?B+_H&^%?_"3TK_Y&
MH_X67XB_Z!OA7_PD]*_^1J .+HKM/^%E^(O^@;X5_P#"3TK_ .1J/^%E^(O^
M@;X5_P#"3TK_ .1J .+HKM/^%E^(O^@;X5_\)/2O_D:C_A9?B+_H&^%?_"3T
MK_Y&H XNBNT_X67XB_Z!OA7_ ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\ Y&H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .U^%/\ R6_P'_V,%A_Z4I7ZQU^3GPI_Y+?X#_[&
M"P_]*4K]8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /(OVC+N'3_P!GOQ/>7FEVFK0Q_9=UI=M*L4F;J$#<
M8G1^"<C##D#.1D'\]_\ A,O#O_1)_"O_ ($ZK_\ )M??W[4?_)LGB[_MS_\
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M,O#O_1)_"O\ X$ZK_P#)M'_"9>'?^B3^%?\ P)U7_P"3:XRB@#L_^$R\._\
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M3Q%_T$O"O_A6:5_\DT?\*T\1?]!+PK_X5FE?_)-<710!VG_"M/$7_02\*_\
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M<.J:-J5KJ5A,3Y5U:3K-%)ABIVNI(.""#@]017X^5^F/[+G_ ";)X1_[?/\
MTLFH ]GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q
MC]J/_DV3Q=_VY_\ I9#7YG5^GG[14NF1?L]^)Y-:L[N]L!]E\V"SN5MY7_TJ
M'&V1HY N#@G*'(!'&<C\]_[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^
M*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;
M_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0
M^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)O
MBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_
M .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+H
MKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G
M_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\
MPIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0
M*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_
M $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_P
MIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0*
M .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[
M0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^
M*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;
M_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0
M^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)O
MBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_
M .0* .+HKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+H
MKM/[0^%G_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G
M_0F^*O\ PIK;_P"0*/[0^%G_ $)OBK_PIK;_ .0* .+HKM/[0^%G_0F^*O\
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M/^%3_%+_ *)IXJ_\$US_ /$4?\*G^*7_ $33Q5_X)KG_ .(H XNBNT_X5/\
M%+_HFGBK_P $US_\11_PJ?XI?]$T\5?^":Y_^(H XNBNT_X5/\4O^B:>*O\
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M ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XB@#BZ*[3_ (5/\4O^B:>*O_!-<_\
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M\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+KBZ* .T_X6Q\4O\ HI?BK_P<W/\
M\71_PMCXI?\ 12_%7_@YN?\ XNN+HH [3_A;'Q2_Z*7XJ_\ !S<__%T?\+8^
M*7_12_%7_@YN?_BZXNB@#M/^%L?%+_HI?BK_ ,'-S_\ %T?\+8^*7_12_%7_
M (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\ Q='_  MCXI?]%+\5?^#FY_\
MBZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8^*7_ $4OQ5_X.;G_ .+KBZ*
M/T0_9,\0:]XE^$>JWWB#6M0UB[CUR:%9[^Y>XD5!;P$*&<D@99CCIDGUKZ(K
MYE_8J_Y(CK/_ &,$W_I-;U]-4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!Y'^T5%IDO[/?B>/6KR[LK _9?-GL[9;B5/]*AQMC:2,-DX!
MRXP"3SC!_/?^S_A9_P!#EXJ_\)FV_P#D^OOW]J/_ )-D\7?]N?\ Z60U^9U
M':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z
M'+Q5_P"$S;?_ "?1_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-
MM_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?
M\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1_9_PL_Z'+Q5_
MX3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GU
MQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_
MPL_Z'+Q5_P"$S;?_ "?1_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_
M (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P G
MT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1_9_PL_Z'
M+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_
M ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =
MI_9_PL_Z'+Q5_P"$S;?_ "?1_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<
MO%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW
M_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1_9_P
ML_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A
M,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%
MT4 =I_9_PL_Z'+Q5_P"$S;?_ "?1_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"
MS_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\
MA,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1
M_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O
M%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\
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M3H;2*/%LI*,%N93T@.".[ 8'6OK^OS._9;_Y.;\(_P#;Y_Z1S5^F- !1110
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M^#FY_P#BZ .+HKM/^%L?%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+H
MXNBNT_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\ @YN?_BZ .+HKM/\
MA;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H XNBNT_X6Q\4O\
MHI?BK_P<W/\ \71_PMCXI?\ 12_%7_@YN?\ XN@#BZ*[3_A;'Q2_Z*7XJ_\
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M%?\ EHWG_P 50!XS17LW_"O/@3_T<5_Y:-Y_\51_PKSX$_\ 1Q7_ ):-Y_\
M%4 >,T5[-_PKSX$_]'%?^6C>?_%4?\*\^!/_ $<5_P"6C>?_ !5 'C-%>S?\
M*\^!/_1Q7_EHWG_Q5'_"O/@3_P!'%?\ EHWG_P 50!XS17LW_"O/@3_T<5_Y
M:-Y_\51_PKSX$_\ 1Q7_ ):-Y_\ %4 >,T5[-_PKSX$_]'%?^6C>?_%4?\*\
M^!/_ $<5_P"6C>?_ !5 'C-%>S?\*\^!/_1Q7_EHWG_Q5'_"O/@3_P!'%?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'V9^PS_S4'_N'?\
MMS7V97QG^PS_ ,U!_P"X=_[<U]F4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7XB_Z!OA7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:N+HH [3_A9?B+_H&^%?\
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M2O\ Y&KBZ* .T_X67XB_Z!OA7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:N+HH
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M5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH
M]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_
MX4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%
M_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]
MKKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?
M]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:
MZ/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A
M5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH
M]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_
MX4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%
M_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]
MKKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?
M]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:
MZ/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A
M5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH
M]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_
MX4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%
M_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:Z/\ A07_ %6GX5?^%'_]
MKKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A5_X4?_VNO&** /9_^%!?
M]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH ]G_X4%_U6GX5?^%'_P#:
MZ/\ A07_ %6GX5?^%'_]KKQBB@#V?_A07_5:?A5_X4?_ -KH_P"%!?\ 5:?A
M5_X4?_VNO&** /9_^%!?]5I^%7_A1_\ VNC_ (4%_P!5I^%7_A1__:Z\8HH
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M^%?_  )U7_Y-H XRBNS_ .$R\._]$G\*_P#@3JO_ ,FT?\)EX=_Z)/X5_P#
MG5?_ )-H XRBNS_X3+P[_P!$G\*_^!.J_P#R;1_PF7AW_HD_A7_P)U7_ .3:
M .,HKL_^$R\._P#1)_"O_@3JO_R;1_PF7AW_ *)/X5_\"=5_^3: .,HKL_\
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M_@3JO_R;1_PF7AW_ *)/X5_\"=5_^3: .,HKL_\ A,O#O_1)_"O_ ($ZK_\
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M -$G\*_^!.J__)M'_"9>'?\ HD_A7_P)U7_Y-H XRBNS_P"$R\._]$G\*_\
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M:\.6/V[5;S[-Y%OYB1[]ES$[?,Y"C"JQY/:OA[_AESXZ_P#0B_\ E3L__CU
M'C%%>S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]0!XQ17L_P#P
MRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./4 >,45[/_ ,,N?'7_ *$7
M_P J=G_\>H_X9<^.O_0B_P#E3L__ (]0!XQ17L__  RY\=?^A%_\J=G_ /'J
M/^&7/CK_ -"+_P"5.S_^/4 >,45[/_PRY\=?^A%_\J=G_P#'J/\ AESXZ_\
M0B_^5.S_ /CU 'C%%>S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\
MX]0!XQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU 'C%%>
MS_\ #+GQU_Z$7_RIV?\ \>H_X9<^.O\ T(O_ )4[/_X]0!XQ17L__#+GQU_Z
M$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\ \,N?'7_H1?\ RIV?
M_P >H_X9<^.O_0B_^5.S_P#CU 'C%%>S_P##+GQU_P"A%_\ *G9__'J/^&7/
MCK_T(O\ Y4[/_P"/4 >,45[/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\
ME3L__CU 'C%%>S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]0!X
MQ17L_P#PRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./4 >,45[/_ ,,N
M?'7_ *$7_P J=G_\>H_X9<^.O_0B_P#E3L__ (]0!XQ17L__  RY\=?^A%_\
MJ=G_ /'J/^&7/CK_ -"+_P"5.S_^/4 >,45[/_PRY\=?^A%_\J=G_P#'J/\
MAESXZ_\ 0B_^5.S_ /CU 'C%%>S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(
MO_E3L_\ X]0!XQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\
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M0!XQ17L__#+GQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\
M\,N?'7_H1?\ RIV?_P >H_X9<^.O_0B_^5.S_P#CU 'C%?IC^RY_R;)X1_[?
M/_2R:OC7_AESXZ_]"+_Y4[/_ ./5]P_ ?PWKG@_X'>'_  UXCL?L.JV?VGS[
M?S$DV;[F5U^9"5.593P>] 'J%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'C'[4?_ ";)XN_[<_\ TLAK\SJ_3']J/_DV3Q=_
MVY_^ED-?F=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"%-;?_ "!1_:'PL_Z$WQ5_X4UM_P#(%<710!VG]H?"S_H3?%7_ (4UM_\
M(%']H?"S_H3?%7_A36W_ ,@5Q=% ':?VA\+/^A-\5?\ A36W_P @4?VA\+/^
MA-\5?^%-;?\ R!7%T4 =I_:'PL_Z$WQ5_P"%-;?_ "!1_:'PL_Z$WQ5_X4UM
M_P#(%<710!VG]H?"S_H3?%7_ (4UM_\ (%']H?"S_H3?%7_A36W_ ,@5Q=%
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MS_H3?%7_ (4UM_\ (%']H?"S_H3?%7_A36W_ ,@5Q=% ':?VA\+/^A-\5?\
MA36W_P @4?VA\+/^A-\5?^%-;?\ R!7%T4 =I_:'PL_Z$WQ5_P"%-;?_ "!1
M_:'PL_Z$WQ5_X4UM_P#(%<710!VG]H?"S_H3?%7_ (4UM_\ (%']H?"S_H3?
M%7_A36W_ ,@5Q=% ':?VA\+/^A-\5?\ A36W_P @4?VA\+/^A-\5?^%-;?\
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M_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\
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M7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%+_HFGBK_ ,$US_\
M$4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7
M_@YN?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\
MA;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%+_HFGBK_
M ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?\+8^
M*7_12_%7_@YN?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y
M_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%
M+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<_
M_%T?\+8^*7_12_%7_@YN?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$
MT\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+
MH /^%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7X
MJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"
MI_BE_P!$T\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_
MX.;G_P"+H /^%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;
M'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZ #_A4_Q2_P"B:>*O_!-<
M_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/B
ME_T4OQ5_X.;G_P"+H /^%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()K
MG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZ #_A4_Q2_P"B
M:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%
MT?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-
M/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZ #_A
M4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_
M\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%+_HFGBK_ ,$US_\ $4?\
M*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN
M?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\ A;'Q
M2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%+_HFGBK_ ,$U
MS_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_1
M2_%7_@YN?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B
M*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^%3_%+_HF
MGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\ !S<__%T?
M\+8^*7_12_%7_@YN?_BZ #_A4_Q2_P"B:>*O_!-<_P#Q%'_"I_BE_P!$T\5?
M^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\ "V/BE_T4OQ5_X.;G_P"+H /^
M%3_%+_HFGBK_ ,$US_\ $4?\*G^*7_1-/%7_ ()KG_XBC_A;'Q2_Z*7XJ_\
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M_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B*/\ A;'Q2_Z*7XJ_\'-S_P#%T?\
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M_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\
MPF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3
MZ/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_
M $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_P
MF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z
M .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[
M/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>
M*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;
M_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/
M^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7
MBK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_
M .3Z .+HKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+H
MKM/[/^%G_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G
M_0Y>*O\ PF;;_P"3Z/[/^%G_ $.7BK_PF;;_ .3Z .+HKM/[/^%G_0Y>*O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "NU^%/_ "6_P'_V,%A_Z4I7%5VOPI_Y+?X#_P"Q@L/_ $I2@#]8Z***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \O\ CQXDUSP?
M\#O$'B7PY??8=5L_LWD7'EI)LWW,2-\K@J<JS#D=Z^'O^&H_CK_T/7_E,L__
M (S7V5^U'_R;)XN_[<__ $LAK\SJ /9_^&H_CK_T/7_E,L__ (S1_P -1_'7
M_H>O_*99_P#QFO&** /9_P#AJ/XZ_P#0]?\ E,L__C-'_#4?QU_Z'K_RF6?_
M ,9KQBB@#V?_ (:C^.O_ $/7_E,L_P#XS1_PU'\=?^AZ_P#*99__ !FO&**
M/9_^&H_CK_T/7_E,L_\ XS1_PU'\=?\ H>O_ "F6?_QFO&** /9_^&H_CK_T
M/7_E,L__ (S1_P -1_'7_H>O_*99_P#QFO&** /9_P#AJ/XZ_P#0]?\ E,L_
M_C-'_#4?QU_Z'K_RF6?_ ,9KQBB@#V?_ (:C^.O_ $/7_E,L_P#XS1_PU'\=
M?^AZ_P#*99__ !FO&** /9_^&H_CK_T/7_E,L_\ XS1_PU'\=?\ H>O_ "F6
M?_QFO&** /9_^&H_CK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QFO&** /9
M_P#AJ/XZ_P#0]?\ E,L__C-'_#4?QU_Z'K_RF6?_ ,9KQBB@#V?_ (:C^.O_
M $/7_E,L_P#XS1_PU'\=?^AZ_P#*99__ !FO&** /9_^&H_CK_T/7_E,L_\
MXS1_PU'\=?\ H>O_ "F6?_QFO&** /9_^&H_CK_T/7_E,L__ (S1_P -1_'7
M_H>O_*99_P#QFO&** /9_P#AJ/XZ_P#0]?\ E,L__C-'_#4?QU_Z'K_RF6?_
M ,9KQBB@#V?_ (:C^.O_ $/7_E,L_P#XS1_PU'\=?^AZ_P#*99__ !FO&**
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M $/7_E,L_P#XS1_PU'\=?^AZ_P#*99__ !FO&** /9_^&H_CK_T/7_E,L_\
MXS1_PU'\=?\ H>O_ "F6?_QFO&** /9_^&H_CK_T/7_E,L__ (S1_P -1_'7
M_H>O_*99_P#QFO&** /9_P#AJ/XZ_P#0]?\ E,L__C-'_#4?QU_Z'K_RF6?_
M ,9KQBB@#V?_ (:C^.O_ $/7_E,L_P#XS1_PU'\=?^AZ_P#*99__ !FO&**
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ME% '9_\ "&^'?^BL>%?_  &U7_Y"H_X0WP[_ -%8\*_^ VJ__(5<910!V?\
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M  &U7_Y"H_X0WP[_ -%8\*_^ VJ__(5<910!V?\ PAOAW_HK'A7_ ,!M5_\
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MZ*QX5_\  ;5?_D*C_A#?#O\ T5CPK_X#:K_\A5QE% '9_P#"&^'?^BL>%?\
MP&U7_P"0J/\ A#?#O_16/"O_ (#:K_\ (5<910!V?_"&^'?^BL>%?_ ;5?\
MY"H_X0WP[_T5CPK_ . VJ_\ R%7&44 =G_PAOAW_ **QX5_\!M5_^0J/^$-\
M._\ 16/"O_@-JO\ \A5QE% '9_\ "&^'?^BL>%?_  &U7_Y"H_X0WP[_ -%8
M\*_^ VJ__(5<910!V?\ PAOAW_HK'A7_ ,!M5_\ D*C_ (0WP[_T5CPK_P"
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MX5_\)/2O_D:C_A9?B+_H&^%?_"3TK_Y&H XNBNT_X67XB_Z!OA7_ ,)/2O\
MY&H_X67XB_Z!OA7_ ,)/2O\ Y&H XNBNT_X67XB_Z!OA7_PD]*_^1J/^%E^(
MO^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\ PD]*_P#D:C_A9?B+_H&^%?\
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M7XB_Z!OA7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\
MPD]*_P#D:C_A9?B+_H&^%?\ PD]*_P#D:@#BZ*[3_A9?B+_H&^%?_"3TK_Y&
MH_X67XB_Z!OA7_PD]*_^1J .+HKM/^%E^(O^@;X5_P#"3TK_ .1J/^%E^(O^
M@;X5_P#"3TK_ .1J .+HKM/^%E^(O^@;X5_\)/2O_D:C_A9?B+_H&^%?_"3T
MK_Y&H XNBNT_X67XB_Z!OA7_ ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\ Y&H
MXNBNT_X67XB_Z!OA7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:@#BZ*[3_A9?B+
M_H&^%?\ PD]*_P#D:C_A9?B+_H&^%?\ PD]*_P#D:@#BZ^FOV*_^2VZS_P!B
M_-_Z4V]>,_\ "R_$7_0-\*_^$GI7_P C5LZ+\:/'GAJ^?4/#MUHNCW4D9A::
MP\.Z=;R,A()4LEN"1E5..F0/2@#]2Z*\*_9F\<^*OB'\+]3UOQ=JQU._BUB6
MU27R8H=L0AA8+B-5'5V.<9YKW6@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\
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MK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
ML^[L[74+&>SO+:*YM9XVBEAF0.DB$8*LIX((X(-)Z("_[TG?-?&/@W08;KPC
MX/\ ^$!\(ZA;>+[+Q'.UQJ]IILEO!]B6ZDWI)=%5CE78%4)N8Y7&!7LVG_&B
M^G\&:UXRU3P<FG:1IMY)IJPG4Q+>3W:RK$L8C$?E@%FP6\TXP>".::U6@/1V
M/::!7D&I?$Z]LF\2^&_%W@5!JECHK:NMA:WR7=OJ%I]R0>9(D8!4Y#*R\CIN
MR <V;XS'3]*TFR\)_#^ZU21-&L]1FT_3XKAUM(YDS'!%Y%M(NX*IP'\I< 8/
M4  ]RQ25YC+\0]:U'5K[3?!O@V75[C2[:UN-1@O+T6$T1G7>L**Z,&E"<L':
M,#@;L](_!?BSQ?KWQ3\;Z)K&G6$&DZ)-!#;F&Y9I4+Q!QD>4 VX-ECN&T@*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ltbr_ex101img20.jpg
<TEXT>
begin 644 ltbr_ex101img20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M_P"BE^%?_!S;?_%T =G17&?\+8^%G_12_"O_ (.;;_XNC_A;'PL_Z*7X5_\
M!S;?_%T =G17&?\ "V/A9_T4OPK_ .#FV_\ BZ/^%L?"S_HI?A7_ ,'-M_\
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M_P"%L?"S_HI?A7_P<VW_ ,70!V=%<9_PMCX6?]%+\*_^#FV_^+H_X6Q\+/\
MHI?A7_P<VW_Q= '9T5QG_"V/A9_T4OPK_P"#FV_^+H_X6Q\+/^BE^%?_  <V
MW_Q= '9T5QG_  MCX6?]%+\*_P#@YMO_ (NC_A;'PL_Z*7X5_P#!S;?_ !=
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M_P#&*/\ ABOXI?\ 0?\ "O\ X%7/_P 8H ^9:*^FO^&*_BE_T'_"O_@5<_\
MQBC_ (8K^*7_ $'_  K_ .!5S_\ &* /F6BOIK_ABOXI?]!_PK_X%7/_ ,8H
M_P"&*_BE_P!!_P *_P#@5<__ !B@#YEHKZ:_X8K^*7_0?\*_^!5S_P#&*/\
MABOXI?\ 0?\ "O\ X%7/_P 8H ^9:*^FO^&*_BE_T'_"O_@5<_\ QBC_ (8K
M^*7_ $'_  K_ .!5S_\ &* /F6BOIK_ABOXI?]!_PK_X%7/_ ,8H_P"&*_BE
M_P!!_P *_P#@5<__ !B@#YEHKZ:_X8K^*7_0?\*_^!5S_P#&*/\ ABOXI?\
M0?\ "O\ X%7/_P 8H ^9:*^FO^&*_BE_T'_"O_@5<_\ QBC_ (8K^*7_ $'_
M  K_ .!5S_\ &* /F6BOIK_ABOXI?]!_PK_X%7/_ ,8H_P"&*_BE_P!!_P *
M_P#@5<__ !B@#YEHKZ:_X8K^*7_0?\*_^!5S_P#&*/\ ABOXI?\ 0?\ "O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAW%58]$., \XKY%_X8K^*7_0?\*_^!5S_P#&*8'S+17TU_PQ7\4O^@_X5_\
M JY_^,4?\,5_%+_H/^%?_ JY_P#C% 'S+17TU_PQ7\4O^@_X5_\  JY_^,4?
M\,5_%+_H/^%?_ JY_P#C% 'S+17TU_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H
M/^%?_ JY_P#C% 'IW[)&O:?HGP5NUOWG07OB:2VB>.VEE02-!;*H=T4K&"2
M"Y4$D#->G_'J&[O/AU;Z78V.KW=U/J5I(ITNQENI(DCG1WD^1'"E5!(W#DC
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MNYZ3H_Q*\%Z[/>0V&MX-E9KJ$S7-O+;*+9LXF5I44/'P?F4D#UJ#0?B;X/\
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M22,,BD'(8KANBY) J34-+^+6K?#G4=#^UZ'H>MFT6&VU"PNYY1+("N6.85,
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MHZD%T24Q+IFE#49M06R"@ABLLR(ZJWRXC^8+C[QS566HKLU[SXE>#=/\5?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** ,O3]-L]/CG%K&R_:)3-*[R-(\CD 9+,23P !SP
M. *U*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:1?3P1I\ZVZN@0QD')' /RXS\NVOKWO1WH6ERK_E8^3_  SI^I_\(E\/]/\
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M3&UGF"C"QD-O*$L#M4@C/HB>(+-/"TGB34(KC2[*&![F9;Z(QR0(H)8NO)'
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MD20221NI /*N>ASBL+6?CIX$T/QDWABZN)9;E+Q-/DEBFMB(YV'"&,RB8C)
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M0%$FC[E6-^%GB5IR(I@,*S\[AQA:]ZHHWW \FTKX8Z]X<U.RU?P[XPM+:_\
M[)MM)U 76DM-;WBVX*Q2JBSHT;@$C[[ YZ5BZY\%_$FLR^.O-\>62IXPCM8K
M@G1&+PK  J$$7(!8J/F.T#)R HXKW.C-.^H;'C/B#X2>*?$'B._UIO&VF6\U
M_P"'3X<F3^PY&7RFY>1?]*&&+%B!R " =V,F/3OA3XLTW5=)U"'QII;2:9X>
M;P]&AT23:\1P1(?]+SNRJ>QP>F>/:2>:,\TGJK >(Z)\&?$N@OX%>W\;:9)_
MPAD5S#:^9H<F9Q.-K;\7788QCOR<]*Y?7/AYK_A3P]X1\*W&K76I6-GJ5YJ7
M]K:;X>O)3;NX9E1EM+C[0I+ROAXW08&&SW^EL4M-Z@M#@/AG9WVF^$3I<VG6
MUAI]K*8]/:WL9K$S1%0Q=H)I))$;>SY+MN;&X@9KA]/^!NL:7?Z9J%GXVLY+
MS39-0*3W.CF22Y%VI!-PXG5I9%SP^1D # ZU[MFC/:D]7<%IL>&Z+\$=:TM/
M!5K/XTL+RP\+6UU9"'^QG1KN&X&V4,WVD[6V\ @8!Y(/2I]+^#>O:?<>#(Y/
MB$\FG^#IG;3HX=+C2=X679Y4LC.RM\GR[@B\$]\$>V44[N]Q6TL<#\1/!>K>
M.-(TW3=/UZVT@6=_#?L\]@UT9'B<.BC$L>T9'/7(Z8KD]<^$/BC7-2\9WTOC
M;38CXLTV'3;E$T20B%8P1N3-UU(9^O'(].?:2:6EY#N>+_\ "I_%7]LR:E_P
MF^E;I/#@\-E/[#DP(AD^9_Q]9W9)/ICCWJE=? F\U#P5H7AK4/$FFRMHMK#:
M6VHIHICN[=8V8^9!*L^Z.0@H#DNF4SLYKW6EIW$D>'^(/@OK^M7/CO;XVLX8
M/&*6T4RMH[R/;I  J8;[2 S%1\Q(&3R .E)X@^#OBCQ!JNO:A-XYTN%M=T./
M0[E5T*0A8UY,B_Z7PQ8MC.0 0.<9/N%%(JYX9JGP[\7:%_:/BJ#7+?6[FW\+
M'P_'IEGHNV2=54E'4R7#KNWG)!5@5RN,\U6^$V@WVB:[8_V;;M>6[VBVE[=7
M^@ZEI]Q;11IF-$DO;B0%=YQY42!!DGY< 'WOK10MV2[62//->\"ZI=>/4\:>
M%_$D6AZP]B=-NEN;'[9#<0[BR'8)(RKJQ)#;B.Q!KS&S\%ZQX5^,'AWPWX+F
MO["WT[P[<6+ZU?:#/>6LD\LPF8,ZF- Q^9@0^T$!3DG;7TA2CO0M+#O=,\DT
MKX0R>$I] O/!/B0:=?:98OIUR;^S^UQ7\;R&9BZ+)&5?S&9@5;C.,$5I6OP]
MUJ/XKKXYN/%,4T?]D?V.]L;!EF9"WF&03>=@-YA)'[O 7"XR-U>E44;@>+>$
M?@G>^%]?T+59/%5O??V7!>6LF-+\J6]2X8,7ED\TEI01RY!# #Y0<DU[/X,^
M(+'0?!FCP>.K:2'PEJ'VZW,VCDF0 $+&=LZX&&?).2201M Q7N%%%]@WOYGC
MR_!>1;2X\-_\),#X+GU8:J=):Q!G5O,$IA%QYF/*,@SCR]V.-U9M[\%?$UW9
M>(K4>.-/B76]=AUV1AH;DQ21LK",?Z5RN43WX;U&/=#11M8#RK_A5D\_Q(TS
MQM>:W8QWUG,\TTNGZ7]EN;L$$"&2592'A *_*R,WRCYZW/%7@>Y\0>*O"OB*
MQUTZ9<Z!-.V/LZS>='-'L=1D@*V.C$,!_=-=S13[>0=;GC6G_!N6SL[+PS)X
MH\_P9I^JC5;72C9 3HPD,BPM<>80T0D);'EAN@W5UWC[P9/XTTK2[>SU@:3>
M:7J=OJD$[6_VA=\1)"LFY<@Y/?\ .NVI>]2];>3N+JWW/"M6^"GB;5+7Q?9O
MX\LE7Q7>6MY.[:(Q>+R-NT#%R 2=B;C@#K@#( ZS3_ /B#1_$FK:AI?BV*WL
MM<F2ZU*T.G%F%QY:I));2>:/)W!1PXEQVKTJBJ&>?_$;P3J/CS2=*L+#7H-(
M-AJ,.I%Y[%KKS'B;<BX$L>!GKUR.F.M13^!]?M/'.I>*/#OBJ+3VUF"&+4K6
MXT_[2DCQKM66$B5#$^W(^;>O3(.*]$I:2T ^;_BU\.]=T7P/XZD\+ZMJ&H6G
MB:2*:318-)DO;A[H;0S)+&245E0%MR'D<,I(KJ=;^%M[XP7Q!JVE^*I=%L?%
M^CV]E>VMUI+&=/+5@C#S'0Q\.0R,F>N"IP1[+2T>0[]4>+7/PE\1MXC?6(?'
M5L^_PY_PC>+S1_,<Q'DRLT<\:E]Q.,*!C P3\QT+/X4ZKI_AGP5:6/BR*+7/
M""M#9Z@--)@GA90C1RP&7)RH&2LBG(R,=*]9I:9)Y;K'P_\ &&K>+?#'B9?&
MFGI=Z";B3RY='>2.:29=CX N5*($P%7)(()+-FN<LO@OXKL]-T&P7QYIC1Z+
MK<FN1DZ#)F65V=BC?Z5]W,C].>G/'/N>:6A:#W5CS3PSX!\2>$=+ET/2?&$+
M:%#)++I]M<::6GMRY++&\JS*)(E=B=NU6(XW@5S7AWX-^(O#T/@:WC\;V,\'
MA"YN9X0=$=6N5GW!U8_:3@@.^"!QQD''/MYHIBWT/&[/X-W-M\.8O ]SK]AK
M&G0W,TT,.J:*L\(1V=@&42*^\&0G>LB'@8 YSU6D^ K&S^$Z?#G5=2NM6M6L
M7LI[F5B)'1\YQDL5 W84$G  &3BNZ]J6I:O>_4=]4^QY5HOPQUNSU'0+_7/%
MD.L3>%[.:UT0MIOD^4TB"/S+C$I\Y@@"_+Y8/)ZG(U_AOX,UCP+X<N=#U'7K
M;68GNY;N*2&P:U9&ED:1PV99 PW-QC&!US7?9YH[TQ'AWB3X+:QKQ\21V'C:
M+3[#7M5AU9[>;2?.:*6,1X&\3(3S$N.!@,P()P5N7GP=U?5=6\4ZEJ7C*%;G
M6KFROK>6RTPQ-8W-I@0N-\SAUP/F4@9SP17LM%):)+L/=W,#1;+7+2&1O$6M
M6^J7CA5W6=F;6%5&>D;22'<<\G=S@8 Q7+Z;X$US0_$.LSZ'XM6VT/6KUM1N
M+":P\R:*9L>9Y,XD78KD#(9&(YP03FO2**?6X=+'C"_"GQ1;^*;/QG!XZMHO
M$\=S-)?7PTB5EO[9@H2U:+[3@1H%XQSG!&&W%N2\$>"=9\:1>*].UJ>_TKPS
M<>+)M7?3;[0I[6>]C\T21%9I2H$;%%++Y98;<97=7TGZ4F:2T:\@>JL><:+X
M!USPYJ6IQZ/XJ5- O[^34OL$UCOG@E=][I'.)5 C9LY4H3@D!AG-<P/@WKG_
M  JGQ-X"F\963CQ!?2WDEVNCNOD^:^^10GVDY^8#:<\#.0W4>VYI>U 79XO?
M_"GQA?:UJVJ/XVTI)=2T%?#\BC0I,+$,YD7_ $O[Q+-UX''!QDPI\$]8N)-)
MM];\765[IUEX?E\-R06^D/!)+;.H!<.;E@LGR)SM(X/R\\>WT9I CRF^^'/C
M#5OAM?\ @O5O'-M<1SV1TZ*Z_LAE81-@%I5%QB20*,!AL4$DE6JE#\(]>;6Y
M;[4/&%E/;S^&O^$9D@M](>)O)VG$BN;AL/N.>01CCWKV.BGZ]0.-\+>%;C0_
M %GX0U;5CJZP68L6G%N+<-$$V !06(^4=V)R2>F //X/@EJ_D^%=.O?B"\ND
M>%VECLH8=+2.>2WD0QF*61G96_=DKN"*<$GK@CW&BC=M@M+6/./#O@+Q'H/A
M<>%V\;)=Z79VKVFGE]-43Q*4*1B=C(4G" C \M,X&<UQE[\ YIO"_BG0=-\4
M6&CP>(9[>22"RTETM+=86WYC@^T861F"[G!"X7 0=1[W13OK?J"T/FOQ;X=U
M+5OBAJ3ZU:W+%;2RM4_XI?4;RRU'8"Y/^B7*1[/,/^KN6?;CJ!UZ>Z^%_C+Q
M)?ZUXBU+Q)I>CW_B/P^NBW5BFE/.+12"6*N+D!FRS]L=.N,GVVBE;0.MSDO"
M.A:_X?T73M'U+6K#4+2PLHK2,V^GO;2,R<!R3,XQL"C:!U!.<':.M[4O%%&[
MN)*P4444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 >9>-/BQI_@F/5KS4/"^O
MWNFZ.D+7FH626WDQF4@*H\R9'9LD9"J<9&:UO"?CJ/Q9,8D\-:QHVZSAU""3
M45@V7$,N=K(T,L@SQR#@C(R.:X/]I[4K&S^ &OV=U>P07%Z8([:*20*\[">-
MB$!Y8A02<= ,TS4/%GAO3_V7]$UJ;7]3BT];&RM6N?#MRBS^8%1#%YO(C^8%
M6.05YP0:B+O=OH[#:VMU/=*XOQEX_P!-\"G0VU;2]0N(=9U"/3(I;18V6&:0
M_)YFYU(!YY4-]T^V?"?".N^)-8\'_$[P_P#\)Q/ILFG:W''IUS>WUS<^1$6W
M>6;GB<0L%V^;D%5)8$5C^//%UK<?!CP->,[QW$'C2-D74M9-ZDXA9]TD5V^6
MDMP64"0YV@X.<<UU7R^YB_X/X'V)VI*^7M.\1KXA\&>)K6/Q[=:#XZBU3_B;
M65]K%RUI;;)&9H8I(W/V>W958&5""O0D8 KV#X2ZP-<^&NGWZ1ZA$OF3I_IU
M^U^S8E892X;F:/\ N.>JXZ]:?2XKG?TOK7R5HOC]KCXY^"V\/^*/$<FB:K?:
ME9ZA_;6I._GLB_*/(P(H K<)MPY&-P!Z\3H_Q(O+#4-*NE^)6I2M'X^:T\NZ
MUR66,Z5\HRZNY#1_[;9 [$<T+6WF/N?77C[QM8_#OPE<>*M1TV_U#3[5E%P+
M'RFDB5C@.1(Z9&2!P2>1QC)&C=ZX(_#+:];Z7=ZA'Y*W*VEOY8F<$ X'F.J9
M .>6'3C/%?)GQ0URXU*#XX6/B+Q+J*WEC/91Z5I1OI!#Y!*Y98 =C C:Q;;P
M<'()KZ9CUK2;;X/V^M7&J6L6F'2HV^V/,JQ8,8 .\G')( ]S4.]F_2P:.27W
MG(:;^T/X0U'P]8>*+K0O$.D^&[ZY-I'J]Y! ;=)0<;9/*F=T&>[*!QUKTA?$
M4;>+T\.QZ/J;H]G]M75%M\V6-VWR_-S_ *S^+;CISFOC+P_J^FZM^Q>?A[I$
MB:MXLU742EMI%H1-<)BY5_,9!DHFU3\S8'/6O4-#6\M/V@].^&=[XNU)(?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 5Y 6B8*Q0D$!EQD>XSQ7&?#WX=V'PYT[4-/TS6M5U*WO[MKU
MUU$PL4F?[[*8XD/S<9!R!CC'.>[H-): %%%%, HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]PS0#FDKJWDK#>M_,X?Q1HWB:^U*Y:SL]#US1+FUCMYM&U@O''(X9RTGF!)
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MZ/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\
MAM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3X
MI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\
M0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*
M_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@
M+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__
M !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^O
MF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@
M#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_
MX;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^
M*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0
M \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_
M^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS
M_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'
MZ/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\
MAM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3X
MI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\
M0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*
M_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@
M+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__
M !^OF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^O
MF6B@#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@
M#Z:_X;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_
MX;4^*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^
M*7_0 \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0
M \*_^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_
M^ MS_P#'Z/\ AM3XI?\ 0 \*_P#@+<__ !^OF6B@#Z:_X;4^*7_0 \*_^ MS
M_P#'Z]]_9S^-'BGXN?\ "3_\)-8:5:?V1]E\G^SXI$W>;YV[=OD?/^K7&,=3
MUK\Z*^S/V&?^:@_]P[_VYH ^S**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M _,[_AESXZ_]"+_Y4[/_ ./4?\,N?'7_ *$7_P J=G_\>KQBB@#V?_AESXZ_
M]"+_ .5.S_\ CU'_  RY\=?^A%_\J=G_ /'J\8HH ]G_ .&7/CK_ -"+_P"5
M.S_^/4?\,N?'7_H1?_*G9_\ QZO&** /9_\ AESXZ_\ 0B_^5.S_ /CU'_#+
MGQU_Z$7_ ,J=G_\ 'J\8HH ]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\
M*G9__'J\8HH ]G_X9<^.O_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZO&*
M* /9_P#AESXZ_P#0B_\ E3L__CU'_#+GQU_Z$7_RIV?_ ,>KQBB@#V?_ (9<
M^.O_ $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !ZO&** /9_^&7/CK_T(O_E3
ML_\ X]1_PRY\=?\ H1?_ "IV?_QZO&** /9_^&7/CK_T(O\ Y4[/_P"/4?\
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MY\=?^A%_\J=G_P#'J\8HH ]G_P"&7/CK_P!"+_Y4[/\ ^/4?\,N?'7_H1?\
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M*[3^T/A9_P!";XJ_\*:V_P#D"C^T/A9_T)OBK_PIK;_Y H XNBNT_M#X6?\
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MK_PIK;_Y H XNBNT_M#X6?\ 0F^*O_"FMO\ Y H_M#X6?]";XJ_\*:V_^0*
M.+HKM/[0^%G_ $)OBK_PIK;_ .0*/[0^%G_0F^*O_"FMO_D"@#BZ*[3^T/A9
M_P!";XJ_\*:V_P#D"C^T/A9_T)OBK_PIK;_Y H XNBNT_M#X6?\ 0F^*O_"F
MMO\ Y H_M#X6?]";XJ_\*:V_^0* .+HKM/[0^%G_ $)OBK_PIK;_ .0*/[0^
M%G_0F^*O_"FMO_D"@#BZ*[3^T/A9_P!";XJ_\*:V_P#D"C^T/A9_T)OBK_PI
MK;_Y H XNBNT_M#X6?\ 0F^*O_"FMO\ Y H_M#X6?]";XJ_\*:V_^0* .+HK
MM/[0^%G_ $)OBK_PIK;_ .0*/[0^%G_0F^*O_"FMO_D"@#BZ*[3^T/A9_P!"
M;XJ_\*:V_P#D"C^T/A9_T)OBK_PIK;_Y H XNBNT_M#X6?\ 0F^*O_"FMO\
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MHOV;3WOOM']M6UQNVR1ILV_8TQ_K,YSVZ<T ?/M%??\ _P ,5?"W_H/^*O\
MP*MO_C%'_#%7PM_Z#_BK_P "K;_XQ0!\ 5^S%?,W_#%7PM_Z#_BK_P "K;_X
MQ7TS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'XST444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7TU^Q7_P EMUG_ +%^;_TIMZ^9:^FOV*_^2VZS_P!B_-_Z4V] 'W]1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!^3?_  MCXI?]%+\5?^#FY_\
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M?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\ \77%T4 =I_PMCXI?]%+\5?\
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M =I_9_PL_P"AR\5?^$S;?_)]']G_  L_Z'+Q5_X3-M_\GUQ=% ':?V?\+/\
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MVW_R?1_9_P +/^AR\5?^$S;?_)]<710!VG]G_"S_ *'+Q5_X3-M_\GT?V?\
M"S_H<O%7_A,VW_R?7%T4 =I_9_PL_P"AR\5?^$S;?_)]']G_  L_Z'+Q5_X3
M-M_\GUQ=% ':?V?\+/\ H<O%7_A,VW_R?1_9_P +/^AR\5?^$S;?_)]<710!
MVG]G_"S_ *'+Q5_X3-M_\GT?V?\ "S_H<O%7_A,VW_R?7%T4 =I_9_PL_P"A
MR\5?^$S;?_)]']G_  L_Z'+Q5_X3-M_\GUQ=% ':?V?\+/\ H<O%7_A,VW_R
M?1_9_P +/^AR\5?^$S;?_)]<710!VG]G_"S_ *'+Q5_X3-M_\GT?V?\ "S_H
M<O%7_A,VW_R?7%T4 =I_9_PL_P"AR\5?^$S;?_)]']G_  L_Z'+Q5_X3-M_\
MGUQ=% ':?V?\+/\ H<O%7_A,VW_R?1_9_P +/^AR\5?^$S;?_)]<710!VG]G
M_"S_ *'+Q5_X3-M_\GT?V?\ "S_H<O%7_A,VW_R?7%T4 =I_9_PL_P"AR\5?
M^$S;?_)]']G_  L_Z'+Q5_X3-M_\GUQ=% ':?V?\+/\ H<O%7_A,VW_R?6[X
M5N_A=X7\::%XF_X2;Q5=_P!DZA;WWD?\(];)YOE2*^S=]N.W.W&<'&>AKRZB
M@#[_ /\ AM7X6_\ 0 \5?^ MM_\ 'Z]9^&7Q/T'XJ>&+GQ!X=L]0MK2WO&LW
M2^C1)"ZHCD@([#&)%[YSGBORGK[^_8J_Y(CK/_8P3?\ I-;T ?35%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?C/17L_\ PU'\=?\ H>O_ "F6?_QFC_AJ
M/XZ_]#U_Y3+/_P",T >,45[/_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\
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M  &U7_Y"H_X0WP[_ -%8\*_^ VJ__(5 '&45V?\ PAOAW_HK'A7_ ,!M5_\
MD*C_ (0WP[_T5CPK_P" VJ__ "%0!QE%=G_PAOAW_HK'A7_P&U7_ .0J/^$-
M\._]%8\*_P#@-JO_ ,A4 <9179_\(;X=_P"BL>%?_ ;5?_D*C_A#?#O_ $5C
MPK_X#:K_ /(5 '&45V?_  AOAW_HK'A7_P !M5_^0J/^$-\._P#16/"O_@-J
MO_R%0!QE%=G_ ,(;X=_Z*QX5_P# ;5?_ )"H_P"$-\._]%8\*_\ @-JO_P A
M4 <9179_\(;X=_Z*QX5_\!M5_P#D*C_A#?#O_16/"O\ X#:K_P#(5 '&45V?
M_"&^'?\ HK'A7_P&U7_Y"H_X0WP[_P!%8\*_^ VJ_P#R%0!QE%=G_P (;X=_
MZ*QX5_\  ;5?_D*C_A#?#O\ T5CPK_X#:K_\A4 <9179_P#"&^'?^BL>%?\
MP&U7_P"0J/\ A#?#O_16/"O_ (#:K_\ (5 '&45V?_"&^'?^BL>%?_ ;5?\
MY"H_X0WP[_T5CPK_ . VJ_\ R%0!QE%=G_PAOAW_ **QX5_\!M5_^0J/^$-\
M._\ 16/"O_@-JO\ \A4 <9179_\ "&^'?^BL>%?_  &U7_Y"H_X0WP[_ -%8
M\*_^ VJ__(5 '&45V?\ PAOAW_HK'A7_ ,!M5_\ D*C_ (0WP[_T5CPK_P"
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MJ_\ R%0!QE%=G_PAOAW_ **QX5_\!M5_^0J/^$-\._\ 16/"O_@-JO\ \A4
M<9179_\ "&^'?^BL>%?_  &U7_Y"H_X0WP[_ -%8\*_^ VJ__(5 '&45V?\
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MJZC&<\T >145]-?\,5_%+_H/^%?_  *N?_C%'_#%?Q2_Z#_A7_P*N?\ XQ0
M?L5_\EMUG_L7YO\ TIMZ^_J^6_V?_P!G_P 9?"GXBW_B+Q%J>CW-I<:7)9*E
MA-*\@=I8G!(>)1C$;=\YQQ7U)0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XS
MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7TU^Q7_R6W6?^Q?F_]*;>OF6OIK]BO_DMNL_]
MB_-_Z4V] 'W]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^9W_"_?
M^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME>,44 >S_\+]_ZHM\*O_"<_P#M
ME'_"_?\ JBWPJ_\ "<_^V5XQ10![/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K
M_P )S_[97C%% 'L__"_?^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME>,44
M>S_\+]_ZHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^V5XQ10![/_POW_JBWPJ_
M\)S_ .V4?\+]_P"J+?"K_P )S_[97C%% 'L__"_?^J+?"K_PG/\ [91_POW_
M *HM\*O_  G/_ME>,44 >S_\+]_ZHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^
MV5XQ10![/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K_P )S_[97C%% 'L__"_?
M^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME>,44 >S_\+]_ZHM\*O_"<_P#M
ME'_"_?\ JBWPJ_\ "<_^V5XQ10![/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K
M_P )S_[97C%% 'L__"_?^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME>,44
M>S_\+]_ZHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^V5XQ10![/_POW_JBWPJ_
M\)S_ .V4?\+]_P"J+?"K_P )S_[97C%% 'L__"_?^J+?"K_PG/\ [91_POW_
M *HM\*O_  G/_ME>,44 >S_\+]_ZHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^
MV5XQ10![/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K_P )S_[97C%% 'L__"_?
M^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME>,44 >S_\+]_ZHM\*O_"<_P#M
ME'_"_?\ JBWPJ_\ "<_^V5XQ10![/_POW_JBWPJ_\)S_ .V4?\+]_P"J+?"K
M_P )S_[97C%% 'L__"_?^J+?"K_PG/\ [91_POW_ *HM\*O_  G/_ME>,44
M>S_\+]_ZHM\*O_"<_P#ME'_"_?\ JBWPJ_\ "<_^V5XQ10!]2_!WXC:7\0OB
MYHG@_6OA#\.+>PO_ #_-DL_#ZK*NR"20;2S,.J#.0>,U]@?\*G^%G_1-/"O_
M ()K;_XBO@']EO\ Y.;\(_\ ;Y_Z1S5^F- '&?\ "I_A9_T33PK_ .":V_\
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M (BC_A4_PL_Z)IX5_P#!-;?_ !%=G10!QG_"I_A9_P!$T\*_^":V_P#B*/\
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M<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\ *G9__'J_3&B@#\SO^&7/CK_T(O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH
M]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\
MY3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C
M%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK
M_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\
MC%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&
M:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^
MJJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y
M3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_X
MQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\
M9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_J
MJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4
MZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_
M *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^4ZO&:* /
M9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^,6O^JJ_^
M4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_ZJK_Y3J/^
M,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH ]F_XQ:_Z
MJK_Y3J/^,6O^JJ_^4ZO&:* /9O\ C%K_ *JK_P"4ZC_C%K_JJO\ Y3J\9HH
M]F_XQ:_ZJK_Y3J]-^%?P9^!/Q?\ [7_X1G4/'MI_9)A\_P#M&6R3=YN_;MV1
MOG_5MG..HZU\F5]F?L,_\U!_[AW_ +<T =G_ ,,5?"W_ *#_ (J_\"K;_P",
M5ZS\,OAAH/PK\,7/A_P[>:A<VEQ>->.]](CR!V1$(!1%&,1KVSG/->@44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^,]%=I_PMCXI?\
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MZ*7XJ_\ !S<__%T <717:?\ "V/BE_T4OQ5_X.;G_P"+H_X6Q\4O^BE^*O\
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M%?\ EHWG_P 50!XS17LW_"O/@3_T<5_Y:-Y_\51_PKSX$_\ 1Q7_ ):-Y_\
M%4 >,T5[-_PKSX$_]'%?^6C>?_%4?\*\^!/_ $<5_P"6C>?_ !5 'C-%>S?\
M*\^!/_1Q7_EHWG_Q5'_"O/@3_P!'%?\ EHWG_P 50!XS17LW_"O/@3_T<5_Y
M:-Y_\51_PKSX$_\ 1Q7_ ):-Y_\ %4 >,T5[-_PKSX$_]'%?^6C>?_%4?\*\
M^!/_ $<5_P"6C>?_ !5 'C-%>S?\*\^!/_1Q7_EHWG_Q5'_"O/@3_P!'%?\
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M5'_"O/@3_P!'%?\ EHWG_P 50!XS17LW_"O/@3_T<5_Y:-Y_\51_PKSX$_\
M1Q7_ ):-Y_\ %4 >,T5[-_PKSX$_]'%?^6C>?_%4?\*\^!/_ $<5_P"6C>?_
M !5 'C-%>S?\*\^!/_1Q7_EHWG_Q5'_"O/@3_P!'%?\ EHWG_P 50!XS17LW
M_"O/@3_T<5_Y:-Y_\51_PKSX$_\ 1Q7_ ):-Y_\ %4 >,T5[-_PKSX$_]'%?
M^6C>?_%4?\*\^!/_ $<5_P"6C>?_ !5 'C-%>S?\*\^!/_1Q7_EHWG_Q5'_"
MO/@3_P!'%?\ EHWG_P 50!XS17LW_"O/@3_T<5_Y:-Y_\51_PKSX$_\ 1Q7_
M ):-Y_\ %4 >,T5[-_PKSX$_]'%?^6C>?_%4?\*\^!/_ $<5_P"6C>?_ !5
M'C-%>S?\*\^!/_1Q7_EHWG_Q5'_"O/@3_P!'%?\ EHWG_P 50!XS17N^D_"G
MX-ZYK5AH^E_'W[1?W]Q':V\7_"*W:^9([!47+. ,D@9) KU7_AAC_JJ/_E$_
M^Z* /LRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /QGHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#M?A3_R6_P !_P#8P6'_ *4I7ZQU^3GPI_Y+?X#_ .Q@L/\
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M .":V_\ B*[.B@#C/^%3_"S_ *)IX5_\$UM_\11_PJ?X6?\ 1-/"O_@FMO\
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M3_"S_HFGA7_P36W_ ,11_P *G^%G_1-/"O\ X)K;_P"(KLZ* .,_X5/\+/\
MHFGA7_P36W_Q%'_"I_A9_P!$T\*_^":V_P#B*[.B@#C/^%3_  L_Z)IX5_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .6UCQUX)\/WYT_7O&&B:3>!0YM[[4(8)-I
MZ':[ X/K4VA^+O"GB::=/#?B;2M8:W ,RV%[%<&,'."VQCC.#U]*\P_:2TVQ
MM_@'XVU""W5+N\6T$\R_>D"3QA03Z 9X]SZUN:8W]A_!G2?%.EG1;'6%T"RA
M-_K,K0VRQJBD>:R\X&YB!ZG&1FI3O>_1C:U5NIZG6-J7B#0=#GLX-:UJPTV6
M]D\JUCNKE(6N'X&U Q&X\C@9ZBO'O#_Q:\;ZUI7Q$L['0[/6==\+2PK9FTLY
MK9;Q) 3DV\LA<,JJQV[P6X QUKDOB5XR_P"$B^&O@S7=0U*SOGL_'%I',UEI
M\]J\&P,6CDMY&>1)1SE06SQC.:;T:^7XB[^1]4UB3^(O#]KKL&@W&O:?!J]P
MNZ&PDND6>4>JQD[B.#T%<O\ #CQ5JWC;2KOQ--?Z5-HMS<.FG6]K;21W,"*Q
M&VY+2,/,Z94*,=>^!Q?Q*\ ^'?$GCWPY_9>F6MGKEIJD>N:MK0&V6"TBSQ)+
MU^<A512< (Q& II_:28NC?8]VKFM8\:^#_#=ZEEXB\6:-H]RZ>8D-_?Q6[LF
M2-P5V!(R",^QI\?_  E7_"9W'G?V3_PBWV1?(V>;]M^T9YW?P>7CICG->)?M
M+&=;[X9/;PQRW2^)(?*220QJS9& 6"L5!.,D X]#2ZKS=BEU]+GN&A^+/"_B
M=IQX;\3:5K7V<+YW]GWD=QY6[.-VQCC.#C/H:LZOKNB>']/^WZ_K%EI-EN"?
M:+VX2"/<>@W.0,GTKAHKWQ)IO@#6/%NKV.@:%XM+2PRS:C.T=E'#'<.(=\JJ
M&=1&V0< L3_#GCQ[QM\0M:\9?!;XO:#KD5C)+X>>TCBN[2UFM5N8Y)%8$PRL
MS(1M_O=_S'I>W02U:OLSZHAECN(DFA=9(W4,KJ<A@>00>XJ&]OK'2]/GU'4K
MR&RM+=#)-/<2"..-1U+,< #W->/:#X[\3V7BD> ;Y=+FF_X11-:L;V"WD"PD
M'9Y<R&0F0=#N!3// SQS"_$;XD>)/V<[KXCZAI_@Z;37TVYDN-.N+&XF69DG
MV!2AEVE&0/D$G!"GD$@/:XETOU/HFUN+>[M8KRUG2>WF021RQL&1U(R&!'!!
M'>KF.:\(M?B5XHU*_P#!W@GPC8Z#IFL:CX7CUUFOH)?L:Y4!+>)(W5E&<_-E
MMJC[K4GQ4^*GC/X>6$VI1R^&)FLK>UEN-*1;FYN)"[JDK%U*+;Q@MA&=6W^@
M/%#T=@6NWJ>]5EZ=JVE:M%-+I.J6FH1P2M;RO:SK*(Y%^\C%2<,.X/(KQN]\
M1>,-2_:HTC0;'6+2TTF+PX=26VFLWE!\R15<';*N7^7Y7Z*"1M.23R_A#XN>
M(O[*L=+T_0_#>EZKK/BZZT=I[/3Y([5=BJSSO")0SR,3_?&>YXHL%SZ?-+7S
M9K7QR\86/PNO?$%A8Z-_;.C^)F\.W\<T4IM[@@X\V+$@:/.0<,7QS7H'PU\>
M:]XI\3>./#VMPV(G\-:BMI'/9QO&LR,"1E7=R&&T\YP<]!1:X]CL5\7>%9/$
MG_"-IXFTIM<#$'31>QFY!"[B/*W;ON\].G-+K?B[PIX9EAC\1>)M*T9K@$PK
M?WL=OY@&,[=[#.,CIZUX=^T%I-[9ZC;?$O0X<ZOX.-C><9S);M+,)4..H^Z3
M[;JP/B-J5KXF^,GP6\86;B6QU352+)L8)@0PX)![EVD/TVU*UMZV8/3[KH^K
M(Y$D19(V#(PRI4Y!%2]Z\!\6?&3Q-HNK_$*YTW3M,.D>!GL5N+>YCD,]^)_O
ME)%<+%C(QE'SCG&>-D?$;Q=XG^(VK^%? <&BP#1;6SNKC^VDFW78G <JC1L/
M+VH?O%7RQ P!S3W#U/2M-\0Z#K5W>VNCZY8:E<6$GE7<5K<I*]L^2-L@4DH<
MJ>#CH?2MG':OE2P\:3>%_CW\3M*TFXL+/6]=U?3;6SFU.WD>S0^0Q;S61EP2
M,A1NRS$<8R1VWC+XE>//#'C[5_#<#Z%<K9^$9?$$<TEC,I,T1PZ$"?[C;6QS
ME=PY;:=Q]E/NKA:\FNQ[L>U%?/-G\5OB%JU[\*K2P7P];-XWT^>:X:>RFD%M
M+$A<L@$XW*01\IYX/S<\=[\)_'&J^.O#.JW6M6UI%J&F:M<Z9(UFC+%)Y3##
MJ&9B,@CN>156%?8]+HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH Y3QAX)\.^.]'_L7Q3:SWNG%@SV\=Y/;I(1R-XB==X!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"[5?)MYKR.-YBW38K,"P)Z8ZU!J'CWP3I.HW6GZGXRT.QN[10UQ;W.HPQR0
MXP75F!4'<O7U'K7AOC+X=^.KB?QY/IOA.;5AXQT*QMH8_M5LC:=<0JJM'+OD
M _V@T989'XUE^,OAO\1;KQ?J]U;^#KG68Y_!:>'8KX7=HOFW>%W2XDF#!?O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVW_R?1_9_P +/^AR\5?^$S;?_)]<710!VG]G_"S_ *'+Q5_X3-M_\GT?V?\
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MY3+/_P",T >,45[/_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\ E,L__C-
M'C%%>S_\-1_'7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#XS0!XQ17L_P#P
MU'\=?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,T >,45[/_ ,-1_'7_ *'K
M_P IEG_\9H_X:C^.O_0]?^4RS_\ C- 'C%%>S_\ #4?QU_Z'K_RF6?\ \9H_
MX:C^.O\ T/7_ )3+/_XS0!XQ17L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#
MU_Y3+/\ ^,T >,45[/\ \-1_'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C
M- 'C%%>S_P##4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S0!XQ17L__
M  U'\=?^AZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,T >,45[/_PU'\=?^AZ_
M\IEG_P#&:/\ AJ/XZ_\ 0]?^4RS_ /C- 'C%%>S_ /#4?QU_Z'K_ ,IEG_\
M&:/^&H_CK_T/7_E,L_\ XS0!XQ17L_\ PU'\=?\ H>O_ "F6?_QFC_AJ/XZ_
M]#U_Y3+/_P",T >,45[/_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\ E,L_
M_C- 'C%%>S_\-1_'7_H>O_*99_\ QFC_ (:C^.O_ $/7_E,L_P#XS0!XQ17L
M_P#PU'\=?^AZ_P#*99__ !FC_AJ/XZ_]#U_Y3+/_ .,T >,45[/_ ,-1_'7_
M *'K_P IEG_\9H_X:C^.O_0]?^4RS_\ C- 'C%%>S_\ #4?QU_Z'K_RF6?\
M\9H_X:C^.O\ T/7_ )3+/_XS0!XQ17L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK
M_P!#U_Y3+/\ ^,T >,45[/\ \-1_'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS
M_P#C- 'C%%>S_P##4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S0!XQ1
M7L__  U'\=?^AZ_\IEG_ /&:/^&H_CK_ -#U_P"4RS_^,T >,45[/_PU'\=?
M^AZ_\IEG_P#&:/\ AJ/XZ_\ 0]?^4RS_ /C- 'C%%>S_ /#4?QU_Z'K_ ,IE
MG_\ &:/^&H_CK_T/7_E,L_\ XS0!XQ17L_\ PU'\=?\ H>O_ "F6?_QFC_AJ
M/XZ_]#U_Y3+/_P",T >,45[/_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\
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M/:ON:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q
MC]J/_DV3Q=_VY_\ I9#7YG5^G?[1EI#J'[/?B>SO-4M-)AD^R[KN[65HH\74
M)&X1([\D8&%/)&<#)'Y[_P#"&^'?^BL>%?\ P&U7_P"0J .,HKL_^$-\._\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIXB_Z"7A7_PK-*_^2:/^%:>(O^@EX5_\*S2O_DFN+HH [3_A6GB+_H)>%?\
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MA%_\J=G_ /'J_3&B@#\SO^&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\
MQZOTQHH _,[_ (9<^.O_ $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !ZOTQHH
M _,[_AESXZ_]"+_Y4[/_ ./4?\,N?'7_ *$7_P J=G_\>K],:* /S._X9<^.
MO_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZOTQHH _,[_AESXZ_P#0B_\
ME3L__CU'_#+GQU_Z$7_RIV?_ ,>K],:* /S._P"&7/CK_P!"+_Y4[/\ ^/4?
M\,N?'7_H1?\ RIV?_P >K],:* /S._X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A
M%_\ *G9__'J_3&B@#\SO^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\
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MX9<^!?\ T(W_ )4[S_X]0!^9U%?IC_PRY\"_^A&_\J=Y_P#'J/\ AESX%_\
M0C?^5.\_^/4 ?F=17Z8_\,N? O\ Z$;_ ,J=Y_\ 'J/^&7/@7_T(W_E3O/\
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M )4[S_X]0!^9U%?IC_PRY\"_^A&_\J=Y_P#'J/\ AESX%_\ 0C?^5.\_^/4
M?F=7Z8_LN?\ )LGA'_M\_P#2R:C_ (9<^!?_ $(W_E3O/_CU>D>%_"^A^#_#
M5IX;\.V/V'2[/?Y-OYKR;-[L[?,Y+'+,QY/>@#?HHHH **** "BBB@ HHHH
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M='_"V/A9_P!%+\*_^#FV_P#BZ_)JB@#]9?\ A;'PL_Z*7X5_\'-M_P#%T?\
M"V/A9_T4OPK_ .#FV_\ BZ_)JB@#]9?^%L?"S_HI?A7_ ,'-M_\ %T?\+8^%
MG_12_"O_ (.;;_XNOR:HH _67_A;'PL_Z*7X5_\ !S;?_%T?\+8^%G_12_"O
M_@YMO_BZ_)JB@#]9?^%L?"S_ **7X5_\'-M_\71_PMCX6?\ 12_"O_@YMO\
MXNOR:HH _67_ (6Q\+/^BE^%?_!S;?\ Q='_  MCX6?]%+\*_P#@YMO_ (NO
MR:HH _67_A;'PL_Z*7X5_P#!S;?_ !='_"V/A9_T4OPK_P"#FV_^+K\FJ* /
MUE_X6Q\+/^BE^%?_  <VW_Q='_"V/A9_T4OPK_X.;;_XNOR:HH _67_A;'PL
M_P"BE^%?_!S;?_%T?\+8^%G_ $4OPK_X.;;_ .+K\FJ* /UE_P"%L?"S_HI?
MA7_P<VW_ ,71_P +8^%G_12_"O\ X.;;_P"+K\FJ* /UE_X6Q\+/^BE^%?\
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M_)JB@#]9?^%L?"S_ **7X5_\'-M_\71_PMCX6?\ 12_"O_@YMO\ XNOR:HH
M_67_ (6Q\+/^BE^%?_!S;?\ Q='_  MCX6?]%+\*_P#@YMO_ (NOR:HH _67
M_A;'PL_Z*7X5_P#!S;?_ !='_"V/A9_T4OPK_P"#FV_^+K\FJ* /UE_X6Q\+
M/^BE^%?_  <VW_Q='_"V/A9_T4OPK_X.;;_XNOR:HH _67_A;'PL_P"BE^%?
M_!S;?_%T?\+8^%G_ $4OPK_X.;;_ .+K\FJ* /UE_P"%L?"S_HI?A7_P<VW_
M ,71_P +8^%G_12_"O\ X.;;_P"+K\FJ* /UE_X6Q\+/^BE^%?\ P<VW_P 7
M1_PMCX6?]%+\*_\ @YMO_BZ_)JB@#]9?^%L?"S_HI?A7_P '-M_\71_PMCX6
M?]%+\*_^#FV_^+K\FJ* /UE_X6Q\+/\ HI?A7_P<VW_Q='_"V/A9_P!%+\*_
M^#FV_P#BZ_)JB@#]9?\ A;'PL_Z*7X5_\'-M_P#%T?\ "V/A9_T4OPK_ .#F
MV_\ BZ_)JB@#]9?^%L?"S_HI?A7_ ,'-M_\ %T?\+8^%G_12_"O_ (.;;_XN
MOR:HH _67_A;'PL_Z*7X5_\ !S;?_%T?\+8^%G_12_"O_@YMO_BZ_)JB@#]9
M?^%L?"S_ **7X5_\'-M_\71_PMCX6?\ 12_"O_@YMO\ XNOR:HH _67_ (6Q
M\+/^BE^%?_!S;?\ Q='_  MCX6?]%+\*_P#@YMO_ (NOR:HH _67_A;'PL_Z
M*7X5_P#!S;?_ !='_"V/A9_T4OPK_P"#FV_^+K\FJ* /UE_X6Q\+/^BE^%?_
M  <VW_Q='_"V/A9_T4OPK_X.;;_XNOR:HH _67_A;'PL_P"BE^%?_!S;?_%T
M?\+8^%G_ $4OPK_X.;;_ .+K\FJ* /UJTOXA>!=:U*+2]$\;:!J>H3D^7:V>
MIPS2R84L=J*Q)P 2<#H":ZZOS._9;_Y.;\(_]OG_ *1S5^F- !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XQ^U'_P FR>+O
M^W/_ -+(:_,ZOU(^/&H:'I?P/\0ZAXD\/?\ "1Z3%]F\_3?MCVGG9N8@O[U
M67#%6XZ[<=Z^'?\ A8?P)_Z-U_\ +NO/_B: /&:*]F_X6'\"?^C=?_+NO/\
MXFC_ (6'\"?^C=?_ "[KS_XF@#QFBO9O^%A_ G_HW7_R[KS_ .)H_P"%A_ G
M_HW7_P NZ\_^)H \9HKV;_A8?P)_Z-U_\NZ\_P#B:/\ A8?P)_Z-U_\ +NO/
M_B: /&:*]F_X6'\"?^C=?_+NO/\ XFC_ (6'\"?^C=?_ "[KS_XF@#QFBO9O
M^%A_ G_HW7_R[KS_ .)H_P"%A_ G_HW7_P NZ\_^)H \9HKV;_A8?P)_Z-U_
M\NZ\_P#B:/\ A8?P)_Z-U_\ +NO/_B: /&:*]F_X6'\"?^C=?_+NO/\ XFC_
M (6'\"?^C=?_ "[KS_XF@#QFBO9O^%A_ G_HW7_R[KS_ .)H_P"%A_ G_HW7
M_P NZ\_^)H \9HKV;_A8?P)_Z-U_\NZ\_P#B:/\ A8?P)_Z-U_\ +NO/_B:
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M_P"/4?\ #+GP+_Z$;_RIWG_QZ@#XU_9;_P"3F_"/_;Y_Z1S5^F->7>&_@/\
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MZ)IXJ_\ !-<__$4 <717:?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\
MP37/_P 10!Q=%=I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\
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MBC_A4_Q2_P"B:>*O_!-<_P#Q% '%T5VG_"I_BE_T33Q5_P"":Y_^(H_X5/\
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MRS1V\+332+'&BEG=CA5 Y))/05R]O\3OAK>7"VUK\0O#5Q/(=J11:M;LSGT
M#Y-&X'94444 %%%% !1110 4444 %%%9<VKZ99ZA9Z;>:E:P7]]N%M;2S*DD
M^T9;8I.6P.3C.* -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX\;#P#\8/$^IS:#KMMI>N-9-IFJ:3)-#,D;1QA0// 5-O.TJQW9)8YKZ%F\
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MK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5
M\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"
MW_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_
M  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]
M'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_
MZ 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%
MMO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!
M],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\
M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H
M>*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %M
MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:
MOPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'B
MK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5
M\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"
MW_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_
M  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]
M'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_
MZ 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%
MMO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!
M],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\
M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H
M>*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %M
MO_C]'_#:OPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:
MOPM_Z 'BK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'B
MK_P%MO\ X_0!],T5\S?\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX.;G_P"+KBZ* .T_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\ 12_%7_@YN?\
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M -%8\*_^ VJ__(5'_"&^'?\ HK'A7_P&U7_Y"KC** .S_P"$-\._]%8\*_\
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M>%?_  &U7_Y"KC** .S_ .$-\._]%8\*_P#@-JO_ ,A4?\(;X=_Z*QX5_P#
M;5?_ )"KC** .S_X0WP[_P!%8\*_^ VJ_P#R%1_PAOAW_HK'A7_P&U7_ .0J
MXRB@#L_^$-\._P#16/"O_@-JO_R%1_PAOAW_ **QX5_\!M5_^0JXRB@#L_\
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M_@-JO_R%1_PAOAW_ **QX5_\!M5_^0JXRB@#L_\ A#?#O_16/"O_ (#:K_\
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MPK_X2>E?_(U'_"R_$7_0-\*_^$GI7_R-0!Q=%=I_PLOQ%_T#?"O_ (2>E?\
MR-1_PLOQ%_T#?"O_ (2>E?\ R-0!Q=%=I_PLOQ%_T#?"O_A)Z5_\C4?\++\1
M?] WPK_X2>E?_(U '%T5VG_"R_$7_0-\*_\ A)Z5_P#(U'_"R_$7_0-\*_\
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MOQ%_T#?"O_A)Z5_\C4?\++\1?] WPK_X2>E?_(U '%T5VG_"R_$7_0-\*_\
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MS) &&&53P>U?H'I>E:;H>EPZ7HVFVNFV$)/E6MI L,4>6+':B@ 9)).!U)-
M&K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?_
M ";)XN_[<_\ TLAK\SJ_4CX\:!_PDWP.\0Z'_;6E:)]I^S?Z=J]S]GM8MMS$
M_P \F#MSMVCCDD#O7P]_PH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C
M_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"J
MT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M=
M'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM
M/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_
MPH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\
M"C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L_
M_"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C
M_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"J
MT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M=
M'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM
M/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_
MPH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\
M"C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L_
M_"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C
M_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"J
MT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M=
M'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM
M/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_
MPH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\
M"C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L_
M_"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M= 'C%%>S_\*"_ZK3\*O_"C
M_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM/PJ_\*/_ .UT?\*"_P"J
MT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_PH+_ *K3\*O_  H__M=
M'C%%>S_\*"_ZK3\*O_"C_P#M='_"@O\ JM/PJ_\ "C_^UT >,45[/_PH+_JM
M/PJ_\*/_ .UT?\*"_P"JT_"K_P */_[70!XQ17L__"@O^JT_"K_PH_\ [71_
MPH+_ *K3\*O_  H__M= 'C%%?1&B_LI>,O$FGO>>'?&_@C6;5)#"T]AJDMQ&
MK@ E2R0D X93CK@CUK2_X8K^*7_0?\*_^!5S_P#&* /F6BOIK_ABOXI?]!_P
MK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* .,_9;_ .3F_"/_ &^?^D<U?IC7
MQ]\'_P!F7Q[\/?B[H?C#6M6T&XL+#S_-CL[B9I6WP21C:&A4=7&<D<9K[!H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \8_:C_Y-
MD\7?]N?_ *60U^9U?IC^U'_R;)XN_P"W/_TLAK\SJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** /O[]BK_DB.L_\ 8P3?^DUO
M7TU7S+^Q5_R1'6?^Q@F_])K>OIJ@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /(OVC+N'3_P!GOQ/>7FEVFK0Q_9=U
MI=M*L4F;J$#<8G1^"<C##D#.1D'\]_\ A,O#O_1)_"O_ ($ZK_\ )M??W[4?
M_)LGB[_MS_\ 2R&OS.H [/\ X3+P[_T2?PK_ .!.J_\ R;1_PF7AW_HD_A7_
M ,"=5_\ DVN,HH [/_A,O#O_ $2?PK_X$ZK_ /)M'_"9>'?^B3^%?_ G5?\
MY-KC** .S_X3+P[_ -$G\*_^!.J__)M'_"9>'?\ HD_A7_P)U7_Y-KC** .S
M_P"$R\._]$G\*_\ @3JO_P FT?\ "9>'?^B3^%?_  )U7_Y-KC** .S_ .$R
M\._]$G\*_P#@3JO_ ,FT?\)EX=_Z)/X5_P# G5?_ )-KC** .S_X3+P[_P!$
MG\*_^!.J_P#R;1_PF7AW_HD_A7_P)U7_ .3:XRB@#L_^$R\._P#1)_"O_@3J
MO_R;1_PF7AW_ *)/X5_\"=5_^3:XRB@#L_\ A,O#O_1)_"O_ ($ZK_\ )M'_
M  F7AW_HD_A7_P "=5_^3:XRB@#L_P#A,O#O_1)_"O\ X$ZK_P#)M'_"9>'?
M^B3^%?\ P)U7_P"3:XRB@#L_^$R\._\ 1)_"O_@3JO\ \FT?\)EX=_Z)/X5_
M\"=5_P#DVN,HH [/_A,O#O\ T2?PK_X$ZK_\FT?\)EX=_P"B3^%?_ G5?_DV
MN,HH [/_ (3+P[_T2?PK_P"!.J__ ";1_P )EX=_Z)/X5_\  G5?_DVN,HH
M[/\ X3+P[_T2?PK_ .!.J_\ R;1_PF7AW_HD_A7_ ,"=5_\ DVN,HH [/_A,
MO#O_ $2?PK_X$ZK_ /)M'_"9>'?^B3^%?_ G5?\ Y-KC** .S_X3+P[_ -$G
M\*_^!.J__)M'_"9>'?\ HD_A7_P)U7_Y-KC** .S_P"$R\._]$G\*_\ @3JO
M_P FT?\ "9>'?^B3^%?_  )U7_Y-KC** .S_ .$R\._]$G\*_P#@3JO_ ,FT
M?\)EX=_Z)/X5_P# G5?_ )-KC** .S_X3+P[_P!$G\*_^!.J_P#R;1_PF7AW
M_HD_A7_P)U7_ .3:XRB@#L_^$R\._P#1)_"O_@3JO_R;1_PF7AW_ *)/X5_\
M"=5_^3:XRB@#L_\ A,O#O_1)_"O_ ($ZK_\ )M'_  F7AW_HD_A7_P "=5_^
M3:XRB@#L_P#A,O#O_1)_"O\ X$ZK_P#)M'_"9>'?^B3^%?\ P)U7_P"3:XRB
M@#L_^$R\._\ 1)_"O_@3JO\ \FT?\)EX=_Z)/X5_\"=5_P#DVN,HH [/_A,O
M#O\ T2?PK_X$ZK_\FT?\)EX=_P"B3^%?_ G5?_DVN,HH [/_ (3+P[_T2?PK
M_P"!.J__ ";1_P )EX=_Z)/X5_\  G5?_DVN,HH [/\ X3+P[_T2?PK_ .!.
MJ_\ R;1_PF7AW_HD_A7_ ,"=5_\ DVN,HH [/_A,O#O_ $2?PK_X$ZK_ /)M
M'_"9>'?^B3^%?_ G5?\ Y-KC** .S_X3+P[_ -$G\*_^!.J__)M'_"9>'?\
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M /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\ X]7C%% 'L_\ PRY\=?\
MH1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU>,44 >S_\ #+GQU_Z$7_RIV?\
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M>,44 >S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\ X]7C%% 'L_\
MPRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU>,44 >S_\ #+GQU_Z$
M7_RIV?\ \>H_X9<^.O\ T(O_ )4[/_X]7C%% 'L__#+GQU_Z$7_RIV?_ ,>H
M_P"&7/CK_P!"+_Y4[/\ ^/5XQ10![/\ \,N?'7_H1?\ RIV?_P >H_X9<^.O
M_0B_^5.S_P#CU>,44 >S_P##+GQU_P"A%_\ *G9__'J/^&7/CK_T(O\ Y4[/
M_P"/5XQ10![/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\ E3L__CU>,44
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M%% 'L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU>,44 >S_\
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M5^F-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C
M'[4?_)LGB[_MS_\ 2R&OS.K]//VBI=,B_9[\3R:U9W=[8#[+YL%G<K;RO_I4
M.-LC1R!<'!.4.0".,Y'Y[_VA\+/^A-\5?^%-;?\ R!0!Q=%=I_:'PL_Z$WQ5
M_P"%-;?_ "!1_:'PL_Z$WQ5_X4UM_P#(% '%T5VG]H?"S_H3?%7_ (4UM_\
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MS_H3?%7_ (4UM_\ (%']H?"S_H3?%7_A36W_ ,@4 <717:?VA\+/^A-\5?\
MA36W_P @4?VA\+/^A-\5?^%-;?\ R!0!Q=%=I_:'PL_Z$WQ5_P"%-;?_ "!1
M_:'PL_Z$WQ5_X4UM_P#(% '%T5VG]H?"S_H3?%7_ (4UM_\ (%']H?"S_H3?
M%7_A36W_ ,@4 <717:?VA\+/^A-\5?\ A36W_P @4?VA\+/^A-\5?^%-;?\
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M/_M??Y7FR*F_;Y W8W9QD9QU% 'UE1110 4444 %%%% !1110 4444 %%%%
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M:>*O_!-<_P#Q%'_"I_BE_P!$T\5?^":Y_P#B* .+HKM/^%3_ !2_Z)IXJ_\
M!-<__$4?\*G^*7_1-/%7_@FN?_B* .+HKM/^%3_%+_HFGBK_ ,$US_\ $4?\
M*G^*7_1-/%7_ ()KG_XB@#BZ*[3_ (5/\4O^B:>*O_!-<_\ Q%'_  J?XI?]
M$T\5?^":Y_\ B* .+HKM/^%3_%+_ *)IXJ_\$US_ /$4?\*G^*7_ $33Q5_X
M)KG_ .(H XNBNT_X5/\ %+_HFGBK_P $US_\11_PJ?XI?]$T\5?^":Y_^(H
MXNBNT_X5/\4O^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\ @FN?_B* .+HKM/\
MA4_Q2_Z)IXJ_\$US_P#$4?\ "I_BE_T33Q5_X)KG_P"(H XNBNT_X5/\4O\
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MJ_\ !-<__$4?\*G^*7_1-/%7_@FN?_B* .+HKM/^%3_%+_HFGBK_ ,$US_\
M$4?\*G^*7_1-/%7_ ()KG_XB@#BZ*[3_ (5/\4O^B:>*O_!-<_\ Q%'_  J?
MXI?]$T\5?^":Y_\ B* .+HKM/^%3_%+_ *)IXJ_\$US_ /$4?\*G^*7_ $33
MQ5_X)KG_ .(H XNBNT_X5/\ %+_HFGBK_P $US_\11_PJ?XI?]$T\5?^":Y_
M^(H XNBNT_X5/\4O^B:>*O\ P37/_P 11_PJ?XI?]$T\5?\ @FN?_B* .+HK
MM/\ A4_Q2_Z)IXJ_\$US_P#$4?\ "I_BE_T33Q5_X)KG_P"(H XNNU^%/_);
M_ ?_ &,%A_Z4I2?\*G^*7_1-/%7_ ()KG_XBNP^&_P ,_B-8?%GP9?7OP_\
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MX.;G_P"+H_X6Q\4O^BE^*O\ P<W/_P 77%T4 =I_PMCXI?\ 12_%7_@YN?\
MXNC_ (6Q\4O^BE^*O_!S<_\ Q=<710!VG_"V/BE_T4OQ5_X.;G_XNC_A;'Q2
M_P"BE^*O_!S<_P#Q=<710!VG_"V/BE_T4OQ5_P"#FY_^+H_X6Q\4O^BE^*O_
M  <W/_Q=<710!VG_  MCXI?]%+\5?^#FY_\ BZ/^%L?%+_HI?BK_ ,'-S_\
M%UQ=% ':?\+8^*7_ $4OQ5_X.;G_ .+H_P"%L?%+_HI?BK_P<W/_ ,77%T4
M=I_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\ \77%T4 =I_PMCXI?
M]%+\5?\ @YN?_BZ/^%L?%+_HI?BK_P '-S_\77%T4 =I_P +8^*7_12_%7_@
MYN?_ (NC_A;'Q2_Z*7XJ_P#!S<__ !=<710!VG_"V/BE_P!%+\5?^#FY_P#B
MZ/\ A;'Q2_Z*7XJ_\'-S_P#%UQ=% ':?\+8^*7_12_%7_@YN?_BZ/^%L?%+_
M **7XJ_\'-S_ /%UQ=% ':?\+8^*7_12_%7_ (.;G_XNC_A;'Q2_Z*7XJ_\
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M_P"%L?%+_HI?BK_P<W/_ ,77%T4 =I_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\
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MS_H<O%7_ (3-M_\ )]']G_"S_H<O%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\
MA,VW_P GT?V?\+/^AR\5?^$S;?\ R?7%T4 =I_9_PL_Z'+Q5_P"$S;?_ "?1
M_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\ )]']G_"S_H<O
M%7_A,VW_ ,GUQ=% ':?V?\+/^AR\5?\ A,VW_P GT?V?\+/^AR\5?^$S;?\
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M_P"$S;?_ "?1_9_PL_Z'+Q5_X3-M_P#)]<710!VG]G_"S_H<O%7_ (3-M_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8;0?F# 9<@ [!DGW3M3:MN M%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ltbr_ex101img19.jpg
<TEXT>
begin 644 ltbr_ex101img19.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M_P"4R\_^,T >ST5XQ_PU%\"O^AZ_\IEY_P#&:/\ AJ+X%?\ 0]?^4R\_^,T
M>ST5XQ_PU%\"O^AZ_P#*9>?_ !FC_AJ+X%?]#U_Y3+S_ .,T >ST5XQ_PU%\
M"O\ H>O_ "F7G_QFC_AJ+X%?]#U_Y3+S_P",T >ST5XQ_P -1? K_H>O_*9>
M?_&:/^&HO@5_T/7_ )3+S_XS0![/17C'_#47P*_Z'K_RF7G_ ,9H_P"&HO@5
M_P!#U_Y3+S_XS0![/17C'_#47P*_Z'K_ ,IEY_\ &:/^&HO@5_T/7_E,O/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?F=^U)_R<WX
MN_[<_P#TCAK],:^&?CI\"OBIXT^./B+Q-X9\*_;])N_LWDW'VZVCW[+:)&^5
MY PPRL.1VH ^3:*]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\ *G9__'J
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M $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3L_\
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MV8=488SGB@#W6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[-YY,^UMNYX(C&1*J!ADETYR!G!KT*&:.XMXYXCF.10ZGID$9%"UU L4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (.M<)\1K;3=0\-V^
MDZ[X.G\5Z1>W(BO(((S(]M&$=O/"CYB05 ^4AOF^7)P#W=%)JX'S7I]GXDTS
MX;_$[1;:/Q7JOA)]/:T\/1:IIUP]^99(G5XDC*><8@Q0!G4 #V!-=-X!\&Z?
M9^&O#?CKQ!?>)]5U/1='%M;6>I6;*^G'RPLJQ6T<"2,QP5!8.S*!@G@U[91Z
MTN_GH'8^>/@S\.8]2\ >$KSQ9-XG%QX?N9+B'0M5MOLEO:7.]F614,*228#
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MH<6R?4)+?P_?727V"&6W1XHF7;D NV<8PHSEBOH]G-)<V,%PUK+:F6-7\B8
M/%D9VL 2 1T.":T**%HK#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU;3M;TFVU;2+R*]L+I!)#/$VY)%/<&OD'7-0\::=XH^.]YX4AM+NP%U;1ZQ
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MKXSHI ?9G_#<_P#U2[_RM_\ W/1_PW/_ -4N_P#*W_\ <]?&=% 'V9_PW/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0_ZN*^LXYTC_ -T."!^%7K&QL]-LH[#3;&"RM(5VQP6\8CC0>@4  #Z5?HH
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M4!P14EIH^DZ?I":38Z7:6NG(AC6TAA5(0IZJ$ QCVQ6I11Y <QH_@7P7X=U
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M4\$$=C65HO@WPAX;N)+CP[X5TC1II5V22:?8Q6[.N<X)102,]JZ2B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )WKRO]H0?\8\
M^,<_\^8_]&+7JE<UXM\(Z%XVT%]$\26MQ>:<[!I((KN:W$N.S^4ZEE[[3D9
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MU\<2>-H+&_7Q#*2)+PZM>,77.=A4R[2G PA&T8&!P*[H=*7V4NP_M-^A\V>
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M3,$.W@%0".V*=]_-DI;>5SQ+Q)HNK?"/Q&?C-X1MI+O2+RXFB\4:6G(>/SW
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_$,>\Y^:CHGW'LVNP^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$1'&X.5*Y&<9%7?$'B31_"^D?VKK-Q+#:^:D(,-O)<.SNVU55(U9F))[ T;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY6-F"*TD1;&5&0V>K8QQB_>^/O'=Q\./"/C+^W)[737T3[9K4NC0VLMW!(2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ5@VUAJ4?Q8US5/$G@76M>\&W7B2:9M.F\/W4FQGB"QWP0Q?OD78ZE3G&X,
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M\4:1H_@^_;2+KP5-86\2:9,;!;S=YB1Q$IY,9VHA&W"[Q_?S51_"</AOX:>
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M37:.D)10S1  ;F(W+EB%'/&><=[J&K:9I=YI]G?7B6\^HS?9[6-OO32;2Q4
M>BJ3GH,5X!X'_M"'Q%\&(KCPUXAMO[(T*ZL;YY]&NXX[69TC15=VC"C)C;G.
M ,$G!!KL?B]X<@U+QA\/-9F\'OXBM[+4I4NUAL!<N(V@?8&!'">9M.6(4'!)
M'6K=E:Q,=;W/9Z0^M?,OA[P1)-XTN=6\8)XPM_%5IJES.\MCIZ);75JSMC;>
M16YD>/R2 (?.W C"J#C''1^"[>/]GCS/^$%U]?%HUP_O$TB]6^D@^U^9\[!
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ML=\T;3K;/,HD,:\,X7.=HR,GH,UY-KGCKXEV6J67A;1]/TS7/$,^F-K#M;6
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MH(V"H!YTOG-=*5*ELA/(8$#._GC*/Q8^)$5A?:I/I?AQ(M/\5CPY)9I]H9I
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$D$K CJ&8Y[U!-\-_"=QK]OKQL[^'4;:T:PAEM]5NX1% 5VE%5)0JYZY SN
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MIMYNT^\>_@D75;M9/M+'YIG<2[I).,;G+''&<<57_P"%)?#G8J?V;J>U;_\
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MO+<$2(T?!+R$F0RNQQR.>.DA\ ^%;?Q1<Z_;Z;);WMS,+BX6&[F2WGE'21X
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M"1WNX@[2_-^^)W$YDW?-ANH!'T)15 ?C/17[,44 ?C/17[,44 ?C/17[,44
M?C/7L_[+?_)S?A'_ +?/_2.:OTQHH S-/TZWTV*6&WDNI!+,TS&YNI;A@S')
M ,C,57T484=@*TZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;^$$#!!((Q1UL!UM%%% !115-KJWCNXK62XC2:8,T<;. SA<;B!U.,C/ID4
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MR:D;^07GFCSWA1F8"00%WV* /E!*U]=44+3\"GJ?+_Q$\1>'=*^#&NZU\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(9=A(XP".FA-X\NH_'_@S2/%'@2Q@NM6CNKJQU.*^6Z6S1("[X+1(ZR%<!@
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MDU#[0V$*!DD3RU"_?!!#'(QD Y ]9[TVFMQ)I["T444#"BBB@ HHHH ****
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MXY%-JSL^@D^IP.F_!/3-(F\+R:;XO\0P#PNMPNFKNLW$8G),F[=;DMD'')X
M&.<DFE_!/1]+TW2+>P\5>(H+S1KJ>YL-1$MM]H@\\YFC_P!1L=&;)(=&YZ$#
MBNY\2>(M.\-Z-+>7VK:7I\C[H[4ZI>+:PRS8)5"YSU/H"<=C7)^!OB=I^I_"
MC0/&7C75M&T"75A(,2W2V\)99'4*AD;DX4=Z$[W?;]1FSX)\ Z3X!TV\LM)O
M-2O%OKN2\F>_NC,?,<DMM& J\GL 3W)-5='^&EOX=%S:Z!XKU[3-+EDEFBTR
M*2W>"VDDR2T9>%I  Q+!"Y3/52.*W/\ A,/":ZJ^CGQ9I U%(O/:T-]%YRQ[
M-^\INR%V?-G&,<]*KR>//!<.F6FJS^,M#BT^]9DM;E]0A$5PP."$?=AB#P0"
M:3U_(/\ ASC='^!VCZ-#X9M[;Q=XCDMO#4T\UC!*]H5_?9$JN1;AF5@S#J"
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M>O:?>:Q;:;=7*7?GK&LLJH=GE'#,,]V&/0]*%T2ZCONREJGP+\.ZQ=:E-?\
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MC"Y!D&2P+#& ']O\1>*-%\)VD-UKEXT*SN8X8XH)+B65@I8A(XU9VPH). <
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M%&[;%;1+L>9?!70?$WA;X/:3X>\3:3#IU_8>8BPP7*S[D+EP20 JGYB, L.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#S'Q!\1M1T7XJ:?X13PS?WUE+IL^H
MSW5J(Y'VHRCY(_,#L%R<@*7)*A5;FJ%O\<_#$O@N'Q@^CZM8Z)=S?9[&ZOFM
M;=;V7>R[$WSC9]QCNDV* .O:MWQ%X'U34_'^E^,M&\1II-Y8V,]BT<MD+E)E
MD9''\:X^9 #W*D@%3AAS.D_!V_TGX:Z!X5C\8*NJ>'-0;4=+U6'3M@1B7)66
M%I6\Q3YL@.&7@CH1DROAU'U+]G\:_#>J^%CXCT?2=5U*%+R2RN([<6Y%HZ+N
M9I9S,+=4QC#^;M;( )/%4?\ A<BZAJ'@%O#OAK4-2TSQ8L\WG_N5DC2)&+H$
M,HRZL 6Z@J#LWD@#2\0?#O7_ !-?^']2U/Q9;37FEW<ES) VEE[&<-&(P%MV
MF.UEP65V=\,Q.".!E:3\&]2T;2_ UK8^-%2Z\(RW9AN?[-!\^*X!#*5,A 8
M\-R/]FJ%_DR:U^,G@W3_  D/$5OI_B66UO\ 7)-,6*:"6:871< C$CGRDR<!
M"5Q@A4[5J_\ "WM!BTG4KJ[TG5[2^T_4XM';2I8XC<R74H4QHA60QD,&!#%P
M.N2*Y8? _P 2#PD-!_X3K3>/$7_"1^=_84G^M\SS/+Q]J^YN]\XXSWK)\:?#
M_P 2Z99ZY<3ZM_;-KXGURTO+L:=X?FE;3Q$!AML5P9F7$:#,6UP3N#*.*D#U
M'P3X\@\9W6MVL6@ZQI$NC71L[H:D+=3YP )4"*5R< J=V I!&">:\UT;XB77
M@OQ+\1V\3-XCU[1M.UF(-?@1S1Z9#)%&<,NY2$!<_P"K1L 9/J>R^%-CJ&FV
MNIV_V*/^RY7%RE\^F7FGW%U<.6\TRI>32SN0 G[QR,YP,@9JMJ_PCN-6U+Q3
M"OBG[/H?BN:*;5;'[&&G;8JH5BGW@(K*@!S&QZX(I[2^7XBWW[D'B;QAI>M6
MOQ&TOP[J&O:9KFBZ,MQ)>HSQQ ;'DC,"R$KSM(,BH-P(PQP",'0-:UJ/QK\(
M+B\\2:E)9:IX6FGOK:>?,,DD=O$WG/QEG.\DEB>@QCG/0WWPKUR3Q#XSU+3_
M !5I]I!XFTR/25MVTAW^QQ(I12&^T#>VQG'0#)4XP"#%9_";6EU+P=->^++*
MYM/#6ERZ.]NFDO&UW%(@C<E_M!V-L5,<$ @GD$ "TU!ZV*:_M$^"[XW\6AVM
MUJ-[#83ZA:11W%J1>)$I9ONS,T1"@MME5&V@X4GBMG2?BJ)O#_A2;4O#FJ-K
M>OZ>=0%C9_9V;RT1"\J S_,IW@JBEI".J9!JQH_PYUS3_!4O@F_\9?;M"2QE
MT^TVZ?Y5RD31M&HED\PK*$5N,(F2 3FL75?@W>ZU\/M'\)ZGXBTZ_.FV8LXK
MJ[T0,T. JK+ 4F62)U5!SYC DDD$8 -MA]KG=>+O$%[HOPUU?Q)INFW-Q=V]
M@]S%;[461&V9RX=E'R]6&<X! !. ?)/A_P".FTF?0+>\T_Q]K?B3Q+I,5Y]@
MNKB">UE94#27$#RS!(PVX_('4 ;040D ^LZUX9O[_P"&EQX-L=:\J>:P_L\Z
MC?0FZ=E*;'=E#IN<KDYW=3D@]#R&A_"OQ)IOB;P7J]UXPT^ZC\*Z<VEQQ1Z,
M\37$3*JDLQN6VOM1>0,9R<<X#6C?83V7<T7^,'A^*Z5IM+U6/2#J/]E-KAAC
M-DEUNVF,D2>9@/\ )OV;-W\55-2^-WAS2KG7S-H?B*2U\.WD5IJEVEB%CMS(
M0%DP[J[IR/NJQP00""#50?!>1;.Y\-_\)-GP5/JPU8Z2UB#.K>8)3"+CS,>4
M9!G'EEL<;JI:Y\&?$^LQ>-[<^-M/M[?Q=<P3S@:&[-;B':$5#]J /"+DD<\X
M S@)=+E:7\COO#?CNQ\1^)-7\/?V3J>EZCI2PRRPW\<:F2*4$QR(4=A@[3P<
M,.A /%<%XX^(7B"XO/B)X1T_2]2T@:%H)U"+6+:: .LFR1U;ER0C>6%&$+?>
M)V<&NH\.>"?$6D_$G5?&6J>)M.U ZG8P6DUK;:2]OM\G.UE=KA\<LV00>HZ8
MYH^*OAAJNN>(_$VK:5XJ33(_$FD)I-U;RZ?]H "B1=X;S$.-LK<#!W!3DC*E
M/71 G;<J?#_XI:>WA?1]+\10ZI8WEMX9AUF:_P!152EW B*LLRL'9R0W7>JD
MYR,@@UK>"?C%X1\>>))_#^CO*E_':B]17FMYEEAW!=P:"60*02,H^UQD96N>
MMO@MJDUQI\>N>+K2]TVV\-/X7F@M]*:"2:W8#]X)#<.%D!5#G:1P>.>.Z\*>
M'_%&BVEK9Z]XJCUN"RA^SVYBLOLKNO #3'S'$C@#&5"#DG!.,6[/4FUDD5]<
M^(5CI.N7FDV?A_6_$%UIT<4U^ND6Z3&S60_)N5G5G) )VQAVP,XZ50UKXL:+
MX?\ &%GX;U31M9@%[>06,%_)#''!+-*,J$5Y!+(HR S)&RJ>"14UWX%URS\?
MZIXL\)^)K?3'UJ&&/4+2]TXW<<C1#:DL966,HX4D<[@>..*Y;5O@O?:GXGOM
M:7Q:GF7&K6>K1/=:6)IXFM]N(3*)5S"<$A %VD]^AE;J^W4;ZV.LM?B5:ZA>
MZK::7X;UC4DTZXGLVN+=8/*>>%&9TR90T?*[09%0$D8)'-<GX>^+6G^(O#W@
M74/$V@ZUIE[XBU IIXM'86[L-VTN\<N&3:2-DG+%2?+P :V(_A*Q^*,7C:75
M[2&6,W!E^P:=]EN+Q9=P6.XD639*B KC,>XE 2W:L2S^"_B"PT'P3H\'CJVD
MB\):A]NMS-HQ;S, A8SMG7 PS9)R22"-H&*0,V+'XV>&;ZZCCAT/Q!'9OK0T
M![Z>T2**&[.-JNK.) "3C.PX/WL9&5UKXR:)I.IW-I#X;U[68;;5(]%EO+&.
MW$"WK@8A)EF1A]Y06(V9(&ZN?_X4GXF^PW5JGCC3%,_B8>*"_P#84G%P&#>7
MC[7]S('OC//-<W)H.MS?$+7]:_LJXDUH:L;JRTZ_\.:A);3O$@2&7SXKE+(9
M )6216=,\DD 4UJTOO!]6OD>S>-/'ND^!=$L]4UBSU*:.ZN8K18[*V,S+(YP
M-V#M49XY/)X&37*ZI\=/#NAKJ<>M:#XAL]1TVY@MYM.:S1YL3?ZJ0,DC1[&(
MQDN.>,9(%1_':/4KKX7VUEIMCJ-UJ,NHV4BC3M/FO3#Y<Z2.Y$:GA0I/S8SC
M'4U2U_X.:QXJM-4U*^\86B:WK,]E)/=?V,Z1QP6S;XH8X3<;D)?EBSL3TPO9
MKSVO^ NGG;\3K+[XGQ6-W'IC>#_$%QK?V5[Z;2;=;62XMK96*^:Y$_EX8CY5
M5V<_W:9_PMKP[?6&E7'ANQU/Q1-J5F^HQ6>EQ1F9+=&VL[B5T P_R;<[BP(
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M-,6&# [C(  "20!67:_M >![S3;2ZM;75KE[G55T?R+:W2Y,<[8VYDB=HBK
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M$/#VM:3%XA\.!->T])81Y0^W0RMG:KPM()!M X1\?-@YZ#T?1_"-WI/PJLO
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M?)?_  BUG=_!6UTC_A5M[#JVB^(+275 -$G?^T5$X$MU#YD8:5'0-E ,J#C
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MDC WDX.<\8-ZW)TL>JZ]X-T/Q+>65]JUO<B]L5=;>ZL[V>SGB#XW*)('1L'
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M%CL+BYG,R [U-LB^;\G5@0N!U(SFCH'41OA/X!;1[G2VT.06=SJ"ZK)']NN
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M>;RX2ZOO?YE&2ORA5/R\D@XKUO/?I3=UJ'H<1)\+_ \VJZSJEUHTEU/K-O\
M9;Y;B\N)8IXA]U/*9RBA?X=JC;_#BN>\3?"FT7X<>(M!\#V%NFJZU9C3VN]7
MU*YE*0XVA?-<2OM4$XC&%SZ4RZ^,GA/2]+CU/3M8U'Q7;ZAKJZ4CVEFTD=K(
MVS=&K10_.JJVY1\[N20"<';VOB3QIH'A/2+;5]?FNK6SN)$A21+&>8AWX4,L
M:,4R2!\P') Z\4K70UH_/<YK0?A3X;M_"3:=K&DO]LOM/CL+]X=6NYB8EZPQ
M3,RR)"3_  )L4@X*XJ>'X.^!+>XL[B&UU>*:RM&L;9TUZ_#0VYZQ*?/X7V]A
MZ#%QOBAX/5M:5KO41)HLT5O?1_V1>;XI)6VQJ%\K+[B1C:#D$'H0:X_X@?$
MQ^"_'^H^ _' DUGP]#$\]N]FDT=@PW HN47YVP<[VDVE?NCI3ONP2Z(Z6W^$
M/@*SL-+M;/2[RU32B_V&6#5+R.>V5_O(DPE$@0_W-VW))QDU+??"OP/?ZO-J
M5QIU\MW-9?V8[0:K>0J;;&/)VI*%"GJ0!R26/))K(TWQ%XF;X\0^&[S58IM%
MG\-+J<=LEJJ,DWFI&2SY);^(\;0 V,'&:A\5^.-4\+?&[0=/U#4F_P"$8OM*
MNIGL[337N)S-$R?-^[#R,,-G"J  "3GJ%VOU$G?Y'16?PR\%Z;+H,MKH\F_P
M^C0Z<TM[<2F!"P;9\[G>H*J55LA2HVXP*U_$WA70_%VD-HGB+34U&P\V.?R7
M9E&]&W*<J0>H]>>0>#63+\3O \>@V&O1ZVUY87\+W,#V-G/=,8D.'D9(D9T5
M3PQ8 *>#@UJ77B_PW8>#CXPN-9MH]!\E;A;\OF(QMC:01USD #KDXH;ZOHQK
MRZDVG^%-!TWQ!J_B#3]-2VU/6?*^W3JS9G\M=J<$X&!Z 9[YK#TWX5^"=&OQ
M>:9HTMO(AF:!%O;@Q6C2\2-!&7V0,03\T84^]26_Q,\'W6CP:Q!=:C)9W3*E
MJ1I%YYEV64N/(C\K?,-H))0, !SBJ"_&;X;3RVMO9^)UO;FZMVN8K6SM9[B<
MHI(;,4:%U8$'*D!A@\<&A^8+78<?@W\/6\)#PF=*OCHPO/MWV4ZO>X\[.=V?
M.W=?FQG&[YL9YK7\.^ _#/AC4]0U+1;6[M[G4Y#-=^9J%Q,DTAQF0I)(R[S@
M?,!GWJ!OB5X+_L#3M>AUA[ZQU*-Y;5K"TGNY)$3[[>5$C. O1B5&T\'!JKJ/
MQ6\":;8V6HSZ\T]M?6;ZA"]E:3W?^C)C?,PA1BB*3@LV #P>E/8-S=U+PKH.
ML>(M)\1:AIJ7&J:-YGV&X+,##Y@ ?@'#9 '4''48-8S?#'P._@B?P.-#:'P]
M/,TTEG!=30B1F8NVYD<,02?NDXX Q@"JDWQ2\.1^/[7P@L=XZW&EG5O[26VE
M-LL65VG>$*["I8F0D(N I.3@:^E_$7PCK%S=6]GJS136MK]NE6]M9K/_ $;_
M )[KYR+OC_VUROO2MIY!U*7_  JOP8-9&L"'5?[0%C_9@N/[;OMXMMNWRP?.
MZ=\]=WS9W<UM>&/"^A^#= @T'P[:RVNFP$F*![F6?R\G) :1F(&>V<=:\\\/
M_$:X\2?'R'1='UEKGPU-X?DOX[>339+5FD$T:K('E4-(A#-M9,(0?XB,U[)W
MHULO,6E_0=1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YEXF\*^*3\3;#Q
MQX5?2[F:+2IM*EM=1FD@50\BR"571'W$%1\A R/XA7#P? F70/\ A&YK;3?#
M_C)-/TZ6QO+#Q!$5B9GF:<S0-Y4WED.[#:4.5P,YKZ#Z"EI+\@[^9P6O^!_[
M:^$-_P" XY+72OM=BUJIL;<100,>0$C7&$!XQW'N:X.\^%OQ#\4:_%=>)=0T
M#2[-_#<_AVZ&FO/<22+)@^:FY8PAW!3@[L $<YR/8(]8C738+C4+.;3;F9&9
M;&<QO<94%BH6)G#M@9PA:LWP3XQTSQ[X73Q!H\=W#9R32P*MY%Y<F8W*-E<G
M'*GKSZ@=*-VPOHCSFV^'OCV\G\,W6O?V ;GPCIES9Z>;*ZF4:A)+$(0TI,/[
MA0@!*J),L?08K)T'X3_$"PM_A[IVH+H'V/PQ97MA=2V^I3F29;E=A>,&V !5
M>0">3QD=:^A\44;WOU#:UNAX_P##7X8W'@XZ9#J'ACPA#<:7&84US3;8+>WR
M[2@,@,*F)B""Q$C[CGIFM/XC> ]6\5ZOX=U3P]J4&F7NGRS6UU-+N!>RGC*3
MJF ?GX5ES@9&<UZ;6=#<327]S;R:?<6\4(0I<.T9CGR#D( Q8;<<[E7J,9YH
M>M@6AY3X=^%OB#PSX8\7:/:W5A>+=13V.@PRS21I9V<C.XCD?8Q!#2M]T,,(
M@^E+1?AOX\T>+X:WD<F@F^\):?<Z;=1M<S-%,CJBJZ-Y0.2$Y! VYSEL8/HG
MC;QQIG@/2X-7U>UOI[::XCM%^QP&4J[G"ECD*JYXRQ') &2<5U]/S^0M-CYV
MT'X5_$C2=+\(6$\/AQQH&O7.KRO'J5QF6.7?\B@VWWAYK=>#M'J<>B^-O"?B
M#5_$?A/Q5X;EL7U+P[<3/]CU"1XH+F*:/RW&]%<HP'*G:P]17H35ROAKQEI?
MBC5?$&GZ?;WL4FA7?V&Y^U6YAW/M#90'YBN",$@9ZC((-'DNFH[Z\W?0\A7X
M+^,KBVGN=8;PMJDR>)+C7HM)NX)9;.=9U99(I793R 5*L(CM(/WL\5O&$</@
MWX@?"W3M,T[PEH>L/J5Y<+I-M.+:U026WE &18@Q+L-HD,7+$#:<5])9H%+L
M'>YX(?A3XVM9]$O;5M"GO/\ A*I/%6J"2\FBC5V4H((<0L6 4_?;;DC[O/&G
MH7PCFT;QAJ5S<>&?"6KVMUJSZI;ZW=VX;4K7?)YC1[3"P<@Y"OYJ[<@[3C%>
MU57D8K$Q52Y )"KC)]AGBA: ]3P3_A3?BIO#UA8W:^&-5&CZ[=:E:6&H1R2V
MU_#.\I=9]R'8X$@VX1]I3.6W?+LQ_#?Q%H?BO0O%WA/1?"NEW5K#<VMUHD!>
MWLUCEV'='+'#EI 8P2S1#<#CC KUNSN)KJQAN9K&>QDD0,UM.4,D1/\ "Q1F
M7(_V6(]ZOTUH&^IYS\)?"/B+P/X&&@^(K_3KR9+N>:(V$;JJI)(TA!+G+'<S
M=A@8'.,G@V^%/Q"CCL=,LK[0(K+3O%TGB.WN9FGDEEC=I'V/&%4!E+XX<AL]
M5Q\WT#5.XNK:V6/[1<1P^8ZQ(9'"[G8X51GJ2>@[TGJ[AW\SQ[1_ /Q&TWP%
MX_TJUU'2=(UOQ#JT^J:?>65[-*(?.92T;L84*85<!U!/S9 !49Y34?@IXZ6P
M\2V>D6?AFUM]<O--O1&=3N3]G:VP74L;=FE+L/OG!.22.U?3-%'9@?/WB3X8
M_$K7HOB;"MKX;@7QHMHL+'5;@FU\E GS?Z+\V0,\8QTYZUHZ]\-_'VHZEK-Y
MI[Z!$VO^%DT.[6>YG86LRA_FCQ$/,0[R,G81UP<;3[A1WHW"]CYYB^&'Q.M;
MC4CM\+70NO"<?AE)!?7$'*A@)BGD/V;&W<<[<Y&<#;\*^ _'^E>,_!6J:E:Z
M MEH&@G1+C[-J,TDDF=G[U%:W4?\LU^4D?>//'/K5]=1Z?I]Q?31S21V\;2-
M'!$TLC!1G"HH)8\< #)K+\'>*M,\<>$+#Q1I,5Q%8WRLT2W*!) %<IR 3CE3
MWJD^HK+8Y#QU!)H?Q%\+_$:19&TG3X;G3=4,:%S;PS;&28@<[5=!N(S@-GH#
M6=IF@_%+2O&OC7Q1I6E^%)U\2O;/;>=K%SBW6&+RU9E6U^?<,,0&7'3)ZU[+
M14+16'UN>)+\$[P?#+5=+D\2++XMU/54UZ;53"1$;Q)%=%"9R(QMVXSGDGVK
MJK;2/&^L^)=#U'Q5;Z+IUGH[O=)#I=W-=-<W#1/%N+/%$(T"R.=N&))'S<<^
M@LP52S' '))[5Q'A?XA6'BW45ATO1-:33I87N+35IK4"SO$5]AV.K$J<@X60
M(2.0".:I/H@?=G,Z3#J&O_%'7_B-X>LX;RU@TJ+1--:[F>WAOW69I99 X1R(
MP2%#A"&(...:[KQ0OB:3PI>P^%H[%=;EA,<+7L[I!$Q&"Y9$9CMZ@;1G':ND
M-<CK?C;2]!\7:!X;O+._>\UZ1XK:6*W)@0JA<[Y#@ X4\#+>V.:FR:Y0ZMGF
M6K?!G5[?P?X1_P"$06.W\3Z%=P72G4?$=_<6<3)_K B,K*0_(.(X\;CCT/4S
M>&_'5U\8=#\:3Z?H,-A::7)I]Q$FIS/*#*R.[IFV ;:4P 2NX<DKTKU(=*Y*
M\\;Z59?$/3/ LEK?_P!I:C;2W4,HMR+?9']X>82 6Z<+G&1G&15=1=#R6U^"
MOBJ'PKX6L-0A\*ZZ_AF^NVATV_222TOK>=V9C(S1MY<@R-N(V"E>ISQO?\*W
M\16_Q!\!ZWI&A^%](TK07O)+FQL;AX%0W*A&6)4MPK[54-N;:7)(P@ ->U44
M)VU'N<'\4O">I^-/A_=Z%H\EM#?M/;7$1NV98B8IDDVL55B,A2,@&O,=>^%W
MQ.UI/B5YD?A=7\9PV<2.NH7"BW,"A2Q7[.<[ASC=P>,GK7T3WKB_%7CNS\+W
MUMIJ:/JNN:G<V\MU'8:5$DLYABQODP[J" 64  EF)P :6WS&FS@YOA3J4WC7
M5=>U+PKX,UY=<B@DF.JQF>;2ITA6-O)9H&\^/Y00I\KGTS5G]HRZL=-^!&J0
MW%Y;6TLL]I';+/($$CK<1M@#C.%5F('8$]J]8LKI;ZP@NA#-"L\:R".>,QR(
M",X93RK#N#R#5_O4N^GDQ*R/GWQ3\,_&7C[2_%&OB;P\NJ>(M*MM)LTM]0FD
MM([59/.,YE\G,C,Q&%"  ?Q&NEF\'^.K'QII_CC0X]%GU"71%TC4--OKR9($
M*-O22&982Q^8G*F-<CT-=KXL\8:-X-\/ZGK>I23SQ:9"MQ<6]G'YLRQL2 VP
M=%)#?,<#Y3SP:UM+U*+5M'L]4AC=8KN%)XU< ,%90P!P2,X/K5Z!VN>0Z'\)
M?$?@3_A#]0\+WFFZI>Z+87.GWMKJ,DEM#<)/+YS-$Z)(8RK\ ;#E>.*M>(/A
MOK.M^/;3QAJ/AWPEXDDFTY;"\TO6 S16Q61W22WE:&0DX<JP*+NQGY>@]FI:
M6X=_,\1U7X7^)?\ A*=,U?PI+IGAZXM_LL$M_IUS-:AK:(+NB>S5&AF7[X0$
MIM&WENVAX9^'_BG0?B6=:L[BUT?0I6N9K^PL]0GGAOY9#E'%O*FVW8'EF1SN
M(^Z :]+U/4(M)TJZU*>">:&VB:5H[:%II6"C.%102Q] *H>$?%%AXS\(Z=XH
MTN&=+'4(S+"LZA9 -Q'(!('3UIKRZ?J)]CD/$W@_Q5JOQB\.^*M/ATE]+TNQ
MNK25;J[E660S@ D(L17"[1QO^;)^[CFM\-? ?B3P;X@O6FO(;+PV;58K?1K;
M4)[R%)]V6EC$R!K=<9'E!G'.<\"O36NK>.^CLVN(Q/(C2)"7&]E4@,P'4@%E
MR>V1ZU=I+38;U/FRZFOO$GQP^*_A7PK?:#-+JNDV=C=->7C+) !')'(Z(B-Y
MA3?AD)3!*Y8=*Z_PE\./$'AKXE/?;K)_#J>'K;0(9$O)/M>(1Q*4\H*"22,!
MSC&<GH.W'C/2S\2/^$!^SWW]J?V>VI><UN5@,8=4P'.-S98?=! P<D'BMQKF
M==5CMETZ=X9(V=KM6C\N,C&$8%@^3DD84C@Y(XRELO,&[M_(\:T?X3^++;2/
M"7@_6+S2)/#OA/5UU.TU"W>7[;=+&SM%&\10)&<N=SB1L@=.2:ZVQ\!ZII_Q
M:U+7H]0@'AB]9=0%@-WFKJ/EF%I.FT(8^>N2^#QCGTGGUHIW \0\'_">^\'G
MR5\*^#=1FL9YKBQUYXO+U&<$LR1RGR&V-EMIE5V.T<)FLCPG\+?B)H%K\-[.
MXA\.2Q^$;N\FG>/4I\W"7 <?(#;#!42$X)YVCD9X];\;>,M+\!^$[OQ-K%O>
MW%I:X+I90&63DX''  _VF( ]:UX[R:34EMQILXMS )A>%H_*))QY>-V_<!S]
MW;@_>SQ5+0'KOU.'^)G@G5/%T6GS:-;VRZC8),;6].I7&G7-I*^P!HY84?Y<
M!MR,A#87IUKG]4^''Q ;7(M6MM8TK4[N[\)GP[J%U?-)"PFW%OM")&A#@ECE
M24]<]J]@N+B&VMY+BXF2&&)2\DCL%5% R22>  .]0+>3&_AMX[&>:VFC:3[:
MCQ^2F,84_/O)8'((4C@Y(XS%D.]K'C_@WX=_$3X?WMEJ&GW'A[7)9=&M-+O[
M>>>>S6,VVY8I(G$<I8;&PP*KDC(QG Z"P\+>/?#7CGQ#K6BMH6IVOB,V\]TM
MY/-;/9W"1+$S1A8Y/-C(7(0LA'3=WKU/O2=ZJ]WJ3L>+67PGFLO'.M7]SX;\
M(ZW9ZGJ1U*/5=0MMVH6+,0715:)Q( 1\A\Q-N>AQBH+?X7^*K7Q1JES8R:78
M:+J-O??;=+%_<SV>I33 ["]LZ8@P3EVCD);G 7->WFCN:GMY(=]SPF'X9^/K
M3P%XU\*V-]9_8-7M18Z5IEYK%Q=0Z<A1D=Q,\!D P5Q#A@-OW^<U;_X03Q]%
MK?AW6K9=!2]M?#LOA^]ADO)WC0%E*31L(5+_ ',E&"=<!CUKVRC%/?YAV\CP
M7PW\,_B%H=Y\+HKF;P_>VW@Z&XBN9$N)X7D69/+PBF)@Q1<'<67<3C:F,GUG
MPWJFK:MI,EUK&C#2KCSGC6)97D5U!X<&2.-P#SPR#IQD$$]#WK-M;J:9[@2Z
M?<68BF,:F9HSYR@#]XNQFPIS_%M;@Y XRVV]Q;6L>'0_"GXA#2K]9/\ A'HK
MUO&B^*[95OIY(V4MEH7;R%((XPP!SD\+C)]6\:>%6\7?#C5_"]U+&+B_LS$L
MH!5$F RC@<D . W<\=ZZVG=J73EZ#^US=3P_0?A+XJL_'FD>*-:UVSNGNH$E
M\211E]MW=PL6MFB!4#:F0,G!Q&O')K/\3?#'XB:O??%%K*'PZMOXTAMK>W:;
M4IP]NL*>7N=1;$$LO. >#QD]:]^JHMS;R74MM'<1M-"%:2-7!9 V=I(ZC.#C
MUP:-P6CNMSS31_"?C2/XP:;XNU*UT6+3H= 71YDM]0FEF#[A(74- H(W#;@L
M#CYNORU>\6^%_$UQ\0M \:>&?[,NKC3+6ZLI++49Y+='6;8=XD1)#D%!\NWD
M'J*])HH[>0K'SU:_ >ZT>]T;5$T[PUXQDCM[B'4;#7HBEN9)9VG,MNWES>60
MS%<%3E>X->D^(/"^HW'P>U+P?H5II=O>76G26,4*YM+2'S%*G:$1BJJ&) "\
MX .,DCO.U%&ZL5UN>(:G\+M<U+P=\/8;W3_#NIZEX3A^RW&E:DS3Z??1F-8B
M=[0DJ^$5E/E'!)'(Y/,:B6\+?'7P/H_AW3_">GZS_9NH;M&ANOL=M$96C*(&
MCA+%B%+ F(%]K<#M]+4<4:\UR;:6/GN/X%WVEQ>'+[[%X;\5W5DMX-1T[6X2
M+25KF;SB\#&.4QLC?*"4.5ZXJ]XR^%/BK7K"VT/3_P"PX?#O]CW-K_9"-):6
MME>2,S)/''%'MF"@[0'VX/S@9)%>[4E%KZ="KZW/"KSX2^*M0DTZ.;4=*M()
M/!I\+Z@\;RRO$V0?,A&U=X.,?,5QGHW2EM?@[=77@/5/#=]X;\'^';VZTN33
MCJN@VX\VZ8[<229AC,:_+ED#/N)ZC'/NO>D[T]R=K6/'M!\&?$C_ (6CH/B[
M7Y/#=I;Z?HK:1<06,D]PTX+!]Z;DC$>65>#NP 1SG(]A'6EI.M )(=1110,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#PKXN-J7A_QOH6M17FNRZ;K<-QHLEC9
M:G=0I]M>/=:.BQR (Q9&0L,=<GUK$\!W&L7GA[6!XD\3:UI=WX(LKO2;[47U
M2;RYKLNY^T'SF9'*Q;&!=6"^:,?=7'T=]:/I2MI8+ZGR'X5UW3=2U3X+^*O$
MGB>]N9'T_4(KJ\;4KC_CY1D*H^Q\ _-\RGAE WY4#%'X=^*M)T6V^'UU8^-G
M@FO?$]_9WEE_:G^CFW9I2NZ#=LY9HR'(SEQSC:!]E8&:/:CJ+[-CQWXT:MJV
MGS^%;./6_P#A&_#][=RQZEJSB<10,(_W*2/!-"\:,Q/S"11D#.1D'SNXU*;2
M_&WPU\-ZU\:+W5-)O$U#[7=17W]GI<PJI\A]XD,C L619#(=WE@J<@L?J>BA
M:#/CO0/'7]OV_P *=+OOBE?2+<:G?V&I00ZWY,LL:M(+=I9$99=S Q@$MSD8
MY.:Z63Q9XATO6/C3HOA7Q5?:]>Z/#9?V;;R7?VR>UBQBY\I>2S1[B"2"VY5W
MEFZ_3])0!\I_$S6/ :_"2]D\/_$B[UJWO[_37$5YK!OOLK+,K,5,NYXW*@LT
M;-QM)"J :=>^-[ZQE^)NB^%/&EUJ%A9:AICK<&]EU*:QLY%47DL9$GF%%/78
MXV9."IQ7U-SYGX4\4^_F';T/F2[U75M!\(1S6_Q4F\0^$[_7;6._U?33-C2K
M1E?S42Z>>>7!98PS%\Q[N",\=+\$K[1W\<_$BST;4+S4[5M3AGM[R9Y;E98O
MLZ*"+E\B3G@98L5 /(YKW<TG<U-[7\] ['R?XZ\37.A6GQ0T@^+-=M=8L-<L
M+K2;9-2NFG2"3RM^P!B3"=\@V\H"5& =M;%CXFM-0^(GQ8OIO&7B+5K?0K2&
M^TZRL=2>&6!3 S3*ENNU"8W8*5E1MI #@M7TM_!1_!3Z?*P_\SXTM_'&JV?A
MGQU'#\1KFWBD\,6FIZ;(-:ENI!/N8%%GN,EI"<*XB"#<=JJI%=%8^.;.SUC5
M=/MOBI<B*[\"Q:@9Y]96=H]1#$GRS*66-RF,HH'!S@'FOJVF^U/?076Y\H>&
M_&"L?"5YK?C75&L-<\$21R2?VM<D3ZC&Z B/:^1<  CY,.3GJ3S5\-^-(M2O
M_A;;>(OB?JUA9WV@77]K07&J/9$R(/DD:0[9,L2V'W<^7\IZY^NJ6ABM8^1?
M _CR%E^%>I7GQ,N;S4+^^O-.U6"[UC?&T*K(L/FPEMH;(BPY7<Q<9)R*])^.
M=MIT5[X U+5+J]M[*'Q%%'/+;WD\ 1&BDY_=,#NRJ@,/FY(!^8@^WF@4GT\F
M/OYJQ\L:QXJUYCXFD7Q/J]E\3++Q L.CZ!]KE6*YLS(HB46F=DL;1%V:0J6!
M&2PQ7IWQ\O-6TOX+ZAK&EZ_?Z)=V4]LYFL) C,K3)&RDX)QAR?EP<@=L@^LU
MR'CSP7:_$#PN_AN_U34-.LI94EE-@8E>38P95)DC? W!3P >!SC(*?3U#S/F
M[XA>*M0TO3?&UUX)^)6J-X82"P:"^_M8SYU!Y=LMO#.^YL>3F1DC8%"H^Z,K
M7=:]J&D:7XZL-'U[QMK.C>!KS0VO-,U9->N0MW>LV6)NO,+,1'M9(BQ0YX4Y
MQ7O=O#-#;10R74ER\:*K32A0\A QN;: N3U. !Z 5<%/R"]SYATWQ9XCND\"
MV/Q6\0:CX>TJ\T6XN!>17$FG/?7HE*PK+(FTAO(VN(\@,S<AN!6!\.]>M-+T
M#X02WVNZMI6B7%OJNEZEYES<VEM+)AG@P,JI<^8=KIR3P#E0!]?4<4^_F!\H
M>%?&EU=>$_ ]KXL\3:[8^%Y;W4[?4M7N;NZM9#.LI-K'+=L5=4V-U#@$KM)^
M4BMGQ5J-P=4\->'X?BG<:1X1FTN8VGB;49YRM[=B4C#7,$]N&94&4+,R..2'
M.#7TH>HHS2[?U<.YPL;0P?"%?^$I\227,,>GXNM7=FTUI5 _UI*N#$6&#PP/
M/OBOGKX>:KH^@^$OA!K,/BR]M=*N9[NPUO\ XGER;2*0P2&.-XS*8X6R5( "
MG)!]#7U_11U;[BZ)'R/I_C#7KCP9I%C+XLU32]!/B/4K2^US5?MS""-6/V2.
M2<30RJAS@L)1@@!NXKH[K4K71]=^#VFZU\0;?Q-.FLW31:E/B$W$+02)&PW2
M.77>P19"QWG')ZGZ6[T4UH'1GD?QFU+4-+MM#O+76K:R@MYI;BYLKC5IM)%\
MBJ %%U'PA#.I"N0K$@'/2O/[SQ!I.O\ CGX6P-JE_:7EYX;U!1%>WOE:BK2Q
M1B(LZ%6$CE&*L,%L9'I7TYWH[TBNWD?+'@'QQ)J'B'X/#_A*M8O[RYTZ]L]:
MA^TW-S&9T0"/SXP2HD5F)+, 0"I8XVFJ_P .=;N/$GCSPP^H?$"Y:YMI;UM3
M27Q5MCU:7S#]G\FP2?S(]H&3&\4:X&"K9KZCN;=;FUFMY&=4D0HQC8HP!&."
M.0?<5R&B_#FWTFUT_3Y_$^MZMI6FR1R6FGWYM_*A:,YC.Z.%)'VG!&]VY )R
M13OJ+I9'G'PA\27UQXZDT'4M7N=>O%T^2[;4K/5Y;NTE#R(09K:4;[.;&T+'
MPN-^!WJ#QI-H2_M2:2(];(UI=#N##:?VS- &NM\9MX2JR *'QDQXP_4JU?1.
M:6EV?8+[^9\N>#_$^J7E]X$N-*\8:M>^*KJYFA\7:5>7<DB6D01C+(]N^4M?
M+8*$*JH;('S<UUOP!NE\0:5KNM3^,-0\2:A:ZO=V:R3ZO)/&+</^Z;R581#<
M!D,$'!...*]U_"EI[7$];'R7\0)=#T?Q-\=X]1U.ZMKV[T:V-G%<7LYCFWP.
M&^1FV$;R%7(PI;:F,X)IOC*^T>[U+2? OB^XUF[E\!PWUM9-?F\*WZGYO)C+
M$*XB^;RD & /EKZRH_AJ4M+%-WL>*_"$S7&IW.H67Q07QAIMU9HTEE''<.ME
M,".7>>YG>*1@3F+Y1P3M&.<NXU"34/VE?$NA?\)=J%]]BT6.]L=&BU=[>-+M
M228_+A9"_P H4E7W</DY&,>_^E%-[I]B5HFCYF^'.M7DQA\3ZY\6%GD2PG_M
MS0;B.=6M) A+/.)[IUMMCC *1QJW  YX\^L_%RM\&_">BZ+XFO=.U"U\,WMW
M&\&JRVMNTR2-^[1+<J\UR, ['<(JG<5;-?;=%#UVT&M#Y<BU22?XH>'O%,-[
M>WVN:CX %S8"*ZF,=Y?@CY!&C;".,LF-F?F(R,U%X=UCQ?#X+U7Q9X:^)3^)
M=>&A2M<^'A;W$LMK= 9,DJ37,ODR*VX!$2-7QPF!Q]3TE/H[ M+7UL?,W@76
M/#$G[0/ANXT'Q-J?B)+[PL\,US/<3WQ2Y,J.RNS;O(.$8E/E53@87(!Z7Q)X
MI6Q_:2CT.Z\?2Z7IL_ANY=[8WL,<=G,"") K#&_8&<&0-P"1\N17NU%+MY"[
M^9\8V_B20_ CP9XLN/BAK$.LZCKR66IN?$#@/#]I.\%2^(ML>QB4V?*PW94B
MN@^,FO7'A^\U32_"_BC6]-NM$T>&^MVN]=NG%P&F+%H$#;KDXR'>9W55  3'
M-?5U%%_S&?(7Q4\26^O>'_B1;^(O$E[;ZC#';?V!IMO>2107EHRQMYR1*=ES
MN8ON8AMNT8VXS707WQ)AM/B'XX=/%6M7>G+X0CO;?3;:98;BTE/WQ%$Z#RY%
M3:Y+JS*"2<C KZ<I:/(.U^A\:3:I?:MX ^+&A77BBXU>TBT*RU/3XH=6N;P*
M"K^:5FD??*N0N_I'G(V#I73W/C*\TWQ]8Z9X'\7W6J>;X-NIM.TJYOFG5[T8
M,>!)EY&8*S+O+97[IVD5]1FDIO7;0.WD?+VD>*/-N=!N/"_Q#U:YMKK0;N3Q
M7)>ZBT_]DS+%E)CYVY;67SBRA,*I X7 S5+X7^.4'B#X2R7'Q"NM0O=>L;Z+
M5[>]UAID:48\@&)F*QON!5< ,W3FOJ_TI:?6XCQ#XP:GJD7C+P_HUQXN7P=X
M<O+6Y+:M*;B.$W8*;(WE@N(#&=N]EW/M8Y!5N,<+\09=7L]#\-6NA_$W5=1\
M80Z?<S70&I/I\-_IZ)(&NC$9MJ2!>8W!)8C<P(!*_5-)46TL5U/E>/Q9X3N_
M%7@:2#XJ:_#X*U'1KQ;@WFNR1.EQ&4/[Z<,'67,G=\<*%PI ->'7_&EUX9\&
M:?XL\;7'AG1+V&_\K7M2^TQ&X*S 6OGRPSV[(QARREGVOW#&O?+_ ,#V^H?$
MO3/'4FN:I%=Z9 ]M#9QF'[.T;XWA@8BYW$*<[^-HQCFNTJO47DCYDTV>XNOC
M3X5\'^(/BIJVL6SZ!+(RPZ@VF?:9UE'E/LAD#DM&-XW.Q8#=]TD5R<WCZ?\
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MOH"BFG96\@>K%ZCCD4M%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 0M\JEN< =NM?&=[X=_M;3/BBUUX1\:S:KJ^M/=:%
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MQU%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.&X-==I_@F2]^)>H:GXL7Q?;^);779+JSN-/L(Q;7%H7_=@7BV[.(Q%PT+3
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MMV=8A%PT+3 \$*N2*%LGW5Q];>9]#:IJ%OH^CWFK7C%;:R@>XE*C)"(I8X_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH ^ ?\ ABOXI?\ 0?\ "O\ X%7/_P 8H_X8K^*7_0?\*_\ @5<__&*^_J*
M/@'_ (8K^*7_ $'_  K_ .!5S_\ &*/^&*_BE_T'_"O_ (%7/_QBOOZB@#X!
M_P"&*_BE_P!!_P *_P#@5<__ !BC_ABOXI?]!_PK_P"!5S_\8K[^HH ^ ?\
MABOXI?\ 0?\ "O\ X%7/_P 8H_X8K^*7_0?\*_\ @5<__&*^_J* /B#P3^R=
M\2/#7Q"\-:]?:UX;DM=+U2UO9DAN+@R,D<JNP4&$ G"G&2!GN*^WZ** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$<&K5 "49I>U<_XG\1V?A/PQJ/B348;J:ST^$S3):0M-)M'7"CTZDG  R20
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M=+J[&&+^V)KH20>5$#+L:1@_S@KYI!(^[NQQ7OQI:2T^ZP]SY9^-GC'4-/\
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MEC\0+\1:WJ$+WZW&N-<1WBM$-[L9&8A!( NU2(P6.5R:^F!10M!?\'\3Y]\
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M78]1D[:](HHJF[DI6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M-B9E5V8#Y3N"<AP0"05'>_#_ ,7#QUX'L_$W]G-IDD[2QRVIE\WRWCD:-@'
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M5VYQ\V[G+=+^$>CZ9;6T:^(-;NWTZQDT[2I+F2!SI4,@VL(1Y04MM 7=(';
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MYW9^9LD][I_PW%OJ4^L3>(=3LKW58XFUJSL)(ULM0G6,*\FUXV>/=C!,;(2
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MN@^IE>'?C!?:Q<Z-_:?@\Z?;:SH<VMV1M[_[5*ZQ!2T;)Y:X)W J0QSQD Y
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M!=LD\DH.AVGI7;_%+Q=K?@GPW9:QH]I83H^HVUK=->NX$44L@0LH7&XY8=6
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M;B1W16*QAVR>6QCD]*T=0\8>$M)NVL]3\5:38W*LB-#<W\4;AGSL!#,#EL'
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MC3H)7ZA1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK[4&5*/O;C)8=*ANR<D"U:3ZGM>EZE9ZSH]GJVGS>=97D*7$$NTKOC=0RG!
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M&Z%$#[ALP?F((QQG)+\^@M3Z'U#4+'2-,NM4U*ZCM;.UC::>>5L+&BC)8GT
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M1/>R*XB8(I7=R6+[SS\I2FM;>8='Y'U;UKG=:\5>'_#]_I.FZUJL5I>:Q/\
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MNI(+;R+QI(G;:'5K>61!@D AV4KD9 S5_4/CAX9T>QURYUC0?$%BVC6T%[)
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MY1,UB-/A\AI!T<Q[=N[WQFH+?X>^ ;.\^U6G@G0+>XV"/S8M,@5]H  7(7.
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M&C>%VZOL=>&/)5@"3C)-W86QT^I>#_">LV-EIVL>&=)U&RL1MMK>ZLHI8[<
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MDDL*NI_=P0H;G,4(RWREG))R"._)V.AZZ?'&J:_#I=Q)K9UJ:^M=*U/PW?\
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M#-QD@C4T'P'<6_B75O$WBK5H==UG4K)-,9H+'[+ ELN24$9>0Y9F)8ECGC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2UNQUA_BDVOR7%@5U/0_)N#):SC!+S":YD^SN&RNU$C5NRX'&M\<];TG2X_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCFFM5H#T=CVF@5Y!J7Q.O;)O$OAOQ=X%0:I8Z*VKK86M\EW;ZA:?<D'F2)&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "J-S!-<6T\$5W+:-(C(L\(4O$2,!E#JRY'49!'J#5ZBE
MN!Q?@CP/;^!/#,GA_3=<U.^M3))-&U[Y#/"SL6?:8XD!RS%OF!Y/IQ6-IOPA
M\.V?@;7/!M_J&IZSIFLW+WDWVQH5DCF=MYDC:*--IW@,,YP0,8'%>E9I<\T]
MP/(=<\"W&DZ)K36,7B'QMXBUK2I-&34+RXM%:SA*,%#9,(V;FW,55W)Y.>*O
MZ1\*8=-CT.^M_$6J:/K5EI%MI-Y-ICQ>7>QQ*  Z2QN.#NPRA6 /6O4/THJ0
M."N/AOIX\32>(=#U_6?#M[<6L5G=_P!G2Q,EY'&,1^8LT<GS*,@.NUL$\U<T
M?P/I>B>--9\56-]J)N-86+[1:R7&ZWW(BH) ,;BVU1RS'OC&379456P'$>//
M </Q T:'2=0U[5M,M8ITN"--:%6D=&#(6,D3D;64$;<>^:/$'@.T\1WWAO5+
MK7-6M]2\/E_(OK9H4DF$B!)1(#&4^8#G:JD'[NVNVS29HMI8#RM/@UHUOX C
M\%P^)M?31HH9;?R6>VE#Q2.7965X&4D$G#[=X'1JSK[]G_PO?7-W=?V_XAM6
MGCM(H1#+; V0M<>0T+F NC* 5W;B2&;).<U[/2=Z.MP.=OO#<.L>$9O#.L:G
M>7\%Q!]GN+EV2.>8'J28U55)]54>V*QM/^'=E;>*[+Q)J>OZSKUWIL4D.GIJ
M4L12R5QARHCC0LQ7Y=TA=L=Z[RBCK<.ECR"R^!?AK3)-+:QU_P 0P/IC72VY
M%U&0L-P<RP8,9 0DGY@ _/W^!B_IOP?T'38_",<.M:T?^$4CE@LW,\:M-#(5
MW12E8QE?E ^7:<<$G)KT^B@'J>=:/\,[/0=,?2-(\4:[:Z2OF&SL!+!)'I[.
M",Q%X2Y W-M61G49SC@8Q],^".GZ0WA<:?XX\3QKX7\Y=-!-BPB$H(D!S;?-
MD''.<=L'FO7J*D#R;3O@GHVD6E@MCXL\1Q7^G7<]Y9ZD);83P&<YF3'D>6Z.
MW)5T;GIBK]Y\+[>[\6:7XDC\7^(+?4=,MIK:&2,VK!O.R99&#P-EF.#V4;0%
M '%>E44P/*M)^"NAZ/IOA>QM_$FONOABXGFL96GA20),,20LR1+E#SR,.,G#
M#C'JM%%.]P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ltbr_ex101img23.jpg
<TEXT>
begin 644 ltbr_ex101img23.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M/@7W\;X_[AMY_P#&:7_AJ/X%_P#0\?\ E,O/_C- 'L]%>,?\-1_ O_H>,?\
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M /&**]G_ .&7/CK_ -"+_P"5.S_^/4?\,N?'7_H1?_*G9_\ QZ@#QBBO9_\
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M^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\ \>H \8HKV?\ X9<^.O\
MT(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /&**]G_P"&7/CK_P!"+_Y4[/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVJ> TMM5N/#XU+P\6"75Q:W)^UP?*[,P@,>UU54R3Y@/WOEXY=QGH_:BO/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 444QWV$<9S0 ^BOF?_ (;4^%G?0?%(/_7K
M;_\ Q^@_MJ?"O'_("\4G_MUM_P#X_0!],45\R_\ #:GPM_Z%_P 4_P#@+;__
M !^G#]M3X5X_Y 7BD?\ ;K;_ /Q^@#Z8HKYH_P"&U/A7_P! /Q3_ . MO_\
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M"_XI_P# 6W_^/T?\-J?"W_H7_%/_ ("V_P#\?H ^FJ*^9?\ AM3X6_\ 0O\
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M_P#Q^@#Z7HKYF/[:GPM!XT#Q2?\ MUM__C]._P"&U/A7_P! /Q3_ . MO_\
M'Z /I>BOFC_AM3X5_P#0#\4_^ MO_P#'Z/\ AM3X5_\ 0#\4_P#@+;__ !^@
M#Z7HKYH_X;4^%?\ T _%/_@+;_\ Q^C_ (;4^%?_ $ _%/\ X"V__P ?H ^E
MZ*^:/^&U/A7_ - /Q3_X"V__ ,?H_P"&U/A7_P! /Q3_ . MO_\ 'Z /I>BO
MFC_AM3X5_P#0#\4_^ MO_P#'Z/\ AM3X5_\ 0#\4_P#@+;__ !^@#Z7HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
M9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]:2E/6D
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]:2E/6
MDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]:2E/
M6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]:2E
M/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]:2
ME/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]:
M2E/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D]
M:2E/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&D
M]:2E/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _&
MD]:2E/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH _
M&D]:2E/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /V8HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *0TM(: /QI/6DI3UI* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "D-+2&@#\:3UI*4]:2@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH _9BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH
M_&D]:2E/6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\#U_PK]&** /SG_X9$^,G_/CI7_@>O\ A1_PR)\9/^?'2O\ P/7_  K]&**
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M'_#(GQD_Y\=*_P# ]?\ "OT8HH _.?\ X9$^,G_/CI7_ ('K_A1_PR)\9/\
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M3_GQTK_P/7_"OT8HH _.?_AD3XR?\^.E?^!Z_P"%'_#(GQD_Y\=*_P# ]?\
M"OT8HH _.?\ X9$^,G_/CI7_ ('K_A1_PR)\9/\ GQTK_P #U_PK]&** /SG
M_P"&1/C)_P ^.E?^!Z_X4?\ #(GQD_Y\=*_\#U_PK]&** /SG_X9$^,G_/CI
M7_@>O^%'_#(GQD_Y\=*_\#U_PK]&** /SG_X9$^,G_/CI7_@>O\ A1_PR)\9
M/^?'2O\ P/7_  K]&** /SG_ .&1/C)_SXZ5_P"!Z_X4?\,B?&3_ )\=*_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 8MYX@T/3;HVNH:Q8VDP4-LGN41L?
M0G/^--_X2WPO_P!#+I7_ (&Q_P"-?!/[5P8_'Z]5NILK;&WK@ICU^OY@?7YY
MH _7S_A+?"__ $,NE?\ @;'_ (T?\);X7_Z&72O_  -C_P :_(.B@#]?/^$M
M\+_]#+I7_@;'_C1_PEOA?_H9=*_\#8_\:_(.B@#]?/\ A+?"_P#T,NE?^!L?
M^-'_  EOA?\ Z&72O_ V/_&OR#HH _7S_A+?"_\ T,NE?^!L?^-'_"6^%_\
MH9=*_P# V/\ QK\@Z* /U\_X2WPO_P!#+I7_ (&Q_P"-'_"6^%_^AETK_P #
M8_\ &OR#HH _7S_A+?"__0RZ5_X&Q_XT?\);X7_Z&72O_ V/_&OR#HH _7S_
M (2WPO\ ]#+I7_@;'_C1_P );X7_ .AETK_P-C_QK\@Z* /U\_X2WPO_ -#+
MI7_@;'_C1_PEOA?_ *&72O\ P-C_ ,:_(.B@#]?/^$M\+_\ 0RZ5_P"!L?\
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MA?\ Z&72O_ V/_&OR#HH _7S_A+?"_\ T,NE?^!L?^-'_"6^%_\ H9=*_P#
MV/\ QK\@Z* /U\_X2WPO_P!#+I7_ (&Q_P"-'_"6^%_^AETK_P #8_\ &OR#
MHH _7S_A+?"__0RZ5_X&Q_XT?\);X7_Z&72O_ V/_&OR#HH _7S_ (2WPO\
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M *&72O\ P-C_ ,:_(.B@#]?/^$M\+_\ 0RZ5_P"!L?\ C1_PEOA?_H9=*_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _.C]KCYOV@K[VL+7KQ_"?\
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M_!G9_P#QVC_AEOXZ?]"./_!G9_\ QV@#Q>BO:/\ AEOXZ?\ 0CC_ ,&=G_\
M':/^&6_CI_T(X_\ !G9__': /%Z*]H_X9;^.G_0CC_P9V?\ \=H_X9;^.G_0
MCC_P9V?_ ,=H \7HKVC_ (9;^.G_ $(X_P#!G9__ !VC_AEOXZ?]"./_  9V
M?_QV@#Q>BO:/^&6_CI_T(X_\&=G_ /':/^&6_CI_T(X_\&=G_P#': /%Z*]H
M_P"&6_CI_P!"./\ P9V?_P =H_X9;^.G_0CC_P &=G_\=H \7HKVC_AEOXZ?
M]"./_!G9_P#QVC_AEOXZ?]"./_!G9_\ QV@#Q>BO:/\ AEOXZ?\ 0CC_ ,&=
MG_\ ':/^&6_CI_T(X_\ !G9__': /%Z*]H_X9;^.G_0CC_P9V?\ \=H_X9;^
M.G_0CC_P9V?_ ,=H \7HKVC_ (9;^.G_ $(X_P#!G9__ !VC_AEOXZ?]"./_
M  9V?_QV@#Q>BO:/^&6_CI_T(X_\&=G_ /':/^&6_CI_T(X_\&=G_P#': /%
MZ*]H_P"&6_CI_P!"./\ P9V?_P =H_X9;^.G_0CC_P &=G_\=H \7HKVC_AE
MOXZ?]"./_!G9_P#QVC_AEOXZ?]"./_!G9_\ QV@#Q>BO:/\ AEOXZ?\ 0CC_
M ,&=G_\ ':/^&6_CI_T(X_\ !G9__': /%Z*]H_X9;^.G_0CC_P9V?\ \=H_
MX9;^.G_0CC_P9V?_ ,=H \7HKVC_ (9;^.G_ $(X_P#!G9__ !VC_AEOXZ?]
M"./_  9V?_QV@#Q>BO:/^&6_CI_T(X_\&=G_ /':/^&6_CI_T(X_\&=G_P#'
M: /%Z*]H_P"&6_CI_P!"./\ P9V?_P =H_X9;^.G_0CC_P &=G_\=H \7HKV
MC_AEOXZ?]"./_!G9_P#QVC_AEOXZ?]"./_!G9_\ QV@#Q>BO:/\ AEOXZ?\
M0CC_ ,&=G_\ ':/^&6_CI_T(X_\ !G9__': /%Z^S/V&?^:@_P#<._\ ;FO&
M_P#AESXZ?]"./_!G9_\ QVOI;]ECX7^.OAO_ ,)=_P )IH?]E_;_ +']F_TJ
M&;S/+\_?_JW;&-Z]<=>.] 'TU1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M \E\[]JS_H:/ W_?J7_XU1YW[5G_ $-'@;_OU+_\:KUJB@#R7SOVK/\ H:/
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MCQ'X-NI/%DMI/K%AJ=UITTMG'LBD,,A0E<]N.#@9&,@5I=C6-\#O^18\4?\
M8UZM_P"E+4 >JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2EI&Z4 >8:?_P A_P 4
M_P#85?\ ]%15<O;>2[L9K:&\FLGD4J+B (7C]UWJRY^JD>U4]/\ ^0_XI_["
MK_\ HJ*M,YP<=:-P.+\$_#G3O >F7NEZ7K6K7EC>,TCP7LD1".W#,K)&C#(
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M>BN9L_'7A?6-9FT'1]:BEU,"01AH7,3LF-P1\!)=N1N"-D=\5R/PY^*,VO>
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M"P4#''7/XXI=8O[ROYE]QG_#[Q=J4<?CW7-7U6ZU'P5IMP9-+U"Y +/&@?S
MC8'F*. &)/ZFM*'XG6NO:7<VL5A=:7<WV@2ZQI\CRC+Q88#[IRL@X.WGCO6/
M8?"76-)/BKPS9W>G_P#"#>(D=WADED%SITS)@F(;"CJ#C@E25 ]#DT;X6>)+
M5DFUBYTR6XT?P])H6DI!+(%E9@R^=-E,I\I VKOQR<G%:6_(5[:^?^12^'/Q
M6>/X;>%HM?O&U7Q'J@O)<W4RPCRH9'Y=SP,[0JC')^A->Q:#K5GXB\/:?KFG
ML3:W\"SQ[L;@",[3[CD'W!KQ?PK\'?%?A.V\(:M8W>CR^(= :>UFB>>06]S:
MRR.W#B/<C@R,/ND$X/;!]VA640)Y[AIL?/M'R_Y^M%[MLGLB2BBBI&%%%% !
M1110 O8UC? [_D6/%'_8UZM_Z4M6SV-8WP._Y%CQ1_V->K?^E+4 >JT444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %-9E& 3@GI3J8RYQSCK0!YEI__(?\4#N=5? _[915
MID'&!UKC[/X9S:]KWBF^_P"%A^+].WZQ-^XL[JW6-<HC  -"QP-VT<]%'UK6
M_P"%+'O\5/'1'_7Y:_\ R/0!DW%C;:_XK\0Z-JNC7$NEW>FP6QGGA(BE8/-O
M"L1U&]2#^70UYG>?"?Q/9_!3Q9X#L;V34)?MR2Z4\S!?/A41-Y7)X^8,,<#(
M[ U["/@RP!S\5/'3$]2;RVY_\EZ7_A3,G_15?'?_ (&VW_R/2MH_/_.X[ZW/
M,-*M?%.D^*M;\=67A>\NA:Z#9Z;;:8[>3)>S JSD9!QLZ9QSSC->PV,\UUIM
MK<3VCVDTL2R/;NP9H6(R4)'!(/&1Q67_ ,*8;G_BZGCK)[_;+7C_ ,EZ</@N
MV/\ DJGCK/K]LM?_ )'JKBZW-JN:\  _\*[T/@\6JU;_ .%+M_T57QW_ .!M
MK_\ (]<WX%^$[:AX T6\_P"%E>-+;S;97\J"[MPB=>%!@/\ ,T@.^HK%_P"%
M+M_T57QW_P"!MK_\CT?\*7;_ **KX[_\#;7_ .1Z -JBL7_A2[?]%5\=_P#@
M;:__ "/1_P *7;_HJOCO_P #;7_Y'H VJ*Q?^%+M_P!%5\=_^!MK_P#(]'_"
MEV_Z*KX[_P# VU_^1Z -JBL7_A2[?]%5\=_^!MK_ /(]'_"EV_Z*KX[_ / V
MU_\ D>@#:HK%_P"%+M_T57QW_P"!MK_\CT?\*7;_ **KX[_\#;7_ .1Z -JB
ML7_A2[?]%5\=_P#@;:__ "/1_P *7;_HJOCO_P #;7_Y'H VJ*Q?^%+M_P!%
M5\=_^!MK_P#(]'_"EV_Z*KX[_P# VU_^1Z ,GXI*3\'?&( Y.D77_HIJV_#/
M_(GZ+W_T&#I_US%<9\2/A.=*^%7BS5&^)'C*^%II5S,;:ZN[=HIML;'8X$ )
M4XP<$<5L^'?A"UUX8TBY_P"%G>-K?S;.&3RHKRV")E < &WZ?X4 =?16+_PI
M=O\ HJOCO_P-M?\ Y'H_X4NW_15?'?\ X&VO_P CT ;5%8O_  I=O^BJ^.__
M  -M?_D>C_A2[?\ 15?'?_@;:_\ R/0!Y_\ &C2]3UJ'PG;:=H=WJJVFM0WU
MTL$6]4B0,#G/!R#]W.3CTK-\.:!K_@_XB>(-,M=,OI_"GB:,W%G?QQEY--E8
M8\MPWSA1[YQA3_>KU%?@S(KAO^%K>.R?^ORU_P#D>C_A3+8P/BIXZ Z?\?EK
M_P#(]):?,;=_E_G<\.\%>!_%EBWP^T?4-%N+)_#5]?7E]=C!C*G_ %:HP_UF
M_.,#L#G%<WH_PZ\:0^%]&NI]%U11I7BB6_NM.@E:WN);:18AYL;*RG(V-C!#
M?-VKZ4_X4N<#_BZGCK(YS]LM?_D>G?\ "F7P1_PM7QUR<\7EK_\ (]5=V%UN
M8&C>&=-TW7=.72])N;;2K,75^ANI99F:YE*C<?-+/OV^:2.OS@]217D=]\/-
M;\7ZM\1XWT[4-'GO[N*\T>\FA9%F,8D!5FZJ&XX;')!_AQ7O7_"EVS_R57QU
M]/MEK_\ (] ^#,F?^2K>.NF!_IEKQ_Y+_2E_E;\;@M-+=;GC'B'2_&'B^V^'
MNOWWA?5+.;0+IH]6TZUE:WE*,$'GP-&RD@!<84AAG'3DZWC7X?HNCZ:W@FVU
MC2-0TA+BXTZ2&22?SWDDWF&7S&+X<@-EC@9;=CH?41\&'!S_ ,+5\==<_P#'
MY:__ "/0?@NY/_)5O'?7/_'Y:_\ R/0]7?Y@CPK5Y+U?V@?%T3:9+J&H77@\
MPF"S7<#*RQC Y^Z6XSC'(S@9ILO@+Q;X>_X1B\?2;C5A!X2NM)EBBVN;>Y=7
M95(ST._9N' QS@5[#'^SWI,/B67Q)'\1/&BZQ+"+=[P7=MYC1Y!VD^1T^4?E
M6L/@PX()^*WCLXZ9O+7C_P EZ??S!:->1X?+X*\3Z9HWP:L9=)N[J70+IKK4
M3!&91;(SAL$KG=CD87/3BJOA#X>ZO-\%;7P[KEAK6@ZG;:O/?07EI$6FM&V?
M(VU>65LLORG()!X )'O/_"EFQ_R5;QWGU^V6O_R/3E^#+ 8_X6IXZ..A-Y;9
M'_DO2;;OYC6AX_\ V%XVO/B7\-M:UC2)GEL='EAU&XA3,<4SQR* Q'?+#..
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M_P# VU_^1Z/^%+M_T57QU_X&VO\ \CT ;5%8O_"EV_Z*KXZ_\#;7_P"1Z/\
MA2[?]%5\=?\ @;:__(] &U16+_PI=O\ HJOCK_P-M?\ Y'IK?!@JI;_A:GCH
M_P#;[;?_ "/0!N45P5UX)T>ST-=9N/B]X[CM'E,$>^XA6264.4\M(_LN]V+
M@*H);MG(IOASP;H7BRSFO/#_ ,7O'MY!"_ER,9XHBC?W2'M0=PP01U4\'!I)
MWV#8[^BL7_A2[?\ 15?'7_@;:_\ R/4,WP?^SJI;XJ>.OF8+S?6H R<?\^],
M#H**Y*U^%L%U>W=G%\4_'WG6C*LRM<VZA=R[A@FVPW![$XZ'!XK3_P"%+M_T
M57QU_P"!MK_\CT ;5%8O_"EV_P"BJ^.O_ VU_P#D>C_A2[?]%5\=?^!MK_\
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M@W_T4+2O^^V_PH ]-HKS'_A?WP;_ .BA:5_WTW^%+_PO[X-_]%"TK_OMO\*
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M?X4?\+^^#?\ T4+2O^^F_P * /3J*\R_X7]\&_\ HH6E?]]M_A1_PO[X-_\
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MD_!'P(2<DZ!8?^DZ5VE<7\)?^2(^!/\ L7[#_P!)TKM* $->9_!W_D%>,/\
ML;]8_P#2IJ],->9_!W_D%>,/^QOUC_TJ:@#TVBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I&Z4M(W2@#F?"G_'YXF_[#$G_HJ*NGKF/"G_'YXF_[#$G_ **BKIZ "BBB
M@ HHHH *Y#X9_P#)+_#O_7FG]:Z^N0^&?_)+_#O_ %YI_6@#KZ*** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D;I2TC=* .9\*?\?GB;_L,2?\ HJ*NGKF/"G_'YXF_[#$G_HJ*NGH
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M_P#1+5D^+/\ DUK6_P#L4+C_ -(FH _+:BGMU_ ?RIE !1110 4444 %%%%
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M?A=X3_[ ]G_Z)6OR0_A%?K=\/O\ DEGA/_L#V?\ Z)6OR1[4 )1110 4444
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MWOOER5"]2588X.)_%'BJ'PW:VJK93ZGJE_+Y%AIUL5$EQ)M+'ER JJH+,Q.
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;I2TC=*
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M:F!^6YZTE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_1*U^2+>G:@!**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "44OYT?G0 E%+^='YT )12_G1^= "4HZT?G4D<>\GYMOUH _5_X2_\ )$?
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M $<4?_"2L_\ XJC_ (5Y\=/^CBC_ .$E9_\ Q5>S44 >,_\ "O/CI_T<4?\
MPDK/_P"*H_X5Y\=/^CBC_P"$E9__ !5>S44 >,_\*\^.G_1Q1_\ "2L__BJP
M/!?@?XQ77@31IM,^.G]FVLENK16__",6LOE+_=W,V6^IKZ%KD/AG_P DO\._
M]>:?UH XC_A7GQT_Z.*/_A)6?_Q5'_"O/CI_T<4?_"2L_P#XJO9J* /&?^%>
M?'3_ *.*/_A)6?\ \51_PKSXZ?\ 1Q1_\)*S_P#BJ]FHH \9_P"%>?'3_HXH
M_P#A)6?_ ,51_P *\^.G_1Q1_P#"2L__ (JO9J* /&?^%>?'3_HXH_\ A)6?
M_P 51_PKSXZ?]'%'_P )*S_^*KV:B@#QG_A7GQT_Z.*/_A)6?_Q5'_"O/CI_
MT<4?_"2L_P#XJO9J* /&?^%>?'3_ *.*/_A)6?\ \51_PKSXZ?\ 1Q1_\)*S
M_P#BJ]FHH \9_P"%>?'3_HXH_P#A)6?_ ,51_P *\^.G_1Q1_P#"2L__ (JO
M9J* /F[XC>"/C!9_"KQ5=ZO\<#JNG0Z7<O<6/_",VD'VF,1MN3S%;*9'&1R*
MU/#_ (#^-%QX:TF6S^/1M+=K.%HX/^$7M)/*4H,+N+?-CIGK7HGQB_Y(7XZ_
M[ =Y_P"B6K>\(_\ (BZ!_P!@^W_]%K0!YI_PKSXZ?]'%'_PDK/\ ^*H_X5Y\
M=/\ HXH_^$E9_P#Q5>S44 >,_P#"O/CI_P!'%'_PDK/_ .*H_P"%>?'3_HXH
M_P#A)6?_ ,57LU% 'C/_  KSXZ?]'%'_ ,)*S_\ BJ/^%>?'3_HXH_\ A)6?
M_P 57LU% 'C/_"O/CI_T<4?_  DK/_XJC_A7GQT_Z.*/_A)6?_Q5>S44 >,_
M\*\^.G_1Q1_\)*S_ /BJ/^%>?'3_ *.*/_A)6?\ \57LU% 'C/\ PKSXZ?\
M1Q1_\)*S_P#BJ/\ A7GQT_Z.*/\ X25G_P#%5[-10!XS_P *\^.G_1Q1_P#"
M2L__ (JC_A7GQT_Z.*/_ (25G_\ %5[-10!XS_PKSXZ?]'%'_P )*S_^*H_X
M5Y\=/^CBC_X25G_\57LU% 'C/_"O/CI_T<4?_"2L_P#XJC_A7GQT_P"CBC_X
M25G_ /%5[-10!XS_ ,*\^.G_ $<4?_"2L_\ XJC_ (5Y\=/^CBC_ .$E9_\
MQ5>S44 >,_\ "O/CI_T<4?\ PDK/_P"*H_X5Y\=/^CBC_P"$E9__ !5>S44
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M@#W[_A;B_P#1X7_E@#_XBC_A;B_]'A?^6 /_ (BOC*B@#[.'Q>1?^;O#)]/
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MW_"WA_T>%_YC\?\ Q%'_  MX?]'A?^8_'_Q%?&-% 'V=_P +B3_H[[_S'_\
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M_P"B6K>\(_\ (BZ!_P!@^W_]%K6#\8O^2%^.O^P'>?\ HEJWO"/_ "(N@?\
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M_H>/_*99_P#QFC_AJ+XZ?]#Q_P"4RS_^,UXQ10![.?VHOCH1C_A./_*99_\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^_OV+/^2(ZS_V'YO\
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MK8/J<$_J:0'F=%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#[+_89Z_$'_ +A__MS7T!\'?^05XP_[&_6/_2IJ
M^?\ ]AGK\0?^X?\ ^W-?0'P=_P"05XP_[&_6/_2IJ /3:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "D;I2TC=* .9\*?\?GB;_L,2?\ HJ*NGKF/"G_'YXF_[#$G_HJ*
MNGH *\H^(WC3QMX,&H>(+'PG8:CX:TI4>[9[XQW<JD#<\:;"NU 3U;)(.!7J
M]>)?$CQLL?B63PG??#7QGX@T>,1S7<^DZ2UQ!=G;N6+.Y05!*LV"<E=I!&12
M8'L%G.+FV@N%!5)4#J&&#@C(R/6KHK-T^X:ZMK:>2V>V:2-6\J0?-&2N2I]Q
MTK2%,2"N0^&?_)+_  [_ ->:?UKKZY#X9_\ )+_#O_7FG]:!G7T444 >;?%#
MQAJG@7PPGB2QT^+4;:&=%NK4J1(T1.69&!ZA03@@@^HQS:\5>/--T?X:MXOT
MUEU19K7S].CC) NV,9=<=\;06)QPH)[56^(FJ6]N-"M+C2]4OTDU&*21;'3)
M[Q4B4G<7,2,%&".#R>< X..%FT75]"\$^,- O-#NIM+T:*^L?#RV=I-=2W"W
M,6Z,*B*2!&',._IRP)&#G)7=[_(=EI;YGI=IXNL;'PUIM]XFU2UM[J]M1=^7
M!&_RIM5V(3+-M7<,L>.1G&<5H:EXO\.Z;I]K?76L6XANXS/;E#YAGC"ARZ*N
M2RA2&+#@#DD"O(M%;4-)\<Z1XVNM'U>YT6[\.PZ.R)I5R;JPN(FW%&M_+\P1
MN<X?:5RHR<$$U++3_%/PQ;PKK%_X3U3Q78KI-QI]S:Z5$MQ<6#23^<BB/(W+
MMVQG!P/+ZXQG5I=^IDI2:V[?\$]#A\?+-\0GL8[S3[KPT^@?VY#=V\;.^T2J
MA.X,0ZXW'A0>W;G>A\=>&9-0.F_;Y%OA:F^^S/:S+*T (!D"% 67) R :\2\
M56NJS?$BQU+PKX?UC1K32?#Z2'3?[&F^RW067SFL&:-#'N:/H%9E#X7DY%=*
M]]>7WQIT#QU;^&]=;2[G09],V3:=-%/!<^:DGERJX7RP1D!R=A(^]TK--V\]
M?^ ;67Y'H1^)'@CSK6%?$=K+-=V?]H00Q[GDDM\9\P( 6QC)Z= ?0UT.FZQI
M>L:7;ZII=]%>65Q&)(IXCN5U/0@U\T>&]8O=!\9_#=]:\+ZY93V'A6XLI+9+
M3S[C*-$ XBC+/M)&,$!AG) 'S5[%X+T6^M?ADVFO#)I%Y=M=S1P-C=9">:62
M-/EX^0.HP,C((%:/0R4K[F_8^,O#-]JT>DV>M03W<OF>4B$D3>6<2;&QA]IX
M;:3@YSBN-\(^-O$7C+Q%JBZ/;V5MI6CZU+IL\5W:SK--%'&N9%DR%63>?]6R
MYQR2*YKPIINN3>'_  'X1N-#U#2-6\(WJ2WTS6S"W,444B%HI\;9/.#CA"2-
MS;@,5J_!-KR.Y\<PWNEZMI[7OB6\U*V:_P!-GM5FMY-NQE,B*"?E/R]1U(YJ
M;)MZ[?B.[<=NQ[-$K*6++BI:**:5BCAOC%_R0OQU_P!@.\_]$M3\9^!X_P"Q
M?_\ ;:F?&+_DA?CK_L!WG_HEJ?NQ\#Q_V+__ +;4P/R=HHHH **** "BBB@
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MIM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5@AP'\OYLYSWSFIEB1?F5<&O&_A;J6HPZS?>&O%1U>P\2V]HDTUE?7YOH+A
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M^E34 >FT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444 <-\8O^2%^.O^P'>?\ HEJ<3CX'K_V+_P#[;4WXQ?\ )"_'7_8#O/\
MT2U._P":'K_V+_\ [;T ?D]12\TE !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7W]^Q9_P D1UG_ +#\W_I-;U\
MU]_?L6?\D1UG_L/S?^DUO0![CX 7=\+?"BYQG1[/_P!$K7YO?'K"_'[QE&!]
MW4'YSUR!7Z0^ 6V_"GPHW/\ R![/IU_U*5^;_P =V+?'GQ@S*P8Z@X;=C)P
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M/'__ (3%U_\ $T >FT5YE_PN33_^A \?_P#A,77_ ,31_P +DT__ *$#Q_\
M^$Q=?_$T >FT5YE_PN33_P#H0/'_ /X3%U_\31_PN33_ /H0/'__ (3%U_\
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M+DT__H0/'_\ X3%U_P#$T >FT5YE_P +DT__ *$#Q_\ ^$Q=?_$T?\+DT_\
MZ$#Q_P#^$Q=?_$T >FT5YE_PN33_ /H0/'__ (3%U_\ $T?\+DT__H0/'_\
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M%J7_ ,C4 >845ZI_PI/Q]N*_\(WJBA6X8Z+J)WC'H+?([]<=./4P_P#"COB
M/^8!JS?]P+4O_D:@#S&BO3O^%'^/_P#H7M6_\$>I_P#R+1_PH_Q__P!"]JW_
M ((]3_\ D6@#S&BO3O\ A1_C_P#Z%[5O_!'J?_R+1_PH_P ?_P#0O:M_X(]3
M_P#D6@#S&BO3O^%'^/\ _H7M6_\ !'J?_P BT?\ "C_'_P#T+VK?^"/4_P#Y
M%H \QHKT[_A1_C__ *%[5O\ P1ZG_P#(M'_"C_'_ /T+VK?^"/4__D6@#S&B
MO3O^%'^/_P#H7M6_\$>I_P#R+1_PH_Q__P!"]JW_ ((]3_\ D6@#S&BO3O\
MA1_C_P#Z%[5O_!'J?_R+1_PH_P ?_P#0O:M_X(]3_P#D6@#S&BO3O^%'^/\
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MMJ\ACM2)DP^$9RV<_= 7KZLH[T^MA-I'545@QZLH-Q]LFLH56X^SQE+G=N)
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M#'KZUY3S3C\*ON4[)NQ[)_PU#\<^WC@_CIMG_P#&:3_AI_XY'KXY'_@LL_\
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MPUYG\'?^05XP_P"QOUC_ -*FH ]-HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(:
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M]PC:M>Z+I<F N//,:S+*ZC&-H8]>@R!Z ^L6MK%:VZV\,*PPQJ$CC0 *B@8
M [#VJX.M4G:_F19O<\T^/W_)O7C3_L'M_P"A+6S\*%#?!'P'G_H7[#_TFCK'
M^/W_ ";UXU_[![?^A+6G\+\?\*0\ Y8J/^$?L.G_ %[1TF[:EGP1^U JK^TS
MXM5>!_H?_I'#7C7-=Q\5-2L]8^*OB/4M/U2]U2VGNV*W5\NV63  /'9000HX
M^4+P.@X;O3B[I#:MH)1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MM>D^6OO]<G-24 >9?\)W\3/^B':K_P"#S3__ ([1_P )W\3/^B':K_X/-/\
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M:QJO_A71?_)=?6M% 'R5_P *7\+_ /1J^J_^%='_ /)='_"E_"__ $:OJO\
MX5T?_P EU]:T4 ?)7_"EO"__ $:OJG_A71__ "72_P#"E_"^?^35]4_\*Z+_
M .2Z^M** /DL_!?PN>G[*^J#_N;HO_DNC_A2_A?_ *-7U3_PKHO_ )+KZTHH
M ^2O^%+^%\_\FKZI_P"%=%_\ET?\*6\,=OV6-5'_ '-T7_R77UK10!\E_P#"
ME_#!Z_LKZJ3_ -C='_\ )=!^#'AH_P#-K.J_^%=%_P#)=?6E% 'R5_PI;PQW
M_98U4_\ <W1__)='_"E_"^?^36-5_P#"NB_^2Z^M:* /DK_A2_A?_HU?5?\
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MC;GZT /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ltbr_ex101img24.jpg
<TEXT>
begin 644 ltbr_ex101img24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M'\#/^AX_\IMY_P#&: /9Z*\7_P"&I/@7_P!#O_Y3;S_XS2_\-1_ O'_(\?\
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MFHKZ8_X8K^*G_0=\+?\ @7<?_&*7_ABOXJ?]![PK_P"!5Q_\8H ^9J*^F/\
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M%?Q3_P"@]X5_\"KC_P",4 ?,U%?3/_#%?Q4_Z#WA7_P*N/\ XQ1_PQ7\5/\
MH/>%?_ JX_\ C% 'S-17TS_PQ7\5/^@[X5_\"KC_ .,4G_#%?Q4_Z#OA;_P*
MN/\ XQ0!\ST5],_\,5_%3_H/>%?_  *N/_C%)_PQ7\5/^@]X5_\  JX_^,4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"_\ @OO/_C] 'LU%>,_VQ\=/^@AX%_\ !?>?_'Z/[8^.G_00\"_^"^\_^/T
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M $$/ @_[A]Y_\?IHU3XZ''_$P\"\_P#4/O/_ (__ )[4 >T45XS_ &Q\=/\
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M $$/ O\ X+[S_P"/T?VQ\=/^@AX%_P#!?>?_ !^@#V:BO&?[8^.G_00\"_\
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M $4U;GAKGP?HN?\ GQA_]%BL/XJ?\D;\8_\ 8'NO_135N>&?^1/T7_KQA_\
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MVRQ"ZB&XO]Q0DBKC&Y%YQWZ"^GQ,TS7M)U*VTK^T-)OWTB74]/GN(H\W$0#
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M$V;77=M_C'3/4FG:3\*O$=O/I\U]<Z;_ ,2CPW)H=HL$SD2RL"IE<E!L7!'
M#')SSBO90 .@P?:C%&X7_K[CY]\/_ ?5]+_X0^\U2/P_K4FCI<6MW876][>X
MBDDDD1U+1$[E,G0IU'6O=]-L;?3=-AL+2RMK*"$$1P6D8CBC&>B@<8Y]LU;(
M!SD9S13N+S"BBBD 4444 %%%% "]C6-\#O\ D6/%'_8UZM_Z4M6SV-8WP._Y
M%CQ1_P!C7JW_ *4M0!ZK1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5&XSC\:DI&Z4 >)
M6?@?QCJWB#Q3=6?Q0O\ 2XFUB;$$>EV<@4%$*C<\9/"D+[[<GDUI?\*M\=_]
M%FU3_P $UC_\;KM?"G_'YXF_[#$G_HJ*NGH \C_X5;X[_P"BS:I_X)K'_P"-
MT?\ "K?'?_19M4_\$UC_ /&Z]<HH \C_ .%6^._^BS:I_P"":Q_^-T?\*M\=
M_P#19M4_\$UC_P#&Z]<HH \C_P"%6^._^BS:I_X)K'_XW7.^!_ASXTO/ .C7
M5M\6M2LX9;='2!=*LG$8Y^4%H\G\:]^KD/AG_P DO\._]>:?UH Y+_A5OCO_
M *+-JG_@FL?_ (W1_P *M\=_]%FU3_P36/\ \;KURB@#R/\ X5;X[_Z+-JG_
M ()K'_XW1_PJWQW_ -%FU3_P36/_ ,;KURB@#R/_ (5;X[_Z+-JG_@FL?_C=
M'_"K?'?_ $6;5/\ P36/_P ;KURB@#R/_A5OCO\ Z+-JG_@FL?\ XW1_PJWQ
MW_T6;5/_  36/_QNO7** /(_^%6^._\ HLVJ?^":Q_\ C='_  JWQW_T6;5/
M_!-8_P#QNO7** /(_P#A5OCO_HLVJ?\ @FL?_C='_"K?'?\ T6;5/_!-8_\
MQNO7** /(_\ A5OCO_HLVJ?^":Q_^-T?\*M\=_\ 19M4_P#!-8__ !NO7**
M/G;XE?#OQIIOPH\5:A=_%;4=1M[;2[F66U?2[.-9U$;$H65 R@CC(.1VK6\/
M?#?QM<>%=)GC^+VI6T<MG"Z1+H]BVP%!A<^7DX&!S7=?&+_DA?CK_L!WG_HE
MJR/%8!_9;UMC_#X0G/\ Y)-0!1_X5AXX'_-:-4_\$UC_ /&Z/^%7^.?^BT:I
M_P"":Q_^-U^9#/N;.T#\*;S0!^G7_"K_ !S_ -%HU3_P36/_ ,;H_P"%7^.?
M^BSZI_X)K'_XW7YB4OTH _3K_A5_CG_HL^J?^":Q_P#C='_"K_'/_1:-4_\
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M\);F_O'\Z-S?WC^= 'W;_P )9X5_Z.I'_@IL_P#XU1_PEGA7_HZD?^"FS_\
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MJ<4MTZJC3LMP09"J@ %B,X  &>*]<->9_!W_ )!7C#_L;]8_]*FH ]-HHHH
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M[C_TB:@#\MSUI*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D;I2TC=* .9\*?\?GB;_L,2?\ HJ*NGKF/"G_'YXF_[#$G_HJ*NGH
M**** "BBB@ KD/AG_P DO\._]>:?UKKZY#X9_P#)+_#O_7FG]: .OHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH X;XQ?\D+\=?]@.\_\ 1+5D^*_^36M<
M_P"Q/N/_ $B:M;XQ?\D+\=?]@.\_]$M63XK_ .36=<_[$^X_](FH _+:BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KV?]EO_ ).;\)_2[_\ 22:O&*]G_9;_ .3F_"?TN_\ TDFH ^U]6&?V
M/[X?]22__I":_,&OT_U;_DT*_P#^Q)?_ -(37Y@4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?K[X2_Y$?0O^P?
M;_\ HI:_(*OU]\)?\B/H7_8/M_\ T4M &T:\S^#O_(*\8?\ 8WZQ_P"E35Z8
M:\S^#O\ R"O&'_8WZQ_Z5-0!Z;1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C=*6D;I0
M!S/A3_C\\3?]AB3_ -%15T]<QX4_X_/$W_88D_\ 145=/0 4444 %%%% !7(
M?#/_ ))?X=_Z\T_K77UR'PS_ .27^'?^O-/ZT =?1110 4444 %%%% !1110
M 4444 %%%% !1110!PWQB_Y(7XZ_[ =Y_P"B6K)\5_\ )K.N?]B?<?\ I$U:
MWQB_Y(7XZ_[ =Y_Z):LGQ7_R:SKG_8GW'_I$U 'Y;4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>S_LM_P#)
MS?A/Z7?_ *235XQ7L_[+?_)S?A/Z7?\ Z234 ?:^K9_X8_OL=?\ A"7_ /2$
MU^878>M?I]J@S^R#>C_J27_](37Y@XXS0 E%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?K[X2_P"1'T+_ +!]O_Z*
M6OR"K]??"7_(CZ%_V#[?_P!%+0!M&O,_@[_R"O&'_8WZQ_Z5-7IAKS/X._\
M(*\8?]C?K'_I4U 'IM%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(37YA?PCZT -HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K]??"7_(CZ%_V#[?_P!%+7Y!5^OOA+_D1]"_[!]O_P"B
MEH VC7F?P=_Y!7C#_L;]8_\ 2IJ],->9_!W_ )!7C#_L;]8_]*FH ]-HHHH
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M2%^.O^P'>?\ HEJWO"/_ "(N@?\ 8/M__1:T >9_\,N_ T_>\#Y/K_:=Y_\
M':/^&7?@5_T(O_E3O/\ X]7L]% 'C'_#+OP*_P"A%_\ *G>?_'J/^&7?@5_T
M(O\ Y4[S_P"/5[/10!XQ_P ,N_ K_H1?_*G>?_'J/^&7?@5_T(O_ )4[S_X]
M7L]% 'C'_#+OP*_Z$7_RIWG_ ,>H_P"&7?@5_P!"+_Y4[S_X]7L]% 'C'_#+
MOP*_Z$7_ ,J=Y_\ 'J/^&7?@5_T(O_E3O/\ X]7L]% 'C'_#+OP*_P"A%_\
M*G>?_'J/^&7?@5_T(O\ Y4[S_P"/5[/10!XQ_P ,N_ K_H1?_*G>?_'J!^RW
M\"\_\B/_ .5*\_\ CU>ST4 >,?\ #+OP*_Z$7_RIWG_QZC_AEWX%?]"+_P"5
M.\_^/5[/10!XS_PRY\"_^A'_ /*G>?\ QZD_X9=^!7_0B_\ E3O/_CU>ST4
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M^$?6OT]U;_DT*_\ ^Q)?_P!(37Y@XX!H 2BBB@ HHHH **** "BBB@ HHHH
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M:5_\FUVE% '%_P#"9>(O^B3^*_\ P(TK_P"3:/\ A,O$7_1)_%?_ ($:5_\
M)M=I10!Q?_"9>(O^B3^*_P#P(TK_ .3:/^$R\1?]$G\5_P#@1I7_ ,FUVE%
M'B_Q/\3:Y=_![QC:W'PX\164,NCW2/<SSZ:8X5,39=@EVS$#J=H)] :VO#?B
MOQ%#X0T:)?ACXFF$=E"HDCN-,"MB,#(W7@./J :U?C%_R0OQU_V [S_T2U;W
MA'_D1= _[!]O_P"BUH QO^$R\1?]$G\5_P#@1I7_ ,FT?\)EXB_Z)/XK_P#
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MBC_H9-4'_;Y+_P#%4O\ PEGB;_H9=3_\#)?_ (J@#[(_X9T^'O\ T1OX@?\
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M%!!8FO-?@[_R"O&'_8WZQ_Z5-0!Z;1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C=*6D
M;I0!S/A3_C\\3?\ 88D_]%15T]<QX4_X_/$W_88D_P#145=/0 4444 %%%%
M!7(?#/\ Y)?X=_Z\T_K77UR'PS_Y)?X=_P"O-/ZT =?1110 4444 %%%% !1
M110 4444 %%%% !1110!PWQB_P"2%^.O^P'>?^B6K>\(_P#(BZ!_V#[?_P!%
MK6#\8O\ DA?CK_L!WG_HEJWO"/\ R(N@?]@^W_\ 1:T ;=%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M\?\ [27_ "9]\.O^OC3?_2":OB>OMC]I+_DS[X=?]?&F_P#I!-7Q/0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MVGPG_P"2V^!?^P_8?^E"5Q==I\)_^2V^!?\ L/V'_I0E 'ZQ]S7F?P=_Y!7C
M#_L;]8_]*FKTSN:\S^#O_(*\8?\ 8WZQ_P"E34 >FT444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %(W2EI&Z4 <SX4_P"/SQ-_V&)/_145=/7,>%/^/SQ-_P!AB3_T5%73
MT %%%% !1110 5R'PS_Y)?X=_P"O-/ZUU]<A\,_^27^'?^O-/ZT =?1110 4
M444 %%%% !1110 4444 %%%% !1110!PWQB_Y(7XZ_[ =Y_Z):OGG]IK5+_2
M_@S\-Y+"^N+1G5 S02LA(%NIYQUKZ&^,7_)"_'7_ & [S_T2U?-G[5W_ "1'
MX:?[J_\ I,M 'RBWBSQ-N.WQ-JA'K]LE'_LU)_PEGB;_ *&74_\ P,E_^*K"
MHH W?^$L\3?]#+J?_@9+_P#%4?\ "6>)O^AEU/\ \#)?_BJPJ* -W_A+/$W_
M $,NI_\ @9+_ /%4?\)9XF_Z&74__ R7_P"*K"HH W?^$L\3?]#+J?\ X&2_
M_%4?\)9XF_Z&74__  ,E_P#BJPJ* -W_ (2SQ-_T,NI_^!DO_P 51_PEGB;_
M *&74_\ P,E_^*K"HH W?^$L\3?]#+J?_@9+_P#%4?\ "6>)O^AEU/\ \#)?
M_BJPJ* -W_A+/$W_ $,NI_\ @9+_ /%4?\)9XF_Z&74__ R7_P"*K"HH W?^
M$L\3?]#+J?\ X&2__%4?\)9XF_Z&74__  ,E_P#BJPJ* -W_ (2SQ-_T,NI_
M^!DO_P 51_PEGB;_ *&74_\ P,E_^*K"HH W?^$L\3?]#+J?_@9+_P#%4?\
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MF_\ I!-7Q/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5VGPG_Y+;X%_[#]A_P"E"5Q==I\)_P#DMO@7_L/V'_I0
ME 'ZQ]S7F?P=_P"05XP_[&_6/_2IJ],[FO,_@[_R"O&'_8WZQ_Z5-0!Z;111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0!S/[27_ "9]\.O^OC3?_2":OB>OMC]I+_DS[X=?]?&F_P#I!-7Q/0 4444
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MU3?6WH-:W^?X([J/XA^%[C2$U*WNKJ6%[J2R$2V%SY_G)]]?(\OS?EY+';@
M$GBH9/%6FWWCG0;.S\5Q1&\LYKA=+6#S/MB?+ME\S^ +AN/XMP]JXFW\&ZE?
M6VHQZOH6LV%U%K][JFFW^EZA;QS1"4_*1^]P<@L"K CH"#DXA@\,_$35O%'@
MW4/%%KMNK;1]0LM2U&SDA AEGVB(JN_<6 49VKM!Z<'@ETMJ-/>YZ+;_ !$\
M*W5^]C%J@2<1O+'Y\,L*7"(,LT+N@68 <DQE@!S1I7Q"\)ZU=Z?;:;J?G/J*
MR-:.894CG\LD.J2,@5F&"=N<X&<8YK@H/#/BF\TCX=65YH,EE)X1E62YD%Q
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M!-7Q/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%=I\)_\ DMO@7_L/V'_I0E<77:?"?_DMO@7_ +#]A_Z4)0!^L?<UYG\'?^05
MXP_[&_6/_2IJ],[FO,_@[_R"O&'_ &-^L?\ I4U 'IM%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !2-TI:1NE ',^%/\ C\\3?]AB3_T5%73US'A3_C\\3?\ 88D_]%15
MT] !1110 4444 %<A\,_^27^'?\ KS3^M=?7(?#/_DE_AW_KS3^M '7T444
M%%%% !1110 4444 %%%% !1110 4444 <-\8O^2%^.O^P'>?^B6KYL_:N_Y(
MC\-/]U?_ $F6OI/XQ?\ )"_'7_8#O/\ T2U?-G[5W_)$?AI_NK_Z3+0!\9T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %??W[%G_)$=9_[#\W_I-;U\ U]_?L6?\ )$=9_P"P_-_Z36] ',_M
M)?\ )GWPZ_Z^--_]()J^)Z^V/VDO^3/OAU_U\:;_ .D$U?$] !1110 4444
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M (BOUDYHYH _)O\ X5/\4_\ HFOBK_P37/\ \11_PJ?XI_\ 1-?%7_@FN?\
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M;_X5/\4_^B:^*O\ P37/_P 11_PJ?XI_]$U\5?\ @FN?_B*_63FCF@#\F_\
MA4_Q3_Z)KXJ_\$US_P#$4?\ "I_BG_T37Q5_X)KG_P"(K]9.:.: /R;_ .%3
M_%/_ *)KXJ_\$US_ /$4?\*G^*?_ $37Q5_X)KG_ .(K]9.:.: /R;_X5/\
M%/\ Z)KXJ_\ !-<__$5]M_LFZ!KWAGX1ZK8^(-$U#1KN36YI4@O[9X)&0P0
M,%< D94C/3@^E?1/-,,88DGJ: /D+]I+_DS[X=?]?&F_^D$U?$]?;'[27_)G
MWPZ_Z^--_P#2":OB>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KM/A/_P EM\"_]A^P_P#2A*XNNT^$_P#R6WP+
M_P!A^P_]*$H _6/N:\S^#O\ R"O&'_8WZQ_Z5-7IG<UYG\'?^05XP_[&_6/_
M $J:@#TVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ I&Z4M,D#$#;C\: .;\*?\?GB;_L
M,2?^BHJZ>O$="^)DD&L^*X;/X?\ BW5X8M>N;<W%C:P/$6BVQ-@M.#PT9/3H
M1]!T7_"U=1_Z)#X^_P# &U_^2* /3**\S_X6KJ/_ $2'Q]_X VO_ ,D4?\+5
MU'_HD/C[_P  ;7_Y(H ],HKS/_A:NH_]$A\??^ -K_\ )%'_  M74?\ HD/C
M[_P!M?\ Y(H ],KD/AG_ ,DO\._]>:?UK"_X6KJ/_1(?'W_@#:__ "17&?#;
MXM/-\-]$?3_AOXTU*U6$PK<VEI;M'*49E;:3."0"I'0'(- 'O]%>9_\ "U=1
M_P"B0^/O_ &U_P#DBC_A:NH_]$A\??\ @#:__)% 'IE%>9_\+5U'_HD/C[_P
M!M?_ )(H_P"%JZC_ -$A\??^ -K_ /)% 'IE%>9_\+5U'_HD/C[_ , ;7_Y(
MH_X6KJ/_ $2'Q]_X VO_ ,D4 >F45YG_ ,+5U'_HD/C[_P  ;7_Y(H_X6KJ/
M_1(?'W_@#:__ "10!Z917F?_  M74?\ HD/C[_P!M?\ Y(H_X6KJ/_1(?'W_
M ( VO_R10!Z917F?_"U=1_Z)#X^_\ ;7_P"2*/\ A:NH_P#1(?'W_@#:_P#R
M10!Z917F?_"U=1_Z)#X^_P# &U_^2*/^%JZC_P!$A\??^ -K_P#)% &G\8O^
M2%^.O^P'>?\ HEJWO"/_ "(N@?\ 8/M__1:UXU\4/B9=7?P@\6VDWPS\::>E
MUI<]O]JN[2W2*$NA0,Y$Y(&2,X!/M6KX1^*UT?!&B26_PP\;7D!L;?R[BWLK
M8QR@QKAES< [2,$9 ."* /:Z*\Q'Q7U @$?"'QZ0>A%C:_\ R13O^%K:A_T2
M'Q[_ . 5K_\ )% 'IE%>9_\ "UM0_P"B0^/O_ &U_P#DBC_A:VH#_FD/C[_P
M!M?_ )(H ],HKS/_ (6KJ/\ T2'Q]_X VO\ \D4?\+5U'_HD/C[_ , ;7_Y(
MH ],HKS+_A:]^#S\(?'O_@%:_P#R11_PM>_SC_A47CW/_7E:_P#R10!Z;17F
M?_"U=1_Z)#X^_P# &U_^2*/^%JZC_P!$A\??^ -K_P#)% 'IE%>9_P#"UM0_
MZ)#X^_\  *U_^2*/^%K:@>GPA\>G_MRM?_DB@#TRBO,_^%JZC_T2'Q]_X VO
M_P D4?\ "U=1_P"B0^/O_ &U_P#DB@#TRBO,_P#A:NH_]$A\??\ @#:__)%'
M_"U=1_Z)#X^_\ ;7_P"2* /3**\S_P"%JZC_ -$A\??^ -K_ /)%'_"U=1_Z
M)#X^_P# &U_^2* /3**\S_X6KJ/_ $2'Q]_X VO_ ,D4?\+5U'_HD/C[_P
M;7_Y(H ],HKS/_A:NH_]$A\??^ -K_\ )%'_  M74?\ HD/C[_P!M?\ Y(H
M],HKS/\ X6KJ/_1(?'W_ ( VO_R11_PM74?^B0^/O_ &U_\ DB@#TRBO,_\
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MJ&1GX1^/5SP,V-K^G^D56^!]VU_X5\2WTEG<63W'BC5)6MKE0LL):X)V.%)
M89P<$\@\F@#UJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %YHYI** %YHYI** %YHYI** %YHYI** %YIR-M=6QG!S3*7F@#],?V7PO\
MPS/X38#&?M9QC_I[FKV7 KQO]EW_ )-C\(_]O?\ Z635[+0!Q7PI&[X+^!9"
M>N@6''_;NE=I@5QGPG_Y(CX$_P"P!8?^DZ5VE "8%&!2T4 )@48%+10 F!1@
M4M% "8%&!2T4 )@48%+10 F!1@4M% "8%&!2T4 )@48%+10 F!1@4M% "8%&
M!2T4 )@48%+10 F!1@4M% "8%&!2T4 1O'NQS@#MBO-O@YQI/C =AXNU@?\
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M(YQM7/# 'MKKXR_#R"ZEL[GQ!,;RV9(YH(]/N6EB=U9EC=%C)5L1ME3R",$
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M@3_L 6'_ *3I7Y.T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^3>O&O\ V#V_]"6OF?\ :#_Y-<^"_P#V#K;_ -(8Z /DRBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "EYI*7F@#],O
MV7?^38_"/_;W_P"EDU>RUXU^R[_R;'X1_P"WO_TLFKV6@#B_A/Q\$? G_8 L
M/_2=*_)[^$?4U^K_ ,*?^2'^!/\ L 6'_I.E?D]_"* $HHHH **** "BBB@
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M 4444 >9?'[_ )-Z\:_]@]O_ $):^9_V@_\ DUSX+_\ 8.MO_2&.OICX_?\
M)O7C7_L'M_Z$M?,_[0?_ ":Y\%_^P=;?^D,= 'R91110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2\TE+S0!^F7[+O\
MR;'X1_[>_P#TLFKV6O&OV7?^38_"/_;W_P"EDU>RT <3\*5W? _P(O3.@6'_
M *3I7:(FP8!XKC?A/_R1'P)_V +#_P!)TKM* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FL&*D*<'UQ3J* &*NW
M/.<UYK\'?^05XP_[&_6/_2IJ],->9_!W_D%>,/\ L;]8_P#2IJ /3:*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "HY%+  #-244 <3<_#/X>W][/?:A\/_#EU=7$C333S
MZ3;O)*['+,S%2222223DFG?\*G^%G_1,_"O_ ()K;_XBNTHH XO_ (5/\+/^
MB9^%?_!-;?\ Q%'_  J?X6?]$S\*_P#@FMO_ (BNTHH XO\ X5/\+/\ HF?A
M7_P36W_Q%'_"I_A9_P!$S\*_^":V_P#B*[2B@#B_^%3_  L_Z)GX5_\ !-;?
M_$4?\*G^%G_1,_"O_@FMO_B*[2B@#B_^%3_"S_HF?A7_ ,$UM_\ $4?\*G^%
MG_1,_"O_ ()K;_XBNTHH XO_ (5/\+/^B9^%?_!-;?\ Q%'_  J?X6?]$S\*
M_P#@FMO_ (BNTHH XO\ X5/\+/\ HF?A7_P36W_Q%'_"I_A9_P!$S\*_^":V
M_P#B*[2B@#B_^%3_  L_Z)GX5_\ !-;?_$4?\*G^%G_1,_"O_@FMO_B*[2B@
M#B_^%3_"S_HF?A7_ ,$UM_\ $4?\*G^%G_1,_"O_ ()K;_XBNTHH XO_ (5/
M\+/^B9^%?_!-;?\ Q%'_  J?X6?]$S\*_P#@FMO_ (BNTHH XO\ X5/\+/\
MHF?A7_P36W_Q%'_"I_A9_P!$S\*_^":V_P#B*[2B@#B_^%3_  L_Z)GX5_\
M!-;?_$4?\*G^%G_1,_"O_@FMO_B*[2B@#B_^%3_"S_HF?A7_ ,$UM_\ $4?\
M*G^%G_1,_"O_ ()K;_XBNTHH XO_ (5/\+/^B9^%?_!-;?\ Q%'_  J?X6?]
M$S\*_P#@FMO_ (BNTHH XO\ X5/\+/\ HF?A7_P36W_Q%'_"I_A9_P!$S\*_
M^":V_P#B*[2B@#B_^%3_  L_Z)GX5_\ !-;?_$4?\*G^%G_1,_"O_@FMO_B*
M[2B@#B_^%3_"S_HF?A7_ ,$UM_\ $4?\*G^%G_1,_"O_ ()K;_XBNTHH XO_
M (5/\+/^B9^%?_!-;?\ Q%'_  J?X6?]$S\*_P#@FMO_ (BNTHH XO\ X5/\
M+/\ HF?A7_P36W_Q%'_"I_A9_P!$S\*_^":V_P#B*[2B@#B_^%3_  L_Z)GX
M5_\ !-;?_$4?\*G^%G_1,_"O_@FMO_B*[2B@#B_^%3_"S_HF?A7_ ,$UM_\
M$4?\*G^%G_1,_"O_ ()K;_XBNTHH XO_ (5/\+/^B9^%?_!-;?\ Q%'_  J?
MX6?]$S\*_P#@FMO_ (BNTHH XO\ X5/\+/\ HF?A7_P36W_Q%'_"I_A9_P!$
MS\*_^":V_P#B*[2B@#B_^%3_  L_Z)GX5_\ !-;?_$4?\*G^%G_1,_"O_@FM
MO_B*[2B@#B_^%3_"S_HF?A7_ ,$UM_\ $4?\*G^%G_1,_"O_ ()K;_XBNTHH
M XO_ (5/\+/^B9^%?_!-;?\ Q%'_  J?X6?]$S\*_P#@FMO_ (BNTHH XO\
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MNTHH XO_ (5/\+/^B9^%?_!-;?\ Q%'_  J?X6?]$S\*_P#@FMO_ (BNTHH
MXO\ X5/\+/\ HF?A7_P36W_Q%'_"I_A9_P!$S\*_^":V_P#B*[2B@#B_^%3_
M  L_Z)GX5_\ !-;?_$4?\*G^%G_1,_"O_@FMO_B*[2B@#B_^%3_"S_HF?A7_
M ,$UM_\ $4?\*G^%G_1,_"O_ ()K;_XBNTHH XO_ (5/\+/^B9^%?_!-;?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ,*6X_\ D"C^W/B=_P!";X6_\*6X_P#D"@#NJ*X7^W/B=_T)OA;_ ,*6X_\
MD"C^W/B=_P!";X6_\*6X_P#D"@#NJ*X7^W/B=_T)OA;_ ,*6X_\ D"C^W/B=
M_P!";X6_\*6X_P#D"@#NJ*X7^W/B=_T)OA;_ ,*6X_\ D"C^W/B=_P!";X6_
M\*6X_P#D"@#NJ*X7^W/B=_T)OA;_ ,*6X_\ D"C^W/B=_P!";X6_\*6X_P#D
M"@#NJ*X7^W/B=_T)OA;_ ,*6X_\ D"C^W/B=_P!";X6_\*6X_P#D"@#NJ*X7
M^W/B=_T)OA;_ ,*6X_\ D"L'Q!X\\>>&?[)_M#P3X?D_M748=,A\CQ%.VV63
M=M9LV0POR\D9/L: /6**X4ZY\3,_+X.\+D>_B2X!_P#2"C^W/B=_T)OA;_PI
M;C_Y H [JBN%_MSXG?\ 0F^%O_"EN/\ Y H_MSXG?]";X6_\*6X_^0* .ZHK
MA?[<^)W_ $)OA;_PI;C_ .0*/[<^)W_0F^%O_"EN/_D"@#NJ*X7^W/B=_P!"
M;X6_\*6X_P#D"C^W/B=_T)OA;_PI;C_Y H [JBN%_MSXG?\ 0F^%O_"EN/\
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MJWU.VTVVM]8OH=0OD0++<V]N;=9".X0LVW/^\?PKD?AO_P ??CG_ +&:Z_\
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M +1110 5YO\ %GIX#_[&W3__ &>O2*\W^+/3P'_V-NG_ /L] 'I'6BCL*/\
M/7% !17D_P 6OB)XF\":_P"#K71ETJ2V\0:DNGR"]M9)'AW,HW I*H/WNF*[
M&XU#6K7QI964DUH=+DL+BZEB6TD:??&T2@(PD(PWF]-A;Y0!R<TKV5_ZT Z>
MBN%TKXN?#W7+O2K/3=?:675Y)8K'=9W$8G>/[Z@N@&1D<$_3-<J/C,ESX?\
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M HHHH **** "BBB@!1UK@O@NH_L/Q<,<?\)=K Q_V]-7>CK7!_!?_D">+O\
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MFU:W>Y\]'X0Z[X,U/X=ZQX;LQX@3PQ9W%M=VD4Z12SRS(^94\UE3&^0YRP(
M&,XQ7H7PG\(ZGX%^$.F:%JNVYU&W66>6.!@1O>1W$:$D XW8SD#/?'->AD9&
M/;%"_+G;QGKBJU=[]1::>1\E^'?AW\2]+\->%=/N? 5ZT^E^+#KLSQWMB5,!
MQ\JGS\E^O' ]ZW+[X/\ C+RO%7A*"S6:Q\2>(H]8&M+/&$M80Y=E=2PD,N<
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M0U?P=KFGPV+6-I>B)+$PJBA95=T,D6%)&W>?]GUSO''PW\;3Z_\ $@:'H_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6I^*M1GUF\L+&V2&UCGD6"5T"KM$4?"1EV9B!Z$<"GV\U<7^=A__  LW5/\
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M-N[81G&YL9Z9/J: /6_^%G:HO7X0^/!];.U_^2:3_A:&I_\ 1(?'?_@':_\
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MI?\ 12O%0^FLW'_Q= 'Z%_\ "S=4_P"B0>//_ *U_P#DFC_A9NJ?]$@\>?\
M@%:__)-?GI_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\ \70!^A?_
M  LW5/\ HD'CS_P"M?\ Y)H_X6;JG_1(/'G_ (!6O_R37YZ?\+8^*7_12_%7
M_@YN?_BZ/^%L?%+_ **7XJ_\'-S_ /%T ?H7_P +-U3_ *)!X\_\ K7_ .2:
M/^%FZI_T2#QY_P" 5K_\DU^>G_"V/BE_T4OQ5_X.;G_XNC_A;'Q2_P"BE^*O
M_!S<_P#Q= 'Z%_\ "S=4_P"B0>//_ *U_P#DFC_A9NJ?]$@\>?\ @%:__)-?
MGI_PMCXI?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\ \70!^A?_  LW5/\
MHD'CS_P"M?\ Y)H_X6;JG_1(/'G_ (!6O_R37YZ?\+8^*7_12_%7_@YN?_BZ
M/^%L?%+_ **7XJ_\'-S_ /%T ?H7_P +.U3_ *(_X]_\ K7_ .2:/^%FZI_T
M2#QY_P" 5K_\DU^>G_"V/BG_ -%*\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\
M\70!^A?_  L[5/\ HC_CW_P"M?\ Y)I/^%H:F>GPA\>'_MSM?_DFOSV_X6Q\
M4,<_$;Q0Q]3K%SG_ -#H_P"%K_%#M\2?%8/_ &&KC_XN@#]"O^%FZI_T2#QY
M_P" 5K_\DTG_  L[5,X_X5#X\S_UYVO_ ,DU^>O_  MCXI?]%+\5?^#FY_\
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M,/\ L;]8_P#2IJ /3:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;[II:9(2 ,=_09H
MX?X9_P#'AXG_ .QDU+_TH:N[KQGP3\0/ ^A#Q-8ZUXTT'3+M?$>I%H+S4H87
M -PV#M9@?7M7:?\ "UOA?_T4CPO_ .#BW_\ BZ .RHKC?^%K?"__ **1X7_\
M'%O_ /%T?\+6^%__ $4CPO\ ^#BW_P#BZ .RHKC?^%K?"_\ Z*1X7_\ !Q;_
M /Q='_"UOA?_ -%(\+_^#BW_ /BZ .RKS_X:_P#'YX[_ .QHN?\ T5#5[_A:
MWPO_ .BD>%__  <6_P#\77G_ ,/?B3X!L[WQH;[QYX=MEN/$5Q/"9=5@7S8S
M%$ ZY;E20<$>AH ]RHKC?^%K?"__ **1X7_\'%O_ /%T?\+6^%__ $4CPO\
M^#BW_P#BZ .RHKC?^%K?"_\ Z*1X7_\ !Q;_ /Q='_"UOA?_ -%(\+_^#BW_
M /BZ .RHKC?^%K?"_P#Z*1X7_P#!Q;__ !='_"UOA?\ ]%(\+_\ @XM__BZ
M.RHKC?\ A:WPO_Z*1X7_ /!Q;_\ Q='_  M;X7_]%(\+_P#@XM__ (N@#LJ*
MXW_A:WPO_P"BD>%__!Q;_P#Q='_"UOA?_P!%(\+_ /@XM_\ XN@#LJ*XW_A:
MWPO_ .BD>%__  <6_P#\71_PM;X7_P#12/"__@XM_P#XN@#LJ*XW_A:WPO\
M^BD>%_\ P<6__P 71_PM;X7_ /12/"__ (.+?_XN@#LJ*XW_ (6M\+_^BD>%
M_P#P<6__ ,71_P +6^%__12/"_\ X.+?_P"+H [*BN-_X6M\+_\ HI'A?_P<
M6_\ \71_PM;X7_\ 12/"_P#X.+?_ .+H [*BN-_X6M\+_P#HI'A?_P '%O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6O#VF:P/"FE0"]M8KGR_LL;;-Z!MN=HSC/7'X5K_ /"(^%O^A;TO_P  HO\
MXFLSP#<12_#SPXL4GF;-.MXV*MG:RQJ&4^A!&".H/%=>*LE&)_PB/A;_ *%O
M2O\ P"B_^)KSWX<^&= FO/&XN- TZ41>);F./?:QMM010X R.![#UKUVO/\
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MD>QXKV>O,OB]][P!_P!C?I__ +/0!V*^$?"P'_(M:5_X!1_X5YE\>(;/P?\
M WQ!XD\-Z3I5CJMG]F\F?^SH)-F^YB1OE="IRK,.1WKVFO&/VH_^39/%W_;G
M_P"ED- 'PY_PO;XE_P#04TK_ ,)_3_\ XQ2?\+W^)?\ T%-*_P#"?T__ .,5
MYE10!Z;_ ,+V^)?_ $%-*_\ "?T[_P",4?\ "]OB7_T%-*_\)_3O_C%>944
M>F_\+V^)?_04TK_PG]._^,4?\+V^)?\ T%-*_P#"?T[_ .,5YE10!Z;_ ,+V
M^)?_ $%-*_\ "?T[_P",4?\ "]OB7_T%-*_\)_3O_C%>944 >F_\+V^)?_04
MTK_PG]._^,4?\+V^)?\ T%-*_P#"?T[_ .,5YE10!Z;_ ,+V^)?_ $%-*_\
M"?T[_P",4?\ "]OB7_T%-*_\)_3O_C%>944 >F_\+V^)?_04TK_PG]._^,4?
M\+V^)?\ T%-*_P#"?T[_ .,5YE10!Z;_ ,+V^)?7^U-*_P#"?T__ .,4?\+V
M^)?_ $%-*_\ "?T[_P",5YE10!Z;_P +V^)?_04TK_PG]._^,4?\+W^)G_04
MTK_P0:?_ /&*\RHH ]/'QV^)7\6J:7^'A_3_ /XQ2'X[_$K/&IZ5C_L7]/\
M_C%>8T4 >F_\+V^)?_04TK_PG]._^,4?\+V^)?\ T%-*_P#"?T[_ .,5YE10
M!Z;_ ,+W^)G_ $%-*_\ !!I__P 8H_X7M\2_^@II7_A/Z=_\8KS*B@#TW_A>
MWQ+_ .@II7_A/Z=_\8H_X7M\2_\ H*:5_P"$_IW_ ,8KS*B@#TW_ (7M\3/^
M@II7_A/Z?_\ &*/^%[?$O_H*:5_X3^G?_&*\RHH ]-_X7M\2_P#H*:5_X3^G
M?_&*/^%[?$O_ *"FE?\ A/Z=_P#&*\RHH ]/_P"%[?$KOJFE_AH&G?\ QBC_
M (7M\2_^@II?XZ!IW_QBO,** /3?^%[?$O\ Z"FE?^$_IW_QBC_A>WQ+_P"@
MII7_ (3^G?\ QBO,J* /3?\ A>WQ+_Z"FE?^$_IW_P 8H_X7M\2^^J:5_P""
M#3__ (Q7F5% 'IO_  O;XE=M4TO\= T__P",4?\ "]OB7_T%-*_\)_3O_C%>
M944 >F_\+V^)?_04TK_PG]._^,4?\+V^)?\ T%-*_P#"?T[_ .,5YE10!Z;_
M ,+U^)?_ $%-)_\ "?T[_P",4?\ "]OB5_T%-*_\)_3O_C%>944 >F_\+V^)
M?_04TK_PG]._^,4?\+V^)?\ T%-*_P#"?T[_ .,5YE10!]-_ OXD^*O&GQQ\
M.^&O$DVF7^E7?VCSH/[%L8M^RVE=?F2(,,,JG@]J^XO^$1\+?]"WI7_@%%_\
M37YT_LM_\G-^$?\ M\_](YJ_3&@#$_X1'PM_T+>E?^ 47_Q-'_"(^%O^A;TK
M_P  HO\ XFMNB@# D\)>&&*[?#6E\<Y^QQC_ -EKC/@S#'#H/BRWA18HHO%F
MKHB( %4"Y8  #@#VKU$UYG\'?^05XP_[&_6/_2IJ /3:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "D;[II:1ONF@#A?AG_QX>)_^QDU+_P!*&KN6564JPR#V-<-\,_\
MCP\3_P#8R:E_Z4-7=T 1^1%G.P4GDQ[MVSFI:* (UC5?NYZYZFI*** "O/\
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M 4444 %%%% !1110 4444 %%%% 'L_[+?_)S?A'_ +?/_2.:OTQK\SOV6_\
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M^8'RY%#KD8ZX(H ^7_V6_P#DYOPC_P!OG_I'-7Z8U\__ /#(?P<_Y\M5_P#
M]O\ "C_AD/X-_P#/CJO_ ('M_A0!] 45\_\ _#(?P;_Y\=5_\#V_PH_X9#^#
M?_/CJO\ X'M_A0![Z[;<87->:_!W_D%>,/\ L;]8_P#2IJXH_LD_!^%E\NSU
M0$GO?,?Z5T?P#TNTT'P1KVAV <6FG>)-3M(0[;F"1SE%!/<X Y[T >OT444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%(WW32TC?=- '"_#/_CP\3_]C)J7_I0U=W7"?#/_ (\/$_\ V,FI?^E#5W=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 *.M?K'\)?^2(
M^!/^Q?L/_2=*_)P=:_6/X2_\D1\"?]B_8?\ I.E ':4444 %%%% "&O,_@[_
M ,@KQA_V-^L?^E35Z8:\S^#O_(*\8?\ 8WZQ_P"E34 >FT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %-9@%YIU-89% 'AGA/XM?#GPM-XJTKQ!XNL=.O8_$>HEH9BVX
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M\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1J .+HKM/\ A9?B+_H&^%?_  D]*_\
MD:C_ (67XB_Z!OA7_P )/2O_ )&H XNBNT_X67XB_P"@;X5_\)/2O_D:C_A9
M?B+_ *!OA7_PD]*_^1J .+HKM/\ A9?B+_H&^%?_  D]*_\ D:C_ (67XB_Z
M!OA7_P )/2O_ )&H XNBNT_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_P
MD]*_^1J .+HKM/\ A9?B+_H&^%?_  D]*_\ D:C_ (67XB_Z!OA7_P )/2O_
M )&H XNBNT_X67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1J .+HK
MM/\ A9?B+_H&^%?_  D]*_\ D:C_ (67XB_Z!OA7_P )/2O_ )&H XNBNT_X
M67XB_P"@;X5_\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1J .+HKM/\ A9?B+_H&
M^%?_  D]*_\ D:C_ (67XB_Z!OA7_P )/2O_ )&H XNBNT_X67XB_P"@;X5_
M\)/2O_D:C_A9?B+_ *!OA7_PD]*_^1J .+HKM/\ A9?B+_H&^%?_  D]*_\
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MX@F3[LD;W!96'U!!KU1UW8P<?UKS;X._\@OQA_V-VL?^E34 >F4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(WW32TC?=- '"_#/_CP\3_\ 8R:E_P"E#5V\Q A8GD#T
MKB/AG_QX>)_^QDU+_P!*&KNZ3 \;T_7+7Q1\0M#U[P+XL?6+)A/#JUGY@\JT
MMPAP/**AH9#*(\!OF89ZA>/7;?\ X]UZ?@<U/2=Z.PNMQ:***8PKS_X:_P#'
MYX[_ .QHN?\ T5#7H%>?_#7_ (_/'?\ V-%S_P"BH: ._P"U<_KVJ:7HND7F
MHZQ?V^GVD29DN+J58HUSA1EFXZD#ZD#TKH.U%2US(:T/G_2]:\/WO[(!DB9-
M:M[+0$MKRWM+K:Z.L2[HW9<E,9!;C(4DX.>>*T%M/O?%7Q!34O$,5JMU#HE]
M;:AI5JYM=\8.R58SN#P*RJK$G!56)(P2/K6BJ;O=]R4K*Q\IZIXKU?4(O"<=
MAKGA73/%SZQ?-;W-K(!8W[?9I(TG0,<[9&/E;N1YF<9S7M/P\\4>%O%7A"TF
M\,W5J8[=1'-:Q2*9+20<%7 .<Y#?,?O?>!(.3Z)14J-BF[V\CYZGTO1?B-IN
MJ7_@SQ1:?\);X=UBXO=,N;6Y638[$820 \Q2[=OH<$C."*SO#.N:M:Z-X,\2
M^,+>/1=*37=5?6(YAA;&\DEF6%W)Z(':1=QX!923T-?2>*6AJ_X?@+_.YXK\
M,[NU\+)K+W$WV+0=>\33#P_&(V995D4']W@';&SB1E)PN.1PP)[3QI9^)M2L
M;*UT.WL;N$S;KV"\O6M/.B X0.D,O!;&X;1D @'FNWI:+ ]3Q;X(W&KS:9XM
M74;&R@C_ .$DOVS;W;2D2F7YUPT:84'@-U/=5KV?L:*/6A*R7D#U;8ZBBBJ
M**** "BBB@ HHHH *\R^+WWO '_8WZ?_ .SUZ;7F7Q>^]X _[&_3_P#V>@#T
MVOC/]N;_ )I]_P!Q#_VVK[,KXS_;F_YI]_W$/_;:@#XSHHHH **** "BBB@
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M;[IH X7X9_\ 'AXG_P"QDU+_ -*&KNZX3X9_\>'B?_L9-2_]*&KNZ "BBB@
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M+W4K6"*4%L +(\H1V_V58L.XK:B_9G^-5Q DT'@<E9%#*'U"U4@'IP90?S%
M'C-%>S?\,O\ QT_Z$?\ \J=G_P#'J/\ AE_XZ?\ 0C_^5.S_ /CU 'C-%>S?
M\,O_ !T_Z$?_ ,J=G_\ 'J/^&7_CI_T(_P#Y4[/_ ./4 >,T5[-_PR_\<O\
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MA_V-^L?^E35Z8:\S^#O_ ""O&'_8WZQ_Z5-0!Z;1110 4444 %%%% !1110
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M:#_PJ-5_^/T?\+F\._\ 1-!_X5&J_P#Q^O&:* /9O^%S>'?^B:#_ ,*C5?\
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MS3X._P#(*\8?]C?K'_I4U>FT 9LFFV4U_;7LEC#+=6P=89G0,\0;&X*QY4'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?LO\
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MK_\ )- 'IM%>9?\ "*_&7_HKVE?^$JO_ ,DT?\(K\9?^BO:5_P"$JO\ \DT
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MBC_AAG_JJ/\ Y1/_ +HH ^-**^R_^&&?^JH_^43_ .Z*/^&&?^JH_P#E$_\
MNB@#XTHK[+_X89_ZJC_Y1/\ [HH_X89_ZJC_ .43_P"Z* /C2BOLO_AAG_JJ
M/_E$_P#NBC_AAG_JJ/\ Y1/_ +HH ^-**^R_^&&?^JH_^43_ .Z*/^&&?^JH
M_P#E$_\ NB@#XTHK[+_X89_ZJC_Y1/\ [HH_X89_ZJC_ .43_P"Z* /C2BOL
MO_AAG_JJ/_E$_P#NBC_AAG_JJ/\ Y1/_ +HH ^-**^R_^&&?^JH_^43_ .Z*
M/^&&?^JH_P#E$_\ NB@#XTHK[+_X89_ZJC_Y1/\ [HH_X89_ZJC_ .43_P"Z
M* /C2BOLO_AAG_JJ/_E$_P#NBC_AAG_JJ/\ Y1/_ +HH ^-**^R_^&&?^JH_
M^43_ .Z*/^&&?^JH_P#E$_\ NB@#XTHK[+_X89_ZJC_Y1/\ [HH_X89_ZJC_
M .43_P"Z* /C2BOLO_AAG_JJ/_E$_P#NBC_AAG_JJ/\ Y1/_ +HH ^-**^R_
M^&&?^JH_^43_ .Z*/^&&?^JH_P#E$_\ NB@#XTHK[+_X89_ZJC_Y1/\ [HH_
MX89_ZJC_ .43_P"Z* /C2BOLO_AAG_JJ/_E$_P#NBC_AAG_JJ/\ Y1/_ +HH
M ^-**^R_^&&?^JH_^43_ .Z*/^&&?^JH_P#E$_\ NB@#XTHK[+_X89_ZJC_Y
M1/\ [HH_X89_ZJC_ .43_P"Z* /C2BOLO_AAG_JJ/_E$_P#NBC_AAG_JJ/\
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ML2F&QL(O.E8?>;' 5>1DDX &>214+>*M$C\$#QA=:@+?1?L:WYG<%ML)3?G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_H>O_*99_P#QFC_AJ/XZ_P#0]?\ E,L__C->,44 >S_\-1_'7_H>O_*99_\
MQFC_ (:C^.O_ $/7_E,L_P#XS7C%% 'L_P#PU'\=?^AZ_P#*99__ !FC_AJ/
MXZ_]#U_Y3+/_ .,UXQ10![/_ ,-1_'7_ *'K_P IEG_\9H_X:C^.O_0]?^4R
MS_\ C->,44 >S_\ #4?QU_Z'K_RF6?\ \9H_X:C^.O\ T/7_ )3+/_XS7C%%
M 'L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#U_Y3+/\ ^,UXQ10![/\ \-1_
M'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C->,44 >S_P##4?QU_P"AZ_\
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M7C%% 'L__#4?QU_Z'K_RF6?_ ,9H_P"&H_CK_P!#U_Y3+/\ ^,UXQ10![/\
M\-1_'7_H>O\ RF6?_P 9H_X:C^.O_0]?^4RS_P#C->,44 >S_P##4?QU_P"A
MZ_\ *99__&:/^&H_CK_T/7_E,L__ (S7C%% 'L__  U'\=?^AZ_\IEG_ /&:
M/^&H_CK_ -#U_P"4RS_^,UXQ10![/_PU'\=?^AZ_\IEG_P#&:/\ AJ/XZ_\
M0]?^4RS_ /C->,44 >S_ /#4?QU_Z'K_ ,IEG_\ &:/^&H_CK_T/7_E,L_\
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M$X0KY@:9B&QVSG./>CK8+''4444 %%%% !1110 4444 %%%% !1110 4444
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MS_X]1_PR[\"O^A%_\J=Y_P#'J /S/YHYK],/^&7?@5_T(O\ Y4[S_P"/4?\
M#+OP*_Z$7_RIWG_QZ@#\S^:.:_3#_AEWX%?]"+_Y4[S_ ./4?\,N_ K_ *$7
M_P J=Y_\>H _,_FCFOTP_P"&7?@5_P!"+_Y4[S_X]1_PR[\"O^A%_P#*G>?_
M !Z@#\S^:.:_3#_AEWX%?]"+_P"5.\_^/4?\,N_ K_H1?_*G>?\ QZ@#\S^:
M.:_3#_AEWX%?]"+_ .5.\_\ CU'_  R[\"O^A%_\J=Y_\>H _,_FCFOTP_X9
M=^!7_0B_^5.\_P#CU'_#+OP*_P"A%_\ *G>?_'J /S/YHYK],/\ AEWX%?\
M0B_^5.\_^/4?\,N_ K_H1?\ RIWG_P >H _,_FCFOTP_X9=^!7_0B_\ E3O/
M_CU'_#+OP*_Z$7_RIWG_ ,>H _,_FCFOTP_X9=^!7_0B_P#E3O/_ (]1_P ,
MN_ K_H1?_*G>?_'J /S/YHYK],/^&7?@5_T(O_E3O/\ X]1_PR[\"O\ H1?_
M "IWG_QZ@#\S^:.:_3#_ (9=^!7_ $(O_E3O/_CU'_#+OP*_Z$7_ ,J=Y_\
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M\"O^A%_\J=Y_\>H _,_FCFOTP_X9=^!7_0B_^5.\_P#CU'_#+OP*_P"A%_\
M*G>?_'J /S/YHYK],/\ AEWX%?\ 0B_^5.\_^/4?\,N_ K_H1?\ RIWG_P >
MH _,_FCFOTP_X9=^!7_0B_\ E3O/_CU'_#+OP*_Z$7_RIWG_ ,>H _,_FCFO
MTP_X9=^!7_0B_P#E3O/_ (]1_P ,N_ K_H1?_*G>?_'J /S/YHYK],/^&7?@
M5_T(O_E3O/\ X]1_PR[\"O\ H1?_ "IWG_QZ@#\S^:.:_3#_ (9=^!7_ $(O
M_E3O/_CU'_#+OP*_Z$7_ ,J=Y_\ 'J /S/YHYK],/^&7?@5_T(O_ )4[S_X]
M1_PR[\"O^A%_\J=Y_P#'J /S/YHYK],/^&7?@5_T(O\ Y4[S_P"/4?\ #+OP
M*_Z$7_RIWG_QZ@#\S^:.:_3#_AEWX%?]"+_Y4[S_ ./4?\,N_ K_ *$7_P J
M=Y_\>H _,_FCFOTP_P"&7?@5_P!"+_Y4[S_X]1_PR[\"O^A%_P#*G>?_ !Z@
M#\S^:.:_3#_AEWX%?]"+_P"5.\_^/4?\,N_ K_H1?_*G>?\ QZ@#\S^:.:_3
M#_AEWX%?]"+_ .5.\_\ CU'_  R[\"O^A%_\J=Y_\>H _,_FCFOTP_X9=^!7
M_0B_^5.\_P#CU'_#+OP*_P"A%_\ *G>?_'J /S/YHYK],/\ AEWX%?\ 0B_^
M5.\_^/4?\,N_ K_H1?\ RIWG_P >H _,_FCFOTP_X9=^!7_0B_\ E3O/_CU'
M_#+OP*_Z$7_RIWG_ ,>H _,_FCFOTP_X9=^!7_0B_P#E3O/_ (]1_P ,N_ K
M_H1?_*G>?_'J /S/YKZ9_8K&/C9K#'I_8$W_ *46]?2__#+OP*_Z$7_RIWG_
M ,>KH?!OP=^'/P_UR76O"/AW^S-0FMVM7E^UW$VZ(LK%<22,/O(ISC/'UH ]
M&HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ!YHHU9I'"JHRQ/  ]30!
M/152WN(+B%)H9%ECD4.CH<JRGD$'N/>K= !17R!^V;JFJ:7)X%_L_4KJQ$WV
M_=]FG:,MC[/UV]<9./J:^0?^$L\4?]#%JG_@9+_\50!^OM%?D&/%GBC_ *&3
M5!_V^2__ !5!\6>*,_\ (R:H?^WR7_XJ@#]?**_(3_A+/$W_ $,NI_\ @9+_
M /%4?\)9XF_Z&74__ R7_P"*H _7NBOR#/BSQ1G_ )&35#_V^2__ !5+_P )
M9XF_Z&74_P#P,E_^*H _7NBOR$_X2SQ-_P!#+J?_ (&2_P#Q5'_"6>)O^AEU
M/_P,E_\ BJ /U[HK\A/^$L\3?]#+J?\ X&2__%4A\6>*/^ADU0_]ODO_ ,50
M!^OE%?D%_P )9XH_Z&+5/_ R7_XJE'BSQ1G_ )&/5!_V^2__ !5 'Z^45^0G
M_"6>)O\ H9=3_P# R7_XJC_A+/$W_0RZG_X&2_\ Q5 'Z]T5^07_  EGBC_H
M8M4_\#)?_BJ4>+/%'_0R:H/^WR7_ .*H _7RBOR$_P"$L\3?]#+J?_@9+_\
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M_P #)?\ XJD'BSQ1G_D9-4'_ &^2_P#Q5 'Z^45^0G_"6>)O^AEU/_P,E_\
MBJ/^$L\3?]#+J?\ X&2__%4 ?KW17Y"?\)9XF_Z&74__  ,E_P#BJ/\ A+/$
MW_0RZG_X&2__ !5 'Z]T5^0G_"6>)O\ H9=3_P# R7_XJD'BSQ1G_D9-4'_;
MY+_\50!^OE%?D)_PEGB;_H9=3_\  R7_ .*H_P"$L\3?]#+J?_@9+_\ %4 ?
MKW17Y"?\)9XF_P"AEU/_ ,#)?_BJ/^$L\3?]#+J?_@9+_P#%4 ?KW17Y"?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /N;
M]B/_ )$KQ9_V$(O_ $6:^LJ^3?V(_P#D2O%G_80B_P#19KZRH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /C3]N3[_P^^NH?^VU?&5?9O[<GW_A
M]]=0_P#;:OC*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^YOV(_P#D2O%G_80B_P#19KZRKY-_
M8C_Y$KQ9_P!A"+_T6:^LJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#XT_;D^_\/OKJ'_MM7QE7V;^W)]_X??74/_;:OC*@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ^YOV(_^1*\6?\ 80B_]%FOK*ODW]B/_D2O%G_80B_]%FOK*@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^-/VY/O_  ^^NH?^VU?&5?9O[<GW
M_A]]=0_]MJ^,J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#[F_8C_Y$KQ9_V$(O_19KZRKY-_8C
M_P"1*\6?]A"+_P!%FOK*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^-/VY/O\ P^^NH?\ MM7QE7V;^W)]_P"'WUU#_P!MJ^,J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#[F_8C_P"1*\6?]A"+_P!%FOK*ODW]B/\ Y$KQ9_V$(O\ T6:^LJ "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XT_;D^_\/OKJ'_MM7QE
M7V;^W)]_X??74/\ VVKXRH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /N;]B/\ Y$KQ9_V$(O\
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M?_*G9_\ QZ@#QBBO9_\ AESXZ_\ 0B_^5.S_ /CU'_#+GQU_Z$7_ ,J=G_\
M'J /&**]G_X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\ *G9__'J /&**]G_X
M9<^.O_0B_P#E3L__ (]1_P ,N?'7_H1?_*G9_P#QZ@#QBBO9_P#AESXZ_P#0
MB_\ E3L__CU'_#+GQU_Z$7_RIV?_ ,>H \8HKV?_ (9<^.O_ $(O_E3L_P#X
M]1_PRY\=?^A%_P#*G9__ !Z@#QBBO9_^&7/CK_T(O_E3L_\ X]1_PRY\=?\
MH1?_ "IV?_QZ@#QBBO9_^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\
M\>H \8HKV?\ X9<^.O\ T(O_ )4[/_X]1_PRY\=?^A%_\J=G_P#'J /&**]G
M_P"&7/CI_P!"+_Y4[/\ ^/4?\,N?'3_H1?\ RIV?_P >H \8HKV?_AESXZ_]
M"+_Y4[/_ ./4?\,N?'7_ *$7_P J=G_\>H \8HKV?_AESXZ?]"+_ .5.S_\
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MY\=?^A%_\J=G_P#'J /&**]G_P"&7/CK_P!"+_Y4[/\ ^/4?\,N?'7_H1?\
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M \8HKV?_ (9<^.O_ $(O_E3L_P#X]1_PRY\=?^A%_P#*G9__ !Z@#W_]B/\
MY$KQ9_V$(O\ T6:^LJ^>/V8OA[XL^'?AG7['Q?HYTN:^NXY8$^T13[U6/!.8
MV8 9]37T/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M '-^+-4O]#\,W^KZ=8PW\]G"T_V>>X,"NJC<PWA'(. <?*<G XZCC/#_ ,2-
M;N]4\-6_B+PK%I=EXEM1/IM[:Z@;M&<Q^;Y,@,491]@)& 5.#S75^.YHH?A]
MK[2D*#I]PH+=R8R H]220 .]><>$?#5J/AWH/BZ^U37/%-SI.B[K73)'C46T
MOV?:\<:11HWF8+1@N689/.>:F]HM]K!U4>]_OZ'J^E^)?#VNO<KHNN6&IM:2
M>5<"SN4F\E_[K[2=IX/!]*?IGB+0=:-R-'UNQU(VC^5<"TG67R7_ +K[2=I]
MCS7@&G_NIM=:^FN3IU]X'$45OI%H\?V6-/-(MXW.XR2HA(W.V=Q/"YVUF^%/
M^$?UO3X%TVXLF\6V'@]](TQ3I-Q;2O,(C\ZR31*H<#@*A8X:0Y(Z5LA>I]'Z
M7XBT+6C<+H^M6.HM:OY<XM)UE,+?W6"D[3[&L/Q-XPBT6^MM+TVPDUC7KQ6>
MVT^)MF44@-)))@B*,;N6/X!C@'C/AM=^!==UB#7-#\,:[I.MP:?]ANDU&.[C
M6TB1QBW)D/E,=W*A<D '[O2IO$D%E8_$'7[W7;K4;:+4-#AATZ[LGFC>,Q/,
M984:(Y,A+QL%ZMT .,5$GR[_ ( G?\#T_3;B^DLH9-4@@MKMU!DBMY6FC1NX
M5RJEA[E5^E5(/%?ANYCOY+;Q!ILZ:=G[8T=TC"UQR?,P?DP.3NQ7':;;^,KG
MX!K:ZA/,OB^?0WC:1S^\6X:$[=V.C D9Q_%FN:T3^P]4\4> =:\/:.='&G:3
M<Q:HLMJT'V2W$8"VTQ( 4B;#!6YPK,.#DUMH"UL;?@WXC:AXVUB&YT.STN]T
M(SW4-U)#?HUQ8^6S+!(Z?Q";:2  -HYRPZW;KXD36=R+^X\/X\*'4/[+_MA;
MP,XF\PQ;VAV\0^:/+W[]V>=FWFJGP3FB;X706_F8GAO;PR1-]Y UU*RDJ>>0
M01ZCI7.>(O";:SXA;PGX5UO5'TJ;5$U/68I,-86>V=972)_+#&620$[/,*K\
MY('RBE*RDHK;^M1+9M^9[Q ,0KSGWJ2H;<@VZ%5VC' QC%34T4%%%%, HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MST#&AWC*S7D"U1[U]GAY^6D\B'S/,V'=ZY-<OXDTZ]U;P+JFE+JD5G?7MI)
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MD $FNIHS5B:N<7XN\%+XP2QCE\2:MI$-G<1W2IIPMQOEC97C9C+$Y^5ER ,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ltbr_ex101img25.jpg
<TEXT>
begin 644 ltbr_ex101img25.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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MQ/$6M6OAOPUJOB*^CFEM=*M)KV9(0"Y2-"[!02 3A3C) SW%> _\-J_"W_H
M>*O_  %MO_C] 'TS17S-_P -J_"W_H >*O\ P%MO_C]'_#:OPM_Z 'BK_P !
M;;_X_0!],T5\S?\ #:OPM_Z 'BK_ ,!;;_X_1_PVK\+?^@!XJ_\  6V_^/T
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MK\+?^@!XJ_\  6V_^/T ?3-%?,W_  VK\+?^@!XJ_P# 6V_^/T?\-J_"W_H
M>*O_  %MO_C] 'TS17S-_P -J_"W_H >*O\ P%MO_C]'_#:OPM_Z 'BK_P !
M;;_X_0!],T5\S?\ #:OPM_Z 'BK_ ,!;;_X_1_PVK\+?^@!XJ_\  6V_^/T
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MK\+?^@!XJ_\  6V_^/T ?3-%?,W_  VK\+?^@!XJ_P# 6V_^/T?\-J_"W_H
M>*O_  %MO_C] 'TS17S-_P -J_"W_H >*O\ P%MO_C]'_#:OPM_Z 'BK_P !
M;;_X_0!],T5\S?\ #:OPM_Z 'BK_ ,!;;_X_1_PVK\+?^@!XJ_\  6V_^/T
M?3-%?,W_  VK\+?^@!XJ_P# 6V_^/T?\-J_"W_H >*O_  %MO_C] 'TS17S-
M_P -J_"W_H >*O\ P%MO_C]'_#:OPM_Z 'BK_P !;;_X_0!],T5\S?\ #:OP
MM_Z 'BK_ ,!;;_X_1_PVK\+?^@!XJ_\  6V_^/T ?3-%?,W_  VK\+?^@!XJ
M_P# 6V_^/U[]X=UJU\2>&M*\16,<T5KJMI#>PI, '"2('4, 2 <,,X)&>YH
MVZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XOX
MK?\ )$/'G_8OW_\ Z3/7Y-U^LGQ6_P"2(>//^Q?O_P#TF>OR;H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]9/A3
M_P D0\!_]B_8?^DR5^3=?K)\*?\ DB'@/_L7[#_TF2@#M**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (NC_A;'PL_Z*7X5_P#!S;?_ != '9T5QG_"V/A9_P!%+\*_^#FV_P#BZ/\
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M (.;;_XNC_A;'PL_Z*7X5_\ !S;?_%T =G17&?\ "V/A9_T4OPK_ .#FV_\
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M%G_12_"O_@YMO_BZ/^%L?"S_ **7X5_\'-M_\70!V=%<9_PMCX6?]%+\*_\
M@YMO_BZ/^%L?"S_HI?A7_P '-M_\70!V=%<9_P +8^%G_12_"O\ X.;;_P"+
MH_X6Q\+/^BE^%?\ P<VW_P 70!V=%<9_PMCX6?\ 12_"O_@YMO\ XNC_ (6Q
M\+/^BE^%?_!S;?\ Q= '9T5QG_"V/A9_T4OPK_X.;;_XNC_A;'PL_P"BE^%?
M_!S;?_%T =G17&?\+8^%G_12_"O_ (.;;_XNC_A;'PL_Z*7X5_\ !S;?_%T
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M\9)KO: /&/VH_P#DV3Q=_P!N?_I9#7YG5^F/[4?_ ";)XN_[<_\ TLAK\SJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#Z:_8K_ .2VZS_V+\W_ *4V]??U? /[%?\ R6W6?^Q?F_\ 2FWK[^H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /&/VH_^
M39/%W_;G_P"ED-?F=7Z8_M1_\FR>+O\ MS_]+(:_,Z@ HHHH **** "BBB@
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MHK]F** /QGHK]F** /&/V7/^39/"/_;Y_P"EDU>ST44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >,?M1_\ )LGB[_MS_P#2R&OS
M.K]:_'G@W2_'W@;4/!^MW%U#8:AY8DDM'595V2K(-I96'5!G(/&:\3_X8J^%
MO_0?\5?^!5M_\8H ^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^
M!5M_\8H ^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H
M^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H ^ **^_\
M_ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H ^ *_63X4_P#)$/ ?
M_8OV'_I,E>-?\,5?"W_H/^*O_ JV_P#C%>_>'=%M?#?AK2O#MC)-+:Z5:0V4
M+S$%RD:!%+$  G"C. !GL* -NBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P!#U_Y3+S_XS1_PU%\"O^AZ_P#*9>?_ !F@#V>BO&/^&HO@5_T/7_E,O/\
MXS1_PU%\"O\ H>O_ "F7G_QF@#V>BO&/^&HO@5_T/7_E,O/_ (S1_P -1? K
M_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\ E,O/_C-'_#47P*_Z'K_RF7G_ ,9H
M ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\ &: /9Z*\8_X:
MB^!7_0]?^4R\_P#C-'_#47P*_P"AZ_\ *9>?_&: /9Z*\8_X:B^!7_0]?^4R
M\_\ C-'_  U%\"O^AZ_\IEY_\9H ]GHKQC_AJ+X%?]#U_P"4R\_^,T?\-1?
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M_;Y_Z635[/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% ':?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,17
MZR44 ?DW_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !%?K)10
M!^3?_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\17ZR44 ?DW_P
MJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \17ZR44 ?DW_ ,*G^*7_
M $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,17ZR44 ?DW_P *G^*7_1-/
M%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !%?K)10!^3?_"I_BE_T33Q5_P""
M:Y_^(H_X5/\ %+_HFGBK_P $US_\17ZR44 ?DW_PJ?XI?]$T\5?^":Y_^(H_
MX5/\4O\ HFGBK_P37/\ \17ZR44 ?DW_ ,*G^*7_ $33Q5_X)KG_ .(H_P"%
M3_%+_HFGBK_P37/_ ,17ZR44 ?DW_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z
M)IXJ_P#!-<__ !%?K)10!^3?_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK
M_P $US_\17ZR44 ?DW_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?_)LGB[_MS_\
M2R&OS.K]>?%'A?0_&'AJ[\-^(K'[=I=YL\ZW\UX]^QU=?F0AAAE4\'M7F_\
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MO/\ X]1_PRY\"_\ H1O_ "IWG_QZ@#\SJ*_3'_AESX%_]"-_Y4[S_P"/4?\
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M[2YOK'<;:YE@5Y8-PPVQB,KD=<8S6K3O>XDK'BO[2T,$7[.GB^541))A;%W
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M'%XE^!/@KP/\0+=FFN=(NL)*<36XWHT++GD,BE/IC!XR*/A#_P )AI_CF_\
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M-V_^T!81?:-WKYFW=GWS5;W\[7]43MIV>GS/(?VG+6QLOV;]7CL[=((VGM,
M+M+8D11G/)(55'/. /2NA\;:-X=UKX0:98Z]K!T'[<EC%;ZM$51K:=</ Q8D
M?*'[9ZMQC.:]#UKPKX9\2B >)/#NF:TL.3$-0LX[@1DXSMW@XS@=/2I;70=%
MT_2H='L=%L;;3H,F*TAMD2&/.<[4 P,[FS@=SZU/1I][@]UY'D?PRU'QU8_%
M75?!'Q!DL-?U*QTJ.ZMM?LD\MY+=I<+%,H  ;(+#C/#<MG->ZUBZ+X=\/^';
M:2V\/Z#I^D02MO>.QM4@5V]2$ !/O6SWJKW#JQU%%% PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!]__ /#:OPM_Z 'BK_P%MO\ X_1_PVK\+?\ H >*O_ 6V_\ C]? %% 'W_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M44 %%%% !1110 4444 %%%% !1110!^LGPI_Y(AX#_[%^P_])DKM*XOX4_\
M)$/ ?_8OV'_I,E=I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!QG_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7_P $UM_\179T4 <9_P *
MG^%G_1-/"O\ X)K;_P"(H_X5/\+/^B:>%?\ P36W_P 179T4 <9_PJ?X6?\
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MT4 <9_PJ?X6?]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\ !-;?_$5V=% '&?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<_\ Q= 'ZR45^3?_  MCXI?]%+\5?^#FY_\ BZ/^%L?%+_HI?BK_ ,'-S_\
M%T ?K)17Y-_\+8^*7_12_%7_ (.;G_XNC_A;'Q2_Z*7XJ_\ !S<__%T ?K)1
M7Y-_\+8^*7_12_%7_@YN?_BZ/^%L?%+_ **7XJ_\'-S_ /%T ?K)17Y-_P#"
MV/BE_P!%+\5?^#FY_P#BZ_62@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***]X\#_ +,OCSXB>"-.\8:+JV@06%\)/*CN[B995V2-
M&=P6%AU0XP3QB@#P>BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S
M_P#&* /F6BOIK_ABOXI?]!_PK_X%7/\ \8H_X8K^*7_0?\*_^!5S_P#&* /F
M6OV8KX!_X8K^*7_0?\*_^!5S_P#&*^_J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /QGHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K],?V7/^39/"/_;Y_P"EDU?F=7Z8_LN?\FR>
M$?\ M\_]+)J /9Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH _)O_A;'Q2_Z*7XJ_\ !S<__%T?\+8^
M*7_12_%7_@YN?_BZXNB@#M/^%L?%+_HI?BK_ ,'-S_\ %T?\+8^*7_12_%7_
M (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\ Q='_  MCXI?]%+\5?^#FY_\
MBZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8^*7_ $4OQ5_X.;G_ .+KBZ*
M.T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ5_X.;G_XNN+HH [3_A;'Q2_Z
M*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^+KBZ* .T_P"%L?%+_HI?BK_P
M<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH [3_A;'Q2_P"BE^*O_!S<_P#Q
M='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?%+_HI?BK_P '-S_\71_PMCXI
M?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\ P<W/_P 71_PMCXI?]%+\5?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ
M/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X8
M8_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ
M/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X8
M8_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ
M/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X8
M8_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ
M/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X8
M8_ZJC_Y1/_NBC_AAC_JJ/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBC_AAC_JJ
M/_E$_P#NBOLRB@#XS_X88_ZJC_Y1/_NBO>O@U\*_^%0^"KSPS_;W]M&YU![[
M[1]E^S[=T<:;-N]\_P"KSG/?IQ7J5% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% "453N%NE@D:W5))@I*)(Y16;' + $@9[X./0UXMX9^,GC
M;Q9)XGAT?X=Z0USX<O7T^:WE\1.CW,R[LK#_ *)AL[&QN*U/6PSW6E[54MY)
M)K6.22,PNZ!F0]4)'3\*M=JK8E.X8I *\M\:_$3Q%X7^('AKPGI_A.PU,^(S
M,MG<S:L]MM>) SB11;O@8(P03GN!7-S?'B\_X5AXC\86_@]!=^%[\V&KZ9/J
M6SRV#!<PRK$PD^9AU"< ^V5I:X];I=SW>E[UX[:_%[5K3QEX0T'Q1X2@TZ'Q
M=!YNGWNGZD;Q0VT-LD5H8BIPR\C<.?KB\OQ+U+Q!XTUSPSX \-V^MG0#Y>HW
MU]J!LK=)CG]S&5BE9VX.>% (ZTVK"NCU*BO/O!/Q$M_'GAW5+K2=/^RZ[I,\
MEE>Z5>S;#;W*9&QG56^0D<.%/&>,@BN(T+XU>)-<\ >+O%T/@6PAM_"T\\$\
M#ZXY>9H5W2;2+7&,$8SU/7'6D-:_?8]XI>U>4^!_B)XP\8:3X?U[_A#-/M]&
MU<!W>#6VGN;.,[PKO";9 063;PYZY[&K#?$R]UKQWJG@_P "^'8-=FT;:NIW
MUY?FSM;:1LXB#+%*SOP<@+@8.33M9VZBT/3J3%>;W'C;Q=)YL>E> 1YMI+<1
MWAU/4OLT40BCB<,KQQ2[P_FG;P"0I)QR!A_#/XK>*/B+I6CZ]%X&MK+0M1N)
MK:2XBU=IY;5HU8[GC^SH-K,NT$/U89I+78>RN>R8HQ7EGQ:^)VK?"_2;;78_
M"<>N:09!'<R)?F&6WR?O>7Y3!EQWW Y/3'-.^)WQ<L_A_P##2U\:6.E_V]%=
MF)X8%G\@-$^/WA;:V -R#IU84KZ7\[?,+=#U&E[5R<'B6>W\ ?\ "6:_916+
MI9F\EMK:X-PJC;N55<HA9B,#&T<G SU.?X#\<?\ "POAA9^,M#L84N;J%\6,
M]T0D<RDJ8WD"$@9'WMA."#CM5-6OY"3ND^YW>,T$5XOX-^-5QXLU+Q!X9N/"
M\6B^+]*3S[?3+O46\F^AP")$F$.0,'/^K/!4^NWL6\97&G_"V3QQKNFPV;I8
M&^-E;737 .5W1QAS&A+-E1]W[QP,]3-TE<=G>W4[BCUKC?!OC33O&GPWTKQM
M#MM+2\MOM$J-(&%N5R)%+8&=I##.!TSQ7/>'?B9X@\:V=SKG@SP7'?>&XIGA
MAN[O4OLT][L)#-##Y3*5R, O(F?:JZM=A7TN>IT=J\6\<_&75/!_A7PYXDA\
M%K<VFN72V(M[W4#:W%M,Q8!718I%QA#DAN#Q@]:ZVU\0>.I!JD5YX1TJ*6WM
MQ+:2V^M/-;W+AB'B:0VRM&RX_N-G/L:3V;[#[>9W=+WKRSX7_%B#XA:'K=Y?
M:.= OM#N&@O;*2X\_P M0NX/OVKP<-V_AK"\%_&/Q%XXT?Q;JFG>";.S3P[)
M)!Y5WK#K)/(AR00MN0@V;CG+?, ,8)8#TOY*X;[=['N-)7B_@'XK>+O'GAS2
M/%%CX#TZ/3-1NO(>--=9[J&,2B.2;RC;*K*I.3A\XQ4^I?&.3P[\6K;P1XQ\
M.QZ3I^HN8;'7(;XSP22\%(Y%:)/+8AESRP!8#)&2'V\Q=_(]AHKS7_A+/B#<
M7=S9VO@729Y8=2-B'77)1$JB$RF61OLF4',:@ ,2S'I@$X'P_P#BYXL\?0OJ
M%G\/[2+3;76/[(O)(]::6: C&Z81_9U#1C</X@>^,#-+<>Q[317%>/O'FC_#
MKPQ_;FL+-.TLJV]I:0#=-=SM]V- >YYY/0"JUKXH\70_V:?$?@5+"/4+A(0U
MCJ@NS:%N]QF./;Z?(9!G ) .:%KL&QWO&*3C%>56GQ0U;Q1XE\0:3\/_  S;
MZY:Z!(;>\O[[4C90R7 ZPP[892Y&#DG:OO@@U43XR3:O\,KGQAX1\*MJUYIM
MP;34M%N;LV]S;S!@IC3;%()#EAC[H([Y^6CS#K8]BHXKR30/BU-XR\(:!XD\
M%Z/97Z:C<_8KVVO=1:V?3YL9*G;#)OZ'GY<C:0.3C+\6?&'Q;X3UC0K*\^'=
MEL\0:J^EZ>TFMO'(2)-BRRI]E.Q6!##!8X-/K81[=BEKDM-\1:J/#VI:EXMT
M6/09M-DE$D<5T;F.2)%#"5)#&A92#_=!!!'7BJ/PQ^(-C\2/ %IXLL[0V)ED
MDAFM&D\QK=T8@J3@=L-T'#"EW&=U17E>@_$[5/&FKZG_ ,('X9@U;0M+N&M)
MM5O=1^RI<2K@LMNBQ2&3&?O,44^O>C6/B'XJL_#5QX@L? 7F65E8W5]>C5-2
M^R20>1(ZF(".*57D(C+<,%''/()-$KL+:GJE&.M>/>%/B[K.M^#;?QQK/@Z'
M3_#$VFW6HF[M-3:[EA\@\QO&8(P"P#$$,1\O.,UM>&/'VLZ[_P (_/>>&X(=
M.\0J9+.]L-1%Y'&HB:3;-^[38Y"XPN]<Y^;C!=GJNPKK0])HHHH&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWX ,32  <,%X/TA157]YR[BM[O*+1112*"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C]?,M%
M 'TU_P -J?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X_7S+10!]-?\
M#:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/U\RT4 ?37_  VI\4O^
M@!X5_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C]?,M% 'TU_P -J?%+_H >%?\
MP%N?_C]'_#:GQ2_Z 'A7_P !;G_X_7S+10!^N'@C6KKQ+X \-^(KZ...[U32
M[6]F2$$1J\D2NP4$D@98XR2<=S745Q?PI_Y(AX#_ .Q?L/\ TF2NTH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /QGHHHH **** "BBB@ HHHH ****
M /T*^'_[1'P?T/X7>$]%U3QE]FOM/T>SM;F+^S[I_+E2%%=<K$0<$$9!(KI_
M^&HO@5_T/7_E,O/_ (S7YG44 ?IC_P -1? K_H>O_*9>?_&:/^&HO@5_T/7_
M )3+S_XS7YG44 ?IC_PU%\"O^AZ_\IEY_P#&:/\ AJ+X%?\ 0]?^4R\_^,U^
M9U% 'Z8_\-1? K_H>O\ RF7G_P 9H_X:B^!7_0]?^4R\_P#C-?F=10!^F/\
MPU%\"O\ H>O_ "F7G_QFC_AJ+X%?]#U_Y3+S_P",U^9U% 'Z8_\ #47P*_Z'
MK_RF7G_QFC_AJ+X%?]#U_P"4R\_^,U^9U% 'Z8_\-1? K_H>O_*9>?\ QFC_
M (:B^!7_ $/7_E,O/_C-?F=10!^F/_#47P*_Z'K_ ,IEY_\ &:/^&HO@5_T/
M7_E,O/\ XS7YG44 ?IC_ ,-1? K_ *'K_P IEY_\9H_X:B^!7_0]?^4R\_\
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M*_Z'K_RF7G_QFC_AJ+X%?]#U_P"4R\_^,U^9U% 'Z8_\-1? K_H>O_*9>?\
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M_P"(H _)JBOUE_X5/\+/^B:>%?\ P36W_P 11_PJ?X6?]$T\*_\ @FMO_B*
M/R:HK]9?^%3_  L_Z)IX5_\ !-;?_$4?\*G^%G_1-/"O_@FMO_B* /R:HK]9
M?^%3_"S_ *)IX5_\$UM_\11_PJ?X6?\ 1-/"O_@FMO\ XB@#\FJ*_67_ (5/
M\+/^B:>%?_!-;?\ Q%'_  J?X6?]$T\*_P#@FMO_ (B@#\FJ_63X4_\ )$/
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MQ=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4 <717:?\
M"I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\ P37/_P 10!Q=%=I_PJ?XI?\
M1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\ Q% '%T5VG_"I_BE_T33Q5_X)
MKG_XBC_A4_Q2_P"B:>*O_!-<_P#Q% '%T5VG_"I_BE_T33Q5_P"":Y_^(H_X
M5/\ %+_HFGBK_P $US_\10!Q=>S_ ++?_)S?A'_M\_\ 2.:N,_X5/\4O^B:>
M*O\ P37/_P 17K?[._P_\>:'^T)X7U36/!.OZ986XNO,NKS3)H8H\VLRC<[*
M ,D@#)ZD"@#]":*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#R3QY\4M>\'_$3PUX1L_"UAJ7_"22-#9W
M4NK/;[77;N\Q1;OM'S#!!;/H*Z_POK7B#5?MZ>(-!M=+>WD589;*_-Y!<J1R
MRN8HR"&!4J5R"*\5^.&GW6N?&;X<M%H?B*ZTW2)YI-2N],T^]/V=)/+VE9H%
MSGY3_JV)&.<5T'Q'\%ZM8?![PYX=\.1WVKZ?I&J6D]_;(ADGN[%)&+H4ZRGE
M25ZMM/':I7PIO=NWR[A+XK+M<]TSVI.QKXS\7^%=>U#X7_$72]+\&ZU_8TOB
M.UD\.Z:NCW >%.LTD,.S=%&1GG"CDC@G%?4WA7P[H/A_3YY_#^FM8KJ;K>7
M<2*\DAC5=S*_*L0JY& <Y)&2:KS%V./L?BK>:M#JVJ:/X774=!TR_?3I)H-0
M'VP2(X0R-;E,+%G)SYA?:-VRO5?>OEWQ5X,N+SQ#;>+O _AWQ)X3^)<MY&9%
MM;60:?>(91OEFD ,*J4RQ5G#GHR$G-<IXKT'1[SXA?'C3X?"%SJVJ36]H=-6
MPTR2Y,5R\!9G'EJWELQ).\XS\PSEL%+5>95M7V/L\\T"OECQ=X7\1MJ-M=^+
M?#>I>(+9O 1L+(6UC)?&UU95#$[4#&*0D#$G'(QNXK'U[P]K5YXE^$NH>+/"
M.M:O<6GAZ>/7)X](N+HY>!A#',R1G<VXG*G)!)SUY'H):ZGV!17Q_H?A;6KS
M]G;P=;ZSH.L?VSX<:^(TO5_#UQ>VMQE\)#+!M\P95TV2H"$P_(P<7_&OAKQ#
M/>:IJ&M^!]2N4NO!L,.@VUG:RW_]DZA&H)C5D#&*0-R)#C=C&XGBC9L%J?6-
M)WZU\OR^$=0USXR_#23QEX9U+4%/A7['K5V=/G:%[AXF&R>95VYR6SD\$\XR
M*]9L=%\+Z3\4[&WL/!^KQ:C8Z&MI;ZP%E:RCM5;"VV\N09. >5+8[U5B;Z'I
M-%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^,_P#AN;_JEO\ Y6__ +GH
M_P"&Y_\ JEW_ )6__N>OC.B@#[,_X;F_ZI;_ .5O_P"YZ/\ AN?_ *I=_P"5
MO_[GKXSHH ^S/^&YO^J7?^5O_P"YZYC2/VH/"VA^+M5\6Z7\)KF'6=6.;V9O
M%5Q(L_IF-HRG'1<+\HX&!Q7RY11UN'0^RO\ AN?_ *I=_P"5O_[GH_X;F_ZI
M;_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^
MS/\ AN?_ *I=_P"5O_[GKZ3^&?CEOB3\,-(\:+I?]E?VCYW^B>?YWE^7,\7W
M]JYSLST'7'O7Y05^F/[+G_)LGA'_ +?/_2R:@#V>BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#\9Z*** "BBB@ HHHH **** "BBB@ K]"OV=_B!X#T/]
MGOPOI>L>-M TR_M_M7F6MYJ<,,L>;J9AN1F!&001D="#7YZT4 ?K+_PMCX6?
M]%+\*_\ @YMO_BZ/^%L?"S_HI?A7_P '-M_\77Y-44 ?K+_PMCX6?]%+\*_^
M#FV_^+H_X6Q\+/\ HI?A7_P<VW_Q=?DU10!^LO\ PMCX6?\ 12_"O_@YMO\
MXNC_ (6Q\+/^BE^%?_!S;?\ Q=?DU10!^LO_  MCX6?]%+\*_P#@YMO_ (NC
M_A;'PL_Z*7X5_P#!S;?_ !=?DU10!^LO_"V/A9_T4OPK_P"#FV_^+H_X6Q\+
M/^BE^%?_  <VW_Q=?DU10!^LO_"V/A9_T4OPK_X.;;_XNC_A;'PL_P"BE^%?
M_!S;?_%U^35% 'ZR_P#"V/A9_P!%+\*_^#FV_P#BZ/\ A;'PL_Z*7X5_\'-M
M_P#%U^35% 'ZR_\ "V/A9_T4OPK_ .#FV_\ BZ/^%L?"S_HI?A7_ ,'-M_\
M%U^35% 'ZR_\+8^%G_12_"O_ (.;;_XNC_A;'PL_Z*7X5_\ !S;?_%U^35%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!5M_\8H ^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H
M^ **^_\ _ABKX6_]!_Q5_P"!5M_\8H_X8J^%O_0?\5?^!5M_\8H ^ **^_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^,]%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?9G
M[#/_ #4'_N'?^W-?9E?&?[#/_-0?^X=_[<U]F4 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-=!110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)-#T?PI\>;&XU.ZAU.:^"Q6]U>SLK1LL#*=KL4+L=VTGYBJD+\JD">K7E?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA;:5F4("!]\@"OH#6_"-IXJ^%L_@_6HWN1<Z>+<O?%9I4E$>%D9@,&16PVX
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MO>Z=KMK:36JIJ4+QR12!W$>0X&5 V8(XQTI7T;[!U2[GK/S9%**^=/"?A_\
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M4X(.#S@@UH5\^:M\9/'6G^%O%FHQZ'H7VO0_$L6BB-IIFC$3[ 'S@%VW..R
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M7****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ^,_\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[
MGKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_
M *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;
MG_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXS
MHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=
M_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI
M=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^
MS/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5
MO_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6
M_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\
MAN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[G
MH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[
MGKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_
M *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;
MG_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXS
MHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=
M_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI
M=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^
MS/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5
MO_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6
M_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\
MAN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[G
MH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[
MGKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_
M *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;
MG_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXS
MHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=
M_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI
M=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^
MS/\ AN?_ *I=_P"5O_[GH_X;G_ZI=_Y6_P#[GKXSHH ^S/\ AN?_ *I=_P"5
MO_[GKZM\*:Z?%'@O0O$WV46@U?3[>^^S[]_E>;&K[-V!NQNQG SCH*_(:OUD
M^%/_ "1#P'_V+]A_Z3)0!VE%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^,]%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7ZR?"G_ )(AX#_[%^P_])DK\FZ_63X4
M_P#)$/ ?_8OV'_I,E ':4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XST5^F/\
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MX9<^!?\ T(W_ )4[S_X]0!^9U%?IC_PRY\"_^A&_\J=Y_P#'J/\ AESX%_\
M0C?^5.\_^/4 ?F=17Z8_\,N? O\ Z$;_ ,J=Y_\ 'J/^&7/@7_T(W_E3O/\
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M )4[S_X]0!^9U%?IC_PRY\"_^A&_\J=Y_P#'J/\ AESX%_\ 0C?^5.\_^/4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &#XBU9?#^@7VM/I]SJ$=E$9FM[3R_-9%Y8KYCHO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "J-S!-<6T\$5W+:-(C(L\(4O$2,!E#JRY'49!'J#5ZBEN!
MQ?@CP/;^!/#,GA_3=<U.^M3))-&U[Y#/"SL6?:8XD!RS%OF!Y/IQ6-IOPA\.
MV?@;7/!M_J&IZSIFLW+WDWVQH5DCF=MYDC:*--IW@,,YP0,8'%>E9I<\T]P/
M(=<\"W&DZ)K36,7B'QMXBUK2I-&34+RXM%:SA*,%#9,(V;FW,55W)Y.>*OZ1
M\*8=-CT.^M_$6J:/K5EI%MI-Y-ICQ>7>QQ*  Z2QN.#NPRA6 /6O4/THJ0."
MN/AOIX\32>(=#U_6?#M[<6L5G=_V=+$R7D<8Q'YBS1R?,HR Z[6P3S5S1_ ^
MEZ)XTUGQ58WVHFXUA8OM%K)<;K?<B*@D QN+;5'+,>^,9-=E15; <1X\\!P_
M$#1H=)U#7M6TRUBG2X(TUH5:1T8,A8R1.1M901MQ[YH\0> [3Q'?>&]4NM<U
M:WU+P^7\B^MFA2282($E$@,93Y@.=JJ0?N[:[;-)FBVE@/*T^#6C6_@"/P7#
MXFU]-&BAEM_)9[:4/%(Y=E97@9202</MW@=&K.OOV?\ PO?7-W=?V_XAM6GC
MM(H1#+; V0M<>0T+F NC* 5W;B2&;).<U[/2=Z.MP.=OO#<.L>$9O#.L:G>7
M\%Q!]GN+EV2.>8'J28U55)]54>V*QM/^'=E;>*[+Q)J>OZSKUWIL4D.GIJ4L
M12R5QARHCC0LQ7Y=TA=L=Z[RBCK<.ECR"R^!?AK3)-+:QU_Q# ^F-=+;D749
M"PW!S+!@QD!"2?F #\_?X&+^F_!_0=-C\(QPZUK1_P"$4CE@LW,\:M-#(5W1
M2E8QE?E ^7:<<$G)KT^B@'J>=:/\,[/0=,?2-(\4:[:Z2OF&SL!+!)'I[.",
MQ%X2Y W-M61G49SC@8Q],^".GZ0WA<:?XX\3QKX7\Y=-!-BPB$H(D!S;?-D'
M'.<=L'FO7J*D#R;3O@GHVD6E@MCXL\1Q7^G7<]Y9ZD);83P&<YF3'D>6Z.W)
M5T;GIBK]Y\+[>[\6:7XDC\7^(+?4=,MIK:&2,VK!O.R99&#P-EF.#V4;0% '
M%>E44P/*M)^"NAZ/IOA>QM_$FONOABXGFL96GA20),,20LR1+E#SR,.,G##C
M'JM%%.]P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ltbr_ex101img26.jpg
<TEXT>
begin 644 ltbr_ex101img26.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M5?\ @+;?_'Z /IFBOF;_ (;5^%O_ $ /%7_@+;?_ !^C_AM7X6_] #Q5_P"
MMM_\?H ^F:*^9O\ AM7X6_\ 0 \5?^ MM_\ 'Z/^&U?A;_T /%7_ ("VW_Q^
M@#Z9HKYF_P"&U?A;_P! #Q5_X"VW_P ?H_X;5^%O_0 \5?\ @+;?_'Z /IFB
MOF;_ (;5^%O_ $ /%7_@+;?_ !^C_AM7X6_] #Q5_P" MM_\?H ^F:*^9O\
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MX6_] #Q5_P" MM_\?H ^F:*^9O\ AM7X6_\ 0 \5?^ MM_\ 'Z/^&U?A;_T
M/%7_ ("VW_Q^@#Z9HKYF_P"&U?A;_P! #Q5_X"VW_P ?H_X;5^%O_0 \5?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!XQ17L__#+GQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\
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M )4[/_X]0!XQ17L__#+GQU_Z$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4
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M&\5?#SX7ZGHGB[23IE_+K$MTD7G13;HC#"H;,;,.J,,9SQ0![K1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.O\ T/7_ )3+/_XS0,_3&BOS._X:C^.O_0]?^4RS_P#C-'_#4?QU_P"AZ_\
M*99__&: /TQHK\SO^&H_CK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#]
M,:*_,[_AJ/XZ_P#0]?\ E,L__C-'_#4?QU_Z'K_RF6?_ ,9H _3"EKPG]F;Q
MQXK^(7POU/6O%VK'4[^+6);5)?)BAVQ"&%@N(U4=78YQGFNX^(WC+5/ OAZV
MUG3M#MM826\AM)(Y[]K4H99%C1@1%)N&YN>F!TSTI=D!WM(#S7D4?Q0\32>+
MK[P.? L \5VIAF$*ZLS64EK)NS<>>(-RA2N"#$#DC&:D\,_$;QEXBNKF3_A!
M;%+.QUI]$O9;?69)Y871@KS+&;50T8)'.X'') Q2!Z;GK=%><V'Q"O=>CBU;
MPSH"ZWX>>^73S>0WF)T<3B*21H-G$:\MG=NP,E0IW5W4S-%&TB1/.5!(C0@%
MCZ#) R?<@572X=;%FEKB? 'C:3QQX>O=3N-%DT::SU"?3Y+6299F5HFVL2R_
M+UST)''4UM>([Z]TOPY?ZEI]E#>W%I"9E@GN# DFT9(+A'*\ X^4\XZ=:ENR
MNPM?3J;9Z4N*\Y^'_P 4M*\>?#)_&DUO_8RV@E%_;2R[S9F,;FRV%R-F&S@<
M&F?"?XB7GQ*\/W>NMX?71;".Z>U@1KPS3.4.&+IY2B/JN &;OTQR^K0M+)GI
M6*.]&>:XG3?&<EY\4-:\#MHDMI_9=G!>I=O.C"Y61F7Y47.T J1\Q!XZ 8)>
M[L/8[?M17FOCOQ_K7@NSU#7%\'O?^']):,7]V;SR9]K;=SP1&,B54##)+ISD
M#.#7H4,T=Q;QSQ',<BAU/3((R*%KJ!8HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@?"'6_".BS6UO?W_ )'E27CLL2[)XY#N*JQZ(<8!YQ7R+_PQ7\4O^@_X5_\
M JY_^,4P/F6BOIK_ (8K^*7_ $'_  K_ .!5S_\ &*/^&*_BE_T'_"O_ (%7
M/_QB@#YEHKZ:_P"&*_BE_P!!_P *_P#@5<__ !BC_ABOXI?]!_PK_P"!5S_\
M8H ^9:*^FO\ ABOXI?\ 0?\ "O\ X%7/_P 8H_X8K^*7_0?\*_\ @5<__&*
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M W,>"2,UT7PWTVST_P".&L7GACX?ZMH'AR^T6UCCEFTQK"&.5'<NI23:VXY
M^53D@L>#N/O])GFCJ#U5CRKQUKUAJNJ-X0U;2-?;0XMD^H26_A^^NDOL$,MN
MCQ1,NW(!=LXQA1G+%?1[.:2YL8+AK66U,L:OY$P >+(SM8 D CH<$UH44+16
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17C'_  U%
M\"O^AZ_\IEY_\9H_X:B^!7_0]?\ E,O/_C- 'L]%>,?\-1? K_H>O_*9>?\
MQFC_ (:B^!7_ $/7_E,O/_C- 'L]%>,?\-1? K_H>O\ RF7G_P 9H_X:B^!7
M_0]?^4R\_P#C- 'L]%>,?\-1? K_ *'K_P IEY_\9H_X:B^!7_0]?^4R\_\
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M![/17C'_  U%\"O^AZ_\IEY_\9H_X:B^!7_0]?\ E,O/_C- 'L]%>,?\-1?
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M5_\ !-;?_$4?\*G^%G_1-/"O_@FMO_B*[.B@#C/^%3_"S_HFGA7_ ,$UM_\
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M_P 11_PJ?X6?]$T\*_\ @FMO_B*[.B@#C/\ A4_PL_Z)IX5_\$UM_P#$4?\
M"I_A9_T33PK_ .":V_\ B*[.B@#C/^%3_"S_ *)IX5_\$UM_\11_PJ?X6?\
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MVUC8VL=K:6\:PPP0H$CB11A551P    !P!6A10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'QG_P ,,?\ 54?_ "B?_=%'_##'_54?_*)_]T5]F44 ?&?_  PQ
M_P!51_\ *)_]T4?\,,?]51_\HG_W17V910!\9_\ ##'_ %5'_P HG_W11_PP
MQ_U5'_RB?_=%?9E% 'QG_P ,,?\ 54?_ "B?_=%'_##'_54?_*)_]T5]F44
M?&?_  PQ_P!51_\ *)_]T5[)\#?@;_PIAM?_ .*H_MW^U_L__+E]F\GRO-_Z
M:/NSYOMC'?/'M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXM7']E_LV^(HM?FL[*Z;1VMF59]T;3E-H1&95+9/3Y03Z4/:_D@M>R\W_P
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M8UV-G/R@L/\ :K3I%!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?]B_?_\ I,]?DW2 _3'_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
M&:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QFOS.HH _3
M'_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QFOS.HH _3'_AJ+X%?]#U
M_P"4R\_^,T?\-1? K_H>O_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-
M'_#47P*_Z'K_ ,IEY_\ &:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\
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MO_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
M&:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QFOS.HH _3
M'_AJ+X%?]#U_Y3+S_P",T?\ #47P*_Z'K_RF7G_QFOS.HH _3'_AJ+X%?]#U
M_P"4R\_^,T?\-1? K_H>O_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-
M'_#47P*_Z'K_ ,IEY_\ &:_,ZB@#],?^&HO@5_T/7_E,O/\ XS1_PU%\"O\
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MO_*9>?\ QFOS.HH _3'_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
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MV@$!>OS5ZO7Q#^UGXU\9>&OBWI5CX?\ %VLZ/:/HD,S06.H2V\;.;B<%BJ,
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M3(R6/.3R><8 P_#/AWXK>%-7\/ZA8_!O7)SH,,]K90W/C+36C6"4AFB($ )
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ME-Q7W]7P#^VI_P EMT;_ +%^'_TIN* /F6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_63
MX4_\D0\!_P#8OV'_ *3)7Y-U^LGPI_Y(AX#_ .Q?L/\ TF2@#M**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *^ ?VU/^2VZ-_V+\/_ *4W%??U? /[:G_)
M;=&_[%^'_P!*;B@#YEHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\
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M;*&:"9"DD3K;H&5E/(((((/(- '94444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5\ _MJ?\EMT;_L7X?_2FXK[^KX!_;4_Y+;HW_8OP_P#I3<4 ?,M%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 >S_LM_\G-^$?\ M\_](YJ_3&OS._9;_P"3F_"/_;Y_
MZ1S5^F- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/^&7/@7_ -"-_P"5.\_^/4?\,N? O_H1O_*G>?\ QZO9Z* /&/\ AESX%_\
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MY\"_^A&_\J=Y_P#'J]GHH \8_P"&7/@7_P!"-_Y4[S_X]1_PRY\"_P#H1O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M - #Q5_X"VW_ ,?I/VU?^2(Z-_V,$/\ Z37%? -44??_ /PVK\+?^@!XJ_\
M 6V_^/T?\-J_"W_H >*O_ 6V_P#C]? %% 'W_P#\-J_"W_H >*O_  %MO_C]
M'_#:OPM_Z 'BK_P%MO\ X_7P!10!]_\ _#:OPM_Z 'BK_P !;;_X_1_PVK\+
M?^@!XJ_\!;;_ ./U\ 44 ??_ /PVK\+?^@!XJ_\  6V_^/T?\-J_"W_H >*O
M_ 6V_P#C]? %% 'W_P#\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_7P!10!]_\ _#:OPM_Z 'BK_P !;;_X_1_PVK\+?^@!XJ_\!;;_ ./U\ 44
M ??_ /PVK\+?^@!XJ_\  6V_^/T?\-J_"W_H >*O_ 6V_P#C]? %% 'W_P#\
M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_7P!10!]_\ _#:OPM_Z
M 'BK_P !;;_X_1_PVK\+?^@!XJ_\!;;_ ./U\ 44 ??_ /PVK\+?^@!XJ_\
M 6V_^/T?\-J_"W_H >*O_ 6V_P#C]? %% 'W_P#\-J_"W_H >*O_  %MO_C]
M'_#:OPM_Z 'BK_P%MO\ X_7P!10!]_\ _#:OPM_Z 'BK_P !;;_X_1_PVK\+
M?^@!XJ_\!;;_ ./U\ 44 ??_ /PVK\+?^@!XJ_\  6V_^/T?\-J_"W_H >*O
M_ 6V_P#C]? %% 'W_P#\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_7P!10!]_\ _#:OPM_Z 'BK_P !;;_X_1_PVK\+?^@!XJ_\!;;_ ./U\ 44
M ??_ /PVK\+?^@!XJ_\  6V_^/T?\-J_"W_H >*O_ 6V_P#C]? %% 'W_P#\
M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_7P!10!]_\ _#:OPM_Z
M 'BK_P !;;_X_1_PVK\+?^@!XJ_\!;;_ ./U\ 44 ??_ /PVK\+?^@!XJ_\
M 6V_^/T?\-J_"W_H >*O_ 6V_P#C]? %% 'W_P#\-J_"W_H >*O_  %MO_C]
M'_#:OPM_Z 'BK_P%MO\ X_7P!10!]_\ _#:OPM_Z 'BK_P !;;_X_1_PVK\+
M?^@!XJ_\!;;_ ./U\ 44 ??_ /PVK\+?^@!XJ_\  6V_^/T?\-J_"W_H >*O
M_ 6V_P#C]? %% 'W_P#\-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\
MX_7P!10!]_\ _#:OPM_Z 'BK_P !;;_X_1_PVK\+?^@!XJ_\!;;_ ./U\ 44
M ??_ /PVK\+?^@!XJ_\  6V_^/T?\-J_"W_H >*O_ 6V_P#C]? %% 'W_P#\
M-J_"W_H >*O_  %MO_C]'_#:OPM_Z 'BK_P%MO\ X_7P!10!]_\ _#:OPM_Z
M 'BK_P !;;_X_1_PVK\+?^@!XJ_\!;;_ ./U\ 44 ??_ /PVK\+?^@!XJ_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7ZR?"G_DB'@/_ +%^P_\ 29*_)NOUD^%/_)$/ ?\
MV+]A_P"DR4 =I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P#^VI_R6W1
MO^Q?A_\ 2FXK[^KX!_;4_P"2VZ-_V+\/_I3<4 ?,M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5^LGPI_Y(AX#_ .Q?L/\ TF2OR;K]9/A3_P D0\!_]B_8?^DR4 =I1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7P#^VI_R6W1O^Q?A_P#2FXK[^KX!
M_;4_Y+;HW_8OP_\ I3<4 ?,M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^LGPI_P"2(> _
M^Q?L/_29*_)NOUD^%/\ R1#P'_V+]A_Z3)0!VE%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %? /[:G_);=&_[%^'_TIN*^_J^ ?VU/^2VZ-_V+\/\ Z4W%
M 'S+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?L19VEO86=M8V-K':VEO&L,,$*!(XD485
M54<     < 5^.]?LQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\ _M
MJ?\ );=&_P"Q?A_]*;BOOZO@']M3_DMNC?\ 8OP_^E-Q0!\RT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OV8K\9Z_6;X;W5U?_  G\&7U]<S75U<Z+9333S.7DE=K="S,Q
MY)))))Y)H [*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@']M3_DMNC?
M]B_#_P"E-Q7W]7P#^VI_R6W1O^Q?A_\ 2FXH ^9:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BO4O@U\*_\ A;WC:\\,_P!O?V*+;3WOOM'V7[1NVR1I
MLV[TQ_K,YSVZ<U[U_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T
M4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\
M*)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_
MPPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\
M=%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_
M "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F
M?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_
M '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'
M_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?
M9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG
M_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!5
M1_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG1
M7V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*
M)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\
M54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9
MT5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\
MRB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_
M %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?
M&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_
M ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ
M_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=%
M'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51
M_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,
M,?\ 54?_ "B?_=% 'QG7ZR?"G_DB'@/_ +%^P_\ 29*^9_\ AAC_ *JC_P"4
M3_[HKZM\)Z$?"_@K0O#/VH78TC3[>Q^T;-GF^5&J;]N3MSMSC)QGJ: -^BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[E7J,9YKY-\3^-I+&7XGZ@/BAJ#7^B:Y8+I,*ZULC4,Z>=&(HRJR(/WBE2I
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M_>%)?>)M>L9=;.B^*-6OOA@/$%A#+KB7TMS+;6S1L;H1763(8A)Y:F0,2N2
M>M,1]5T5\B>+_%FK:;X4\5G0?B-J2^%[?7=/BT/5#J7F27(DQ]KA2YDW/-''
MG.0QQ@@D@$5LMXH\R\^)GA;P_P#$J(Q6E]ITNGRZAK4\O[ME0W*"X1FEBC+#
M:74XC+=5J1];'U#WHKY?M?'3:A;>$GUK4=;T#P5<:E?6VIZD=<>6,SHJBW1-
M0C*N;8G=A]PW%2&)P2<>X\3ZUY'@NRUCXAZK;Z+=>++BQLYFU'[++J>D@?)/
M)*-LC#=\@D# $,#U(-5871L^N*K7%S;V=M)=7=Q';PQC+RRN%51ZDG@5Y]\4
M-0@\'?!O4Y$NM9CAMXHK=;BTOF%U&&=5#-<2"1E'/S2$,P&2.<5X!J^HW.J?
M"GXA:9J_B>;5(M$U_3I[9X-3NI4BMI&A)82R2&22+!8AG8KD;EV\82UDT/HF
MSZ]N+BWL[66ZO)TMX(5+R2RL%1%')))X 'K7-V'CC2]0^(NJ>!8+6^74]-M8
M[R:26$I"R.<#8Q.7Y[@8X(SD8K@_C=;V=[^S1JDNGS7\MG!;6\T$AN;CS'C$
MB#=(S-OD&TDGS,Y^\>1FO+?%6M>%1\0_&MUI/CBZL5L?!"-87$6LS13R7".[
M1AI6?S9#ED(5F.X.IPP(I;/7H&Z5NI]?54O+JWT^PN+ZZF6&WMXVEED;HBJ,
MDGZ 5\QZAXFUCQ;>Z/!?_%*/P=9W7A^RN=-U(F81WET0?M!1XKF&-Y5<*IBD
M$@]%'.?6_B+-;+\ ]:;Q%JCQ?\2=O,NFE:P:6;R_E!"N"I=\#R\D'.TY!P6]
M$V"LVD;/A/QQ;^+Y9#:^'];T^V:WBN[:[O[54@O(9.5>-U9AG&"4;:X!&5%3
M^(O&FE^&==\/Z1J%K?2SZ[=_8[:2"W+1))C/[QSA5XS@9+'!P#@UX/H>M:39
M>'?AA8WOBR^TWP->Z0QO-3M];G1!J0BC MY+D2;H%4!\1AE7<,8XQ5>3Q1<?
MV#\,3XM\0!V3QF[:?=ZC((Y[O3D$J17$@;!(.Y1O(YRI/6AJUDA)[W/?_!_C
M33?'%IJ=UI-K?6Z:;?2:?,E];F!_-0*6^0G<!\P'S '@\5UF:^3;+Q@D.@^*
MYM%UPKHDWQ!D;6[_ $NX_>VVG2!?WH>,[DC9EQYBD8 .#6O=1^(M8\)_$B7P
MEXJUG4M!T.>&^\/:C%JUPSW!5/,NK87"ONN(N"@+,V"W!R,T=+O30-;V\SZ<
M)QS6?;W5Q)>W5O)I]Q!'"5$=Q(T92XRN24"L6 !X.X+STR.:^;M#UC5O$/CY
MM)AN_$<&A^.OL^J:/,=8O ]I;6\A-TH/F9B$@&1M(XE4=, <YXP\?7UCH/Q=
MM;/XI7R7>FZQ9)IK+J<?FF-L++%'@?=7+YV8;,?S$X;)V&M3[%I*^5-8\<+I
M_P#PMC2?#/Q*DFCMM/TZ\T^:?56NW5GXN/)D+,4#90$KA8RX/RCIW/P7N(-3
M\4^*]6M_%%S?6;F%;#2;GQ1_;$UG'M'F,X2XEC4,X^4DEL \@'%.UQ7L>XUR
MWC;QEI?@/PG=^)-8M[VXM+7&]+* RR<G XX"C_:8@#UKP3XU>,M0T_QEK_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** ,G5;&ZU#3Y+6TU>\TF5MN+JS6%I4P<\"6-TY
MZ<J?;'6DT;2+/0M(ATVR#F.,LQ>1M[R.S%G=CW9F))/J:UZ* "BBB@ HHHH
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MA]O\/ZQ8ZM9[BGVBQN$GCW#J-R$C(]* ->BBB@ HHHH **** "BBB@ HHHH
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K'UG39]6TPV$6HSZ>LCKYLUNQ64Q@Y95<$%"PXW#D G&#@C8KG_$EA
MKFI>'KBR\/ZQ%HE_,-JWDML;CRU[X42)\V.AW<4F-'&_#>'6K/Q;XYTUM6O]
M5\,V=_%%I<VH7+W,J2>7FXB$KDNZHY"C<3@AAG(->H5Q&A^'?&&C:/-8KX@T
M1?*A6&PBM=%DAMX#G+/(AN6>0GVD3N3DFNP7>(P&;<^.2HP"?ISBA]"3YO\
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MY%1&(X:F:%X%UCP[K&I1Z;XJV^';_4'U)]/EL=UQ#)(^^1([@2 "-FSD&-B
M2 PZTG@WP+KG@N.+0]/\40S^%H+B2:WL9=/_ -*B1V+>5]H\W:4#,?\ EENQ
MQNJ=;>=A]78YG1?CMI[?#K3?%7BK1Y=)EU.\GM[*V-U:QBY5'<9626=47:J@
M,9&3+?=!RN="'XQ>&O%7ARS'A>/6]2U#5[>X:.VTJ. W=FD?R22L9'\H;6(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***YC6]*\27U\DFC^*_[)MU0*T/V&.?<V3EMS'(X(&/;WH Z>
MBN,_X1WQW_T47_RD0_XT?\([X[_Z*+_Y2(?\: .SHKC/^$=\=_\ 11?_ "D0
M_P"-<IXTUN_^'^APZUXP^+']F6$UPMK'+_8*RYE*LP7$88]$8YQCB@#UZBOF
M;_AH+P+_ -%^_P#+5F_^-T?\-!>!?^B_?^6K-_\ &Z /IFBOF;_AH+P+_P!%
M^_\ +5F_^-T?\-!>!?\ HOW_ ):LW_QN@#Z9HKYF_P"&@O O_1?O_+5F_P#C
M='_#07@7_HOW_EJS?_&Z /IFBOF;_AH+P+_T7[_RU9O_ (W1_P -!>!?^B_?
M^6K-_P#&Z /IFBOF;_AH+P+_ -%^_P#+5F_^-T?\-!>!?^B_?^6K-_\ &Z /
MIFBOF;_AH+P+_P!%^_\ +5F_^-U;TGXT^%=<UJPT72?CI]HO[^XCM;>+_A&I
M%\R5V"HN6C &20,D@4 ?1U%<9_PCOCO_ **+_P"4B'_&C_A'?'?_ $47_P I
M$/\ C0!V=%<9_P ([X[_ .BB_P#E(A_QH_X1WQW_ -%%_P#*1#_C0!V=%<9_
MPCOCO_HHO_E(A_QH_P"$=\=_]%%_\I$/^- '9T5QG_".^._^BB_^4B'_ !KQ
MG_AH+P+_ -%^_P#+5F_^-T ?3-%?,W_#07@7_HOW_EJS?_&Z/^&@O O_ $7[
M_P M6;_XW0!],T5\S?\ #07@7_HOW_EJS?\ QNC_ (:"\"_]%^_\M6;_ .-T
M ?3-%?,W_#07@7_HOW_EJS?_ !NC_AH+P+_T7[_RU9O_ (W0!],T5\S?\-!>
M!?\ HOW_ ):LW_QNND\&_$.R^(.N3:'X1^,G]IZA#;M=21?\(ZT.V,,JELR*
MHZNHQG/- 'NM%<9_PCOCO_HHO_E(A_QH_P"$=\=_]%%_\I$/^- '9T5QG_".
M^._^BB_^4B'_ !H_X1WQW_T47_RD0_XT =G17&?\([X[_P"BB_\ E(A_QH_X
M1WQW_P!%%_\ *1#_ (T =G17&?\ ".^._P#HHO\ Y2(?\:/^$=\=_P#11?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?,O[:O\ R1'1
MO^Q@A_\ 2:XKZ:KYE_;5_P"2(Z-_V,$/_I-<4 ? -%%% !1110 4444 %%%%
M !1110 5VOPI_P"2W^ _^Q@L/_2E*XJNU^%/_);_  '_ -C!8?\ I2E 'ZQT
M444 %%%% !1110 5^,]?LQ7XST %%%% !1110 4444 %?37[%?\ R6W6?^Q?
MF_\ 2FWKYEKZ:_8K_P"2VZS_ -B_-_Z4V] 'W]1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX.;G_P"+KBZ* .T_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\ 12_%7_@YN?\
MXNN+HH [3_A;'Q2_Z*7XJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZXNB@#M/^
M%L?%+_HI?BK_ ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^
MBE^*O_!S<_\ Q='_  MCXI?]%+\5?^#FY_\ BZXNB@#]$/V3/$&O>)?A'JM]
MX@UK4-8NX]<FA6>_N7N)%06\!"AG)(&68XZ9)]:^B*^9?V*O^2(ZS_V,$W_I
M-;U]-4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5^,]?LQ7XST %%%% !1110 4444 %%%% !1110 4444 =S\,_ Z_$KXG:1
MX+75/[*_M'SO]+\CSO+\N%Y?N;ESG9CJ.N?:OI/_ (88_P"JH_\ E$_^Z*\:
M_9;_ .3F_"/_ &^?^D<U?IC0!\9_\,,?]51_\HG_ -T4?\,,?]51_P#*)_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?C/7[,5^,] !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 =K\*?^2W^ _\ L8+#_P!*4K]8Z_'S
M2=5OM#UJPUK2Y_L]_8W$=U;2[5;RY48,C88$'! .""*]2_X:C^.O_0]?^4RS
M_P#C- 'Z8T5^9W_#4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S0!^F-
M%?F=_P -1_'7_H>O_*99_P#QFC_AJ/XZ_P#0]?\ E,L__C- 'Z8T5^9W_#4?
MQU_Z'K_RF6?_ ,9H_P"&H_CK_P!#U_Y3+/\ ^,T ?IC17Q]^S+\8OB+\0OBE
M?Z+XL\1?VG86^D2W4<7V.WAVRB:%0V8XU/1V&,XYK[!H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\9Z_9BOQGH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^FOV
M*_\ DMNL_P#8OS?^E-O7W]7YE_ #XE:#\*/B+?>(O$5K?W5K<Z7)9*EA&CR!
MVEB<$AW48Q&W?.<<5^@_@/QEI?C[P+I_C#1+>ZAL-0,ACCNT595V2M&=P5F'
M5#C!/&* .MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBN8UCQ-_8]ZEK_ ,(_K6I;HQ)YMA:>;&,DC:3D<\9QZ$4 =/17&?\ "?\
M_4E>*_\ P6__ &5'_"?_ /4E>*__  6__94 =G17&?\ "?\ _4E>*_\ P6__
M &5'_"?_ /4E>*__  6__94 =G17&?\ "?\ _4E>*_\ P6__ &5'_"?_ /4E
M>*__  6__94 =G17&?\ "?\ _4E>*_\ P6__ &5'_"?_ /4E>*__  6__94
M=G17&?\ "?\ _4E>*_\ P6__ &5'_"?_ /4E>*__  6__94 =G17&?\ "?\
M_4E>*_\ P6__ &5'_"?_ /4E>*__  6__94 =G17&?\ "?\ _4E>*_\ P6__
M &5'_"?_ /4E>*__  6__94 =G17&?\ "?\ _4E>*_\ P6__ &5'_"?_ /4E
M>*__  6__94 =G17&?\ "?\ _4E>*_\ P6__ &5'_"?_ /4E>*__  6__94
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ K\9Z_9BOQGH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ^@_V>_C-XH\%ZSH?P]TNSTJ;2=<U^#[3+<Q2-.O
MG-%"^PK(%&%4$94\^O2OT5K\G/A3_P EO\!_]C!8?^E*5^L= !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?C/7[,5^,] !111
M0 4444 %%%% !1110 4444 %%%% !7<^!_AEX[^)":@O@O0AJO\ 9WE_:?\
M2H8?+\S=L_UCKG.QNF>G/:N&K[,_89_YJ#_W#O\ VYH \:_X9<^.O_0B_P#E
M3L__ (]1_P ,N?'7_H1?_*G9_P#QZOTQHH _,[_AESXZ_P#0B_\ E3L__CU'
M_#+GQU_Z$7_RIV?_ ,>K],:* /S._P"&7/CK_P!"+_Y4[/\ ^/4?\,N?'7_H
M1?\ RIV?_P >K],:* /S._X9<^.O_0B_^5.S_P#CU'_#+GQU_P"A%_\ *G9_
M_'J_3&B@#\SO^&7/CK_T(O\ Y4[/_P"/4?\ #+GQU_Z$7_RIV?\ \>K],:*
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M43_[HH_X88_ZJC_Y1/\ [HH ^,Z*^S/^&&/^JH_^43_[HH_X88_ZJC_Y1/\
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M^#FV_P#BZ .SHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *_&>OV8K\9Z "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH _9BBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KE-4\!>%=:U2;4M2TOS[N;&^3SY5
MSA0HX5@.@%=710!QG_"K? G_ $ O_)J;_P"+H_X5;X$_Z 7_ )-3?_%UV=%
M'&?\*M\"?] +_P FIO\ XNC_ (5;X$_Z 7_DU-_\779T4 <9_P *M\"?] +_
M ,FIO_BZ/^%6^!/^@%_Y-3?_ !==G10!QG_"K? G_0"_\FIO_BZ/^%6^!/\
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M>G_]^%H_X0OPC_T+>G_]^%KH:* .>_X0OPC_ -"WI_\ WX6O.?\ AESX%_\
M0C?^5.\_^/5[/10!XQ_PRY\"_P#H1O\ RIWG_P >H_X9<^!?_0C?^5.\_P#C
MU>ST4 >,?\,N? O_ *$;_P J=Y_\>H_X9<^!?_0C?^5.\_\ CU>ST4 >,?\
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MJ?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z
M'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P#
M6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'
M_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O
M^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_
M  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X
M_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%
M? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -
MJ?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z
M'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P#
M6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'
M_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O
M^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_
M  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X
M_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%
M? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -
MJ?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z
M'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P#
M6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'
M_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O
M^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_
M  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X
M_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%
M? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -
MJ?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z
M'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P#
M6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'
M_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O
M^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_
M  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X
M_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_1_PVI\4O^@!X5_\  6Y_^/T ??U%
M? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C] 'W]17P#_P -
MJ?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !;G_X_0!]_45\ _\ #:GQ2_Z
M'A7_ ,!;G_X_7VOX(UJZ\2^ ?#?B*]CCCN]4TNUO9DA!$:O)$KL%!)(&6.,D
MG'<T =/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P#^VI_R6W1O^Q?A_
M]*;BOOZO@']M3_DMNC?]B_#_ .E-Q0!\RT444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZR?
M"G_DB'@/_L7[#_TF2OR;K]9/A3_R1#P'_P!B_8?^DR4 =I1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7P#^VI_P EMT;_ +%^'_TIN*^_J^ ?VU/^2VZ-
M_P!B_#_Z4W% 'S+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML=K:6\:PPP0H$CB11A551P    !P!6A10 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ89V[6)#;3\IP#QG&N/CIX=MY;R.W\.^(KY['28M<N!#:1J([5T#[]TDBAL
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M]]<):6ZOUEE;HBCN>"?8 DU8MY+\ZC=QW-K;QVJLOV:2.9G>4;?F+J4 0@\
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M4SGS$*HHQE3G)SVILWP5OKR77+RX\=3MJU]JUKK=K,FG1+#97<"A5;R\DNI
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M@P7ERWVJW:\@L%1KB:T$JF9(U<%68J#\I!##(P<XKTFBDU<:=CYDN/ .FP>
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M.Y.C:/\ %:3Q-<VRZ#;06=WHVGQZ@;:X5W,D;N8)GAE ,8$R[ =O+\#'M7Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9HF*,54'J%QSMYKVCPZNK:MH6I:MI?Q/U'6=&O(7CL;Q[6Q\VWEBE=7DC:.
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MR,=1JOP[G\>_"V\\(>/K#3[6[DFEDMI]-N'N1;N6+I*K/%&0P+$$8P0.OS8
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MKN.Q=[TZJ<#:)/,ABVJI&0"9,9Q]32_S_#H)W_#\3WGM1113&%%%% !1110
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M0&M/P]J&M:EH=O>:_H1T+4&W":Q-RER(R&(!$B<," ". >>0#Q26H&[1113
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MBD:-RC'JI*Y'Y=J\M,^J_#\VB^+K.R\:^ [O6DN[/Q%;.#=V-Q).&C><9_>
M/A=ZGH,$8PM>YZ-I.FZ#H]MI.D6L=E86J;(8(EPJ#_'.22>222:YZ'X6^!X;
MJSFCT5PEG,+F&T-W.;5)AR)?LY?RC)GG>4+9YSGFC[2?0%LT>:7GQ7^(MAX?
M\7>)KK3?#ZV'A77!IMU80K/)-<PYB!,<I90''F C,9#9QA<?-H:Q\6/%4>E>
M,O%FBV>DMH'A'4C87.GW4<GVN[";/-=90X6+[_RJ8WW8/(R*M>#_ (2RIXG\
M3:UX[TRPN&U'6/[6M8K/5KJ:$' "K- R1Q.4*AE9E8Y8],#/8WWPS\$ZMXAN
M=<O=%\R\NFB>Z1;F9(+MH^4::!7$4I'8NK=!Z4]K>GXAI<\Q\0?%[QY8S_$*
MZM=.T&*Q\'K97"Q3QSRS7<-P-VTL&01OL(/W6 ((PP.X=/=?$[6+'XGR>']4
M^QZ+ITEQ%'8+?:?< ZE&8@[M#=*QB,F[*B(J#WW'I6WJ7P?\"ZO/KEQJ6FW\
MSZ\RMJ0_MB]5+K:<H&43!<+T    X&!Q5ZW^&OA&WO[*^6QNYI;*9;F%;C4K
MJ>/SE7:LK(\A5Y   '8%ACK1V!['G^F?%?Q?<:3X/\97%CH]QX;\5ZG_ &;!
M8VZ2K=V1=G6%WE+LLG*'>!&I7/&<&NB^%?BSQKXVM=3U;Q VBV=I9:A<Z;]A
ML;:9I-\3A=_GO)@CKQY0)X.1TK<T_P"&/@G3=9_M2QT4P3K/)<QQB[G,$$SC
M#RQ0E_+B<@GYD4'GK6AX5\%>'_!EG=6GANWN;2WNIVN9EGO)[G=*WWGS,[$$
MGDXQD\G-"LKB>NQYEX\^*WB7PWXWEL])CTK4=*L[VQM;F..UGEE@\]PK>=/O
M2.%_F&U%65B.6V@USGBVS\2W/Q.^*4S:AH5S#8>'+>X2'4-&:Z7RE\^2-%#3
M[0ZLN2Y5@3@[!CGUO6?A7X'U[5-1U'5-%DEN=2>&6Z,=[<1++)%CRY-B2!0Z
MX #@!L9&<$U,OPU\'IXDU/7FL[V34-5A:WO6EU2ZD2XB*E=C1M*4*@,<#;A<
M\8J?L^95U?[CS>P\??$"S\)^!O#^CVT7B#Q+JNA#59+@VJD")5C"JRRWD6]R
M7^9Q)VR(^<#1T+QY\3M<^)%EX+U#2= \,S_V*-4NA)OU!PPG\EXQY<J(OS!L
M?,^!C/.5KL!\*_ ZZ3I6FQ:'+;QZ06-C/;WUQ#<V^0%(6=)!+@@ 8+XP .@%
M6['X=^$]/\70^*K6QNX]8BM_LBS?VA<LOD_W#&9"A!.6.5Y8EC\QS5;LA72,
MOXB>--<\.ZCX>T'PSI/V[5]<EF$0:..01I$F]SL>>!6/(X\U>,GG&#Q>N_$[
MXE:3X;TT7FCZ-I?BK[/=SWFE&)]0F=8@"CHD,P2*,@@LTDWRY  <UZUXB\)^
M'_%EM;1:Y8FY-I,+BVFCFD@FMY!T>.6-E=#[JPK'O/A?X(U%[.2]TF:::SBE
MMXYC?7 DDCE.9%E<2;I@QY/F%LFIU+NM#D=-^)'B[QE<:3I?A.'1M,U2?PY;
MZ]<-JD4L\3M-PD*!'1E&0<R?-C(&TFN.UZ]\2>&?C7XU\2:';Z'9ZM:^#(-2
MOTFADFAGDC9RRKM,;$G8%#MR !\IZ#UP_"OP2+?28(-+NK5M&MS:65Q::G=6
M]Q#"?^67G1R"1D_V68@=A5>Z^$?@._O[Z\N-,O?-O[)=.N#'JUY&LEL  (=J
MR@!..@ !R?4YKK?872SU+.J>.ETKX-R_$&:R\PII2ZA]E5NK-&&";NPRP&?3
MFO.-:^)GQ>\-^"O$7B#5O!NF1165DEY97-R\<"OEU5T,,-U<,^-ZD-N0'OMX
MS[#9^&=%L?"<?A1;,S:.D!M!:W,CW(,)R-A:0LS#!Q@DX&!T%8#?"?P--X=N
M/#,NFWTNDS(L;6\FK7C!8U.1$I,N4CR =BD*<#(X%+=MK8%LE]YPVH?%SQ-X
M6?Q-;>(+#3+^XLM.L+ZQ^PI) F^ZE,0CE+N^0K8)<!<C/R@G%3>!+/5K']I/
MQ:->?29-1N-"L9II-+M&MHYB9)!N96=R6&-NXL<@+TZ#KS\(_ 4UW>75UI%W
M=R7MFMA<_;-4N[A9H%&%1EDE(.W&0<9#?,#GFKNA?#/P7X;U\>(-+TAQJ_V<
M6HO;N[GNYA$.BAYG8@8X^@ Z "GI>Y.MK>AAZ]XT\677C_6O"/@U=)M[C1-,
MCU&>35H9)!=-(6V1($D38,+S(=V"0-M<!J/B#7?B%XJ^#6OZ?)8Z;::Q#?3K
M8WUB]R(I5MV60MB9!(I4D)PN,Y.X':/8_$7P]\)^*M4CU36=,E>^B@:U%Q;7
MD]K(\+?>B=H74NA_NMD<GCDU7OOAKX.U#5-&U233[J"YT2,0Z<+/4+FVCM4
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M3!%]C59'BDMVC7:C1R(5=& [J0>M5+KX:^#[Y],>\TN>>?3?,\BX>^N#,WF
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MDDY-4]V_*R)L[*_<\JU+XM?$2PM?%>J2:;X=6V\.^((-*:T!G=[F.4Q@$2Y
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MM2:+\9O#GB^\AUFUF\<^?9ZQ'>Z7=VT,,[,9+-4>:-48A (OD8]">0<U[?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^0;79J_%KXM1Z/X2N/\ A#]<DM->MYK1I5DTB:7RDF=0(I&= EO*5;=MD^;
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MQIOV'7+3+"6Y:)B]NR8&.&;YB2. !SFIUT&NM_D;WB#XD>#--TW6$U#Q)>:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ DG:V <51TWXA76I6VG7[^ ?$UIIE^@FBOI/L<D:H8S(K.(KEW0$#&2N,D
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MWQ)9Z$OA'PNNHZSJFC?VW)97>H"UCMX=VP+YHC?<[/E5&T#@DE:BD\>>.O\
MA;MOX=_X1FUCL6\-MJ\U@;Y?M7F;U4KNV&,NK H%WA"&+%^ H.MF3<]@I .:
M\3\*_%2WU#PIX.M_"/@NTM=3\3&\DM-)-VMM;VT4,C>;))(D38R><+&<LQ]S
M1_PO*ZF31[6U\$W#ZM?:W+X?N[:2^C2.QNXQDJ9,$NI'S!@F,9[X!?D,]LQ2
M5Q?@/QA-XST?4KJ[TE=,O-,U*XTNYMH[C[0GFPM@E)"J;E.01E17!Q_'#55T
MN[\0:AX#DL-"T_7#HFH2OJ2/<VS[U3S!$J%74,P!Q)QG(W"EUL@Z-GN'>F_Q
M5X+X/U=O!47Q:U*QLA??8_$>5BO=2$" -##EGGF)VJ-Q/\1P,*#P*FMOCU<7
M&DV5S!X)DN+FY\1#PV1'?[8%E*JR.'EC20JRL2,Q#[IR1D9=KV]+D_YGO'%%
M>+W'QHFL/#>H:AJGA^TL+[3O$!\/W"S:DWV*%]H83/<"'<L9!')BZD XZUZ)
MH_B!K[P@OB&YMHX%,3S[+>Z2Z1HU+;661/E8,H##'KCM2V3?1%=;'1=:.*^=
M$\3^*-)^$.A_$;3(;6[\1^+]2M%N[B\G8""":?$4$0".%148+TXRSX9C6?#X
MLU;X=_$OXO\ B)?#ZZG:V9TJXU"-M4?_ $<21$N(2Z,9,-(Q"D1K@<;>%IVU
M?D2?3M+7D.I?$:PTGQ_XNAD\%N;W0?#ZZC]O5HVGOH-Q*Q+M!8)NW?>/!R=O
M.3T_@7Q>WC;1IM26'3/(!14GTO5%OH9"5W$9V(RE<@%713G/&.2EM<9VU%>)
M7'Q5L-&/Q!U8^"H]-N]#U&UL;J:6=$-V9 JI//)$CE$5"IS\Y"]@1BO1/#7B
M"Z\1>&UU=+:PR[.L!L]06[MYP. ZS(OW2<]5R!U /%"U5Q];'445\^Z7\7O'
M=K\/O^$MUWPSI%YIYUJ:PN+F/59(18Q_:3$'9/LQS&AP"V22,$@9('1>(?BQ
MK6B7;36_@E=3TR378M!M;VWU-5$LK$*S,K1C: Q*?*7!9&!*X!+73S!Z7N>P
MT5X3XI^+JV'A?QC8^*OAW'?7OAVXM8;_ $U;V.XM)8;CF&;S)$4LI; *^66!
M(XQDCKAX\UK4_$.I6/A7P>NM6&C7T>GW]RVH+;2K*55G\J-DVN(U<;MSH3R%
M#4;@>C]J3/%>03_%Z:U^*EGX(NO#\$<5WJ+Z?'<0:F)YT(C+K))&D92,-CA6
ME\S')3%>3:II5K;_  @\?1QO<[=.^("BW+7<K''G6\>')8F3Y6(^?=Z]0#26
MK7F)Z>I]<TM>277Q2URQU_Q7H-[X3L8M5T<6SZ?;?VLY.JK/)Y<;)_H_R#)V
MG[V&X.!\U=AXH\61^#O!+^(-6LS).OE0BSMI-_F7$C*BQJ[!<@NP&X@<<X[4
M=F/R.J-)T->;ZIXX\7:#X8U/5->\%V5C-9S0QQ/_ &]']CF1\;I#,\:NNPG!
M7RBS' 0/FO,O$'C.W^(V@^!?$;:=-IMWIWCNWTQX4NI6B8J^68!ECW X0C?&
M&7G@<Y-W8'HFSZ7I*^>H_$EC\/?BI\6M6:UN[YI9]'BM[59)9GFGG5\(O#L%
MW,3M53@9"J>!72V_QBU Z8RZAX$U"QUNXU.+2]-M+@3V]OJ$D@+!TEN((G"*
M%8L3%D8X#9%'H&VY[#25XI\&8[V+Q?\ $Z._L_L=T-<C,D O7O%1C;HQVRN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8KD(57E<\[FSUKI=:?2_A#I[WGA+POIMM;ZQ> SV[72:?:PN(L HD<;N[-L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ltbr_ex101img27.jpg
<TEXT>
begin 644 ltbr_ex101img27.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+HHHH **
M*^3/^&W?#'_0CZK_ .!,?^% 'UG17R9_PV[X6_Z$?5?_  )CH_X;=\+?]"/J
MO_@3'0!]9T5\F?\ #;OA;_H1]5_\"8Z/^&W?"_\ T(^J?^!,?^% 'UG17R9_
MPV[X6_Z$?5?_  )CH_X;=\+?]"/JO_@3'0!]9T5\F?\ #;OAC_H1]5_\"8_\
M*/\ AMWPM_T(^J_^!,= 'UG17R9_PV[X6_Z$?5?_  )CH_X;=\,?]"/JO_@3
M'_A0!]9T5\F?\-N^%O\ H1]5_P# F.C_ (;=\+?]"/JO_@3'0!]9T5\F?\-N
M^%O^A'U7_P "8Z/^&W?"_P#T(^J?^!,?^% 'UG17R9_PV[X6_P"A'U7_ ,"8
MZ/\ AMWPQ_T(^J_^!,?^% 'UG17R9_PV[X8_Z$?5?_ F/_"C_AMWPO\ ]"/J
MG_@3'_A0!]9T5\F?\-N^&/\ H1]5_P# F/\ PH_X;=\+?]"/JO\ X$QT ?6=
M%?)G_#;OA?\ Z$?5/_ F/_"C_AMWPQ_T(^J_^!,?^% 'UG17R9_PV[X8_P"A
M'U7_ ,"8_P#"C_AMWPO_ -"/JG_@3'_A0!]9T5\F?\-N^%O^A'U7_P "8Z/^
M&W?"_P#T(^J?^!,?^% 'UG17R9_PV[X6_P"A'U7_ ,"8Z/\ AMWPO_T(^J?^
M!,?^% 'UG17R9_PV[X7_ .A'U3_P)C_PH_X;=\,?]"/JO_@3'_A0!]9T5\F?
M\-N^%_\ H1]4_P# F/\ PH_X;=\+?]"/JO\ X$QT ?6=%?)G_#;OAC_H1]5_
M\"8_\*/^&W?"_P#T(^J?^!,?^% 'UG17R9_PV[X8_P"A'U7_ ,"8_P#"C_AM
MWPQ_T(^J_P#@3'_A0!]9T5\F?\-N^%_^A'U3_P "8_\ "C_AMWPQ_P!"/JO_
M ($Q_P"% 'UG17R9_P -N^&/^A'U7_P)C_PH_P"&W?#'_0CZK_X$Q_X4 ?6=
M%?)G_#;OA?\ Z$?5/_ F/_"C_AMWPM_T(^J_^!,= 'UG17R9_P -N^&/^A'U
M7_P)C_PH_P"&W?"__0CZI_X$Q_X4 ?6=%?)G_#;OA?\ Z$?5/_ F/_"C_AMW
MPO\ ]"/JG_@3'_A0!]9T5\F?\-N^%O\ H1]5_P# F.C_ (;=\+?]"/JO_@3'
M0!]9T4@.:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OQGK]F*_,[_AESXZ_]"+_ .5.S_\ CU 'C%%>S_\ #+GQU_Z$7_RIV?\
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M 'C%%>S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\ X]0!XQ17L_\
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MXQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU 'Z8"EHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWU^+F.)D0#+R1Q'+2*HZ\KT.,XS7?J<J#G/O0 ZBBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN(@V\NQ##+[B3Z<XQB@"EXK^)>N:/X0T_P 3VO\ 95K:3Z7%J(M[O=)->R,
MS00JCAEVIEBY5AR.,9(;)8:7<_%O6I8]-MEBU3PB)+A?*7]_NE=?WF.&^4!>
M<\ #I6I/\+6NM ET5_$#HD^BPZ'+(MJN[R8BQ1ER3M8AR&[, . 0"-.'P/>1
MZ[)J[:V&D;2!I"QFV&%4$L'^]R=Q/' QQU^:@#.^%>GV.I? #PY8ZA9P7=K-
MIX62":,.CCG@J>*YWPKXLUSPKX8^'HUN"P?P]JFE0V\<ELLGGVCI:AU9R3AP
MR(V0%4J>,MC)]$\'^&6\*^$-/\.B\:]BL8_)21UV,4Z@$ XR,XS65I/P]M[/
M^P8]3U"75;;P] UMIL,T2J$5E\O=)CB1A&-@. ,$D@D[J *_A'Q1XLUR[L-4
MET6-?#>K6QN+>5?+26U! :,.?.8R[E)^ZB[3@8(Y":WXH\8)\3[/P;HZ:1;6
MUWIDE['>W4<D[!T<*08U9!CD#&[OG/&#)X6\ R>$YD@B\3:C=Z-;%VL-+N&0
MI:%N,"0#>P4,54,2!G.,X(R->T_5[GX^Z!>:?'<PQ6^D7,,EVUC));AF=2J,
M_"\@$CYL@@=>E &0OQ0\::UJ'AS2_#FFZ/!>ZM;7J2MJ'FLD5Y:L4D7"8/EE
M@,'YF(;H,<[>H>./%ECILWBI;73)O#ECJ#6-W JO]I*1R^1-.CEMN!*K80KD
MJ,[L\5HV_P .8--\0>&=6T_4'B3P_#/$D,D8;[2TYS+([9&&8\\# ))P>@=)
MX!CD?4[-]8NAHNJ:@NISZ?Y:$>8'#NBOU$;NH9EQD\X(W$$ PKKQIX[L9/%F
MFSWFASZ[IMQ;0Z9:PZ?+MN5N& B9\SYY)9#C 0HS$L,"K2^)M;T_5O%Z7FBZ
M1_:MD;"WM)+0LOVV2=C'#YK,,@;F''S; 6PS=:ZF[\':??>/]+\:,TD5_8VK
MVS1KC9,K?=W9[H2V/]ZLO4/A^VK7OB::\UJ54UQ;? MHA&]H\!S"\;$GD'DY
MZG'0<4 </;7UYX3^*7C36-<L].>_70[21CIT9B2ZE>9T0D,20=Q5,DG[N>,[
M1T]UXR\;:'8WXUSP_#-/+<6]KI%S$R017,T[A%CD032L@5B"6R0RYP%(P;$_
MPS_M35-5U#7M>NM0;5M*72[F-(8HH\*25E7C<K G<,'&XDXQ@".3X8W.H^&Y
M]'\0>,M9U6X_<FTOI#'')9&-PZ,FU?F?<!N9LD@ 9'6@!O@BQOM/^)?C(:A:
M:7'>3VNGS2S:="T,=RS-<YD96)(8XP<LV=H.><"MXV^('B3PSXECA%GIT>E"
MYM(5BFS+<WT<KA))4V-B%8V95S(I#'H<X!ZO3/"]YI_BR]\177B"YNY;ZUAM
MI[<0QI"?+W;67@N#\[<;L98^P'/:Q\,X=3U#Q!<+KES;1ZW<VM[(HB1RDEN5
M**&89V'8"1Z]#U! -#P[<^*+KQMXKAU/5[*XT^RO([>&&*S>-QNMXI%^<RD
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M?+BR?^F2T 95OXT\87NLV>@PG2TOM6FNY[*Y>TD\N"RA;8KR()<R.[$8 90
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M,,)#@G=P,LNT_*.G.0!EGXN\8#5=(L]4&E1-XGL99=)\F"0_9+E8C*(I\O\
MO%V<[E\O)5A@<&L3PY\3O$&H:GX'75KK2HX]<>[M;^VCL98Y;6XA+J K&5@
M7VIR#D@D=?E[30?!L6BKHL=QJ$FJ)HEN]IIQF0"1$8*-SG^)PJ[00!QGCDFL
M[6?A/H>M:?XAMUN+BSEUR[BO&N8&&ZV="K?N\],N'8^\C>U &3!XP^(4OB?P
M_H#?V$6UO3KB_BNEMI@(@K#8&C\P_P #*3\W)) QM!;L_ /B*Z\5>!=)UZ^A
MC@N+N$/(D6=@<$JVW/.,J2,DG!YJMJ'@VXN/&>C^)+'4$M'TJTEM(;5K?S(V
M63&[<=P.!M7 !'3WXO\ @OPX_A7PG9^'OMAO$LP529D",P+%N0"1G)/3'&*
M.HHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[<IU]=:^T2XCL?#G_"/?#]]&M[;7DOI[*V%I T<:Q,C2.$DV%B3QM+':HZ4
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M0![SYB_WN/6FO(C(5#<]*X;P%<3S?\)/;374]REEKMQ!"9YFF9(PL;!-S$G
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M].:Z6PN;QEV_Z/;*&D.6 S@D# SDG/0'K7B/A>&WB^%]_$LTBD^-H48&9B5
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MM6GAV'EB)QD2(GRD@] O'0FO9+6XAN/,\ED;RV\M]K [6'53CH1Z4 7****
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MIX/<5O44 588EA58HXQ'&@"JJ@  #H .PJU110 4444 %%%% !1110 4444
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M2INX[5%E(/4;P,X/UJ[:V-C8R3_8K6&W^T2F:;RD"^9(>KMCJQP,D\G%:%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPR Y!P">1VH \FU#X:^+=7\/>"(]:N]+U:_\/LZ7L!N)K6&XA,7EC;(BERP
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MZ9P"N!R21BN$\+^#=0L_&_PN6]LY)+@I=>(+Z=8&_P!9.<I&6[,OR@YQT[X
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M7?V23RKA7GB.<;BA &,\<-6G8^,_!T>CZKHMKXRLM8>UM;N^N;P7*2)$CRG
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M,)R'.W+$5K_%KQ_X/\2:=\/-0TO7K:6(:];WTD9E42V\2DAF=,Y7:<CGT]*
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MTU;E3.9GDVJI0991D@DD<#\*Y7PU>:;KGQY^*FF6.M6C2ZU8&TLG\]2)I!"
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M5 P!^ P*NT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 455N&F^SR
M>3(D4FWY7D0NJGU(!&1^(KSSPE\0;K6/$>J>%=>L8M(URVDF^R-EO(U")&*,
M\6[!)5E.Y>W7UP >FT5Q&C^))&TG4]2\3:AIVGVME>S68G8^1&HCD*;F9V(&
MXXP.W3+5T$>N:+-8VM_#JUG):7CK';SK<*8YV;A51LX8GL!UH UZ*YS_ (3+
MPBMJUTWBS1U@2;[,TAOH@JR_\\R=V W^SUJYJFO:)H=LEQK6L66F6[OY:RWD
MZPHS?W06(&?:@#7HK+_M;3/[2@TYM2MA>W"-+#;F5?,E1<;F5<Y(&1DCCFM2
M@ HHHH **** /SV^('[17QBT/XH>*]&TOQD;>PT_5[NUMXO[/M6\N-)F55RT
M1)P !DDFN7_X:C^.O_0]?^4RS_\ C-<=\66S\;_'A_ZCU]_Z4/7$T >S_P##
M4?QU_P"AZ_\ *99__&:/^&H_CK_T/7_E,L__ (S7C%% 'L__  U'\=?^AZ_\
MIEG_ /&:/^&H_CK_ -#U_P"4RS_^,UXQ10![/_PU'\=?^AZ_\IEG_P#&:/\
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M?3/[%?\ R6[6?^P!-_Z46] 'W^**!THH **** "BBB@ HHHH **** "BBB@
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MVEE EO$O^RHP/QH UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+[PO;:?'>Z?81WB13 '[1#(CP3,C,0F=H!^49SCY?ICRT..O'N:4*H[?F>M
M'">&+;P[I2>&-',%Q+JD&G;;&>_M=]REN%&5>4( AP5!7(YXYQ7?4F #2T %
M%%% !144S,H&TD>I S7#74/Q8:_N&T_4O":69E?R%GL;EI!'N.W>1, 6QC.
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MU'D_&;_H*>"__ &Z_P#CU '?T5P'D_&;_H*>"_\ P!NO_CU'D_&;_H*>"_\
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MP'D_&;_H*>"__ &Z_P#CU'D_&;_H*>"__ &Z_P#CU '?T5P'D_&;_H*>"_\
MP!NO_CU'D_&;_H*>"_\ P!NO_CU '?T5P'D_&;_H*>"__ &Z_P#CU'D_&;_H
M*>"__ &Z_P#CU '?T5P'D_&;_H*>"_\ P!NO_CU'D_&;_H*>"_\ P!NO_CU
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MX_\ *9>?_&: /9:*\:_X:B^!?_0\?^4R\_\ C-'_  U%\"_^AX_\IEY_\9H
M]EHKQK_AJ+X%_P#0\?\ E,O/_C-'_#47P+_Z'C_RF7G_ ,9H ]EHKQK_ (:B
M^!?_ $/'_E,O/_C-'_#47P+_ .AX_P#*9>?_ !F@#V6BO&O^&HO@7_T/'_E,
MO/\ XS2V_P"TM\%[R]@M+/QD9III%B11IUV,LQP.L7K@?C0![)134;>@;UIU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !137;:!QFHH9HYXA+#(LB-T9&# _B* )Z*** "BBD8[5S0 M%5H[B.8
MN(W5MC;6VL#@^GUJS0 4444 %%%% !1110 457$\9F\G<N_;NV[AG'KBF37,
M-K&))Y%C4D*"[ 9)Z#ZT 6Z*16W(&]:6@ HHHH **** "BBB@ HHHH ****
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MFY=VWO2T %8&O2:[]D$7AUK**\,J!IKZ-I(HH\Y=BJLI8X!P-PYQG YK?HH
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M>#N^[C! ^][5RGA'Q5-X5_9PT#Q1I>BVUOIMO)YM[9VXED\NV:Y<2M%O=GW
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MIO+MI'5MK!&(/OBN'\+_  WL_"VIQ7EIXD\17EO!&8K>PO=1,MM;J1C:J8'
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M#S[_ (1OXI_]%.T[_P )T?\ Q^C_ (1OXI_]%.T[_P )T?\ Q^O0:* //O\
MA&_BG_T4[3O_  G1_P#'Z/\ A&_BG_T4[3O_  G1_P#'Z]!HH \^_P"$;^*?
M_13M._\ "='_ ,?H_P"$;^*?_13M._\ "='_ ,?KT&B@#S[_ (1OXI_]%.T[
M_P )T?\ Q^C_ (1OXI_]%.T[_P )T?\ Q^O0:* //O\ A&_BG_T4[3O_  G1
M_P#'Z/\ A&_BG_T4[3O_  G1_P#'Z]!HH \^_P"$;^*?_13M._\ "='_ ,?H
M_P"$;^*?_13M._\ "='_ ,?KT&B@#S[_ (1OXI_]%.T[_P )T?\ Q^C_ (1O
MXI_]%.T[_P )T?\ Q^O0:* //O\ A&_BG_T4[3O_  G1_P#'Z/\ A&_BG_T4
M[3O_  G1_P#'Z]!HH \^_P"$;^*?_13M._\ "='_ ,?H_P"$;^*?_13M._\
M"='_ ,?KT&B@#S[_ (1OXI_]%.T[_P )T?\ Q^C_ (1OXI_]%.T[_P )T?\
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MNU&6/>J/)NM)LVH?E#<?)_H^01_K=GZ5LPZQ8S:W<:.DDGVV")9Y$,+A0C<
MA\;2>.@.1WH V:*** "BBB@ K@?BUXUNOA[\*]8\96=C#?3Z?Y.VWF8A7\R:
M.,Y(] Y/X5WU>,?M1_\ )LGB[_MS_P#2R&@#P'_AMWQ5_P!"1I7_ ($24?\
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M]%_ WXHWWQ9\"WOB2_TV#3I+;49+$1P,S*P6*)]W//\ RT_2OS!K] /V*_\
MDB6L?]A^;_TFMJ /IBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<@E<[N!@=: .SU;7+B3QQH_A72;AH[DYU#4'C0/Y5JF55#N! ,CX7CG"OC!
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M (.X/_D.O2/!?QT;X>Z'<:+X1M]=L;*>X:Z>(ZA9RYD*JA.7L2?NHO'3CH*
M/TFHK\_O^&N?%W][6O\ P,L/_D"C_AKGQ=_>UK_P,L/_ ) H _0&BOS^_P"&
MN?%W][6O_ RP_P#D"C_AKGQ=_>UK_P #+#_Y H _0&BOS^_X:Y\7?WM:_P#
MRP_^0*/^&N?%W][6O_ RP_\ D"@#] :*_/[_ (:Y\7?WM:_\#+#_ .0*/^&N
M?%W][6O_  ,L/_D"@#] :*_/[_AKGQ=_>UK_ ,#+#_Y H_X:Y\7?WM:_\#+#
M_P"0* /T!HK\_O\ AKGQ=_>UK_P,L/\ Y H_X:Y\7?WM:_\  RP_^0* /T!H
MK\_O^&N?%W][6O\ P,L/_D"C_AKGQ=_>UK_P,L/_ ) H _0&BOS^_P"&N?%W
M][6O_ RP_P#D"C_AKGQ=_>UK_P #+#_Y H _0&BO#/V?_'&N?$SPOJ'BS4M2
MOVB@O7T\65RULX#+'&_F;XK>(]),8.>]>YT %<=\0+74M2^'GB#2=)TUK^\O
M[&:UBAC=$.YXRH)+LH &>N?PKL:* /*]>M?%FJ?"W_A#]/\ #LUK>WNGII\M
MU=SP>3;J4"2,1'(SL0N[ 4')QTKGK_P'XAAT75?"]CILMQI,'AU-.TV\L988
M);N8(X*W#%P^S<V0H.S#-G->ZT4 >06WAOQ$OQ?T;Q1_9<T>G+X:_LF9_-AW
MP2^;N!/S\C!S\N?P[Y_@GP3>0G08_$G@^^&IZ!(J0:G-X@DN;,*J[?-BA,S%
M68 ?(8U SUXQ7M]% &=8W%Q<6_F7%G+:2;F7RIBA; ) ;Y688.,CG.#R <@:
M-%% !1110 5\M_M ?M >,OA7\0;+P]X>TS1KBVN--CO7>^AF=][2RH0"DB#&
M(QVSUY[#ZDK\_P#]M'/_  NO1O;P_#_Z4W% "']M#XHD8/A_PM_X"W/_ ,?I
MR_MH?%+;QX=\+$?]>MS_ /'Z^9J* /I?_AM+XIY_Y /A;_P%N/\ X_2']M#X
MHYS_ &!X6SW/V6XY_P#(]?--% 'TL?VS_BCQ_P 2'PMQ_P!.MS_\?H'[9_Q1
M&6'A_P *_7[)<?\ Q^OFFB@#Z6'[:'Q1&?\ B0>%>>_V6X_^/T#]L_XH<8\/
M^%>.G^BW''_D>OFFB@#Z7'[9WQ.YSX?\+'T_T6X_'_EO3A^VC\5,?+H'A?!Z
M?Z+<?_'Z^9J* /IG_AM3XIY_Y 7A8#_KUN/_ (_3_P#AM/XI_P#0O>%__ 6X
M_P#C]?,=% 'TY_PVG\4_^A>\+_\ @+<?_'Z/^&T_BG_T+WA?_P !;C_X_7S'
M10!].?\ #:?Q3_Z%[PO_ . MQ_\ 'Z/^&T_BG_T+WA?_ ,!;C_X_7S'10!].
M?\-I_%/_ *%[PO\ ^ MQ_P#'Z/\ AM/XI_\ 0O>%_P#P%N/_ (_7S'10!].?
M\-I_%/\ Z%[PO_X"W'_Q^O3O@E^T9XX^)?Q-M_"^NZ;HEM92VLTS/903)(&4
M?*,O(PP?IFOA6O<OV8;.^U#XW6MMIVLW&DS_ &*X/VF"..1U&T9 $BLO/TS0
M!^DU%<3_ ,(CXN_Z*GK7_@!8?_(]'_"(^+O^BIZU_P" %A_\CT =M17$_P#"
M(^+O^BIZU_X 6'_R/1_PB/B[_HJ>M?\ @!8?_(] ';45Q/\ PB/B[_HJ>M?^
M %A_\CT?\(CXN_Z*GK7_ ( 6'_R/0!VU%<3_ ,(CXN_Z*GK7_@!8?_(]'_"(
M^+O^BIZU_P" %A_\CT =M17$_P#"(^+O^BIZU_X 6'_R/1_PB/B[_HJ>M?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OH#]D/_ ).%M?\
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M5/[S()(S@@CFNQ\/V-SH^EW6JV_@_P"P:AJ,T;W%H+Y9IW)8*TDLK':649.
MQX7J2<  [Q65AE3D4M0QL!GMTZFI=U 'PW^V]_R._A+_ +!\O_HRODRONG]I
M[X3_ ! ^)'BCP_?>#_#YU*&SLY(IC]J@AVL9,@?O'7MSQFOGW_AESXZ?]"+_
M .5.S_\ CU 'C%%>S_\ #+GQT_Z$7_RIV?\ \>H_X9<^.G_0B_\ E3L__CU
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M5[-_PR]\=.W@?\]3LQ_[6I?^&7_CM_T(_P#Y5+/_ ./4 >,45[-_PR_\=/\
MH1__ "IV?_QZE_X9=^.G_0C_ )ZG9_\ QZ@#QBBO9O\ AE[XZ?\ 0C#_ ,&=
MG_\ 'J7_ (9=^.1_YD@_CJ5G_P#'J /&**]F_P"&7_CI_P!"/_Y4[/\ ^/4?
M\,O?'+_H1S^&I6?_ ,>H \9HKV?_ (9=^.G_ $(W_E3L_P#X]1_PRY\=/^A%
M_P#*G9__ !Z@#QBBO9_^&7/CI_T(O_E3L_\ X]1_PRY\=/\ H1?_ "IV?_QZ
M@#QBBO9_^&7/CI_T(O\ Y4[/_P"/4?\ #+GQT_Z$7_RIV?\ \>H \8HKV?\
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MX[?2T@D9IK6=?)M6W96(*Q#MP3\P7'&<#I7Q?^VAG_A=>DGI_P 4_#_Z4W%
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M:M<_[_1__&Z/^$9N/^AJUS_O]'_\;KHJ* .=_P"$;N/^AIUO_O['_P#&Z/\
MA&[C_H:=;_[^Q_\ QNNBHH YW_A&9\_\C1K?_?V/_P"-T?\ "-W!_P"9IUO_
M +^Q_P#QNNBHH YW_A&;C_H:M<_[_1__ !NC_A&Y_P#H:-;_ ._L?_QNNBHH
M YW_ (1FX_Z&K7/^_P!'_P#&Z/\ A&Y_^AHUO_O['_\ &ZZ*B@#G/^$8G_Z&
MK7/^_P!'_P#&Z7_A&;C_ *&K7/\ O]'_ /&ZZ*B@#G?^$9N/^AJUS_O]'_\
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M]FOX5_$+PE\:K?6/$GA.^TNP6SGC,\R@*&*C X/>@#[#_P"$9N/^AJUS_O\
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M75NG/.>]344 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !350+WIU% !BC%%
M% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !BC%%% !B
MHBA+D[L#C@5+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+L4G/?&!792>.=>TWPG=:UJC:=)*NKRZ+!%#;2('E^V?9TE8F1MJ@!F*\YX
M8'J >C75S#9V\]S=7"P6\*F225R%2- ,EB3TZ$YI]K<+<JDL4BRPNH973D,"
M,@@^G_UJ\QUKQIJVF:YXG\+WD.GS75AH)URUF:V?R9X5++)%)&9"<Y& =V,,
M>.,%;OQIXLEM(;/PKX;_ +1OX]'M=0=(UB6%9)@^V,^9<1,B_)U4/C/^S@@'
MK+*K$$C..E)L7T_6O--)\5>+/$UUK-C96.G:7?:.;6*>TO2\VZ:2)))%WQL-
MH7<5#88$KFM7PK-J\OB3Q>M_J$-U!;:H(8D$14H#9VS@ [R HWGC&<Y.><4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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J1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ltbr_ex101img21.jpg
<TEXT>
begin 644 ltbr_ex101img21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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MTAW%9F/1#C /.* />**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *_)SXK?\EO\>?\ 8P7_ /Z4O7ZQU^9?Q(^&?Q&O_BSXSOK+
MX?\ B.ZMKG6KV:&:'2;AXY4:X<JRL$P00001P10!XW17:?\ "I_BE_T33Q5_
MX)KG_P"(H_X5/\4O^B:>*O\ P37/_P 10!Q=%=I_PJ?XI?\ 1-/%7_@FN?\
MXBC_ (5/\4O^B:>*O_!-<_\ Q% '%T5VG_"I_BE_T33Q5_X)KG_XBC_A4_Q2
M_P"B:>*O_!-<_P#Q% '%T5VG_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK
M_P $US_\10!Q=%=I_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__
M !% '%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$4 <7
M17:?\*G^*7_1-/%7_@FN?_B*/^%3_%+_ *)IXJ_\$US_ /$4 <717:?\*G^*
M7_1-/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]$T\5
M?^":Y_\ B*/^%3_%+_HFGBK_ ,$US_\ $4 <717:?\*G^*7_ $33Q5_X)KG_
M .(H_P"%3_%+_HFGBK_P37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\
M4O\ HFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IX
MJ_\ !-<__$4 <717:?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\ P37/
M_P 10!Q=%=I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\ Q% '
M%T5VG_"I_BE_T33Q5_X)KG_XBC_A4_Q2_P"B:>*O_!-<_P#Q% '%T5VG_"I_
MBE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\10!Q=%=I_P *G^*7_1-/
M%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y
M_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$4 <717:?\*G^*7_1-/%7_@FN?_B*/^%3
M_%+_ *)IXJ_\$US_ /$4 <717:?\*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:
M>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$U
MS_\ $4 <717:?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,10
M!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!Q=>S_LM_
M\G-^$?\ M\_](YJXS_A4_P 4O^B:>*O_  37/_Q%>M_L[_#_ ,>:'^T)X7U3
M6/!.OZ986XNO,NKS3)H8H\VLRC<[* ,D@#)ZD"@#]":*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKF/%?BS3_  G9
M64M\RFXU&[CL+*%G"":X?.U2YX4<$DGL#@$X! .F(XHKSG5O&GBS1_"?B35K
M_P $P)=:%:B[,9U-OL]V@5VD\J80Y)54Z,BDDX(48)P]-^+&ORZQX?T?5O!M
MI8W?B?37OM%DCU9IH)W6,2F&9OLZM$P4CD(XYXS2[@>PT5XCH?QLU2\TWP?K
MNN>#8=/T+Q5=_P!GVMW:ZH;F2WN"[(BRQM#'@,4;E6;&.:Z7XF>/M6^'>F6N
MM0^%UUS2WF6&X\B\9+J/.22D7E,L@"J3RZ],>]#TW[V#_*YZ717G5SX[OKK4
MO"+>%M+T[6=$\2Y\K4'U-X&C"QM(Q\L0ON^1#CY@=WRG;UKT6G:PD[A17E_Q
MX\2:YX/^!WB#Q+X;OOL&JV?V;R)_+239ON8D;Y7!4Y5F'([U\/?\-1_'7_H>
MO_*99_\ QF@9^F-%?F=_PU'\=?\ H>O_ "F6?_QFC_AJ/XZ_]#U_Y3+/_P",
MT ?IC17YG?\ #4?QU_Z'K_RF6?\ \9H_X:C^.O\ T/7_ )3+/_XS0!^F-%?F
M=_PU'\=?^AZ_\IEG_P#&:/\ AJ/XZ_\ 0]?^4RS_ /C- 'Z84M>$_LS>./%?
MQ"^%^IZUXNU8ZG?Q:Q+:I+Y,4.V(0PL%Q&JCJ['.,\UW'Q&\9:IX%\/6VLZ=
MH=MK"2WD-I)'/?M:E#+(L:,"(I-PW-STP.F>E+L@.]I >:\BC^*'B:3Q=?>!
MSX%@'BNU,,PA75F:RDM9-V;CSQ!N4*5P08@<D8S4GAGXC>,O$5U<R?\ ""V*
M6=CK3Z)>RV^LR3RPNC!7F6,VJAHP2.=P..2!BD#TW/6Z*\YL/B%>Z]'%JWAG
M0%UOP\]\NGF\AO,3HXG$4DC0;.(UY;.[=@9*A3NKNIF:*-I$B><J"1&A +'T
M&2!D^Y JNEPZV+-+7$^ /&TGCCP]>ZG<:+)HTUGJ$^GR6LDRS,K1-M8EE^7K
MGH2..IK:\1WU[I?AR_U+3[*&]N+2$S+!/<&!)-HR07".5X!Q\IYQTZU+=E=A
M:^G4VSTI<5YS\/\ XI:5X\^&3^-)K?\ L9;02B_MI9=YLS&-S9;"Y&S#9P.#
M3/A/\1+SXE>'[O76\/KHMA'=/:P(UX9IG*'#%T\I1'U7 #-WZ8Y?5H6EDSTK
M%'>C/-<3IOC.2\^*&M>!VT26T_LNS@O4NWG1A<K(S+\J+G: 5(^8@\= ,$O=
MV'L=OVHKS7QWX_UKP79ZAKB^#WO_  _I+1B_NS>>3/M;;N>"(QD2J@89)=.<
M@9P:]"AFCN+>.>(YCD4.IZ9!&10M=0+%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=Q]_I,\T=0>JL>5>.M>L-5U1O"&K:1K[:'%LGU"2W\/WUTE]@AEMT>*)EVY
M+MG&,*,Y8KZ/9S27-C!<-:RVIEC5_(F #Q9&=K $@$=#@FM"BA:*PPHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*P/%'BC0_!_AJ[\2>(K[[#I=IL\ZX\IY-F]U1?E0%CEF4<#O7F__  U%\"O^
MAZ_\IEY_\9H ]GHKQC_AJ+X%?]#U_P"4R\_^,T?\-1? K_H>O_*9>?\ QF@#
MV>BO&/\ AJ+X%?\ 0]?^4R\_^,T?\-1? K_H>O\ RF7G_P 9H ]GHKQC_AJ+
MX%?]#U_Y3+S_ .,T?\-1? K_ *'K_P IEY_\9H ]GHKQC_AJ+X%?]#U_Y3+S
M_P",T?\ #47P*_Z'K_RF7G_QF@#V>BO&/^&HO@5_T/7_ )3+S_XS1_PU%\"O
M^AZ_\IEY_P#&: /9Z*\8_P"&HO@5_P!#U_Y3+S_XS1_PU%\"O^AZ_P#*9>?_
M !F@#V>BO&/^&HO@5_T/7_E,O/\ XS1_PU%\"O\ H>O_ "F7G_QF@#V>BO&/
M^&HO@5_T/7_E,O/_ (S1_P -1? K_H>O_*9>?_&: /9Z*\8_X:B^!7_0]?\
ME,O/_C-'_#47P*_Z'K_RF7G_ ,9H ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#4
M7P*_Z'K_ ,IEY_\ &: /9Z*\8_X:B^!7_0]?^4R\_P#C-'_#47P*_P"AZ_\
M*9>?_&: /9Z*\8_X:B^!7_0]?^4R\_\ C-'_  U%\"O^AZ_\IEY_\9H ]GHK
MQC_AJ+X%?]#U_P"4R\_^,T?\-1? K_H>O_*9>?\ QF@#V>BO&/\ AJ+X%?\
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M'K_RF7G_ ,9H ]GHKQC_ (:B^!7_ $/7_E,O/_C-'_#47P*_Z'K_ ,IEY_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /&/VH_^39/%W_;G_P"ED-?F=7Z8_M1_\FR>+O\
MMS_]+(:_,Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_T/7_E,L_\ XS1_PU'\=?\ H>O_ "F6?_QFO&** /V8HHHH **** "BBB@
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M:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\
M:Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%
M7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&*
M* /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5
M:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\
M:Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%
M7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&*
M* /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5
M:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\
M:Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%
M7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&*
M* /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5
M:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\
M:Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%
M7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&*
M* /9_P#A07_5:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5
M:?A5_P"%'_\ :Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\
M:Z/^%!?]5I^%7_A1_P#VNO&** /9_P#A07_5:?A5_P"%'_\ :ZT-,_9SU37-
M3ATO1OBI\.-3OY<^5:V>N--+)A2QVHL1)P 2<#H":\(KV?\ 9;_Y.;\(_P#;
MY_Z1S4 =G_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P
M#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O
M^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\
M JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?
M\,5_%+_H/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H
M/^%?_ JY_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY
M_P#C%??U% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U
M% 'P#_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C%??U% !1110
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M\J=Y_P#'J /S.HK],?\ AESX%_\ 0C?^5.\_^/4?\,N? O\ Z$;_ ,J=Y_\
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M_H1O_*G>?_'J /S.HK],?^&7/@7_ -"-_P"5.\_^/4?\,N? O_H1O_*G>?\
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M#FV_^+H_X6Q\+/\ HI?A7_P<VW_Q=?DU10!^LO\ PMCX6?\ 12_"O_@YMO\
MXNC_ (6Q\+/^BE^%?_!S;?\ Q=?DU10!^LO_  MCX6?]%+\*_P#@YMO_ (NC
M_A;'PL_Z*7X5_P#!S;?_ !=?DU10!^LO_"V/A9_T4OPK_P"#FV_^+H_X6Q\+
M/^BE^%?_  <VW_Q=?DU10!^LO_"V/A9_T4OPK_X.;;_XNC_A;'PL_P"BE^%?
M_!S;?_%U^35% 'ZR_P#"V/A9_P!%+\*_^#FV_P#BZ/\ A;'PL_Z*7X5_\'-M
M_P#%U^35% 'ZR_\ "V/A9_T4OPK_ .#FV_\ BZ/^%L?"S_HI?A7_ ,'-M_\
M%U^35% 'ZR_\+8^%G_12_"O_ (.;;_XNC_A;'PL_Z*7X5_\ !S;?_%U^35%
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M )4[S_X]0!^9U%?IC_PRY\"_^A&_\J=Y_P#'J/\ AESX%_\ 0C?^5.\_^/4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK-:S1QW@B)$GD2.@2;:0<["V*S=-^-'PUU34+6SLO$$AGNKXZ7'YNGW40^U
M9\EF>,!&YX#$9YQT-):[#V/2J***8!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ,]*\7^*'P_\ ''B[XC^"O$GA^#0Q9>%KHW@6^OYHI+IF*$IA('"
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M_ WXF:S)XQ6WD\,1Q^(=<M]7C:34;C="L._"$"VY)W#G/&#UKTS6O ?B*_\
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M]?9G[#/_ #4'_N'?^W- 'V91110 4444 %%%% !1110 4444 %%%% !1110
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M?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\
M55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-
M_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG
M4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QB
MU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55
M?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17L
MW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*
M=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M
M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_
M "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8
MM?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,
MT5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=1_QBU_U5
M7_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+7_55?_*=
M1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!XS17LW_&+
M7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55_P#*=0!X
MS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4?\8M?]55
M_P#*=0!XS17LW_&+7_55?_*=1_QBU_U57_RG4 >,T5[-_P 8M?\ 55?_ "G4
M?\8M?]55_P#*=0!XS7V9^PS_ ,U!_P"X=_[<UXS_ ,8M?]55_P#*=7IOPK^,
MWP)^$']K_P#",Z?X]N_[6,/G_P!HQ63[?*W[=NR1,?ZQLYST'2@#[EHKDO ?
MC+2_'W@73_&&B6]U#8:@9#''=HJRKLE:,[@K,.J'&">,5UM !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?\ R;)XN_[<_P#T
MLAK\SJ_3']J/_DV3Q=_VY_\ I9#7YG4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!^F/[+G_)LGA'_ +?/_2R:
MO9Z\8_9<_P"39/"/_;Y_Z635[/0 4444 %%%% !1110 4444 %%%% !1110
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M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\
MQ='_  MCXI?]%+\5?^#FY_\ BZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8
M^*7_ $4OQ5_X.;G_ .+KBZ* .T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ
M5_X.;G_XNN+HH [3_A;'Q2_Z*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^
M+KBZ* .T_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH
M[3_A;'Q2_P"BE^*O_!S<_P#Q='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?
M%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\
MP<W/_P 71_PMCXI?]%+\5?\ @YN?_BZXNB@#M/\ A;'Q2_Z*7XJ_\'-S_P#%
MU^@_[/&K:IKG[/?A?5-8U.ZU._G^U>9=7DS32R8NIE&YV))P  ,GH *_,2OT
MQ_9<_P"39/"/_;Y_Z634 >ST444 %%%% !1110 4444 %%%% !1110 4444
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M =I_9_PL_P"AR\5?^$S;?_)]']G_  L_Z'+Q5_X3-M_\GUQ=% ':?V?\+/\
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M_"3TK_Y&H XNBNT_X67XB_Z!OA7_ ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\
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MX5_\)/2O_D:C_A9?B+_H&^%?_"3TK_Y&H XNBNT_X67XB_Z!OA7_ ,)/2O\
MY&H_X67XB_Z!OA7_ ,)/2O\ Y&H XNBNT_X67XB_Z!OA7_PD]*_^1J/^%E^(
MO^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\ PD]*_P#D:C_A9?B+_H&^%?\
MPD]*_P#D:@#BZ*[3_A9?B+_H&^%?_"3TK_Y&H_X67XB_Z!OA7_PD]*_^1J .
M+HKM/^%E^(O^@;X5_P#"3TK_ .1J/^%E^(O^@;X5_P#"3TK_ .1J .+HKM/^
M%E^(O^@;X5_\)/2O_D:C_A9?B+_H&^%?_"3TK_Y&H XNBNT_X67XB_Z!OA7_
M ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\ Y&H XNBNT_X67XB_Z!OA7_PD]*_^
M1J/^%E^(O^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\ PD]*_P#D:C_A9?B+
M_H&^%?\ PD]*_P#D:@#BZ*[3_A9?B+_H&^%?_"3TK_Y&H_X67XB_Z!OA7_PD
M]*_^1J .+HKM/^%E^(O^@;X5_P#"3TK_ .1J/^%E^(O^@;X5_P#"3TK_ .1J
M .+HKM/^%E^(O^@;X5_\)/2O_D:C_A9?B+_H&^%?_"3TK_Y&H XNBNT_X67X
MB_Z!OA7_ ,)/2O\ Y&H_X67XB_Z!OA7_ ,)/2O\ Y&H XNBNT_X67XB_Z!OA
M7_PD]*_^1J/^%E^(O^@;X5_\)/2O_D:@#BZ*[3_A9?B+_H&^%?\ PD]*_P#D
M:C_A9?B+_H&^%?\ PD]*_P#D:@#BZ*[3_A9?B+_H&^%?_"3TK_Y&H_X67XB_
MZ!OA7_PD]*_^1J .+HKM/^%E^(O^@;X5_P#"3TK_ .1J/^%E^(O^@;X5_P#"
M3TK_ .1J .+HKM/^%E^(O^@;X5_\)/2O_D:OT%^'OP[^'^M?##PGK6J?#WPO
M<W^H:3:75S*=%M5\R5X49VPL8 R23@ "@#\^_A3_ ,EO\!_]C!8?^E*5^L=<
M7:_#/X=V-]#?6/@'PW:W5M(LT$T.DVZ21.IRK*P3(((!!'(-=I0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'C'[4?_)LGB[_MS_\ 2R&O
MS.K]2/CQH'_"3? [Q#H?]M:5HGVG[-_IVKW/V>UBVW,3_/)@[<[=HXY) [U\
M/?\ "@O^JT_"K_PH_P#[70!XQ17L_P#PH+_JM/PJ_P#"C_\ M='_  H+_JM/
MPJ_\*/\ ^UT >,45[/\ \*"_ZK3\*O\ PH__ +71_P *"_ZK3\*O_"C_ /M=
M 'C%%>S_ /"@O^JT_"K_ ,*/_P"UT?\ "@O^JT_"K_PH_P#[70!XQ17L_P#P
MH+_JM/PJ_P#"C_\ M='_  H+_JM/PJ_\*/\ ^UT >,45[/\ \*"_ZK3\*O\
MPH__ +71_P *"_ZK3\*O_"C_ /M= 'C%%>S_ /"@O^JT_"K_ ,*/_P"UT?\
M"@O^JT_"K_PH_P#[70!XQ17L_P#PH+_JM/PJ_P#"C_\ M='_  H+_JM/PJ_\
M*/\ ^UT >,45[/\ \*"_ZK3\*O\ PH__ +71_P *"_ZK3\*O_"C_ /M= 'C%
M%>S_ /"@O^JT_"K_ ,*/_P"UT?\ "@O^JT_"K_PH_P#[70!XQ17L_P#PH+_J
MM/PJ_P#"C_\ M='_  H+_JM/PJ_\*/\ ^UT >,45[/\ \*"_ZK3\*O\ PH__
M +71_P *"_ZK3\*O_"C_ /M= 'C%%>S_ /"@O^JT_"K_ ,*/_P"UT?\ "@O^
MJT_"K_PH_P#[70!XQ17L_P#PH+_JM/PJ_P#"C_\ M='_  H+_JM/PJ_\*/\
M^UT >,45[/\ \*"_ZK3\*O\ PH__ +71_P *"_ZK3\*O_"C_ /M= 'C%%>S_
M /"@O^JT_"K_ ,*/_P"UT?\ "@O^JT_"K_PH_P#[70!XQ17L_P#PH+_JM/PJ
M_P#"C_\ M='_  H+_JM/PJ_\*/\ ^UT >,45[/\ \*"_ZK3\*O\ PH__ +71
M_P *"_ZK3\*O_"C_ /M= 'C%%>S_ /"@O^JT_"K_ ,*/_P"UT?\ "@O^JT_"
MK_PH_P#[70!XQ17L_P#PH+_JM/PJ_P#"C_\ M='_  H+_JM/PJ_\*/\ ^UT
M>,45[/\ \*"_ZK3\*O\ PH__ +71_P *"_ZK3\*O_"C_ /M= 'C%%>S_ /"@
MO^JT_"K_ ,*/_P"UT?\ "@O^JT_"K_PH_P#[70!XQ17L_P#PH+_JM/PJ_P#"
MC_\ M='_  H+_JM/PJ_\*/\ ^UT >,45[/\ \*"_ZK3\*O\ PH__ +71_P *
M"_ZK3\*O_"C_ /M= 'C%%>S_ /"@O^JT_"K_ ,*/_P"UT?\ "@O^JT_"K_PH
M_P#[70!XQ17L_P#PH+_JM/PJ_P#"C_\ M='_  H+_JM/PJ_\*/\ ^UT >,45
M[/\ \*"_ZK3\*O\ PH__ +71_P *"_ZK3\*O_"C_ /M= 'C%%>S_ /"@O^JT
M_"K_ ,*/_P"UT?\ "@O^JT_"K_PH_P#[70!XQ17L_P#PH+_JM/PJ_P#"C_\
MM='_  H+_JM/PJ_\*/\ ^UT >,45[/\ \*"_ZK3\*O\ PH__ +71_P *"_ZK
M3\*O_"C_ /M= 'C%%>S_ /"@O^JT_"K_ ,*/_P"UT?\ "@O^JT_"K_PH_P#[
M70!XQ17L_P#PH+_JM/PJ_P#"C_\ M='_  H+_JM/PJ_\*/\ ^UT >,45[/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]F*_&>OV8H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \B_:,NX=/_ &>_
M$]Y>:7::M#']EW6EVTJQ29NH0-QB='X)R,,.0,Y&0?SW_P"$R\._]$G\*_\
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M,O#O_1)_"O\ X$ZK_P#)M'_"9>'?^B3^%?\ P)U7_P"3:XRB@#L_^$R\._\
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M_P#H1O\ RIWG_P >KV>B@#QC_AESX%_]"-_Y4[S_ ./5[/110 4444 %%%%
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MIXB_Z"7A7_PK-*_^2:/^%:>(O^@EX5_\*S2O_DFN+HH [3_A6GB+_H)>%?\
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M2O\ Y)KBZ* .T_X5IXB_Z"7A7_PK-*_^2:/^%:>(O^@EX5_\*S2O_DFN+HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=?\ R[KS_P")H \9HKV;_A8?P)_Z-U_\NZ\_^)H_X6'\"?\ HW7_ ,NZ\_\
MB: /&:*]F_X6'\"?^C=?_+NO/_B:/^%A_ G_ *-U_P#+NO/_ (F@#QFBO9O^
M%A_ G_HW7_R[KS_XFC_A8?P)_P"C=?\ R[KS_P")H \9HKV;_A8?P)_Z-U_\
MNZ\_^)H_X6'\"?\ HW7_ ,NZ\_\ B: /&:*]F_X6'\"?^C=?_+NO/_B:/^%A
M_ G_ *-U_P#+NO/_ (F@#QFBO9O^%A_ G_HW7_R[KS_XFC_A8?P)_P"C=?\
MR[KS_P")H \9HKV;_A8?P)_Z-U_\NZ\_^)H_X6'\"?\ HW7_ ,NZ\_\ B: /
M&:*]F_X6'\"?^C=?_+NO/_B:/^%A_ G_ *-U_P#+NO/_ (F@#QFBO9O^%A_
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M;_TS3;CRO?.>V.0#VBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \8_:C_Y-D\7?]N?_ *60U^9U?IW^T/I.J:Y^SWXH
MTO1],NM3OY_LOEVMG"TTLF+J%CM102< $G Z FOSX_X5/\4O^B:>*O\ P37/
M_P 10!Q=%=I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\ Q% '
M%T5VG_"I_BE_T33Q5_X)KG_XBC_A4_Q2_P"B:>*O_!-<_P#Q% '%T5VG_"I_
MBE_T33Q5_P"":Y_^(H_X5/\ %+_HFGBK_P $US_\10!Q=%=I_P *G^*7_1-/
M%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y
M_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$4 <717:?\*G^*7_1-/%7_@FN?_B*/^%3
M_%+_ *)IXJ_\$US_ /$4 <717:?\*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:
M>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$U
MS_\ $4 <717:?\*G^*7_ $33Q5_X)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,10
M!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!Q=%=I_PJ
M?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4 <717:?\ "I_BE_T3
M3Q5_X)KG_P"(H_X5/\4O^B:>*O\ P37/_P 10!Q=%=I_PJ?XI?\ 1-/%7_@F
MN?\ XBC_ (5/\4O^B:>*O_!-<_\ Q% '%T5VG_"I_BE_T33Q5_X)KG_XBC_A
M4_Q2_P"B:>*O_!-<_P#Q% '%T5VG_"I_BE_T33Q5_P"":Y_^(H_X5/\ %+_H
MFGBK_P $US_\10!Q=%=I_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!
M-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$
M4 <717:?\*G^*7_1-/%7_@FN?_B*/^%3_%+_ *)IXJ_\$US_ /$4 <717:?\
M*G^*7_1-/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]
M$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$US_\ $4 <717:?\*G^*7_ $33Q5_X
M)KG_ .(H_P"%3_%+_HFGBK_P37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_
MX5/\4O\ HFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_
MZ)IXJ_\ !-<__$4 <717:?\ "I_BE_T33Q5_X)KG_P"(H_X5/\4O^B:>*O\
MP37/_P 10!Q=%=I_PJ?XI?\ 1-/%7_@FN?\ XBC_ (5/\4O^B:>*O_!-<_\
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MV3Q=_P!N?_I9#7YG5^F/[4?_ ";)XN_[<_\ TLAK\SJ "BBB@ HHHH ****
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M\9HH ]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.KQFB@#V;_C%K_JJO_E.H_P",6O\
MJJO_ )3J\9HH ]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.KQFB@#V;_C%K_JJO_E.H
M_P",6O\ JJO_ )3J\9HH ]F_XQ:_ZJK_ .4ZC_C%K_JJO_E.KQFB@#V;_C%K
M_JJO_E.H_P",6O\ JJO_ )3J\9HH ]F_XQ:_ZJK_ .4ZOH3P_P#M8_"7PUX7
MTK0;/1?%TEII5G#90O-;VID9(T"*6(F )PHS@ 9["OA6B@#[_P#^&U?A;_T
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M_P 71_PMCXI?]%+\5?\ @YN?_BZ .+HKM/\ A;'Q2_Z*7XJ_\'-S_P#%T?\
M"V/BE_T4OQ5_X.;G_P"+H XNBNT_X6Q\4O\ HI?BK_P<W/\ \71_PMCXI?\
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MJ_\ !S<__%T?\+8^*7_12_%7_@YN?_BZ .+HKM/^%L?%+_HI?BK_ ,'-S_\
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M4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\
M*)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_
MPPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\
M=%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_
M "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F
M?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_
M '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'
M_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?
M9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG
M_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!5
M1_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG1
M7V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9T5]F?\,,?]51_P#*
M)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\ RB?_ '11_P ,,?\
M54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_ %5'_P HG_W10!\9
MT5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?&=%?9G_##'_54?\
MRB?_ '11_P ,,?\ 54?_ "B?_=% 'QG17V9_PPQ_U5'_ ,HG_P!T4?\ ##'_
M %5'_P HG_W10!\9T5]F?\,,?]51_P#*)_\ =%'_  PQ_P!51_\ *)_]T4 ?
M&=%?9G_##'_54?\ RB?_ '11_P ,,?\ 54?_ "B?_=% 'QG7Z8_LN?\ )LGA
M'_M\_P#2R:O&O^&&/^JH_P#E$_\ NBOI/X9^!F^&OPPTCP6NJ?VK_9WG?Z7Y
M'D^9YDSR_<W-C&_'4],^U '<T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'7_H>O\ RF6?_P 9H _3&BOS._X:C^.O_0]?^4RS_P#C-'_#4?QU_P"AZ_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /&/VH_\
MDV3Q=_VY_P#I9#7YG5^JGQD\&ZK\0?A!K?A'19K:WO[_ ,CRI+QV6)=D\<AW
M%58]$., \XKY%_X8K^*7_0?\*_\ @5<__&* /F6BOIK_ (8K^*7_ $'_  K_
M .!5S_\ &*/^&*_BE_T'_"O_ (%7/_QB@#YEHKZ:_P"&*_BE_P!!_P *_P#@
M5<__ !BC_ABOXI?]!_PK_P"!5S_\8H ^9:*^FO\ ABOXI?\ 0?\ "O\ X%7/
M_P 8H_X8K^*7_0?\*_\ @5<__&* /F6BOIK_ (8K^*7_ $'_  K_ .!5S_\
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M_P"&*_BE_P!!_P *_P#@5<__ !BC_ABOXI?]!_PK_P"!5S_\8H ^9:*^FO\
MABOXI?\ 0?\ "O\ X%7/_P 8H_X8K^*7_0?\*_\ @5<__&* /F6BOIK_ (8K
M^*7_ $'_  K_ .!5S_\ &*/^&*_BE_T'_"O_ (%7/_QB@#YEHKZ:_P"&*_BE
M_P!!_P *_P#@5<__ !BC_ABOXI?]!_PK_P"!5S_\8H ^9:*^FO\ ABOXI?\
M0?\ "O\ X%7/_P 8H_X8K^*7_0?\*_\ @5<__&* /F6BOIK_ (8K^*7_ $'_
M  K_ .!5S_\ &*/^&*_BE_T'_"O_ (%7/_QB@#YEHKZ:_P"&*_BE_P!!_P *
M_P#@5<__ !BC_ABOXI?]!_PK_P"!5S_\8H ^E_V7/^39/"/_ &^?^EDU>SUY
MW\&_!NJ_#[X0:)X1UJ:VN+^P\_S9+-V:)M\\D@VEE4]'&<@<YKT2@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLRBOC/\ X;G_ .J7?^5O_P"YZ/\ AN?_ *I=_P"5O_[GH ^S**^,_P#AN?\
MZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>@#[,HKXS_ .&Y_P#JEW_E;_\ N>C_
M (;G_P"J7?\ E;_^YZ /LRBOC/\ X;G_ .J7?^5O_P"YZ/\ AN?_ *I=_P"5
MO_[GH ^S**^,_P#AN?\ ZI=_Y6__ +GH_P"&Y_\ JEW_ )6__N>@#[,K'UGP
M_H/B*S6R\0:'I^KVJMO$-];).@;UVN",U\E_\-S_ /5+O_*W_P#<]'_#<_\
MU2[_ ,K?_P!ST ?7&DZ/I&@Z<FGZ)I=IIEDA)6WLX%AC4GKA5  K4KXS_P"&
MY_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C
M_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>
M@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\
MJEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?
M_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,
MHKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_
M )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW
M_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS
M_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6_
M_N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_
M /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&
MY_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C
M_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>
M@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\
MJEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?
M_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,
MHKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_
M )6__N>C_AN?_JEW_E;_ /N>@#[,HKXS_P"&Y_\ JEW_ )6__N>C_AN?_JEW
M_E;_ /N>@#[,HKYF^%_[5'_"QOB;I'@K_A!?[+_M'SO]+_M/SO+\N%Y?N>2N
M<[,=1US[5],T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?C/17:?\*G^
M*7_1-/%7_@FN?_B*/^%3_%+_ *)IXJ_\$US_ /$4 <717:?\*G^*7_1-/%7_
M ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\
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M (BC_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\
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MUS_\10!Q=%=I_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !%
M'%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\ A4_Q2_Z)IXJ_\$US_P#$4 <717:?
M\*G^*7_1-/%7_@FN?_B*/^%3_%+_ *)IXJ_\$US_ /$4 <717:?\*G^*7_1-
M/%7_ ()KG_XBC_A4_P 4O^B:>*O_  37/_Q% '%T5VG_  J?XI?]$T\5?^":
MY_\ B*/^%3_%+_HFGBK_ ,$US_\ $4 <717:?\*G^*7_ $33Q5_X)KG_ .(H
M_P"%3_%+_HFGBK_P37/_ ,10!Q=%=I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\
MHFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\
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M  37/_Q% '%T5VG_  J?XI?]$T\5?^":Y_\ B*/^%3_%+_HFGBK_ ,$US_\
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M (NC_A;'Q2_Z*7XJ_P#!S<__ !=<710!VG_"V/BE_P!%+\5?^#FY_P#BZ/\
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M_P"#FY_^+H_X6Q\4O^BE^*O_  <W/_Q=<710!VG_  MCXI?]%+\5?^#FY_\
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M?]%+\5?^#FY_^+H_X6Q\4O\ HI?BK_P<W/\ \77%T4 =I_PMCXI?]%+\5?\
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MO_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\
MY/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .
MT_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]
M#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"
M9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H
M_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\
M0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9
MMO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KB
MZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_
MX6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ
M_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_
M )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X
M6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*
MO_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\
MY/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .
MT_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]
M#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"
M9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H
M_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\
M0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9
MMO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KB
MZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_
MX6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ
M_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_
M )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X
M6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*
MO_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\
MY/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .
MT_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]
M#EXJ_P#"9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"
M9MO_ )/H_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H
M_L_X6?\ 0Y>*O_"9MO\ Y/KBZ* .T_L_X6?]#EXJ_P#"9MO_ )/H_L_X6?\
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MCK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#QBBO9_P#AJ/XZ_P#0]?\
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MCK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#QBBO9_P#AJ/XZ_P#0]?\
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MCK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#QBBO9_P#AJ/XZ_P#0]?\
ME,L__C-'_#4?QU_Z'K_RF6?_ ,9H \8HKV?_ (:C^.O_ $/7_E,L_P#XS1_P
MU'\=?^AZ_P#*99__ !F@#QBBO9_^&H_CK_T/7_E,L_\ XS1_PU'\=?\ H>O_
M "F6?_QF@#QBBO9_^&H_CK_T/7_E,L__ (S1_P -1_'7_H>O_*99_P#QF@#Q
MBOTQ_9<_Y-D\(_\ ;Y_Z635\:_\ #4?QU_Z'K_RF6?\ \9KTOX%_'7XJ>-/C
MCX=\,^)O%1O])N_M/G6_V&VCW[+:5U^9(PPPRJ>#VH ^YJ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _&>BNS_ .$-\._]%8\*_P#@-JO_ ,A4?\(;X=_Z
M*QX5_P# ;5?_ )"H XRBNS_X0WP[_P!%8\*_^ VJ_P#R%1_PAOAW_HK'A7_P
M&U7_ .0J .,HKL_^$-\._P#16/"O_@-JO_R%1_PAOAW_ **QX5_\!M5_^0J
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ML>%?_ ;5?_D*@#C**[/_ (0WP[_T5CPK_P" VJ__ "%1_P (;X=_Z*QX5_\
M ;5?_D*@#C**[/\ X0WP[_T5CPK_ . VJ_\ R%1_PAOAW_HK'A7_ ,!M5_\
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M^@_X5_\  JY_^,4?\,5_%+_H/^%?_ JY_P#C% 'S+17TU_PQ7\4O^@_X5_\
M JY_^,4?\,5_%+_H/^%?_ JY_P#C% 'S+17TU_PQ7\4O^@_X5_\  JY_^,4?
M\,5_%+_H/^%?_ JY_P#C% 'S+17TU_PQ7\4O^@_X5_\  JY_^,4?\,5_%+_H
M/^%?_ JY_P#C% 'S+7L_[+?_ "<WX1_[?/\ TCFKL_\ ABOXI?\ 0?\ "O\
MX%7/_P 8KO?@_P#LR^/?A[\7=#\8:UJV@W%A8>?YL=G<3-*V^"2,;0T*CJXS
MDCC- 'V#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XST444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ?3/_"I_A9_T33PK_P"":V_^(H_X5/\ "S_HFGA7_P $UM_\17S-_P -S_\
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MS_HFGA7_ ,$UM_\ $5\S?\-S_P#5+O\ RM__ '/1_P -S_\ 5+O_ "M__<]
M'TS_ ,*G^%G_ $33PK_X)K;_ .(H_P"%3_"S_HFGA7_P36W_ ,17S-_PW/\
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M*G^%G_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_  36W_Q%?,W_  W/_P!4N_\
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M7/\ \10!Q=%=I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4
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M?]$T\5?^":Y_^(H_X5/\4O\ HFGBK_P37/\ \10!Q=%=I_PJ?XI?]$T\5?\
M@FN?_B*/^%3_ !2_Z)IXJ_\ !-<__$4 <77V9^PS_P U!_[AW_MS7S/_ ,*G
M^*7_ $33Q5_X)KG_ .(KZR_8[\)^*O"Y\;?\))X9U71/M/V'R?[0LY+?S=OV
MC=MWJ-V-RYQTR/6@#ZRHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC;SUZXFL;S19/B]>VZ^)M6/B#^R8Y)M >9VLH(BP_?*-FSS,_*2&)QVKR/\
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M)<'><,KAL#L!S3I-2LK[]KCX?3ZU?_9=6E\.K+=P#4)$$5VZ$B'9OPN>#Y8
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M=%':B@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<SXL\-V_BKPEJ?AFZOKNTMM3A-O--:,@E"-]X*75E&1D=.A.,'FD\)^&H?"/
MA2P\,VVHWFH6NG0BW@EO/+,HC7A5)C1 <# !QGCDD\UT])WI;7\P[>0M%%%,
M HHHH **** "BO.O&7QD^'7P]UN'0_%WB+^S+^:!;J.+['<3;HBS*&S'&PZH
MPQG/%<[_ ,-1? K_ *'K_P IEY_\9H ]GHKQC_AJ+X%?]#U_Y3+S_P",T?\
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MBBB@#\9Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "NU^%/\ R6_P
M'_V,%A_Z4I7%5VOPI_Y+?X#_ .Q@L/\ TI2@#V7]M3_DMNC?]B_#_P"E-Q7S
M+7TU^VI_R6W1O^Q?A_\ 2FXKYEH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OIG]G'_DB'Q\_[%\?^DU[7S-7TS^SC_P D0^/G_8OC_P!)KV@#YFHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]G_9;_Y.
M;\(_]OG_ *1S5XQ7L_[+?_)S?A'_ +?/_2.:@#],:*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _&>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M44 <_7V9^PS_ ,U!_P"X=_[<T?\ ##'_ %5'_P HG_W17LGP-^!O_"F&U_\
MXJC^W?[7^S_\N7V;R?*\W_IH^[/F^V,=\\ 'M%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?C/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445MZ+X>USQ+?/8>'=#
MO]8NHXS,T-A;/<2*@(!8J@) RRC/3)'K0!B45VG_  J?XI?]$T\5?^":Y_\
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M (BC_A4_Q2_Z)IXJ_P#!-<__ !% '%T5VG_"I_BE_P!$T\5?^":Y_P#B*/\
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MUS_\10!Q=%=I_P *G^*7_1-/%7_@FN?_ (BC_A4_Q2_Z)IXJ_P#!-<__ !%
M'%UVOPI_Y+?X#_[&"P_]*4I/^%3_ !2_Z)IXJ_\ !-<__$5V'PW^&?Q&L/BS
MX,OKWX?^([6VMM:LIIIIM)N$CB1;A"S,Q3   ))/ % 'Z:4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?C/1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]-?L
M5_\ );=9_P"Q?F_]*;>OF6OIK]BO_DMNL_\ 8OS?^E-O0!]_4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'C'_#+GP+_ .A&_P#*G>?_ !ZC_AESX%_]
M"-_Y4[S_ ./5\T?\-J?%+_H >%?_  %N?_C]'_#:GQ2_Z 'A7_P%N?\ X_0!
M]+_\,N? O_H1O_*G>?\ QZC_ (9<^!?_ $(W_E3O/_CU?-'_  VI\4O^@!X5
M_P# 6Y_^/T?\-J?%+_H >%?_  %N?_C] 'TO_P ,N? O_H1O_*G>?_'J/^&7
M/@7_ -"-_P"5.\_^/5\T?\-J?%+_ * 'A7_P%N?_ (_1_P -J?%+_H >%?\
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M\"_^A&_\J=Y_\>H_X9<^!?\ T(W_ )4[S_X]7S1_PVI\4O\ H >%?_ 6Y_\
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M,N? O_H1O_*G>?\ QZC_ (9<^!?_ $(W_E3O/_CU?-'_  VI\4O^@!X5_P#
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MI\4O^@!X5_\  6Y_^/T ??U%? /_  VI\4O^@!X5_P# 6Y_^/T?\-J?%+_H
M>%?_  %N?_C] 'W]17P#_P -J?%+_H >%?\ P%N?_C]'_#:GQ2_Z 'A7_P !
M;G_X_0!]_45\ _\ #:GQ2_Z 'A7_ ,!;G_X_7OO[.?QH\4_%S_A)_P#A)K#2
MK3^R/LOD_P!GQ2)N\WSMV[?(^?\ 5KC&.IZT ?0-%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XST5[/_ ,,N?'7_ *$7
M_P J=G_\>H_X9<^.O_0B_P#E3L__ (]0!XQ17L__  RY\=?^A%_\J=G_ /'J
M/^&7/CK_ -"+_P"5.S_^/4 >,45[/_PRY\=?^A%_\J=G_P#'J/\ AESXZ_\
M0B_^5.S_ /CU 'C%%>S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(O_E3L_\
MX]0!XQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\ CU 'C%%>
MS_\ #+GQU_Z$7_RIV?\ \>H_X9<^.O\ T(O_ )4[/_X]0!XQ17L__#+GQU_Z
M$7_RIV?_ ,>H_P"&7/CK_P!"+_Y4[/\ ^/4 >,45[/\ \,N?'7_H1?\ RIV?
M_P >H_X9<^.O_0B_^5.S_P#CU 'C%%>S_P##+GQU_P"A%_\ *G9__'J/^&7/
MCK_T(O\ Y4[/_P"/4 >,45[/_P ,N?'7_H1?_*G9_P#QZC_AESXZ_P#0B_\
ME3L__CU 'C%%>S_\,N?'7_H1?_*G9_\ QZC_ (9<^.O_ $(O_E3L_P#X]0!X
MQ17L_P#PRY\=?^A%_P#*G9__ !ZC_AESXZ_]"+_Y4[/_ ./4 >,45[/_ ,,N
M?'7_ *$7_P J=G_\>H_X9<^.O_0B_P#E3L__ (]0!XQ17L__  RY\=?^A%_\
MJ=G_ /'J/^&7/CK_ -"+_P"5.S_^/4 >,45[/_PRY\=?^A%_\J=G_P#'J/\
MAESXZ_\ 0B_^5.S_ /CU 'C%%>S_ /#+GQU_Z$7_ ,J=G_\ 'J/^&7/CK_T(
MO_E3L_\ X]0!XQ17L_\ PRY\=?\ H1?_ "IV?_QZC_AESXZ_]"+_ .5.S_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'(W*P)R#@MK]PNGW_@?<-)7P_JS:TMEX@\[?_P +ED\9*+# _P!-%KP4\O\
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M8Y&C9E]5)4X/<8-8WC;QPOA&[T+3;>S2]U77[S[%8P3W'V>+?M+%I)-K%5'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %>??$[X?P_$CPI!H5U=PP0Q727+)<6IGBFV
M@C:P5XY%Z]8Y$;MD@D'T&CBEN-.QY!\,/@OH7PVUF^UK3VMUO+NW6U:.QBGB
M@"!MV=L\\[;B<#._&!P!DD^O<444VV]R4K"T444#"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9\,? WBSX=OJOA^:[TS4/#MQJ$U]:WGFRB[02$$QO&5VGG^/S/\ @)SQPR?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \8_:C_Y-D\7?]N?_I9#7YG5^F/[4?\ R;)XN_[<_P#T
MLAK\SJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K]F*_&>OV8H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /(_P!HJ73(OV>_$\FM6=W>V ^R^;!9W*V\K_Z5#C;(
MT<@7!P3E#D CC.1^>_\ :'PL_P"A-\5?^%-;?_(%??O[4?\ R;)XN_[<_P#T
MLAK\SJ .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .
MT_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]
M";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"
MFMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H
M_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\
M0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"F
MMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KB
MZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#
MX6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ
M_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_
M ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X
M6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*
MO_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\
MY KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .
MT_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]
M";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"
MFMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H
M_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\
M0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"F
MMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KB
MZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#
MX6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ
M_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_
M ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X
M6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*
MO_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\
MY KBZ* .T_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .
MT_M#X6?]";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]
M";XJ_P#"FMO_ ) H_M#X6?\ 0F^*O_"FMO\ Y KBZ* .T_M#X6?]";XJ_P#"
MFMO_ ) KV7X'?!_X6_&;^WO]%\5:$-(^S_\ ,8MKGSO-\W_IT3;CRO?.>V.?
MF:OLS]AG_FH/_<._]N: .S_X8J^%O_0?\5?^!5M_\8KZ9HHH **** "BBB@
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M (BC_A4_Q2_Z)IXJ_P#!-<__ !%<710!VG_"I_BE_P!$T\5?^":Y_P#B*/\
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M_P"%3_%+_HFGBK_P37/_ ,17%T4 =I_PJ?XI?]$T\5?^":Y_^(H_X5/\4O\
MHFGBK_P37/\ \17%T4 =I_PJ?XI?]$T\5?\ @FN?_B*/^%3_ !2_Z)IXJ_\
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MBKPN?&W_  DGAG5=$^T_8?)_M"SDM_-V_:-VW>HW8W+G'3(]:^&:^_OV*O\
MDB.L_P#8P3?^DUO0!]-4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW_&+7_55?_*=1_P 8M?\
M55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW_&+7_55?_*=1
M_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW_&+7
M_55?_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS
M17LW_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55
M?_*=0!XS17LW_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU
M'_&+7_55?_*=0!XS17LW_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_
MU57_ ,IU'_&+7_55?_*=0!XS17LW_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,T
M5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW_&+7_55?_*=1_P 8M?\ 55?_
M "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW_&+7_55?_*=1_P 8
MM?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW_&+7_55?
M_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=0!XS17LW
M_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+7_55?_*=
M0!XS17LW_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,T5[-_QBU_U57_ ,IU'_&+
M7_55?_*=0!XS17LW_&+7_55?_*=1_P 8M?\ 55?_ "G4 >,U]_?L5?\ )$=9
M_P"Q@F_])K>OF?\ XQ:_ZJK_ .4ZO7_AG^T!\$_A3X:N?#OA_3?'-U:7-XUZ
MSWL-F\F]D1" 4E48Q&O;.<\T ?:=%?,W_#:OPM_Z 'BK_P !;;_X_1_PVK\+
M?^@!XJ_\!;;_ ./T ?3-%>?_  R^)^@_%3PQ<^(/#MGJ%M:6]XUFZ7T:)(75
M$<D!'88Q(O?.<\5Z!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!XQ^U'_P FR>+O^W/_ -+(:_,ZOTQ_:C_Y-D\7?]N?_I9#7YG4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ,'-S_\ %T?\+8^*7_12_%7_ (.;G_XNN+HH [3_ (6Q\4O^BE^*O_!S<_\
MQ='_  MCXI?]%+\5?^#FY_\ BZXNB@#M/^%L?%+_ **7XJ_\'-S_ /%T?\+8
M^*7_ $4OQ5_X.;G_ .+KBZ* .T_X6Q\4O^BE^*O_  <W/_Q='_"V/BE_T4OQ
M5_X.;G_XNN+HH [3_A;'Q2_Z*7XJ_P#!S<__ !='_"V/BE_T4OQ5_P"#FY_^
M+KBZ* .T_P"%L?%+_HI?BK_P<W/_ ,71_P +8^*7_12_%7_@YN?_ (NN+HH
M[3_A;'Q2_P"BE^*O_!S<_P#Q='_"V/BE_P!%+\5?^#FY_P#BZXNB@#M/^%L?
M%+_HI?BK_P '-S_\71_PMCXI?]%+\5?^#FY_^+KBZ* .T_X6Q\4O^BE^*O\
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MBO\ RT;S_P"*H_X5Y\"?^CBO_+1O/_BJ\9HH ]F_X5Y\"?\ HXK_ ,M&\_\
MBJ/^%>? G_HXK_RT;S_XJO&:* /9O^%>? G_ *.*_P#+1O/_ (JC_A7GP)_Z
M.*_\M&\_^*KQFB@#V;_A7GP)_P"CBO\ RT;S_P"*H_X5Y\"?^CBO_+1O/_BJ
M\9HH ]F_X5Y\"?\ HXK_ ,M&\_\ BJ/^%>? G_HXK_RT;S_XJO&:* /9O^%>
M? G_ *.*_P#+1O/_ (JC_A7GP)_Z.*_\M&\_^*KQFB@#V;_A7GP)_P"CBO\
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M_P"*H_X5Y\"?^CBO_+1O/_BJ\9HH ]F_X5Y\"?\ HXK_ ,M&\_\ BJ/^%>?
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MV;_A7GP)_P"CBO\ RT;S_P"*H_X5Y\"?^CBO_+1O/_BJ\9HH ]F_X5Y\"?\
MHXK_ ,M&\_\ BJ/^%>? G_HXK_RT;S_XJO&:* /HWP;\ _AO\0-=ET3P?\</
M[3OX;=KJ2+_A&;B+;$&52V9)%'5U&,YYKO\ _AAC_JJ/_E$_^Z*XW]BO_DMN
ML_\ 8OS?^E-O7W]0!\9_\,,?]51_\HG_ -T4?\,,?]51_P#*)_\ =%?9E% '
MQG_PPQ_U5'_RB?\ W17V9110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!XQ^U'_R;)XN_P"W/_TLAK\SJ_8/5-*TW7-+FTO6=-M=
M2L)B/-M;N!9HI,,&&Y&!!P0",CJ :P?^%3_"S_HFGA7_ ,$UM_\ $4 ?DU17
MZR_\*G^%G_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_  36W_Q% 'Y-45^LO_"I
M_A9_T33PK_X)K;_XBC_A4_PL_P"B:>%?_!-;?_$4 ?DU17ZR_P#"I_A9_P!$
MT\*_^":V_P#B*/\ A4_PL_Z)IX5_\$UM_P#$4 ?DU17ZR_\ "I_A9_T33PK_
M .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\ $4 ?DU17ZR_\*G^%G_1-/"O_ ()K
M;_XBC_A4_P +/^B:>%?_  36W_Q% 'Y-45^LO_"I_A9_T33PK_X)K;_XBC_A
M4_PL_P"B:>%?_!-;?_$4 ?DU17ZR_P#"I_A9_P!$T\*_^":V_P#B*/\ A4_P
ML_Z)IX5_\$UM_P#$4 ?DU17ZR_\ "I_A9_T33PK_ .":V_\ B*/^%3_"S_HF
MGA7_ ,$UM_\ $4 ?DU17ZR_\*G^%G_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_
M  36W_Q% 'Y-45^LO_"I_A9_T33PK_X)K;_XBC_A4_PL_P"B:>%?_!-;?_$4
M ?DU17ZR_P#"I_A9_P!$T\*_^":V_P#B*/\ A4_PL_Z)IX5_\$UM_P#$4 ?D
MU17ZR_\ "I_A9_T33PK_ .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\ $4 ?DU17
MZR?\*G^%G_1-/"O_ ()K;_XBE_X5/\+/^B:>%?\ P36W_P 10!^35%?K+_PJ
M?X6?]$T\*_\ @FMO_B*/^%3_  L_Z)IX5_\ !-;?_$4 ?DU17ZR_\*G^%G_1
M-/"O_@FMO_B*/^%3_"S_ *)IX5_\$UM_\10!^35%?K+_ ,*G^%G_ $33PK_X
M)K;_ .(H_P"%3_"S_HFGA7_P36W_ ,10!^35%?K)_P *G^%G_1-/"O\ X)K;
M_P"(I?\ A4_PL_Z)IX5_\$UM_P#$4 ?DU17ZR_\ "I_A9_T33PK_ .":V_\
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M_P#"I_A9_P!$T\*_^":V_P#B*/\ A4_PL_Z)IX5_\$UM_P#$4 ?DU17ZR_\
M"I_A9_T33PK_ .":V_\ B*/^%3_"S_HFGA7_ ,$UM_\ $4 ?DU17ZR_\*G^%
MG_1-/"O_ ()K;_XBC_A4_P +/^B:>%?_  36W_Q% 'Y-45^LO_"I_A9_T33P
MK_X)K;_XBC_A4_PL_P"B:>%?_!-;?_$4 ?DU17ZR_P#"I_A9_P!$T\*_^":V
M_P#B*/\ A4_PL_Z)IX5_\$UM_P#$4 ?DU17ZR_\ "I_A9_T33PK_ .":V_\
MB*/^%3_"S_HFGA7_ ,$UM_\ $4 ?DU17ZR_\*G^%G_1-/"O_ ()K;_XBC_A4
M_P +/^B:>%?_  36W_Q% 'Y-45^LO_"I_A9_T33PK_X)K;_XBC_A4_PL_P"B
M:>%?_!-;?_$4 ?DU17ZR_P#"I_A9_P!$T\*_^":V_P#B*/\ A4_PL_Z)IX5_
M\$UM_P#$4 ?&G[%?_);=9_[%^;_TIMZ^_JYC1?!'@_PY?/?>'?".C:-=/&86
MGL-/BMY&0D$J6102,JIQTR!Z5T] !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% &#XBU9?#^@7VM/I]SJ$=
ME$9FM[3R_-9%Y8KYCHO R<%ATXR<"N-T'XP:/K.J>']/NM!UO1&\1VWVK29M
M1BA\J]7;OPK0RR!6V\[7VGD5O_$2_L]-^&7B2\U"\AM+==/F4RSR!%#,A51D
M\9+$ #N2!7D?PU\+S>(/ ?@#QQJWBR'6M/\ "VD^9I^FZ18JCQS^1M997,K^
M9(@^7: @W#D=123W;V5@MIZGT917R?\ #?QIJEQXW0V_C:Z:PU;PQ=W<$=_J
M4VI/#=1R @RA_D$RJ26BA1  ,8/!J/X>Z[JVM:E;ZQIOBZZOM4M?#4TG]E77
MBW[8=2U3:666.TCN&*IC.4D1=NX#RP5S1M]UP/K2N)\8>.(/!=M/?7?AO6]2
ML;2$7%Y=V$$;1VL><;FWNA?&"2(PY4#) R,^:_!NXU'4M;LM8?XIMKTEQ8%=
M3T+R;@R6LXP2\PFN9/L[ALKM1(U;LN!QM_&Z[T?4O"%]X<7QY'HFO)";FWTF
M"6"2;46 S'$]NRM)(C,N-JC!YSN Q0[JP+5GKMO<1W5K%<PMNCE0.AQU!&14
M]<3J=[XNA^$%UJ%I8JWBM-',JVT:Y N_)SM4=\/T'?I7D'@_Q%#>>)?"AT'Q
MMJ>K:;?:/<OXPCO]4F<::RQ@B5F9LV<GF%UVJ4&!D 8S3ZM=B4[I7ZGK>C>/
M]/U[Q*VDZ7H^M3V?FW%NNL+:JUBTL!VR)O#%E(8$ NJJQ!VDU2N/BGX=M=5F
MMI+/4WTRWU%=)GUM(XS90W9('E,=_F<,0I;84#'!;-<A^S>V@R>!=1?2-6>^
MN!J=V)XSJ4ER(D^T2&)O+9V";E.=P +]26ZUR^O>&9M2U+6OAKX%\50ZQINN
MZ^-2U:V2S,IT7$JR3A[H2;%)>/Y8BF_)ZX!-"^))]A]';HSZ@HH[44#"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHK/N[.UU"QGL[RVBN;6>-HI89D#I(A&"K*>""."#2>
MB O^])WS7QCX-T&&Z\(^#_\ A ?".H6WB^R\1SM<:O::;);P?8ENI-Z27158
MY5V!5";F.5Q@5[-I_P :+Z?P9K7C+5/!R:=I&FWDFFK"=3$MY/=K*L2QB,1^
M6 6;!;S3C!X(YIK5: ]'8]IH%>0:E\3KVR;Q+X;\7>!4&J6.BMJZV%K?)=V^
MH6GW)!YDB1@%3D,K+R.F[(!S9OC,=/TK2;+PG\/[K5)$T:SU&;3]/BN'6TCF
M3,<$7D6TB[@JG ?REP!@]0 #W+%)7F,OQ#UK4=6OM-\&^#9=7N-+MK6XU&"\
MO1831&==ZPHKHP:4)RP=HP.!NSTC\%^+/%^O?%/QOHFL:=80:3HDT$-N8;EF
ME0O$'&1Y0#;@V6.X;2 H##+46U%?2YWNL:7!K6AWVCW4DT=O>P/!(T$AC<*P
M(.UAR#SUKG]&\#)ILNGM?>)M8\01Z9AK&+4/LRK;,$*!AY,,9<[6(RY;KGKS
M7FOQP\"^$U\.W7B2;0K*ZU;4M<TWSKNYMXY)%3SH83&K%<A"J\KGG<V>M=+K
M3Z7\(=/>\\)>%]-MK?6+P&>W:Z33[6%Q%@%$CC=W9M@&R.-R3SP,FDK)<VVM
MAO5V^9ZU3<]*\57X[6TWAWP?JJ:-:6;>);:>=5U34Q:11M$P4PK*8RK2,<[0
MWE@@<D'BN2M_%3>%_P!I#Q=:6.F_:_$&O6NEK9Z9=:@R1M(5=Y?WQ5PBHNXX
M48.,*.:=GS6$]KGTS17-:U#XHU'P-?6VEW-KH_B.XLV6&57,\-M<%>"&* LH
M/<H#WV]J\D\"ZE8V7CFUT77/!<GA+X@I8SF*(S'[#KAVKOG\]0V]_D!+,#(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$0E!$@.;;YL@XYSCM@\UZ]14@>3:=\$]&TBTL%L?%GB.*_TZ[GO+/4A+;">
MSG,R8\CRW1VY*NC<],5?O/A?;W?BS2_$D?B_Q!;ZCIEM-;0R1FU8-YV3+(P>
M!LLQP>RC: H XKTJBF!Y5I/P5T/1]-\+V-OXDU]U\,7$\UC*T\*2!)AB2%F2
M)<H>>1AQDX8<8]5HHIWN 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486585392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>May 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGHTBRIDGE CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001084554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,434,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1975651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">11710 Plaza America Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Reston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">20190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">730-1200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LTBR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055575812896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 27,942,421<span></span>
</td>
<td class="nump">$ 28,598,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">401,859<span></span>
</td>
<td class="nump">207,063<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">28,344,280<span></span>
</td>
<td class="nump">28,805,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid project costs and other long-term assets</a></td>
<td class="nump">479,625<span></span>
</td>
<td class="nump">483,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Trademarks</a></td>
<td class="nump">108,865<span></span>
</td>
<td class="nump">108,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">28,932,770<span></span>
</td>
<td class="nump">29,397,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">907,421<span></span>
</td>
<td class="nump">486,326<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">907,421<span></span>
</td>
<td class="nump">486,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at March 31, 2024 and December 31, 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 25,000,000 authorized, 14,189,780 shares and 13,698,274 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively</a></td>
<td class="nump">14,190<span></span>
</td>
<td class="nump">13,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">183,228,519<span></span>
</td>
<td class="nump">181,295,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(155,217,360)<span></span>
</td>
<td class="num">(152,397,776)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">28,025,349<span></span>
</td>
<td class="nump">28,911,047<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 28,932,770<span></span>
</td>
<td class="nump">$ 29,397,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055597059568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Shares Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Shares Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">14,189,780<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">14,189,780<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486349520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,157,745<span></span>
</td>
<td class="nump">1,865,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,023,823<span></span>
</td>
<td class="nump">448,044<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">3,181,568<span></span>
</td>
<td class="nump">2,313,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OtherOperatingIncomeAbstract', window );"><strong>Other Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ContributedServicesResearchAndDevelopment', window );">Contributed services - research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,028<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Total Other Operating Income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,028<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="num">(3,181,568)<span></span>
</td>
<td class="num">(2,282,945)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">361,984<span></span>
</td>
<td class="nump">256,365<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Total Other Income</a></td>
<td class="nump">361,984<span></span>
</td>
<td class="nump">256,365<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Loss Before Income Taxes</a></td>
<td class="num">(2,819,584)<span></span>
</td>
<td class="num">(2,026,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (2,819,584)<span></span>
</td>
<td class="num">$ (2,026,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Net Loss Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_EarningsPerSharesBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Common Shares Outstanding</a></td>
<td class="nump">13,491,954<span></span>
</td>
<td class="nump">11,673,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ContributedServicesResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ContributedServicesResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_EarningsPerSharesBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_EarningsPerSharesBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OtherOperatingIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OtherOperatingIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055580057968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Common Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,217<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2022</a></td>
<td class="nump">$ 29,118,155<span></span>
</td>
<td class="nump">$ 173,595,385<span></span>
</td>
<td class="num">$ (144,489,130)<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares', window );">Shares issued - registered offerings - net of offering costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount', window );">Shares issued - registered offerings - net of offering costs, amount</a></td>
<td class="nump">731,052<span></span>
</td>
<td class="nump">730,882<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedToConsultantDirectorsForServicesShares', window );">Shares issued to consultant &amp; directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedToConsultantDirectorsForServicesAmount', window );">Shares issued to consultant &amp; directors for services, amount</a></td>
<td class="nump">215,000<span></span>
</td>
<td class="nump">214,944<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Stock-based compensation</a></td>
<td class="nump">284,360<span></span>
</td>
<td class="nump">284,360<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the three months ended March 31, 2023</a></td>
<td class="num">(2,026,580)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,026,580)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,126,030<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Mar. 31, 2023</a></td>
<td class="nump">28,321,987<span></span>
</td>
<td class="nump">174,825,571<span></span>
</td>
<td class="num">(146,515,710)<span></span>
</td>
<td class="nump">$ 12,126<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2023</a></td>
<td class="nump">28,911,047<span></span>
</td>
<td class="nump">181,295,125<span></span>
</td>
<td class="num">(152,397,776)<span></span>
</td>
<td class="nump">$ 13,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares', window );">Shares issued - registered offerings - net of offering costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount', window );">Shares issued - registered offerings - net of offering costs, amount</a></td>
<td class="nump">1,221,982<span></span>
</td>
<td class="nump">1,221,554<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedToConsultantDirectorsForServicesShares', window );">Shares issued to consultant &amp; directors for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesIssuedToConsultantDirectorsForServicesAmount', window );">Shares issued to consultant &amp; directors for services, amount</a></td>
<td class="nump">255,000<span></span>
</td>
<td class="nump">254,936<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Stock-based compensation</a></td>
<td class="nump">456,904<span></span>
</td>
<td class="nump">456,904<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the three months ended March 31, 2023</a></td>
<td class="num">(2,819,584)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,819,584)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,189,780<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Mar. 31, 2024</a></td>
<td class="nump">$ 28,025,349<span></span>
</td>
<td class="nump">$ 183,228,519<span></span>
</td>
<td class="num">$ (155,217,360)<span></span>
</td>
<td class="nump">$ 14,190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedToConsultantDirectorsForServicesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedToConsultantDirectorsForServicesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesIssuedToConsultantDirectorsForServicesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesIssuedToConsultantDirectorsForServicesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486454816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">$ (2,819,584)<span></span>
</td>
<td class="num">$ (2,026,580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">456,904<span></span>
</td>
<td class="nump">284,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(194,796)<span></span>
</td>
<td class="num">(278,173)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets', window );">Prepaid project costs and other long-term assets</a></td>
<td class="nump">3,375<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">676,095<span></span>
</td>
<td class="nump">440,647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used in Operating Activities</a></td>
<td class="num">(1,878,006)<span></span>
</td>
<td class="num">(1,579,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from the issuances of common stock</a></td>
<td class="nump">1,221,982<span></span>
</td>
<td class="nump">731,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activities</a></td>
<td class="nump">1,221,982<span></span>
</td>
<td class="nump">731,052<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Decrease in Cash and Cash Equivalents</a></td>
<td class="num">(656,024)<span></span>
</td>
<td class="num">(848,694)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents, Beginning of Period</a></td>
<td class="nump">28,598,445<span></span>
</td>
<td class="nump">28,899,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents, End of Period</a></td>
<td class="nump">27,942,421<span></span>
</td>
<td class="nump">28,051,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CashPaidDuringThePeriodAbstract', window );"><strong>Cash paid during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-Cash Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PaymentOfAccruedLiabilitiesWithCommonStock', window );">Payment of accrued liabilities with common stock</a></td>
<td class="nump">$ 255,000<span></span>
</td>
<td class="nump">$ 215,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CashPaidDuringThePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CashPaidDuringThePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PaymentOfAccruedLiabilitiesWithCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PaymentOfAccruedLiabilitiesWithCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486340144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Nature of Operations and Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">When used in these notes, the terms &#8220;Lightbridge&#8221;, &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its next generation nuclear fuel technology. These condensed consolidated financial statements include the accounts of the Company and the Company&#8217;s wholly-owned subsidiaries, TPI, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America, including a summary of the Company&#8217;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 4, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three-month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Summary of Significant Accounting Policies</em></strong><em>&#160;</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair Value of Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities are classified in their entirety in the fair value hierarchy level based on the lowest level of input that is significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of&#160;&#160;accounts payable and accrued liabilities are considered to be a Level 1 measurement, representative of their respective fair values because of the short-term nature of those instruments.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes the valuation of the Company&#8217;s cash equivalents (in millions) that fall within the fair value hierarchy at March 31, 2024. There were no cash equivalents at December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assets</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Treasury Bills</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Certain Risks and Uncertainties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and /or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of our nuclear fuel, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Recent Accounting Pronouncements </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which expands on the required disclosure of incremental segment information. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect this guidance to have a material impact on its consolidated financial statements and related disclosures. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires companies to annually disclose categories in the effective tax rate reconciliation and additional information about income taxes paid. The new guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company expects the new standard to have an immaterial effect on its consolidated financial statements and related disclosures upon adoption.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In August 2020, the FASB issued&#160;ASU 2020-06,&#160;<em>Debt-Debt with Conversion and Other Options&#160;</em>(Subtopic 470-20)<em>&#160;and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity&#160;</em>(Subtopic 815-40), which simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in&#160;ASC 470-20,&#160;<em>Debt: Debt with Conversion and Other Options</em>, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in&#160;Subtopic 815-40&#160;for freestanding financial instruments and embedded features that are both indexed to the issuer&#8217;s own stock and classified in stockholders&#8217; equity, by removing certain criteria required for equity classification; and (3) revises the guidance in&#160;ASC 260,&#160;<em>Earnings Per Share</em>, to require entities to calculate diluted earnings per share for convertible instruments by using the if-converted method.&#160;ASU 2020-06&#160;is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Adoption is either through a modified retrospective method or a full retrospective method of transition. The Company adopted this guidance on January 1, 2024 and the adoption did not have a material impact on its results of operations, financial position, and disclosures because the Company does not have any transactions or instruments to which this standard applies. If in the future, the Company issues new convertible debt, warrants or other instruments, the standard may have a material effect, but it cannot be determined at this time.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and do not believe the future adoption of any such standards will have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 250<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//250/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481562448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2. Net Loss Per Share</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2024 and 2023, as they would have been anti-dilutive due to the Company&#8217;s losses at March 31, 2024 and 2023 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">555,582</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">525,903</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">557,688</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">416,316</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,113,270</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">942,219</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481545552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Project Costs and Other Long-term Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract', window );"><strong>Prepaid Project Costs and Other Long-term Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidProjectCostsDisclosureTextBlock', window );">Prepaid Project Costs and Other Long-term Assets</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3. Prepaid Project Costs and Other Long-term Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company entered into two agreements with Idaho National Laboratory (INL), in collaboration with the United States Department of Energy (DOE), to support the development of Lightbridge Fuel&#8482;. At the time of signing, the Company made advanced payments for future project work totaling $0.4 million to Battelle Energy Alliance, LLC (BEA), DOE&#8217;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing and increasing the advanced payments by $0.1 million to $0.5 million. The prepaid project costs were $0.5 million as of March 31, 2024 and December 31, 2023, recorded under Other Assets - Prepaid project costs and other long-term assets.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidProjectCostsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidProjectCostsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481616768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4. Accounts Payable and Accrued Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable and accrued liabilities consisted of the following (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued legal and consulting expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055482352560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies - Note 5</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5. Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Commitments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024 and December 31, 2023, the Company had total contractual commitments for R&amp;D work for the following three R&amp;D projects (rounded in millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong>&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Project Task Statements - INL</span></em><span style="text-decoration:underline"> </span><em><span style="text-decoration:underline">Project</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 26, 2024, the Company and BEA entered into Modification No. 2 (&#8220;Modification No. 2&#8221;) to the project task statement (PTS) under the Strategic Partnership Project Agreement (SPPA), dated December 9, 2022, as amended on May 23, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 2, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#8220;umbrella&#8221; SPPA to $1.7 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After accounting for Modification No. 2, total cash payments from the Company to BEA under both Agreements were estimated at approximately $4.3 million (excluding project contingencies) on a cost reimbursable basis over the performance periods under the initial releases. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, the Company had approximately $3.1 million in outstanding PTS commitments to BEA relating to the R&amp;D work being conducted under the SPPA and &#8220;umbrella&#8221; Cooperative Research and Development Agreement (CRADA) at INL. Performance of work under these agreements may be terminated at any time by either party, without any liability, after the effective date of termination, upon giving a thirty-day written notice under the SPPA and a sixty-day written notice under the CRADA, to the other party. In the event of termination, the Company shall be responsible for BEA&#8217;s costs (including the closeout costs), through the effective date of termination, but in no event shall the Company&#8217;s cost responsibility exceed the total estimated cost stated in each PTS and any subsequent modification to the PTS.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Romania Feasibility Study of Lightbridge Fuel&#8482; for use in CANDU reactors</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged Institutul de Cercet&#259;ri Nucleare Pite&#537;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in CANDU reactors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, the Company had approximately $0.1 million in remaining outstanding project commitments to RATEN ICN.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy Corp. (Centrus Energy) to conduct a front-end engineering and design (FEED) study to construct a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) to manufacture Lightbridge Fuel&#8482; using high-assay low-enriched uranium (HALEU) at the American Centrifuge Plant in Piketon. The work is expected to be completed in 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These Agreements can be terminated by either Party by giving thirty calendar days' prior written notice of termination to the other Party.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Operating Leases</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leased office space for a 12-month term from January 1, 2024 through December 31, 2024 with a monthly payment of approximately $8,000. The future minimum lease payments required under the non-cancellable operating leases for 2024 total approximately $0.1 million. Total rent expense for the three months ended March 31, 2024 and 2023 was approximately $24,000.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481562448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development Costs</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6. Research and Development Costs</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">INL Project</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#8482;. These framework agreements use an innovative structure that consists of an &#8220;umbrella&#8221; SPPA and an &#8220;umbrella&#8221; CRADA, with an initial duration of seven years. Throughout the duration of these umbrella agreements, all research and development (R&amp;D) work contracted with BEA is through the issuance of PTSs. The initial phase of work under the two agreements will culminate in irradiation testing in the Advanced Test Reactor (ATR) of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#8217;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. The data, which will be obtained during post-irradiation examination work, will support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#8482;. For the three months ended March 31, 2024 and 2023, the Company recorded $0.4 million and $0.2 million in R&amp;D expenses associated with INL, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Romania Feasibility Study</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 16, 2023, the Company engaged RATEN ICN in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#8482; for use in CANDU reactors. The total price of approximately $0.2 million is payable in three installments, including an advance payment of $0.1 million and an interim milestone payment and final payment totaling approximately $0.1 million. For the three months ended March 31, 2024, the Company recorded $0.1 million in R&amp;D expenses associated with RATEN ICN. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Centrus Energy FEED Study</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a FEED study to add a dedicated LPFFF at the American Centrifuge Plant in Piketon, Ohio. As of the date hereof, Centrus Energy has completed the initial phase of the FEED study and issued a preliminary report. For the three months ended March 31, 2024, the Company recorded $0.2 million in R&amp;D expenses associated with this FEED study. After reviewing the preliminary report, the Company will decide whether to proceed to the final phase of the FEED study. If the Company decides to move forward with the final phase of the FEED study, the remaining work is expected to be completed in 2024 at an additional fixed price cost of approximately $0.3 million. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table presents the total R&amp;D expenses for the three months ended March 31, 2024 and 2023 (rounded to millions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong>&#160;&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 985<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//985-730/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481574224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity and Stock-Based Compensation</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7. Stockholders&#8217; Equity and Stock-Based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2024, the Company had 14,189,780 common shares outstanding (including outstanding RSAs totaling 557,688 shares). Also outstanding were stock options relating to 555,582 shares of common stock (of which 542,972 stock options were vested), all totaling 14,745,362 shares of common stock and all common stock equivalents, potentially outstanding at March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2023, the Company had 13,698,274 common shares outstanding (including outstanding RSAs totaling 557,688 shares). Also outstanding were stock options relating to 510,787 shares of common stock (of which 498,177 stock options were vested), all totaling 14,209,061 shares of common stock and all common stock equivalents, outstanding at December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock Equity Offerings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>At-the-Market (ATM) Offerings</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024 (the &#8220;ATM Agreement&#8221;), pursuant to which the Company may issue and sell shares of its common stock from time to time through Stifel as the Company&#8217;s sales agent. Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party. Sales of the Company&#8217;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#8220;at-the-market&#8221; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933. On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#8217;s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 29, 2024, the Company filed a new shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#8217;s securities, which registration statement was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $6.6 million from time to time through its ATM.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records its ATM sales on a settlement date basis. The Company sold 427,300 shares under the ATM for the three months ended March 31, 2024 resulting in net proceeds of $1.2 million (stock issuance costs were approximately $0.1 million). The Company sold approximately 169,978 shares under the ATM for the three months ended March 31, 2023 resulting in net proceeds of $0.7 million (stock issuance costs were approximately $30,000). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-based Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>2020 Equity Incentive Plan </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 9, 2020, the Board of Directors adopted the Company&#8217;s 2020 Omnibus Incentive Plan (the 2020 Plan). On September 3, 2020, the shareholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. The total number of shares of common stock available for issuance under the 2020 Plan is 1,800,000 shares with 758,672 shares available for future issuance at March 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Stock Options</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024 and 2023, the number of stock options the Company granted to a consultant was 58,309 and 0, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Common Stock</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Consultants&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended March 31, 2024 and 2023, the Company issued 3,750 shares (with stock prices at $4.00&#160;per share) to its investor relations firm for services provided during the quarter, recorded to general and administrative expenses. The total stock-based compensation expense recorded for these share issuances was $15,000 for each quarter with a weighted average grant date fair value of $4.00 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Directors&#8217; Stock Issuances</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 20, 2023, the Board of Directors approved an equity grant valued at $240,000 in total to its six directors, which resulted in granting a total of 60,456 shares of common stock, valued on the grant date at $3.97 per share, which vested on January 2, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 15, 2022, the Board of Directors approved an equity grant valued at $200,000 in total to its five independent directors, recorded in general and administrative expenses, which resulted in granting a total of 52,085 shares of common stock to the five independent directors, valued on the grant date at $3.84 per share, which vested on January 3, 2023. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Restricted Stock Awards</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024 and December 31, 2023, there were 557,688 restricted stock awards (RSAs) included in the total issued and outstanding common stock. A total of $0.4 million and $0.3 million of compensation expense was recorded for the three months ended March 31, 2024 and 2023, respectively. Compensation expense is recognized in a straight line over the three-year vesting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of March 31, 2024, total unrecognized compensation cost related to restricted stock units was $2.2 million, which is expected to be recognized over a remaining weighted-average vesting period of 1.9 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-Based Compensation Expense</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Stock Options</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted during the three months ended March 31, 2024 and 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75.36</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.54</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected term </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share &#8211; common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total non-cash stock-based compensation expense recorded related to options granted and restricted stock awards included in the Company&#8217;s unaudited condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 are as follows (rounded in millions):&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481521904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8. Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Amendment to At-the-Market Equity Offering Sales Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 8, 2024, the Company entered into an amendment (the "Amendment") to its&#160;at-the-market equity offering sales agreement, dated May 28, 2019 and as amended on April 9, 2021, with Stifel, Nicolaus &amp; Company, Incorporated (&#8220;Stifel&#8221;) to (i) replace certain references to the Company&#8217;s expired shelf registration statement on Form S-3 (File No. 333-254702) filed on March 25, 2021 with the Securities and Exchange Commission (&#8220;SEC&#8221;) and declared effective April 5, 2021, with reference to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-278388), filed on March 29, 2024 with the SEC and declared effective on April 19, 2024 (the &#8220;Registration Statement&#8221;), (ii) update public float calculations included therein and (iii) reduce the commission rate for fees owed to Stifel from 4.0% of the gross sales price per share sold to 3.0% of the gross sales price per share sold.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>ATM Sales</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of common stock under the ATM from April 1, 2024 to May 10, 2024 amounted to approximately 0.2 million shares, which resulted in total net proceeds of approximately $0.7 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Amendment to 2020 Equity Incentive Plan</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 27, 2024, the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Equity Incentive Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#8217; annual meeting on April 19, 2024.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486588928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (ASC), <em>Fair Value Measurement</em> (ASC 820), establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - Unobservable inputs that reflect management&#8217;s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For disclosure purposes, assets and liabilities are classified in their entirety in the fair value hierarchy level based on the lowest level of input that is significant to the overall fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement within the fair value hierarchy levels.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of&#160;&#160;accounts payable and accrued liabilities are considered to be a Level 1 measurement, representative of their respective fair values because of the short-term nature of those instruments.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes the valuation of the Company&#8217;s cash equivalents (in millions) that fall within the fair value hierarchy at March 31, 2024. There were no cash equivalents at December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assets</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Treasury Bills</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Certain Risks and Uncertainties</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and /or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#8217;s future R&amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#8217;s operations will be subject to other numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;D of our nuclear fuel, regulatory approval of the Company&#8217;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;D milestones toward commercialization, future impairment charges to the Company&#8217;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which expands on the required disclosure of incremental segment information. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect this guidance to have a material impact on its consolidated financial statements and related disclosures. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires companies to annually disclose categories in the effective tax rate reconciliation and additional information about income taxes paid. The new guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company expects the new standard to have an immaterial effect on its consolidated financial statements and related disclosures upon adoption.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In August 2020, the FASB issued&#160;ASU 2020-06,&#160;<em>Debt-Debt with Conversion and Other Options&#160;</em>(Subtopic 470-20)<em>&#160;and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity&#160;</em>(Subtopic 815-40), which simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in&#160;ASC 470-20,&#160;<em>Debt: Debt with Conversion and Other Options</em>, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in&#160;Subtopic 815-40&#160;for freestanding financial instruments and embedded features that are both indexed to the issuer&#8217;s own stock and classified in stockholders&#8217; equity, by removing certain criteria required for equity classification; and (3) revises the guidance in&#160;ASC 260,&#160;<em>Earnings Per Share</em>, to require entities to calculate diluted earnings per share for convertible instruments by using the if-converted method.&#160;ASU 2020-06&#160;is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Adoption is either through a modified retrospective method or a full retrospective method of transition. The Company adopted this guidance on January 1, 2024 and the adoption did not have a material impact on its results of operations, financial position, and disclosures because the Company does not have any transactions or instruments to which this standard applies. If in the future, the Company issues new convertible debt, warrants or other instruments, the standard may have a material effect, but it cannot be determined at this time.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and do not believe the future adoption of any such standards will have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481539760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of fair value of treasury bill</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assets</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level I</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level II</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level III</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Treasury Bills</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481577392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of outstanding securities excluded from diluted weighted shares outstanding</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock options outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">555,582</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">525,903</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted stock awards outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">557,688</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">416,316</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,113,270</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">942,219</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481520848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued liabilities</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued legal and consulting expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued bonus </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.9</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055579596656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies - Note 5</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock', window );">Schedule Of commitments and contingencies R and D works</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong>&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.6</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055482579552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock', window );">Schedule of research and development expenses</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong>&#160;&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">INL Project</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Romania Feasibility Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Centrus Energy FEED Study</em></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allocated employee compensation and stock-based compensation expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other outside R&amp;D expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055574716640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of share-based compensation, stock options, activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75.36</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk free interest rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.54</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected term </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Closing price per share &#8211; common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of stock based compensation expense</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total stock-based compensation expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.5</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055578047040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember', window );">Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Treasury Bills</a></td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember', window );">Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Treasury Bills</a></td>
<td class="nump">17.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember', window );">Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Treasury Bills</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ltbr_TreasuryBillsLevelThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486485440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Stock options outstanding</a></td>
<td class="nump">555,582<span></span>
</td>
<td class="nump">525,903<span></span>
</td>
<td class="nump">510,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Restricted stock awards outstanding</a></td>
<td class="nump">557,688<span></span>
</td>
<td class="nump">416,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Total</a></td>
<td class="nump">1,113,270<span></span>
</td>
<td class="nump">942,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486505536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Project Costs and Other Long-term Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses - Current and Long-term Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid project costs</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses - Current and Long-term Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidProjectCostsAddition', window );">Prepaid project costs- addition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses - Current and Long-term Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_PrepaidProjectCostsAddition', window );">Prepaid project costs- addition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember', window );">Battelle Energy Alliance, LLC (BEA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_PrepaidProjectCostsAddition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_PrepaidProjectCostsAddition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_BattelleEnergyAllianceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486488384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade payables</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued legal and consulting expenses</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrentAndNoncurrent', window );">Accrued bonus</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Total</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486788848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ContractualCommitments', window );">Total contractual commitments</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_INLProjectMember', window );">INL Project [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ContractualCommitments', window );">Total contractual commitments</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_RomaniaFeasibilityStudyMember', window );">Romania Feasibility Study [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ContractualCommitments', window );">Total contractual commitments</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_CentrusEnergyFEEDStudyMember', window );">Centrus Energy FEED Study [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ContractualCommitments', window );">Total contractual commitments</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ContractualCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ContractualCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_INLProjectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_INLProjectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_RomaniaFeasibilityStudyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_RomaniaFeasibilityStudyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_CentrusEnergyFEEDStudyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_CentrusEnergyFEEDStudyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486900080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Total Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease Monthly Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_LeasePaymentUnderNonCancellableOperatingLeases', window );">Future minimum lease payments required under the non-cancellable operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProjectTaskTatementPostemploymentObligations', window );">Project Task Statements (Purchase Orders)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_LesseeOperatingLeaseTerm', window );">Operating Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember', window );">Strategic Partnership Project Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_IncreasedExpensesAmountForProjectTask', window );">Increased expenses amount</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_TotalCostAmountForProject', window );">Total cost amount</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">Total cash payments</a></td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_RATENICNMember', window );">RATEN ICN. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_RemainingOutstandingProject', window );">Remaining outstanding project commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_IncreasedExpensesAmountForProjectTask">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_IncreasedExpensesAmountForProjectTask</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_LeasePaymentUnderNonCancellableOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_LeasePaymentUnderNonCancellableOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_LesseeOperatingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_LesseeOperatingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProjectTaskTatementPostemploymentObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProjectTaskTatementPostemploymentObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_RemainingOutstandingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_RemainingOutstandingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_TotalCostAmountForProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_TotalCostAmountForProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fees classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_StrategicPartnershipProjectAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_RATENICNMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_RATENICNMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055577904384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 1,023,823<span></span>
</td>
<td class="nump">$ 448,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember', window );">Romania Feasibility Study [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember', window );">Centrus Energy FEED Study [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember', window );">Allocated employee compensation and stock-based compensation expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember', window );">Other outside R&amp;D expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research And Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseINLMember', window );">INL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseINLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseINLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486559184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Costs (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 1,023,823<span></span>
</td>
<td class="nump">$ 448,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseINLMember', window );">INL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseRatenIcnMember', window );">RATEN ICN [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentExpenseAmountForProject', window );">Research and development expenses total amount</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount', window );">Research and development expenses advance payment</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount', window );">Research and development expenses interim milestone payment and final payment</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember', window );">Feed Study [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ResearchAndDevelopmentEstimatedExpenses', window );">Estimated expenses for research and development expenses</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentEstimatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentEstimatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ResearchAndDevelopmentExpenseAmountForProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ResearchAndDevelopmentExpenseAmountForProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseINLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseINLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseRatenIcnMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseRatenIcnMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055481348304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInterestAndDividendIncome', window );">Dividend yield rate</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">75.36%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.54%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 2.62<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInterestAndDividendIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInterestAndDividendIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486664592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders Equity and Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsSharebasedCompensationStock', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsSharebasedCompensationStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid stock dividends declared for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsSharebasedCompensationStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055479801712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Nov. 20, 2023</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_OutstandingRestrictedStockAwards', window );">Outstanding restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,189,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,189,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,698,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 456,904<span></span>
</td>
<td class="nump">$ 284,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonStockAndAllCommonStockEquivalents', window );">Total common stock and all common stock equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,745,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,209,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">555,582<span></span>
</td>
<td class="nump">525,903<span></span>
</td>
<td class="nump">510,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_AtTheMarketOfferingsDisclosureDescription', window );">Description related to ATM offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#8217;s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8', window );">Shares sale offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProceedFromSaleOfAvailableForSaleSecurities', window );">Maximum sale of securities registered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember', window );">Available for sale Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_SharesSoldUnderAtmSettlement', window );">Shares sold under the ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,300<span></span>
</td>
<td class="nump">169,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_ProceedsFromSharesSoldUnderTheAtm', window );">Proceeds from shares sold under the ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_StockIssuedDuringPeriodAmount', window );">Stock issuence cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonSharesIssuancesEquityGrant', window );">Common shares issuances equity grant value</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommonSharesEquityGrantPricePerShares', window );">Common shares equity grant price per shares</a></td>
<td class="nump">$ 3.84<span></span>
</td>
<td class="nump">$ 3.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_AdditionalCommonShare', window );">Additional common shares</a></td>
<td class="nump">52,085<span></span>
</td>
<td class="nump">60,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,309<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total number of common stock available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_FutureIssuanceOfShare', window );">Common stock available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_CommonShareIssuancesMember', window );">Common Share Issuances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_StockOptionExercisePrice', window );">Common stock issuance price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardActivityMember', window );">Restricted Stock Award Activity Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_UnrecongnizedCompensationCostRestrictedStockUnit', window );">Unrecognized compensation cost related to restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1', window );">Weighted-average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_AdditionalCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_AdditionalCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_AtTheMarketOfferingsDisclosureDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_AtTheMarketOfferingsDisclosureDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonSharesEquityGrantPricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonSharesEquityGrantPricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonSharesIssuancesEquityGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonSharesIssuancesEquityGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommonStockAndAllCommonStockEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommonStockAndAllCommonStockEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_FutureIssuanceOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_FutureIssuanceOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_OutstandingRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_OutstandingRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProceedFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProceedFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_ProceedsFromSharesSoldUnderTheAtm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_ProceedsFromSharesSoldUnderTheAtm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_SharesSoldUnderAtmSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_SharesSoldUnderAtmSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_StockIssuedDuringPeriodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_StockIssuedDuringPeriodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_StockOptionExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_StockOptionExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_UnrecongnizedCompensationCostRestrictedStockUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_UnrecongnizedCompensationCostRestrictedStockUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average period until annuitization or benefit payment is expected to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 944<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479808/944-20-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ltbr_AvailableForSaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ltbr_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_CommonShareIssuancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_CommonShareIssuancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardActivityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ltbr_RestrictedStockAwardActivityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140055486510832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 08, 2024</div></th>
<th class="th"><div>May 10, 2024</div></th>
<th class="th"><div>Apr. 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sale of common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_CommissionRateDescription', window );">Description related to commission rate</a></td>
<td class="text">reduce the commission rate for fees owed to Stifel from 4.0% of the gross sales price per share sold to 3.0% of the gross sales price per share sold<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Number of common stock shares, sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ltbr_EquityIncentivePlanDescription', window );">Description related to equity incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Equity Incentive Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#8217; annual meeting on April 19, 2024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_CommissionRateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_CommissionRateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ltbr_EquityIncentivePlanDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ltbr_EquityIncentivePlanDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ltbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MN@1C' 0X=@,-&Z!A;^Q_J;W9#3 \9>2?R-@>T:@A&AT52RLE_X'"@5*IS6Y
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M.[RW[45(;P<PF6:9L%<Z./BV5I^)$OK4E8!$X 0;ME'$'H76DQPV>4Y10I.
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MV+@5&U=;H]6!,"RB= ?F'W)-Y(2KB+GW3/Z=P%KA>E6XGC;Y7TDJXXT!3D.
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MR+?[[U0(FN2W>X)#PC(#^7Y+J;@\9!-4)T:C?P%02P,$%     @ ]8&J6!)
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M4@=U%X.R15#W%QBI9KQKM]P;#/AS' ;430%$U8;:]A@=0$+:[9L!J.VBNL_
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MH+Y?<BX?3ZI77LU+U.G_4$L#!!0    ( /6!JEANJS',$ 4  *@3   8
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&ULK5AM;^(X$/XK%G<ZW4G+$COOO1:)
M0JNMM&W1TMY^=A,#N4UBUC;0_ONU'9H08EQ6HA^*D\Q,GL<SGL?QY9:R'WQ)
MB "O15[RJ]Y2B-7%8,"3)2DP_TQ7I)1/YI056,A+MACP%2,XU4Y%/D".$PP*
MG)6]X:6^-V7#2[H6>5:2*0-\7128O5V3G&ZO>K#W?N-;ME@*=6,PO%SA!9D1
M\;R:,GDUJ*.D64%*GM$2,#*_ZHW@Q1@AY: M_LO(EN^-@:+R0ND/=7&77O4<
MA8CD)!$J!)8_&S(F>:XB21P_=T%[]3N5X_[X/?JM)B_)O&!.QC3_GJ5B>=6+
M>B E<[S.Q3>Z_4)VA'P5+Z$YU__!MK(-I'&RYH(6.V>)H,C*ZA>_[B9BST'&
M,3N@G0,Z=/"..+@[!U<3K9!I6A,L\/"2T2U@REI&4P,]-]I;LLE*E<:98/)I
M)OW$\/EA]#RY>[J9@/'CP^3F85:-9H]?[R8C=7OV)'_N;QZ>9N#Q%HQ'LR_@
M]NOC]QGH@^?9!/S]YS^7 R&!J'"#9/?2Z^JEZ,A+77!/2['DX*9,2=KV'T@"
M-0OTSN(:60/>8_89N/ 30 [R#'C&I[N[%CAN/:FNCN<>B?>X(@R+K%R D:K2
M3&2$FV:IBN*9HZ@%?,%7."%7/;E".6$;TAO^]0<,G']-%,\4K$78JPE[MNC#
M!]EOOE)N)%EY!MI3-97-L(\B&/N13-1FGX#)T$&!'SFU80N<7X/SK>!F@B8_
M^FJMIR"AA6R '*L68@);1?+W,'A^$#N'4+MF*/+<X C0H 8:6,MFO,3E@G"0
ME8#6%80Y)X(#7*8@S_!+ENMJNC"!#\Y93F<*UIJ(L)Z(T)JQ*2,KG*6 O*ID
MD8H]%4O"9$MDC)1B-RVF60@[N>G#V OCX""'!CL41C!TS4F,:NS12=A7C/XO
MI4I6'!?[!'):+OJ"L,)"(>I <]W0/\#?-3I2?G&-/+8B'R4)79<2[ J_X9><
M:- X2=B:M&K/A#CN@ G"P(D/,7?-/,\)O- ,'#J-B#D?]I\QYDOPK!:Y7#^G
M=N!=W':U1&$D-T$'T(V6?AB'7G $_9X$P]]#?U=N"#\%/;34P ZVS:2-%S5X
MD;5/W68E+I,3X*%S-J1S16N3;B0=6@54)TFNZ820E(,YHP60RQEDG*_E7,@6
M1>=*7 JY,^5*;XSSX79R 1&"<80.D]8U#%WH^.A(YAJ9AA_KM*ZT*:.;3.Z]
MP,L;.#F=WJGPNX96^(V00[N2*_@3DLC/%4[4.M%45)?2@YN?ZVR#<ZD.9OA=
MT>X'?J WC&WX!L/(BX+8.X*_T7=H5<WA4;R?P#599&6IDB +:4I81E,CB<"P
M\_#CR/,.6ZW1,HKEW[%NVZ@SM,NSA<:-TCDK@:[LHC#VD(?@(0&#9>3XT'6.
M*#1L)!I&]HV6PJU5.ETS->=J*:\T9N/&"EHE_[<;V9FBM<DW*@_M,G]7RMV'
ME!<] 4:V797NJ(K-I/T%UV@XLFOX72G[)P$"OQ)^%!OJJO A-JM)&UNCT A:
M"^:!EGU=-*9>:2P99)7\WRV9<T5KTV\$'UFU=3C%;X7:=,N5;=@/@FTFEA^*
MW^X5^Y]WR/<=IY,^@QULV54D!GMG'@5A"WT4Q('>PE8'!_7=^KAII ]9#NY?
MPXMQ=6C4A*G.L.XQDTV9@YS,94CG<RAKBE7'0M6%H"M]LO)"A:"%'BX)3@E3
M!O+YG%+Q?J%>4!_.#7\!4$L#!!0    ( /6!JEAAS">[/@T  '8E   8
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MV19**_Z53WP(MN%?UDQM"+;FCPLET3_1!KRG+Q:Z![J@_ZG5\;\!4$L#!!0
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MTP *+%DG[(W:7N%0S]SQY4H8O\*VCTTH8]X9JYH!3';#9?]FC\-WV .<1J\
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M F(0H0M:>,0.%"#T1:%+4+H6'_L(?"5)^&<@XJ!CJI*!K/-KN?Y85TO>ZQ^
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M73>R*E%E#QI'$OC^+'R.2K52BXSK?I1<Z<)A>]80C"ZBK(KK8B%5-ZOL61<
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M"8ARO6)7J\6V&4>MDP^UPG8_Q2VO4"M+^1_J(9!0;3%>JC15&TL8V\)E#M_
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MG@M40X5DC0\13*9/H?>U1?AD4LY(D-YZ5=T5)N5&ES0?Q[^B^(/BQFAKNP:
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M'@MLH&R\ -[G&I^_[N -##OM\F]02P,$%     @ ]8&J6"!#EITT"@  2QL
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M@MO"*'!(YKFFY* ,Y@T: C$39TVX/^S=HT<@GW4--HBEEB!;9JL9*J=-*+B
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M44Y#MZ*+$8TOH.\K33_1?N 7:*_:_"]02P,$%     @ ]8&J6*-M2]J9 @
MU04  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&ULG51=;]HP%/TK5^E4
M;=)&/DB[JH5(!5JMTKHAZ+9GDUR(5SO.; ?*O]^U QF5* ][P/''O>>>8W/N
M8*/TLRD1+;Q(49EA4%I;7X>AR4N4S/14C16=+)66S-)2KT)3:V2%3Y(B3*+H
M,I2,5T$V\'M3G0U48P6O<*K!-%(RO1VA4)MA$ ?[C1E?E=9MA-F@9BN<H_U1
M3S6MP@ZEX!(KPU4%&I?#X#:^'J4NW@?\Y+@Q!W-P2A9*/;O%0S$,(D<(!>;6
M(3#ZK'&,0C@@HO%GAQET)5WBX7R/?N^UDY8%,SA6XA<O;#D,K@(H<,D:86=J
M\P5W>BX<7JZ$\2-LVMCT,H"\,5;)73(QD+QJO^QE=P\'"5?1&PG)+B'QO-M"
MGN6$698-M-J =M&$YB9>JL\F<KQRCS*WFDXYY=ELA@:9SDM@50$37-,KU73G
M%L;*6 /OG]A"H/DP""T5<REAO@,>M<#)&\!]>%25+0W<5046K_-#(MDQ3?9,
M1\E)P$>F>]"//T(2)>D)O'ZGO._Q^O^E_)C@%B\]CN?<<VUJEN,P('L8U&L,
MLO.S^#*Z.<$V[=BFI]"S.;FQ: 2"6H(^9%X<,,<7\JK!H^1/PA\G#X^^RO[.
MW="'AV]?8:K5;W(5O(.HE_HQ@9F2K.(,[I$9ON""VRW,;5-LZ32&\[.K)$YN
M8$PT=>/^%*A76[B_NYMT44D7=2N$RIG% E#60FT1(5?2:6.ME4DW.2-__N0,
M6;P^W%^"1W2UO]L2-5!#,KQ F)TS6=],#L-B_WM2E@D2$_>BG;!CSQ8>6$V2
M!M]0##%H*MNZKMOM>M9M:]5_X6W#H]M=\<J P"6E1KW/%P'HMHFT"ZMJ;]R%
MLM0&_+2DOHO:!=#Y4BF[7[@"72?/_@)02P,$%     @ ]8&J6/6026G\ @
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M16767 &.@.L):GS!F'SJZ,JR_*O"^P=02P,$%     @ ]8&J6/G*H9YU @
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M:=VJ5MT>ICV8Y$"L)G%F&RC_?K83 B$T!2GE@?ARSN?OG$].SNFM*'OA 8!
MKU$8\[X1")%<F2;W H@POZ0)Q')G1EF$A9RRN<D3!MC73E%H.I;5,B-,8F/0
MTVL/;-"C"Q&2&!X8XHLHPFP]A)"N^H9M;!8>R3P0:L$<]!(\AR<0S\D#DS,S
M1_%)!#$G-$8,9GWCQKX:V4WEH"U^$5CQG3%2H4PI?5&3.[]O6(H1A. )!8'E
M8PDC"$.%)'G\RT"-_$SEN#O>H-_JX&4P4\QA1,/?Q!=!W^@8R(<97H3BD:Z^
M01:0)NC1D.M_M$IMVUT#>0LN:)0Y2P81B=,G?LT2L>,@<0X[.)F#L^_@ON'0
MR!P:.M"4F0YKC 4>]!A=(::L)9H:Z-QH;QD-B96,3X+)72+]Q. 1.&#F!0C'
M/AK#4NJ:2)4$&E$N.#H?@\ DY%_0!7I^&J/SSU]ZII#G*F_3R\X8IF<X;YS1
M0/<T%@%'D]@'O^AO2KXY:6=#>NA4 MYC=HD:]E?D6(Y[@,_H>/=&!9U&GL.&
MQG./R:&_DT-XE;>- S^4LA2RI2'575L.;,FFHP@M=T,IV[ENQW+=W*Q V<TI
MN]64:81C@M$M8$ZF)"1BC9[$PE^C/_<038']/<2Y$E.]<*YX@CWH&_*-PH$M
MP1B<?;);UO4AC6H"*X3?S,-OUJ]8"MDL**9^>X*5S:S#6K5RLJU*LB-)C"W4
M[0$V7Z/;R61\A%:5F*=J51-8(?QV'GZ[?JW:)1&<0UJ5S=[0JI.3[522O0E#
MZF$!/H(H">D: 'DT4CQQ^M62,<AWNO=RH;X]?G%S$U"EKI7GGZIK36"%5'7S
M5'7KU[5[G*YEL[VK6F!L6]N/I57)^:<(@"%9#7'B WH\PU%R/3Y.MVKD4X6K
M"ZV8AYVBP:Y?NPSSW1?H^W9%ULZ6M7,<ZYN]6F>2LJ[6KQ+[9/UJ0BMF8ENP
MV!]0L62895U* I8-W2H!MT6+75VUW/WX7JU1K05*76C%8+<EBOT!-4J&V7H[
M]5EL93OGD$3F3F<1R?)#-UQ<?K86L4CK]7PU;^IN="NSMSY4S9[N6+8P::<H
MJ_$YB3D*828AK<NVI,;2YBN=")KH_F5*A>R&]#"0#2LP92#W9Y2*S40=D+?
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M=(Z[,JNLZ!2*B:"Y+K:G5,C270]CV5T!4P9R?T:I6$_4 56_%OP'4$L#!!0
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M"/RRDJJB!H=J[>M: 2U<4L7]* @2OZ),>%GJYFY5ELJ-X4S K2)Z4U54/<^
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MP2M">0'V]W6>EX<O/$#[HK2[_P%02P,$%     @ ]8&J6$YN]F*O P  1@L
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M.8=08&(= J/7%F]1" =$;GQM,(/6I%,\_-ZC_^)CIUC6S."M$G_PU.;3X"J
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MQ-3&EN5<LNQP&GLX2;[Z!5!+ P04    " #U@:I8X#T)5V@!  !*%   &@
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M_R3KA];+O_[UUJY)+55S\&?=_\W9%U!+ 0(4 Q0    ( /6!JE@'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ ]8&J6)Y2)ZKN    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ ]8&J6)E<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #U
M@:I8-BJ/G=\%  ">'P  &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ ]8&J6/L20#.Z!   R1$  !@
M         ("!(@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( /6!JE@^I#IUZP(  .L)   8              " @1(3  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #U@:I8(<SQY6P$   ]$@
M&               @($S%@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ ]8&J6!) -KF)!0  4!T  !@              ("!U1H  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( /6!JEANJS',$ 4
M *@3   8              " @90@  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " #U@:I88<PGNSX-  !V)0  &               @(':
M)0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ]8&J6(K-
M\'"Q P  [0@  !@              ("!3C,  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( /6!JECT@M1)EP,  "P(   8
M  " @34W  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #U
M@:I8':I,37H"  #]!0  &0              @($".P  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /6!JEAC*W=@M@<  .@2   9
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M970Q-2YX;6Q02P$"% ,4    " #U@:I8G7%QKF<"  #-!0  &0
M    @($49@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M /6!JEC($C*\;P(  ($%   9              " @;)H  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ ]8&J6 AMO"9C @  AP4  !D
M             ("!6&L  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " #U@:I8PPJG 6X"  !V!0  &0              @('R;0  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /6!JEBC;4O:F0(
M -4%   9              " @9=P  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ ]8&J6/6026G\ @  : <  !D              ("!
M9W,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #U@:I8
MA?31FV<"  " !@  &0              @(&:=@  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( /6!JEA[_"3'M@(  )D(   9
M      " @3AY  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ ]8&J6,J:42,L P  MA   !D              ("!)7P  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #U@:I8^<JAGG4"  #N!@
M&0              @(&(?P  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( /6!JEB]:\3?X0(  ,P)   9              " @32"  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ ]8&J6(P'7*?_
M P  GA$  !D              ("!3(4  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " #U@:I8+!_+LW #   .#P  &0
M@(&"B0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( /6!
MJEC&>]R/10,  +L-   9              " @2F-  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ ]8&J6&S-)^W) @  ; @  !D
M         ("!I9   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " #U@:I8^"=96JH"   \!P  &0              @(&EDP  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( /6!JEB77+-IU D  #1-
M   9              " @8:6  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ ]8&J6$YN]F*O P  1@L  !D              ("!D:
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #U@:I8T[C;
MWSX#   F%   #0              @ %WI   >&PO<W1Y;&5S+GAM;%!+ 0(4
M Q0    ( /6!JEB7BKL<P    !,"   +              "  >"G  !?<F5L
M<R\N<F5L<U!+ 0(4 Q0    ( /6!JEAELS93,0,  ,T6   /
M  "  <FH  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #U@:I8X#T)5V@!
M  !*%   &@              @ $GK   >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #U@:I8')H)78P!  #G%   $P
M@ ''K0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     *0 I !8+  "$KP
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>80</ContextCount>
  <ElementCount>158</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>30</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000007 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000008 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000009 - Disclosure - Prepaid Project Costs and Other Long-term Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets</Role>
      <ShortName>Prepaid Project Costs and Other Long-term Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000010 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000011 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000012 - Disclosure - Research and Development Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCosts</Role>
      <ShortName>Research and Development Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000013 - Disclosure - Stockholders Equity and Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation</Role>
      <ShortName>Stockholders Equity and Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000014 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000015 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000016 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000017 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/NetLossPerShare</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000018 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000019 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000020 - Disclosure - Research and Development Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCostsTables</Role>
      <ShortName>Research and Development Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://ltbr.com/role/ResearchAndDevelopmentCosts</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000021 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000022 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails</Role>
      <ShortName>Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000023 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/NetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/NetLossPerShareTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000024 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative</Role>
      <ShortName>Prepaid Project Costs and Other Long-term Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000025 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000026 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000027 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>000028 - Disclosure - Research and Development Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCostsDetails</Role>
      <ShortName>Research and Development Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/ResearchAndDevelopmentCostsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>000029 - Disclosure - Research and Development Costs (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative</Role>
      <ShortName>Research and Development Costs (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/ResearchAndDevelopmentCostsTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>000030 - Disclosure - Stockholders Equity and StockBased Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>000031 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>000032 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative</Role>
      <ShortName>Stockholders Equity and StockBased Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ltbr_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>000033 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ltbr.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://ltbr.com/role/SubsequentEvents</ParentRole>
      <Position>33</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 16 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:OperatingLeaseExpense, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, us-gaap:PrepaidExpenseNoncurrent, us-gaap:ShareBasedCompensation, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate -  ltbr_10q.htm 1</Log>
    <Log type="Warning">[DQC.US.0043.9873] The company has reported the concept ProfitLoss as part of the cash flow statement. This income item is being deducted from the value of operating cash flows in the calculation defined by the filer.  This implies that the resulting operating cash flow calculation excludes this income item from cash flow from operations.  If  ProfitLoss represents income from discontinued operations then the element NetCashProvidedByUsedInOperatingActivitiesContinuingOperations should be used as the total rather than the current total element of NetCashProvidedByUsedInOperatingActivities. If the item is an income item and is being deducted because the value is negative then consider changing the sign and weight of the element. - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356</Log>
  </Logs>
  <InputFiles>
    <File>ltbr-20240331.xsd</File>
    <File>ltbr-20240331_cal.xml</File>
    <File>ltbr-20240331_def.xml</File>
    <File>ltbr-20240331_lab.xml</File>
    <File>ltbr-20240331_pre.xml</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="ltbr_10q.htm">ltbr_10q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="221">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ltbr_10q.htm": {
   "nsprefix": "ltbr",
   "nsuri": "http://ltbr.com/20240331",
   "dts": {
    "schema": {
     "local": [
      "ltbr-20240331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ltbr-20240331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ltbr-20240331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ltbr-20240331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ltbr-20240331_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ltbr_10q.htm"
     ]
    }
   },
   "keyStandard": 119,
   "keyCustom": 39,
   "axisStandard": 9,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 22,
   "hidden": {
    "total": 21,
    "http://fasb.org/us-gaap/2023": 16,
    "http://xbrl.sec.gov/dei/2023": 5
   },
   "contextCount": 80,
   "entityCount": 1,
   "segmentCount": 30,
   "elementCount": 237,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 221,
    "http://xbrl.sec.gov/dei/2023": 30
   },
   "report": {
    "R1": {
     "role": "http://ltbr.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets",
     "longName": "000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
     "longName": "000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity",
     "longName": "000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_ltbr_CommonShareMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_ltbr_CommonShareMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
     "longName": "000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements",
     "longName": "000007 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://ltbr.com/role/NetLossPerShare",
     "longName": "000008 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets",
     "longName": "000009 - Disclosure - Prepaid Project Costs and Other Long-term Assets",
     "shortName": "Prepaid Project Costs and Other Long-term Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:PrepaidProjectCostsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:PrepaidProjectCostsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "000010 - Disclosure - Accounts Payable and Accrued Liabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://ltbr.com/role/CommitmentsAndContingencies",
     "longName": "000011 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCosts",
     "longName": "000012 - Disclosure - Research and Development Costs",
     "shortName": "Research and Development Costs",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation",
     "longName": "000013 - Disclosure - Stockholders Equity and Stock-Based Compensation",
     "shortName": "Stockholders Equity and Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://ltbr.com/role/SubsequentEvents",
     "longName": "000014 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies",
     "longName": "000015 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:FairValueOfFinancialInstrumentsPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables",
     "longName": "000016 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://ltbr.com/role/NetLossPerShareTables",
     "longName": "000017 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "000018 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://ltbr.com/role/CommitmentsAndContingenciesTables",
     "longName": "000019 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCostsTables",
     "longName": "000020 - Disclosure - Research and Development Costs (Tables)",
     "shortName": "Research and Development Costs (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables",
     "longName": "000021 - Disclosure - Stockholders Equity and StockBased Compensation (Tables)",
     "shortName": "Stockholders Equity and StockBased Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
     "longName": "000022 - Disclosure - Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)",
     "shortName": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "22",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31_ltbr_TreasuryBillsLevelOneMember",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_ltbr_TreasuryBillsLevelOneMember",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://ltbr.com/role/NetLossPerShareDetails",
     "longName": "000023 - Disclosure - Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R24": {
     "role": "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
     "longName": "000024 - Disclosure - Prepaid Project Costs and Other Long-term Assets (Details Narrative)",
     "shortName": "Prepaid Project Costs and Other Long-term Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember",
      "name": "us-gaap:PrepaidExpenseNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ltbr:PrepaidProjectCostsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember",
      "name": "us-gaap:PrepaidExpenseNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ltbr:PrepaidProjectCostsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
     "longName": "000025 - Disclosure - Accounts Payable and Accrued Liabilities (Details)",
     "shortName": "Accounts Payable and Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://ltbr.com/role/CommitmentsAndContingenciesDetails",
     "longName": "000026 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:ContractualCommitments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "ltbr:ContractualCommitments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "000027 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
     "longName": "000028 - Disclosure - Research and Development Costs (Details)",
     "shortName": "Research and Development Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ltbr:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
     "longName": "000029 - Disclosure - Research and Development Costs (Details Narrative)",
     "shortName": "Research and Development Costs (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails",
     "longName": "000030 - Disclosure - Stockholders Equity and StockBased Compensation (Details)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OtherInterestAndDividendIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OtherInterestAndDividendIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1",
     "longName": "000031 - Disclosure - Stockholders Equity and StockBased Compensation (Details 1)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31",
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
     "longName": "000032 - Disclosure - Stockholders Equity and StockBased Compensation (Details Narrative)",
     "shortName": "Stockholders Equity and StockBased Compensation (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "ltbr:OutstandingRestrictedStockAwards",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "ltbr:OutstandingRestrictedStockAwards",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
     "longName": "000033 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ltbr_10q.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "[Accounts Payable and Accrued Liabilities]",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts Payable and Accrued Liabilities",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_AccruedBonusesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedBonusesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonus",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued legal and consulting expenses",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AdditionalCommonShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "AdditionalCommonShare",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional common shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r414",
      "r498"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r324",
      "r441",
      "r442",
      "r443",
      "r484",
      "r500"
     ]
    },
    "ltbr_AdvancePaymentForResearchAndDevelopmentExpenseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "AdvancePaymentForResearchAndDevelopmentExpenseAmount",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses advance payment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "[Assets]",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r70",
      "r88",
      "r114",
      "r120",
      "r124",
      "r159",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r222",
      "r226",
      "r238",
      "r300",
      "r356",
      "r414",
      "r420",
      "r454",
      "r455",
      "r488"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "[Assets, Current]",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r74",
      "r88",
      "r159",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r222",
      "r226",
      "r238",
      "r414",
      "r454",
      "r455",
      "r488"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AtTheMarketOfferingsDisclosureDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "AtTheMarketOfferingsDisclosureDescription",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description related to ATM offerings"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_AvailableForSaleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "AvailableForSaleSecuritiesMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available for sale Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location Axis",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27"
     ]
    },
    "ltbr_BattelleEnergyAllianceLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "BattelleEnergyAllianceLLCMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Battelle Energy Alliance, LLC (BEA) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodStartLabel": "Cash and Cash Equivalents, Beginning of Period",
        "periodEndLabel": "Cash and Cash Equivalents, End of Period",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r43",
      "r86"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Decrease in Cash and Cash Equivalents",
        "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r43"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Bills",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r497"
     ]
    },
    "ltbr_CashPaidDuringThePeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CashPaidDuringThePeriodAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid during the period:"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CentrusEnergyFEEDStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CentrusEnergyFEEDStudyMember",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centrus Energy FEED Study [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r71",
      "r72",
      "r73",
      "r88",
      "r103",
      "r104",
      "r106",
      "r107",
      "r112",
      "r113",
      "r159",
      "r178",
      "r180",
      "r181",
      "r182",
      "r185",
      "r186",
      "r189",
      "r190",
      "r192",
      "r195",
      "r202",
      "r238",
      "r318",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r344",
      "r365",
      "r384",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r427",
      "r439",
      "r444"
     ]
    },
    "ltbr_CommissionRateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CommissionRateDescription",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description related to commission rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies - Note 5"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r172",
      "r173",
      "r404",
      "r453"
     ]
    },
    "ltbr_CommonShareIssuancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CommonShareIssuancesMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Share Issuances [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CommonShareMember",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonSharesEquityGrantPricePerShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CommonSharesEquityGrantPricePerShares",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares equity grant price per shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonSharesIssuancesEquityGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CommonSharesIssuancesEquityGrant",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issuances equity grant value"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_CommonStockAndAllCommonStockEquivalents": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "CommonStockAndAllCommonStockEquivalents",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total common stock and all common stock equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of common stock available for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Par Value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r344"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Issued",
        "verboseLabel": "Shares of common stock issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Outstanding",
        "verboseLabel": "Common stock, shares, outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33",
      "r344",
      "r362",
      "r500",
      "r501"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.001 par value, 25,000,000 authorized, 14,189,780 shares and 13,698,274 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r302",
      "r414"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certain Risks and Uncertainties",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r63"
     ]
    },
    "ltbr_ConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ConsultantMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ContractualCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ContractualCommitments",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total contractual commitments"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ContributedServicesResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ContributedServicesResearchAndDevelopment",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OtherOperatingIncome",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributed services - research and development"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsSharebasedCompensationStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsSharebasedCompensationStock",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total stock-based compensation expense",
        "documentation": "Amount of paid and unpaid stock dividends declared for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r108",
      "r109",
      "r110"
     ]
    },
    "ltbr_EarningsPerSharesBasicAndDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "EarningsPerSharesBasicAndDiluted",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity and Stock-Based Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r66",
      "r77",
      "r78",
      "r79",
      "r89",
      "r90",
      "r91",
      "r93",
      "r98",
      "r100",
      "r111",
      "r160",
      "r161",
      "r203",
      "r212",
      "r213",
      "r214",
      "r218",
      "r219",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r248",
      "r312",
      "r313",
      "r314",
      "r324",
      "r384"
     ]
    },
    "ltbr_EquityIncentivePlanDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "EquityIncentivePlanDescription",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description related to equity incentive plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r11"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information By Category Of Debt Security Axis",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r187",
      "r200",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r308",
      "r409",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r447",
      "r448",
      "r449",
      "r450"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r286"
     ]
    },
    "ltbr_FutureIssuanceOfShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "FutureIssuanceOfShare",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock available for future issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r368"
     ]
    },
    "ltbr_INLProjectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "INLProjectMember",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INL Project [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss Before Income Taxes",
        "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r39",
      "r57",
      "r114",
      "r119",
      "r123",
      "r125",
      "r299",
      "r305",
      "r407"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r369"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r369"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r99",
      "r100",
      "r117",
      "r217",
      "r220",
      "r310"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "[Increase (Decrease) in Prepaid Expenses, Other]",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ltbr_IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid project costs and other long-term assets",
        "label": "[Prepaid project costs and other long-term assets]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_IncreasedExpensesAmountForProjectTask": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "IncreasedExpensesAmountForProjectTask",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increased expenses amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OtherIncome",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r84",
      "r85"
     ]
    },
    "ltbr_InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses interim milestone payment and final payment"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_LeasePaymentUnderNonCancellableOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "LeasePaymentUnderNonCancellableOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future minimum lease payments required under the non-cancellable operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_LesseeOperatingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "LesseeOperatingLeaseTerm",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders' Equity",
        "label": "[Liabilities and Equity]",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r56",
      "r304",
      "r414",
      "r440",
      "r451",
      "r485"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "[Liabilities, Current]",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r69",
      "r88",
      "r159",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r223",
      "r226",
      "r227",
      "r238",
      "r414",
      "r454",
      "r488",
      "r489"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r206",
      "r284",
      "r311",
      "r336",
      "r337",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r405",
      "r406",
      "r408",
      "r410",
      "r411",
      "r415",
      "r456",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r206",
      "r284",
      "r311",
      "r336",
      "r337",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r405",
      "r406",
      "r408",
      "r410",
      "r411",
      "r415",
      "r456",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ]
    },
    "us-gaap_NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average period",
        "documentation": "Weighted average period until annuitization or benefit payment is expected to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Provided by Financing Activities",
        "label": "[Net Cash Provided by (Used in) Financing Activities]",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Used in Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used in Operating Activities",
        "label": "[Net Cash Provided by (Used in) Operating Activities]",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r45"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "label": "[Net Income (Loss) Attributable to Parent]",
        "verboseLabel": "Net loss for the three months ended March 31, 2023",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r45",
      "r58",
      "r67",
      "r75",
      "r76",
      "r79",
      "r88",
      "r92",
      "r94",
      "r95",
      "r96",
      "r97",
      "r99",
      "r100",
      "r105",
      "r114",
      "r119",
      "r123",
      "r125",
      "r159",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r237",
      "r238",
      "r307",
      "r364",
      "r382",
      "r383",
      "r407",
      "r418",
      "r454"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Common Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "[Operating Expenses]",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Loss",
        "label": "[Operating Income (Loss)]",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r119",
      "r123",
      "r125",
      "r407"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Rent Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Monthly Payment",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247"
     ]
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r54"
     ]
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expenses",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r499"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Income",
        "label": "[Other Income]",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r366",
      "r395",
      "r396",
      "r397"
     ]
    },
    "us-gaap_OtherIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInterestAndDividendIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInterestAndDividendIncome",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield rate",
        "documentation": "Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_OtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Operating Income",
        "label": "[Other Operating Income]",
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ltbr_OtherOperatingIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "OtherOperatingIncomeAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development expenses",
        "label": "[Other Research and Development Expense]",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "ltbr_OutstandingRestrictedStockAwards": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "OutstandingRestrictedStockAwards",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding restricted stock awards"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PaymentOfAccruedLiabilitiesWithCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "PaymentOfAccruedLiabilitiesWithCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of accrued liabilities with common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForFees",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total cash payments",
        "documentation": "Amount of cash outflow for fees classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails",
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails",
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Par Value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r189"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r344"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r189"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r344",
      "r362",
      "r500",
      "r501"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, $0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at March 31, 2024 and December 31, 2023",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r301",
      "r414"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs and other long-term assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses - Current and Long-term Assets [Member]",
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidExpensesCurrentAndLongTermAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "PrepaidExpensesCurrentAndLongTermAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Project Costs and Other Long-term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidProjectCostsAddition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "PrepaidProjectCostsAddition",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid project costs- addition"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_PrepaidProjectCostsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "PrepaidProjectCostsDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid Project Costs and Other Long-term Assets",
        "label": "[Prepaid Project Costs and Other Long-term Assets]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ProceedFromSaleOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ProceedFromSaleOfAvailableForSaleSecurities",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum sale of securities registered"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from the issuances of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from sale of common shares",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r318"
     ]
    },
    "ltbr_ProceedsFromSaleOfAvailableForSaleSecuritiesB8": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesB8",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares sale offering price"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ProceedsFromSharesSoldUnderTheAtm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ProceedsFromSharesSoldUnderTheAtm",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from shares sold under the ATM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Loss",
        "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r75",
      "r76",
      "r82",
      "r88",
      "r92",
      "r99",
      "r100",
      "r114",
      "r119",
      "r123",
      "r125",
      "r159",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r221",
      "r224",
      "r225",
      "r237",
      "r238",
      "r299",
      "r306",
      "r323",
      "r364",
      "r382",
      "r383",
      "r407",
      "r412",
      "r413",
      "r419",
      "r438",
      "r454"
     ]
    },
    "ltbr_ProjectTaskTatementPostemploymentObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ProjectTaskTatementPostemploymentObligations",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Project Task Statements (Purchase Orders)"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RATENICNMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "RATENICNMember",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RATEN ICN. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]"
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r204",
      "r206",
      "r209",
      "r210",
      "r211",
      "r260",
      "r284",
      "r311",
      "r336",
      "r337",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r405",
      "r406",
      "r408",
      "r410",
      "r411",
      "r415",
      "r416",
      "r452",
      "r456",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative"
     ],
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r204",
      "r206",
      "r209",
      "r210",
      "r211",
      "r260",
      "r284",
      "r311",
      "r336",
      "r337",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r405",
      "r406",
      "r408",
      "r410",
      "r411",
      "r415",
      "r416",
      "r452",
      "r456",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r249",
      "r250",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r361",
      "r363",
      "r389"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r249",
      "r250",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r361",
      "r363",
      "r389",
      "r487"
     ]
    },
    "ltbr_RemainingOutstandingProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "RemainingOutstandingProject",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining outstanding project commitments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentEstimatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentEstimatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated expenses for research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "verboseLabel": "Research and development expenses",
        "terseLabel": "Research and development expenses",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r215",
      "r496"
     ]
    },
    "ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocated employee compensation and stock-based compensation expenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseAmountForProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseAmountForProject",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses total amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Centrus Energy FEED Study [Member]",
        "label": "[Centrus Energy FEED Study [Member]]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseForFeedStudyMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Feed Study [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseINLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseINLMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INL [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research And Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other outside R&amp;D expenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseRatenIcnMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseRatenIcnMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RATEN ICN [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Romania Feasibility Study [Member]",
        "label": "[Romania Feasibility Study [Member]]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCosts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and Development Costs",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r216"
     ]
    },
    "ltbr_RestrictedStockAwardActivityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "RestrictedStockAwardActivityMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Award Activity Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock awards outstanding",
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r53",
      "r303",
      "r315",
      "r316",
      "r322",
      "r345",
      "r414"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r89",
      "r90",
      "r91",
      "r93",
      "r98",
      "r100",
      "r160",
      "r161",
      "r212",
      "r213",
      "r214",
      "r218",
      "r219",
      "r228",
      "r230",
      "r231",
      "r233",
      "r236",
      "r312",
      "r314",
      "r324",
      "r500"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r88",
      "r115",
      "r116",
      "r118",
      "r121",
      "r122",
      "r126",
      "r127",
      "r128",
      "r159",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r238",
      "r299",
      "r454"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_RomaniaFeasibilityStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "RomaniaFeasibilityStudyMember",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Romania Feasibility Study [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of outstanding securities excluded from diluted weighted shares outstanding",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ltbr_ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of commitments and contingencies R and D works"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "ScheduleOfResearchAndDevelopmentExpensesTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/ResearchAndDevelopmentCostsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock based compensation expense",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r25"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of share-based compensation, stock options, activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r24"
     ]
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of treasury bill",
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r23"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "[Share-Based Payment Arrangement, Noncash Expense]",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r209"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r211"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options outstanding",
        "verboseLabel": "Stock options outstanding",
        "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average grant date fair value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssued",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "label": "[Shares, Issued]",
        "periodEndLabel": "Balance, shares",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued - registered offerings - net of offering costs, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued - registered offerings - net of offering costs, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedToConsultantDirectorsForServicesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "SharesIssuedToConsultantDirectorsForServicesAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to consultant &amp; directors for services, amount"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesIssuedToConsultantDirectorsForServicesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "SharesIssuedToConsultantDirectorsForServicesShares",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to consultant &amp; directors for services, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_SharesSoldUnderAtmSettlement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "SharesSoldUnderAtmSettlement",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares sold under the ATM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r71",
      "r72",
      "r73",
      "r88",
      "r103",
      "r104",
      "r106",
      "r107",
      "r112",
      "r113",
      "r159",
      "r178",
      "r180",
      "r181",
      "r182",
      "r185",
      "r186",
      "r189",
      "r190",
      "r192",
      "r195",
      "r202",
      "r238",
      "r318",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r344",
      "r365",
      "r384",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r427",
      "r439",
      "r444"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r16",
      "r66",
      "r77",
      "r78",
      "r79",
      "r89",
      "r90",
      "r91",
      "r93",
      "r98",
      "r100",
      "r111",
      "r160",
      "r161",
      "r203",
      "r212",
      "r213",
      "r214",
      "r218",
      "r219",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r248",
      "r312",
      "r313",
      "r314",
      "r324",
      "r384"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails",
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r111",
      "r285",
      "r317",
      "r335",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r367",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r417"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetails",
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails",
      "http://ltbr.com/role/PrepaidProjectCostsAndOtherLongTermAssetsDetailsNarrative",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetails",
      "http://ltbr.com/role/ResearchAndDevelopmentCostsDetailsNarrative",
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative",
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r111",
      "r285",
      "r317",
      "r335",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r367",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r417"
     ]
    },
    "ltbr_StockIssuedDuringPeriodAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "StockIssuedDuringPeriodAmount",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issuence cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of common stock shares, sold",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ltbr_StockOptionExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "StockOptionExercisePrice",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issuance price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets",
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "label": "[Stockholders' Equity Attributable to Parent]",
        "periodStartLabel": "Balance, amount",
        "periodEndLabel": "Balance, amount",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r36",
      "r37",
      "r49",
      "r346",
      "r362",
      "r385",
      "r386",
      "r414",
      "r420",
      "r440",
      "r451",
      "r485",
      "r500"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' Equity",
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity and Stock-Based Compensation",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r87",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r203",
      "r235",
      "r387",
      "r388",
      "r403"
     ]
    },
    "ltbr_StrategicPartnershipProjectAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "StrategicPartnershipProjectAgreementMember",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strategic Partnership Project Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r252"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type Axis",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r252"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://ltbr.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r252"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://ltbr.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r253"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TotalCostAmountForProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "TotalCostAmountForProject",
     "crdr": "debit",
     "presentation": [
      "http://ltbr.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total cost amount"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ltbr.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r187",
      "r200",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r308",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r447",
      "r448",
      "r449",
      "r450"
     ]
    },
    "ltbr_TreasuryBillsLevelOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "TreasuryBillsLevelOneMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level I"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "TreasuryBillsLevelThreeMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level III"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TreasuryBillsLevelTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "TreasuryBillsLevelTwoMember",
     "presentation": [
      "http://ltbr.com/role/NatureOfOperationsBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level II"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_TwoThousandTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ltbr_UnrecongnizedCompensationCostRestrictedStockUnit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://ltbr.com/20240331",
     "localname": "UnrecongnizedCompensationCostRestrictedStockUnit",
     "crdr": "credit",
     "presentation": [
      "http://ltbr.com/role/StockholdersEquityAndStockbasedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation cost related to restricted stock units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://ltbr.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "[Weighted Average Number of Shares Outstanding, Diluted, Adjustment]",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://ltbr.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Common Shares Outstanding",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "c(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "250",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//250/tableOfContent"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "985",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//985-730/tableOfContent"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479808/944-20-55-15"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r490": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r501": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0001477932-24-002689-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-24-002689-xbrl.zip
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MMXC>,51KPL(S@T?8LQ#INIB%(:**DKK8<T&.?T&*7D1E+G(9-(UZ7U7/<C<
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MCC6P[<0'%,L6V%#T KLBM6:FD L4&Z.EVPI++TFBOI]\8(&M/>)GOD8P_-G
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M -/12)MT+GM KV&48$2/"4QVXEE$)*YT_=@(N;*,Y,H:0YU&>*)%96I]Y$J
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M%*1ET C(:A+_HW*Y9?;[[ 7>=K?E4I3SO9I9D LJFPE+7S)#8[Q<63K31+3
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M1<NYHSU-4#.TNB&421^WN0N927G#(#<6MUU'$1UDP>?T:%-@X_S<MK6N_GM
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M^)J63QKH06F?KM&_H<CV8N[)L199121I YOS1"289NB9NX[V=8X<Q$:V9,0
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MM3\EBUTVE,ERUVDZ)7X^$_LD%3?W*9IX->2$R^ITC/6%C\S^(QUPK>$CF7N
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MKY[2I,/996P+D"G%]%4GWR-Z"3-RC.7?!Y@\8GWO$'8'RW]=)%F>K3M0#.3
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M7=HMN9;V-:$_PL+N!_- 'U:2?[Q[X+TB?Q7AR?5,;G&NTH]U4.3C(H(9E[/
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MFM'0Q=Y,^!V%+Z^8^,4[2N$+NEN17<<ER;7#@ K2*[-ZX?]SE17'Z_2I,'!
MX/N!KS7*%IS23!B+?,K'U26LTK?9/]SA71(DB9QM&Y'&M>*^5?NVVY39]CM#
M-BQ25?)3$5)M0:\8# QRF[:B(]%F?0RO><+>)<@3#WL'T#";KYA($54M.<P;
M]BZA" ][/Z(($X?WB&G^\8RWCQF>6\7QXT?U-^PX./\8 'IH[HI6MP$B' !1
M<*2\2E=7I+S9%D!D>5"23<X YG<*L093L+#.843>=7UZ1202XJWYR]0Y6@^
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M.S!7+'LNB0A:V<H40 W$02Y*WMS=;L)<S'.\>K,"@"I)I@V%7\VX'A7%0>Y
M/F)RXA!>(YB%Q2;QXRE?^1],/C/[@ ";0U>25$)NIO-!.L@MR L,(UUEZS/:
MZZNKRVX!L+H Q4*&+(6&N/G/A6C<]4<:^Y.XV(.M8%39L]$8W]H8:ZAK27R&
M4.Y/6MC.QB-E:5.>*P2-ZNA\WMVX^P*GZ>?Y/M+GHDIR#?/S L]#LK@.PYC-
MX^>5*$_<S]-US; EV=U2.,SKYY50A/MY1[Y9H-N6"F5;WCA$. #B5MG$"W;
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M1*$Q#QQ)5\D--]OWM.TP3CPMU+#FJJ0%STL.LZ71A"(\+71 J67?U-6Y) &
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ME.F/77D6Q[EQI-D?Q^G&GNC(I\1B:>W11<%3<SS6'-$:F1>L@'5KQC,S!MC
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MUAHRQ(D)?6:YOL7HSQP=PCLN"=5?Z=2&Y];O!L3&5U\I&5FXG7\!$0'0XDP
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M7(WT<V%AE6;H(F5P5C'$U)<+TM1M4]PK\BBZ*'(=HJ7/"]OM_\'/*4TO0\!
M\6:ZMD>H9V:(1'H;*^?!>V?YQGTV-?EA9^QT'']JF7KHCL_L34'JA'=?P,^J
M%Y*&P;/F&&0&0D#SUAO\W@D?DRA *#P-0Y+A9F2.-LMQ]]<2NGODL1FX%+U:
M@8<=P3V]\*6IP8 G8@!I=(:R2MR04KQ+6US<A,19Z&( ,([K+(OI//G0.T+V
MN8[<=*.34_R?F^ \TPD(B!>J+^*B^($OX#!5PW_51%P8"TTP=">"YY'1-R&.
M;#\I$&GAYU3RM+61QEYFQ^NA R*> @ *5_S+7PP8-<QV3$SY=,Q7>&-<]BD^
M[#58AV9Q:L$4K6?^F\0EBJP#@?1GW>R+5)@ )0/J4-3^$\ B@>GR6Y)A+<8/
MX&%7S"'\A5H:0CNDVO"F"#=SE0![8EB!(#=L<B2?RQ^X_.;GS9XIM<G=ZKTF
MEB^RO$JQ[G,/[#5TJSXR>Y%<+?[_^T^@4KT3\@#[3UP;Y;=K<(O,<MT3<WNO
M3=Q[YW?-[O4GT(\VGBDWNS_@31=$5,NI*:3+1(Z*N):#+SCO@; ;D&(]_^F2
MM,<H>#Q6PW81CW$UZO_R-G1M[!S?[[T[N#++WF #JK:O  ,K2HTT\="PR:S7
MWL/V7AVZ'R4V,Q+MV=7$%3-0^4*U\A-M$ :AFQ]XK.VW0N5Y%[-#TD+%OZ$D
M4N'"5U."1->-7E56A(:!A_&JFVKR+#!\I;A2%A5$JLGOUSG>!1:@"2PD6!30
M>-Z.0!DI[ ?-RUA8?>?+US.A.WWSEV%V6.MDRU<!J@-2AE ->$V&:X-?R$:C
M@U<(]9%:*R<A=?;D(H0V H0&*5OB'JDFM!#E%]: HQX19]G2LQN+,P""'B7H
MW> %!G#U^"V#X-[_3+E$KOSU39=?"HQ6(%X'ZF)N 6IWBU !3)'Z@-/P+8,9
M. &*XP"?,_OV7?@D[@1IXLWM0D*P-MUGD,A(SWP,JF(D#USY7+ZJ>&.#4KP%
MIS2'_T\PX<8TT#'PP='A5D5'9(Z&[FB==]V^PP%>KN5SQ?RGV1TN_-DM$/^%
M9_@(BO[&5)CK<XYGA&&XBF.TA5;LS(CJO!J\42=^E#!0O5#)E?/!MK!!\NB8
MS6E[!2K0O7U#LQ",,7,@KM'P)8%]JO,TIQ\7W0ORK=E\%/=6O7C-XCL%W.J#
MR<)B0-<-N)L2R7N"E0G''R$*VP I?%[X-#^WD%$K+LP:/%:)>HJ'!,+C"F]\
M]L#$8D-FH4;B12))?PKP')LO_C5K6++-WSS;CH;/[AN/.7/<OB3KL9O37_%3
MBSTA%'@>W/CFZ^*+ZH-W--0&PKD)WCED/$O+GKF 25\"$P09P4O ^]K .A $
M_E5G AZ/$R<:7KB*TN8+.2]^@IF^:+9'>'L _A.0"*]W\Q'QE6J S3!C?*K-
MP4U\R/6WQ1B7-9R-B9CA> #)IN(=X6!U0;YZ'TQT3,UG;S,?B^]/:^;POGK%
M0 7!(@G+_/.1J</\;>\' =G"J/!Q/; T+@-G-@TNPPM4^:\6EZMXDCPY+T6I
MEXBH8C4,IQ:U#!X">P38=&&W,!\TIC]L!#%@MF"N,K_/K[NX0YG_!A#WX+TA
MG>;W2)C$L%"L3.65&!CFO.?PQAP#UUB]B(DZ\<&[S;&9![[ *!..>?BU%Z05
MU6B:/5-JP#-0KX;)M9[FWW38:%;Y+6?5#,W'NSSBC"S3?1ZA8<?OW#%4@N Y
M!3F9@KI$W,1V=7W!UT-QLU&;&<5!G1,<%'$?,2A#96B\E,+@^EA -553N46Z
MW/)<$'I*BE+Q<&I(M?LYIDZ2'>R9%',%37A,>89*0+902GQU@46"BH<GV[:'
MT;A>M*@.EP%"L\]+.5!VU.)Q9UX$@O,J-+#B5_<1XV$489Y* O4";9J#<4]<
M59_-[KZJXF(I3!PMC&.)\0;4'5% N<B197Z4Q.)Q ]TC?; 7'=@ASDQ.*&']
M$ 2@A#R?%17PG &NCDR\A**BD H,L(!MP0MR-G/X*_NPU;BH%7N/PP-,"_A&
M]<HU.=O7%A4H%Y4]^DSG0;)08#G877B)!*C$K^O-ULBCK8LW7&*6\=:NW\+;
M(PN."3_>W-YW?OE)WVJI9[=:R-)"G[&D!=\J Z.,VV0R!P\CI3B+%^0!)/"]
M:4<LRB.J"8FE+P?P$X?HN,B9T:N)^ ZWB6<6[BO')5-S%,\WGAF>=O7YV7/0
M.@!_#=:!ZP3.2:C9IQ4$3H5=J'C.D'=3T9G9.?XIEPL&B"UT3?C]H4,)>*=K
M@6>,MW(LPJ\BZKH7!KWUK/K=+Y#7KM*&PF_@RCERFK::%(( %^1QP<_\RU;>
M(58XXAM]$!4^%P4\)"1\<#P_$K>4A/=F>E=MCZ+$#UI38:*&,A@,?C$;[ OS
M-5S7[\TKKA6X\(+S06:![_SYW$]B7:2B$^$5G6RO_%;T$A*W*[R8N2TJFH6.
MO/F$P(#6<CYR !1LT3D>8I;9\8M.P1A>X4-^4C?S&@( B)HQ"%[/"0^,N 4$
MQ(J=SZ"J'-\#Y*Z/MQ?00O)JT0W8PMM=H18B'WZUJE2('7#-;E8U@0L^$V:U
M!5L>6% ;W<Q@TAGN7HO)<0GKA.Y6_)+G_]O1'8OJ/NY8\/1,\EV(FQ:*FP7V
MQY:D],<)Y(L,5][6MZV/';$'=!L(!9VL%X$R_NZ$OR59^2MC![:SJV[8]@Y;
M7))>@Y"F.^ .&F?58SGEW&B[QJ(Y:-8QP^9V71/#V2+]\GHZ>\1KM-7$C#SO
M^+$SX]\C]]W:Z)+!P[=,_+G;1FY\+O9<UZU*I:)4ZD7I;EJ<Z,A[@'%##AAO
MW3DN&<;%BM+(EZ2#L9S-A)\8*%V-5V_VSN)?^:&(M IEA8TCP1;=@16V>N\V
M8K&'&2>Y:2#V1IL?V#TPIS,4']R95H^^83_'D6B;8>]%L]24:KV^<DLF&GFG
M)/,SC$<P'KMTOU.,[U;ME M5I52H'@3&Y?1H>J9#=:DW8@E@KIIN7V?2[L38
M%'>T%6-E"?[E'6<T1?S^@1]E>4=B8H.$C,%FT!1C#]JFH!0*):586]T_>'XO
MEC)]<^(PCZ47[!+FNU4XC7)1*18:!P'RM8LE[/WNWJ(\DW*T-3JVUM+41\O$
MQ( ;TW;LV566@\DX*5T0;R'$6PGA2PEEP]\'=TB3:A0>^-E^V\!C[6(T(95'
MHGG2.1Z3OYJ$8KN)T+V(MDI')G;-%=>&[FD?^]'A7>#S]L/])T6T\=)U\7FD
MD5>TB]HMIOL[?H7KEL&L9WC';:?U20D719@O63#7$._.9?K??ZF7Z\4O%Z0I
M'D=:\'P,K)AM/$<7B(V@\ 8\YJZH6-YVUCK,RX^<>&!X-:V?,!.PPO @_K^6
MB,GRO)CT<-5ZPZ 1>S -[' 5DX->T9ABKE ,BL9<4\<!0<\$/9I>-8K[^YN=
ME2C*7Y1C0M(O"8N$]V?@L\2?@X(=)<GY=:L)# (VS=_4Q^L'W@T?I"7\!WBX
M(&ULA38-7:,+=[^$)V99YSS]888VF H0BGDIX?ZK>>]<_,Y[:0/;C D^8TY3
M@#75M2*%<37+HJIW\PW0%]PRUT1$SL\4B@.C/UW*^L8JP=CTKM@ELA[47@59
M[^'F]RAN[*:A<CET(] C9)  PN^VY?S^73.TL3O>(30*2Z&QF!#5?/Y#"4'?
M=DR(>!4OGQ#B;L/$TQR^L!APS<&+(2^#2^5=DL(O+[4YE5*F"69?P49+2)Q*
MZ+^(]U MS.4"KQIOG'%-ZW55R@4J.4K8696#65D'47CA PL=+#*68DSV;L';
MCZ*8.O"I*4JIW\]N%!Z@ 56^\._WV^0Q5"?>6QP)K>ZH#*?FNL7QO;Q2I@;=
MH8)R[N<\J"1N]P7UV/?8&6I1#E\LQAC*X5L#Q3Q1/LO6DS@W)I3(LODAZBQ1
M)?44&*F2Y#*^K<VWL,*7@759?N-AYK]E^8W'S=\LOW&STT +XU:>P9F5J]^L
MMG,IEJ X9\MRZOINLZ&NYX;OQ*?.\@L/$U&Q;NGO0E1)A(!3"N%]-%_E3/7S
MHQ0Z>_8JNZ*[[NH\-,R\D)JDV^*CCY]WN97*L=2]>%C!CVR&/DI=,F=]'"09
M>0_2/);YO3T$=RG*XP=U'\T..8UC7Y3W3<.UB22PS9)70UNL5(MES'E,NT:>
M,5M2XUN&]-0,Q?*@.)80MR6*$[7$IEV > 9&\<M!@%A.'X#G6,NM,)*R3W?I
M%>\ED[183A+_*T\3/T0I'$8*:8;4M) :.P'?*5)WZ1ZL]E!E0.KA)3M7XRW2
MQF.-IZJB&X@U (,60;M+VPFZ/:E-@ 7^XW=6R!<;='\)/94+$EHJCXE%%GM4
M63Q![[[9BH]J?<T-4O*<2-%<560]!SFWKE<'S\<%YO;Z/95XDK1?KVV6WB0J
MM_D/>;E\MJ193X7RK,TLSUZ=Y3PMV?E/\,'MOV#Y6=*3] ?FAY(\$T]ZDH&8
M&?>RU*=#P<HQI,9DJ4_'S=\L]6FS!E</]_X%3;GB'[)GJ53SI8A9>S.SYT-V
M[;KVJKB?",SP>+&SBT4E"5-6I!I96GC5MH57].I_Z/IK"O JKA'1S4Y#N$W(
MQE=/^*E&R1U>BO5Z+7<=5YW.NNC*MT$^^NQQIYNJO'.9[?$TQ%+.T52O#4O
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MG:!ATCT/$1R;Q.J%A),N3AS,X1"QP(] /9&^Z#)VM1#-9KL'FXNQ@&:<9#T
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MR)N\\"@],2>\.4:D;M'B%5=B23%\2M?ST:ZF95'CF5^?O)[.'O&N^W-R=,3
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MO&2^?E_LUFL3HYBPH]XO/!9=<[5FK/>.B3GKR3E>X_U$Q!5?(4QG/4G]]LI
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MW1)@B.=V^W[EN[$>%L7VGPJ2.(./O5F284\7ZHHUP^]\TS^)NHI3\^5,^AD
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M5'3M1UHP_;3WKOW!L7?+ZL!/>^\=QP&<_S$<%U5\VCI$'TZ^5-C[SAJY('5
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M98Z/5. 7B#F?9SQ,[E]QW3WZ0<?HSG$:#;OST>,U_IW-&6U#;[SVX.C7>AZ
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M_U.H+&\JA%^H0OCPH45J387PO4C-[/ C"X2S,'[S\Z#_Z:P[K"M6WD4%T$2
M>@7#>E(%1C$81A8A19"G-/))C$(N\\8%B!X*!(U9UG C>,'C0/183G_'*-%(
M3?UH@KGO^"+*M)<?$!!#@1A6]#Z_R*=)"A3V0O Y]X7K?[)JY1?.@P&-#2GZ
MO]_L/6_>B_#+:?_3K\-?+OO'GWK>T?GEQ?FEP2%<+EQ^R9*>%9W]#G=?I+7?
MX8N,LO\RPW0J>_8=[9)GYR90Q]7?2X!+FY!A]@M<8'^F+O_Y4^! E_A;]C>X
M4D I_Y3Z2K2+[\CW/T;NX9D_4ZMIXZ5G8H[>:X[]V3=[&.;1X\[]D:> /CWJ
M]-7RCJ:AFBP7A)"7XEBC[FX*#3Q'*?+FT-4C5[=U2UW/=JV/[@=[9R,K7Y/R
M=.JGZ<+[E$1C>-!K-*@7U* V82+5XV].?F.5J*</#I%.98OVM$ZU*52PP7?<
M"RI+R^>#.J_]?KG4\D6TJ>\2\?MA(CO/P/<V0O3VOD?Y!/0B;Y[FL^CG_P]0
M2P,$%     @ ]8&J6/5^)L^5 @  :1P   X   !L=&)R7V5X,3 Q+FAT;>V9
M;T_;,!#&O\JM$D-""FW8&%H:(I6UE$BTE;J^8'LS.8F3&!PGLJ]KNT^_2TH!
M5;!_&DRK_":*[N+G['M^OC?Q<RQDX.><)8&/ B4/)$;Z"U^Z'?>0DGY['?5?
M.4Z_C.<%5PBQY@QY G,C5 :#_K W'3&#7#M.X+?78E&9K,#@2O+3UFQP-7-Z
ME^%P[,'UW*!(5UTXGXQG'KB="@%%P0THO@!=%DQU8=2;#L.Q<SDXIT].]NX"
MTW!XT41:@5]MU&LAYV/X>;!66RL[Y[U1>/G)>TK;@TZU[ +R)3I,BDQY6F0Y
M=DG8H"Y5%@RN+L*S<$::AZ[?O@WZ[2J OUXZIJ9R3;5?J\A4W6<NLCG@P<$!
M?. :F5 @$LJ*5)"I0J6E+AB*4D'.#$2<*^#+6,X3RJ94!3 7AD*YB 12/F9S
MPX%>7ZI-FQ/0+J(2<U E NV8:\$D,)70!CG@JN+-B^:9H 6,P,4:7 -TJDJ+
MK[0"2KWN>5RJ=-T$)N^.\9QV2)[BG>,OX[LH,C Z/FW=7W$*N>\/KZOL"?8*
MIC.A/-)L/1U&%DF^246E3F@0F(K%-!R\3C<M%7J/7O.%2#"G5&>O!3&7LF))
M0FM.6YU&56\D<UY?3<\]OBV70"R9,92HHES?[QQI[+11_V3M;>)L,NT/IL[9
M9#:;C#R()(MOP*V68$HIDBXT,RL<]P?UE*I[^IMU[@?4?L4R[D2$WHW#4O+"
M R87;&7VFWORJWK;U>E1]WW[KCVTYO$4_""W;71MGF/$-]XXV'CII*P0<N5M
MN_E0X5_R?-2Q/%N>=XAGU_)L>=XAGH\LSY;G'>+YC>79\KQ#/+^U/%N>=XCG
M8\NSY7F'>'YG>;8\[Q#/)Y;G/^/Y_R"J^1,8? =02P,$%     @ ]8&J6+)B
MMB2,#0  D4@   T   !L=&)R7V5X,3$N:'1M[5P+4R))$OXK==[.KD8  NK.
MC+A&H*++K<H<LG<[=W%Q430%U-BOK:X6V5]_7V95 R+,>!OC/'0BYD4_,JOR
M\>6763@'8QN%AP=C)0>'!U;;4!V&MF_^JVYKM0KN'6R[BP=_*9=/DB"/5&Q%
M8)2T:B#R3,<CT3HY:W8O9&:5*9</#[:=K'XRF(K,3D/UTT:O]5NOW#QOGUWN
MBW=Y9O5PVA"GG<O>OJA54RNLCE0F8C41)HEDW! 7S>Y9^[)\WCK%(R]?S"YT
MVV<_\Y6-PX.TD$Z"RE?M?[6<-">Y?-J\:)^_W5\G>U]4T]N&L.K6EF6H1_&^
MT:.Q;4!P9DT2CPY;O_W</FKW1*U2.]CVUPZVTT/QT347)MDX_#[N9VGC<;0$
M\)PR"QL\R ^;%ZW+$_SNB<M.1=1%KR.:O7+OYU894GYI]43K[[^V>V]%Y_2T
MU6U?GHFKYGGK2C3/NJT6O7:PG1]^?./,?^MXI8L^LID^J.]"3L6KDJA7Z[M?
M<P3,M5SUVJ>M\Y*X;!]WSIN_7HGO990VQ''GXDWS\FU)M"^/.]TWG6ZSUSIY
M[+5T8B6NDMR.Q94U2MF2J.WAPVF8).:Q=1_)$&\E1I7$A3334,8#4:_!ST_#
MS>=RH/$.[>H,V1\JH/?^$]D:I6;?Z,%(B>/$I(F15B>QV+1C);[_ZZMZO=H
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M8G)?97@S,BYH=&W=6&MOXD84_2NW2*D2"8.!I.T:+Y(!0Y!X9,&1LOU2#?:
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M:YA2))'2./6XB!$!X],1HL&"BQS0+T4 H$CL $9$(/T:M3*2H7Y9A@5#])_
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M+GAS9%!+ 0(4 Q0    ( /6!JE@^XF DT H   ]U   5              "
M 4D.  !L=&)R+3(P,C0P,S,Q7V-A;"YX;6Q02P$"% ,4    " #U@:I8@M%C
MK1$4   K( $ %0              @ %,&0  ;'1B<BTR,#(T,#,S,5]D968N
M>&UL4$L! A0#%     @ ]8&J6![C#(_A,P  B8X" !4              ( !
MD"T  &QT8G(M,C R-# S,S%?;&%B+GAM;%!+ 0(4 Q0    ( /6!JEB/+9RF
MJ2D  -<E @ 5              "  :1A  !L=&)R+3(P,C0P,S,Q7W!R92YX
M;6Q02P$"% ,4    " #U@:I8]E@6H7FX  #U-@@ #               @ &
MBP  ;'1B<E\Q,'$N:'1M4$L! A0#%     @ ]8&J6/5^)L^5 @  :1P   X
M             ( !(T0! &QT8G)?97@Q,#$N:'1M4$L! A0#%     @ ]8&J
M6+)BMB2,#0  D4@   T              ( !Y$8! &QT8G)?97@Q,2YH=&U0
M2P$"% ,4    " #U@:I8EBT*0>(&   Q(   #@              @ &;5 $
M;'1B<E]E>#,Q,2YH=&U02P$"% ,4    " #U@:I83+\3Y_(&  "1(   #@
M            @ &I6P$ ;'1B<E]E>#,Q,BYH=&U02P$"% ,4    " #U@:I8
M^VQ'$!L$  #3$@  #0              @ ''8@$ ;'1B<E]E>#,R+FAT;5!+
M 0(4 Q0    ( /6!JEA"5.Q@A D   $H   -              "  0UG 0!L
B=&)R7V5X-3$N:'1M4$L%!@     ,  P Z@(  +QP 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>ltbr_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:ltbr="http://ltbr.com/20240331"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ltbr-20240331.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-01to2024-04-19_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-19</endDate>
        </period>
    </context>
    <context id="From2024-05-01to2024-05-08_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-05-10</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_AvailableForSaleSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ltbr:AvailableForSaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-15_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="From2021-03-01to2021-03-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_RestrictedStockAwardActivityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_CommonShareIssuancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CommonShareIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ltbr_RestrictedStockAwardActivityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_RestrictedStockAwardActivityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RestrictedStockAwardActivityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2022-12-01to2022-12-15_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseForFeedStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseRatenIcnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseINLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ltbr:ResearchAndDevelopmentExpenseINLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_RATENICNMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:RATENICNMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:StrategicPartnershipProjectAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-26</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-12-31_ltbr_CentrusEnergyFEEDStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CentrusEnergyFEEDStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-12-31_ltbr_RomaniaFeasibilityStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RomaniaFeasibilityStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-12-31_ltbr_INLProjectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:INLProjectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_CentrusEnergyFEEDStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:CentrusEnergyFEEDStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_RomaniaFeasibilityStudyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:RomaniaFeasibilityStudyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_INLProjectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ltbr:INLProjectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ltbr:BattelleEnergyAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_TreasuryBillsLevelThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_TreasuryBillsLevelTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_TreasuryBillsLevelOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ltbr:TreasuryBillsLevelOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_ltbr_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_ltbr_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ltbr_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_ltbr_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31_ltbr_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ltbr_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ltbr:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-01to2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001084554</identifier>
        </entity>
        <period>
            <instant>2024-05-10</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-03-31" id="ixv-5821">0001084554</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-03-31" id="ixv-5822">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-01-01to2024-03-31" id="ixv-5823">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-01-01to2024-03-31" id="ixv-5824">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2024-01-01to2024-03-31" id="ixv-5825">2024</dei:DocumentFiscalYearFocus>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="ixv-5826"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="ixv-5827"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="ixv-5828"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="ixv-5829"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="ixv-5830"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="ixv-5831"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="ixv-5832"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2023-12-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="0"
      id="ixv-5833"
      unitRef="USD">500000.0</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="ixv-5834"
      unitRef="USD">24000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-01to2023-03-31"
      decimals="INF"
      id="ixv-5835"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-01to2023-03-31"
      decimals="INF"
      id="ixv-5836"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="0"
      id="ixv-5837"
      unitRef="Shares">557688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="0"
      id="ixv-5838"
      unitRef="Shares">557688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="0"
      id="ixv-5839"
      unitRef="Shares">557688</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="ixv-5840"
      unitRef="Shares">3750</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="ixv-5841"
      unitRef="USD">15000</us-gaap:ShareBasedCompensation>
    <dei:DocumentType contextRef="From2024-01-01to2024-03-31" id="ixv-6446">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2024-01-01to2024-03-31" id="ixv-6447">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-01-01to2024-03-31" id="ixv-6448">2024-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-01-01to2024-03-31" id="ixv-6449">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-01-01to2024-03-31" id="ixv-6450">001-34487</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-03-31" id="ixv-6451">LIGHTBRIDGE CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-03-31" id="ixv-6452">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-03-31" id="ixv-6453">91-1975651</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-03-31" id="ixv-6454">11710 Plaza America Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-03-31" id="ixv-6455">Suite 2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-03-31" id="ixv-6456">Reston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-03-31" id="ixv-6457">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-03-31" id="ixv-6458">20190</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-03-31" id="ixv-6459">571</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-03-31" id="ixv-6460">730-1200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-01-01to2024-03-31" id="ixv-6461">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-01-01to2024-03-31" id="ixv-6462">LTBR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-01-01to2024-03-31" id="ixv-6463">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2024-01-01to2024-03-31" id="ixv-6464">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-01-01to2024-03-31" id="ixv-6465">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-03-31" id="ixv-6466">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-03-31" id="ixv-6467">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-03-31" id="ixv-6468">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2024-01-01to2024-03-31" id="ixv-6469">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-05-10"
      decimals="INF"
      id="ixv-6470"
      unitRef="Shares">14434480</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1415"
      unitRef="USD">27942421</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1416"
      unitRef="USD">28598445</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1417"
      unitRef="USD">401859</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1418"
      unitRef="USD">207063</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1419"
      unitRef="USD">28344280</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1420"
      unitRef="USD">28805508</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1422"
      unitRef="USD">479625</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1423"
      unitRef="USD">483000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1424"
      unitRef="USD">108865</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1425"
      unitRef="USD">108865</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Assets
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1426"
      unitRef="USD">28932770</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1427"
      unitRef="USD">29397373</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1429"
      unitRef="USD">907421</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1430"
      unitRef="USD">486326</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1431"
      unitRef="USD">907421</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1432"
      unitRef="USD">486326</us-gaap:LiabilitiesCurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="fid_1449"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1451"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1453"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1435"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1436"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="fid_1457"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1459"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1460"
      unitRef="Shares">14189780</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1461"
      unitRef="Shares">13698274</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1437"
      unitRef="USD">14190</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1438"
      unitRef="USD">13698</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1439"
      unitRef="USD">183228519</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1440"
      unitRef="USD">181295125</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1441"
      unitRef="USD">-155217360</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1442"
      unitRef="USD">-152397776</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1443"
      unitRef="USD">28025349</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1444"
      unitRef="USD">28911047</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1445"
      unitRef="USD">28932770</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1446"
      unitRef="USD">29397373</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1464"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1465"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1467"
      unitRef="USD">2157745</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1468"
      unitRef="USD">1865929</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1469"
      unitRef="USD">1023823</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1470"
      unitRef="USD">448044</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1471"
      unitRef="USD">3181568</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1472"
      unitRef="USD">2313973</us-gaap:OperatingExpenses>
    <ltbr:ContributedServicesResearchAndDevelopment
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1474"
      unitRef="USD">0</ltbr:ContributedServicesResearchAndDevelopment>
    <ltbr:ContributedServicesResearchAndDevelopment
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1475"
      unitRef="USD">31028</ltbr:ContributedServicesResearchAndDevelopment>
    <us-gaap:OtherOperatingIncome
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1476"
      unitRef="USD">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1477"
      unitRef="USD">31028</us-gaap:OtherOperatingIncome>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1478"
      unitRef="USD">-3181568</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1479"
      unitRef="USD">-2282945</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1481"
      unitRef="USD">361984</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1482"
      unitRef="USD">256365</us-gaap:InterestIncomeOther>
    <us-gaap:OtherIncome
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1483"
      unitRef="USD">361984</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1484"
      unitRef="USD">256365</us-gaap:OtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1485"
      unitRef="USD">-2819584</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1486"
      unitRef="USD">-2026580</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1487"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1488"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1489"
      unitRef="USD">-2819584</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1490"
      unitRef="USD">-2026580</us-gaap:NetIncomeLoss>
    <ltbr:EarningsPerSharesBasicAndDiluted
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_1492"
      unitRef="USDPShares">-0.21</ltbr:EarningsPerSharesBasicAndDiluted>
    <ltbr:EarningsPerSharesBasicAndDiluted
      contextRef="From2023-01-01to2023-03-31"
      decimals="INF"
      id="fid_1493"
      unitRef="USDPShares">-0.17</ltbr:EarningsPerSharesBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1494"
      unitRef="Shares">13491954</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1495"
      unitRef="Shares">11673736</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="AsOf2022-12-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1532"
      unitRef="Shares">11900217</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1533"
      unitRef="USD">11900</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1534"
      unitRef="USD">173595385</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1535"
      unitRef="USD">-144489130</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="fid_1536"
      unitRef="USD">29118155</us-gaap:StockholdersEquity>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1537"
      unitRef="Shares">169978</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1538"
      unitRef="USD">170</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1539"
      unitRef="USD">730882</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1540"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1541"
      unitRef="USD">731052</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesShares
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1542"
      unitRef="Shares">55835</ltbr:SharesIssuedToConsultantDirectorsForServicesShares>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1543"
      unitRef="USD">56</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1544"
      unitRef="USD">214944</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1545"
      unitRef="USD">0</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1546"
      unitRef="USD">215000</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1547"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1548"
      unitRef="USD">284360</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1549"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1550"
      unitRef="USD">284360</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1551"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1552"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1553"
      unitRef="USD">-2026580</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1554"
      unitRef="USD">-2026580</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1555"
      unitRef="Shares">12126030</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1556"
      unitRef="USD">12126</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1557"
      unitRef="USD">174825571</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1558"
      unitRef="USD">-146515710</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="fid_1559"
      unitRef="USD">28321987</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-12-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1560"
      unitRef="Shares">13698274</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1561"
      unitRef="USD">13698</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1562"
      unitRef="USD">181295125</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1563"
      unitRef="USD">-152397776</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1564"
      unitRef="USD">28911047</us-gaap:StockholdersEquity>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1565"
      unitRef="Shares">427300</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsShares>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1566"
      unitRef="USD">428</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1567"
      unitRef="USD">1221554</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1568"
      unitRef="USD">0</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1569"
      unitRef="USD">1221982</ltbr:SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesShares
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1570"
      unitRef="Shares">64206</ltbr:SharesIssuedToConsultantDirectorsForServicesShares>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1571"
      unitRef="USD">64</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1572"
      unitRef="USD">254936</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1573"
      unitRef="USD">0</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <ltbr:SharesIssuedToConsultantDirectorsForServicesAmount
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1574"
      unitRef="USD">255000</ltbr:SharesIssuedToConsultantDirectorsForServicesAmount>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1575"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1576"
      unitRef="USD">456904</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1577"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1578"
      unitRef="USD">456904</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1579"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1580"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1581"
      unitRef="USD">-2819584</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1582"
      unitRef="USD">-2819584</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1583"
      unitRef="Shares">14189780</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_ltbr_CommonShareMember"
      decimals="0"
      id="fid_1584"
      unitRef="USD">14190</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1585"
      unitRef="USD">183228519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1586"
      unitRef="USD">-155217360</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1587"
      unitRef="USD">28025349</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1497"
      unitRef="USD">-2819584</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1498"
      unitRef="USD">-2026580</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1499"
      unitRef="USD">456904</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1500"
      unitRef="USD">284360</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1502"
      unitRef="USD">-194796</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1503"
      unitRef="USD">-278173</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1504"
      unitRef="USD">3375</ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets>
    <ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1505"
      unitRef="USD">0</ltbr:IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1506"
      unitRef="USD">676095</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1507"
      unitRef="USD">440647</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1508"
      unitRef="USD">-1878006</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1509"
      unitRef="USD">-1579746</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1510"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1511"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1513"
      unitRef="USD">1221982</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1514"
      unitRef="USD">731052</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1515"
      unitRef="USD">1221982</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1516"
      unitRef="USD">731052</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1517"
      unitRef="USD">-656024</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1518"
      unitRef="USD">-848694</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1519"
      unitRef="USD">28598445</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="fid_1520"
      unitRef="USD">28899997</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1521"
      unitRef="USD">27942421</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="fid_1522"
      unitRef="USD">28051303</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1525"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1526"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1527"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1528"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <ltbr:PaymentOfAccruedLiabilitiesWithCommonStock
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1530"
      unitRef="USD">255000</ltbr:PaymentOfAccruedLiabilitiesWithCommonStock>
    <ltbr:PaymentOfAccruedLiabilitiesWithCommonStock
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1531"
      unitRef="USD">215000</ltbr:PaymentOfAccruedLiabilitiesWithCommonStock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_292">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 1. Nature of Operations, Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Nature of Operations and Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;When used in these notes, the terms &#x201c;Lightbridge&#x201d;, &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d; mean Lightbridge Corporation and all entities included in the condensed consolidated financial statements. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company was formed on October 6, 2006, when Thorium Power, Ltd., which was incorporated in the state of Nevada on February 2, 1999, merged with Thorium Power, Inc. (TPI), which was incorporated in the state of Delaware on January 8, 1992. On September 29, 2009, the Company changed its name from Thorium Power, Ltd. to Lightbridge Corporation and began its focus on developing and commercializing metallic nuclear fuels. The Company is a nuclear fuel technology company developing its next generation nuclear fuel technology. These condensed consolidated financial statements include the accounts of the Company and the Company&#x2019;s wholly-owned subsidiaries, TPI, and Lightbridge International Holding LLC, a Delaware limited liability company. These wholly-owned subsidiaries are inactive, and all significant intercompany transactions and balances have been eliminated in consolidation. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America, including a summary of the Company&#x2019;s significant accounting policies, have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and footnotes necessary for comprehensive condensed consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 4, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three-month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Summary of Significant Accounting Policies&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;&#160;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Fair Value of Financial Instruments&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Codification (ASC), &lt;em&gt;Fair Value Measurement&lt;/em&gt; (ASC 820), establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 2 - Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability; and&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 3 - Unobservable inputs that reflect management&#x2019;s assumptions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For disclosure purposes, assets and liabilities are classified in their entirety in the fair value hierarchy level based on the lowest level of input that is significant to the overall fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement within the fair value hierarchy levels.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of&#160;&#160;accounts payable and accrued liabilities are considered to be a Level 1 measurement, representative of their respective fair values because of the short-term nature of those instruments.&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarizes the valuation of the Company&#x2019;s cash equivalents (in millions) that fall within the fair value hierarchy at March 31, 2024. There were no cash equivalents at December 31, 2023.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Assets&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Treasury Bills&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;17.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Certain Risks and Uncertainties&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company will need additional funding and /or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#x2019;s future R&amp;amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#x2019;s operations will be subject to other numerous contingencies, some of which are beyond management&#x2019;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;amp;D of our nuclear fuel, regulatory approval of the Company&#x2019;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;amp;D milestones toward commercialization, future impairment charges to the Company&#x2019;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Recent Accounting Pronouncements &lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which expands on the required disclosure of incremental segment information. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect this guidance to have a material impact on its consolidated financial statements and related disclosures. &lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires companies to annually disclose categories in the effective tax rate reconciliation and additional information about income taxes paid. The new guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company expects the new standard to have an immaterial effect on its consolidated financial statements and related disclosures upon adoption.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;In August 2020, the FASB issued&#160;ASU 2020-06,&#160;&lt;em&gt;Debt-Debt with Conversion and Other Options&#160;&lt;/em&gt;(Subtopic 470-20)&lt;em&gt;&#160;and Derivatives and Hedging- Contracts in Entity&#x2019;s Own Equity&#160;&lt;/em&gt;(Subtopic 815-40), which simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in&#160;ASC 470-20,&#160;&lt;em&gt;Debt: Debt with Conversion and Other Options&lt;/em&gt;, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in&#160;Subtopic 815-40&#160;for freestanding financial instruments and embedded features that are both indexed to the issuer&#x2019;s own stock and classified in stockholders&#x2019; equity, by removing certain criteria required for equity classification; and (3) revises the guidance in&#160;ASC 260,&#160;&lt;em&gt;Earnings Per Share&lt;/em&gt;, to require entities to calculate diluted earnings per share for convertible instruments by using the if-converted method.&#160;ASU 2020-06&#160;is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Adoption is either through a modified retrospective method or a full retrospective method of transition. The Company adopted this guidance on January 1, 2024 and the adoption did not have a material impact on its results of operations, financial position, and disclosures because the Company does not have any transactions or instruments to which this standard applies. If in the future, the Company issues new convertible debt, warrants or other instruments, the standard may have a material effect, but it cannot be determined at this time.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and do not believe the future adoption of any such standards will have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-01-01to2024-03-31" id="fid_1117">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company determines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between unaffiliated market participants at the measurement date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounting Standards Codification (ASC), &lt;em&gt;Fair Value Measurement&lt;/em&gt; (ASC 820), establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The hierarchy gives the highest priority to active markets for identical assets and liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 2 - Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability; and&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Level 3 - Unobservable inputs that reflect management&#x2019;s assumptions.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For disclosure purposes, assets and liabilities are classified in their entirety in the fair value hierarchy level based on the lowest level of input that is significant to the overall fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement within the fair value hierarchy levels.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued liabilities. The carrying amounts of&#160;&#160;accounts payable and accrued liabilities are considered to be a Level 1 measurement, representative of their respective fair values because of the short-term nature of those instruments.&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table summarizes the valuation of the Company&#x2019;s cash equivalents (in millions) that fall within the fair value hierarchy at March 31, 2024. There were no cash equivalents at December 31, 2023.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Assets&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Treasury Bills&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;17.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1143">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Assets&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level I&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level II&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Level III&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Treasury Bills&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;17.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-03-31_ltbr_TreasuryBillsLevelOneMember"
      decimals="-5"
      id="fid_1211"
      unitRef="USD">2500000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-03-31_ltbr_TreasuryBillsLevelTwoMember"
      decimals="-5"
      id="fid_1212"
      unitRef="USD">17500000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-03-31_ltbr_TreasuryBillsLevelThreeMember"
      decimals="-6"
      id="fid_1213"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-01-01to2024-03-31" id="fid_1118">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company will need additional funding and /or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&amp;amp;D) activities required to further enhance and complete the development and commercialization of its fuel products.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company&#x2019;s future R&amp;amp;D activities, financial position, results of operations, and cash flows. Also, the success of the Company&#x2019;s operations will be subject to other numerous contingencies, some of which are beyond management&#x2019;s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels, changes in government regulations, risks related to the R&amp;amp;D of our nuclear fuel, regulatory approval of the Company&#x2019;s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&amp;amp;D milestones toward commercialization, future impairment charges to the Company&#x2019;s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1130">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which expands on the required disclosure of incremental segment information. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect this guidance to have a material impact on its consolidated financial statements and related disclosures. &lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires companies to annually disclose categories in the effective tax rate reconciliation and additional information about income taxes paid. The new guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company expects the new standard to have an immaterial effect on its consolidated financial statements and related disclosures upon adoption.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;In August 2020, the FASB issued&#160;ASU 2020-06,&#160;&lt;em&gt;Debt-Debt with Conversion and Other Options&#160;&lt;/em&gt;(Subtopic 470-20)&lt;em&gt;&#160;and Derivatives and Hedging- Contracts in Entity&#x2019;s Own Equity&#160;&lt;/em&gt;(Subtopic 815-40), which simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in&#160;ASC 470-20,&#160;&lt;em&gt;Debt: Debt with Conversion and Other Options&lt;/em&gt;, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in&#160;Subtopic 815-40&#160;for freestanding financial instruments and embedded features that are both indexed to the issuer&#x2019;s own stock and classified in stockholders&#x2019; equity, by removing certain criteria required for equity classification; and (3) revises the guidance in&#160;ASC 260,&#160;&lt;em&gt;Earnings Per Share&lt;/em&gt;, to require entities to calculate diluted earnings per share for convertible instruments by using the if-converted method.&#160;ASU 2020-06&#160;is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Adoption is either through a modified retrospective method or a full retrospective method of transition. The Company adopted this guidance on January 1, 2024 and the adoption did not have a material impact on its results of operations, financial position, and disclosures because the Company does not have any transactions or instruments to which this standard applies. If in the future, the Company issues new convertible debt, warrants or other instruments, the standard may have a material effect, but it cannot be determined at this time.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has evaluated other recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these unaudited condensed consolidated financial statements and do not believe the future adoption of any such standards will have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_293">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 2. Net Loss Per Share&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Basic net loss per share is computed using the weighted-average number of common shares outstanding during the reporting period, except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net loss per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The outstanding securities noted below have been excluded from the computation of diluted weighted shares outstanding for the three months ended March 31, 2024 and 2023, as they would have been anti-dilutive due to the Company&#x2019;s losses at March 31, 2024 and 2023 and also because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company&#x2019;s common stock.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;555,582&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;525,903&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Restricted stock awards outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;557,688&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;416,316&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,113,270&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;942,219&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_310">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;555,582&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;525,903&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Restricted stock awards outstanding&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;557,688&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;416,316&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1,113,270&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;942,219&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1588"
      unitRef="Shares">555582</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1589"
      unitRef="Shares">525903</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1590"
      unitRef="Shares">557688</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1591"
      unitRef="Shares">416316</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1592"
      unitRef="Shares">1113270</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1593"
      unitRef="Shares">942219</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <ltbr:PrepaidProjectCostsDisclosureTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_294">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 3. Prepaid Project Costs and Other Long-term Assets&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In 2022, the Company entered into two agreements with Idaho National Laboratory (INL), in collaboration with the United States Department of Energy (DOE), to support the development of Lightbridge Fuel&#x2122;. At the time of signing, the Company made advanced payments for future project work totaling $0.4 million to Battelle Energy Alliance, LLC (BEA), DOE&#x2019;s operating contractor for INL. In May 2023, the Company and INL modified the agreements to extend the contract term to May 2029, aligning it with the duration of the irradiation testing and increasing the advanced payments by $0.1 million to $0.5 million. The prepaid project costs were $0.5 million as of March 31, 2024 and December 31, 2023, recorded under Other Assets - Prepaid project costs and other long-term assets.&lt;/p&gt;</ltbr:PrepaidProjectCostsDisclosureTextBlock>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2022-12-31_ltbr_BattelleEnergyAllianceLLCMember"
      decimals="-5"
      id="fid_1594"
      unitRef="USD">400000</us-gaap:PrepaidExpenseNoncurrent>
    <ltbr:PrepaidProjectCostsAddition
      contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MinimumMember"
      decimals="-5"
      id="fid_1599"
      unitRef="USD">100000</ltbr:PrepaidProjectCostsAddition>
    <ltbr:PrepaidProjectCostsAddition
      contextRef="AsOf2023-05-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_srt_MaximumMember"
      decimals="-5"
      id="fid_1600"
      unitRef="USD">500000</ltbr:PrepaidProjectCostsAddition>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2024-03-31_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="fid_1595"
      unitRef="USD">500000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_295">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 4. Accounts Payable and Accrued Liabilities&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts payable and accrued liabilities consisted of the following (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued legal and consulting expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued bonus &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_311">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Trade payables&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued legal and consulting expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued bonus &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.9&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="AsOf2024-03-31"
      decimals="-5"
      id="fid_1238"
      unitRef="USD">200000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="fid_1237"
      unitRef="USD">100000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-03-31"
      decimals="-5"
      id="fid_1240"
      unitRef="USD">500000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="fid_1239"
      unitRef="USD">400000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2024-03-31"
      decimals="-5"
      id="fid_1372"
      unitRef="USD">200000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-6"
      id="fid_1373"
      unitRef="USD">0</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-03-31"
      decimals="-5"
      id="fid_1242"
      unitRef="USD">900000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="fid_1241"
      unitRef="USD">500000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_296">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 5. Commitments and Contingencies&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Commitments&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2024 and December 31, 2023, the Company had total contractual commitments for R&amp;amp;D work for the following three R&amp;amp;D projects (rounded in millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;INL Project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Romania Feasibility Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Centrus Energy FEED Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;3.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;3.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Project Task Statements - INL&lt;/span&gt;&lt;/em&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Project&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 26, 2024, the Company and BEA entered into Modification No. 2 (&#x201c;Modification No. 2&#x201d;) to the project task statement (PTS) under the Strategic Partnership Project Agreement (SPPA), dated December 9, 2022, as amended on May 23, 2023, by and between the Company and BEA. Pursuant to the terms of Modification No. 2, the potential amounts payable by the Company to reimburse BEA for its expenses and employee time were increased by approximately $0.6 million, bringing the total estimated cost for the work to be performed under the &#x201c;umbrella&#x201d; SPPA to $1.7 million.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;After accounting for Modification No. 2, total cash payments from the Company to BEA under both Agreements were estimated at approximately $4.3 million (excluding project contingencies) on a cost reimbursable basis over the performance periods under the initial releases. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2024, the Company had approximately $3.1 million in outstanding PTS commitments to BEA relating to the R&amp;amp;D work being conducted under the SPPA and &#x201c;umbrella&#x201d; Cooperative Research and Development Agreement (CRADA) at INL. Performance of work under these agreements may be terminated at any time by either party, without any liability, after the effective date of termination, upon giving a thirty-day written notice under the SPPA and a sixty-day written notice under the CRADA, to the other party. In the event of termination, the Company shall be responsible for BEA&#x2019;s costs (including the closeout costs), through the effective date of termination, but in no event shall the Company&#x2019;s cost responsibility exceed the total estimated cost stated in each PTS and any subsequent modification to the PTS.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Romania Feasibility Study of Lightbridge Fuel&#x2122; for use in CANDU reactors&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On October 16, 2023, the Company engaged Institutul de Cercet&#x103;ri Nucleare Pite&#x219;ti, a subsidiary of Regia Autonoma Tehnologii pentru Energia Nucleara (RATEN ICN) in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#x2122; for use in CANDU reactors. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2024, the Company had approximately $0.1 million in remaining outstanding project commitments to RATEN ICN.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;FEED Study with Centrus Energy for a Lightbridge Pilot Fuel Fabrication Facility&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 5, 2023, the Company entered into an agreement with Centrus Energy Corp. (Centrus Energy) to conduct a front-end engineering and design (FEED) study to construct a Lightbridge Pilot Fuel Fabrication Facility (LPFFF) to manufacture Lightbridge Fuel&#x2122; using high-assay low-enriched uranium (HALEU) at the American Centrifuge Plant in Piketon. The work is expected to be completed in 2024. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;These Agreements can be terminated by either Party by giving thirty calendar days' prior written notice of termination to the other Party.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Operating Leases&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company leased office space for a 12-month term from January 1, 2024 through December 31, 2024 with a monthly payment of approximately $8,000. The future minimum lease payments required under the non-cancellable operating leases for 2024 total approximately $0.1 million. Total rent expense for the three months ended March 31, 2024 and 2023 was approximately $24,000.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1412">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;INL Project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.9&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Romania Feasibility Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Centrus Energy FEED Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;3.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;3.6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ltbr:ScheduleOfCommitmentsAndContingenciesRAndDWorksTableTextBlock>
    <ltbr:ContractualCommitments
      contextRef="From2024-01-01to2024-03-31_ltbr_INLProjectMember"
      decimals="-5"
      id="fid_1603"
      unitRef="USD">3100000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2023-01-01to2023-12-31_ltbr_INLProjectMember"
      decimals="-5"
      id="fid_1607"
      unitRef="USD">2900000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2024-01-01to2024-03-31_ltbr_RomaniaFeasibilityStudyMember"
      decimals="-5"
      id="fid_1604"
      unitRef="USD">100000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2023-01-01to2023-12-31_ltbr_RomaniaFeasibilityStudyMember"
      decimals="-5"
      id="fid_1608"
      unitRef="USD">200000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2024-01-01to2024-03-31_ltbr_CentrusEnergyFEEDStudyMember"
      decimals="-5"
      id="fid_1605"
      unitRef="USD">300000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2023-01-01to2023-12-31_ltbr_CentrusEnergyFEEDStudyMember"
      decimals="-5"
      id="fid_1609"
      unitRef="USD">500000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1602"
      unitRef="USD">3500000</ltbr:ContractualCommitments>
    <ltbr:ContractualCommitments
      contextRef="From2023-01-01to2023-12-31"
      decimals="-5"
      id="fid_1606"
      unitRef="USD">3600000</ltbr:ContractualCommitments>
    <ltbr:IncreasedExpensesAmountForProjectTask
      contextRef="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember"
      decimals="-5"
      id="fid_1618"
      unitRef="USD">600000</ltbr:IncreasedExpensesAmountForProjectTask>
    <ltbr:TotalCostAmountForProject
      contextRef="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember"
      decimals="-5"
      id="fid_1619"
      unitRef="USD">1700000</ltbr:TotalCostAmountForProject>
    <us-gaap:PaymentsForFees
      contextRef="From2024-03-01to2024-03-26_ltbr_StrategicPartnershipProjectAgreementMember"
      decimals="-5"
      id="fid_1620"
      unitRef="USD">4300000</us-gaap:PaymentsForFees>
    <ltbr:ProjectTaskTatementPostemploymentObligations
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1614"
      unitRef="USD">3100000</ltbr:ProjectTaskTatementPostemploymentObligations>
    <ltbr:RemainingOutstandingProject
      contextRef="AsOf2024-03-31_ltbr_RATENICNMember"
      decimals="-5"
      id="fid_1616"
      unitRef="USD">100000</ltbr:RemainingOutstandingProject>
    <ltbr:LesseeOperatingLeaseTerm contextRef="From2024-01-01to2024-03-31" id="fid_1615">P12M</ltbr:LesseeOperatingLeaseTerm>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1612"
      unitRef="USD">8000</us-gaap:OperatingLeasePayments>
    <ltbr:LeasePaymentUnderNonCancellableOperatingLeases
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1613"
      unitRef="USD">100000</ltbr:LeasePaymentUnderNonCancellableOperatingLeases>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1611"
      unitRef="USD">24000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_300">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 6. Research and Development Costs&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;INL Project&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In 2022, Lightbridge entered into agreements with BEA, to support the development of Lightbridge Fuel&#x2122;. These framework agreements use an innovative structure that consists of an &#x201c;umbrella&#x201d; SPPA and an &#x201c;umbrella&#x201d; CRADA, with an initial duration of seven years. Throughout the duration of these umbrella agreements, all research and development (R&amp;amp;D) work contracted with BEA is through the issuance of PTSs. The initial phase of work under the two agreements will culminate in irradiation testing in the Advanced Test Reactor (ATR) of fuel samples using enriched uranium supplied by the DOE. The initial phase of work aims to generate irradiation performance data for Lightbridge&#x2019;s delta-phase uranium-zirconium alloy relating to various thermophysical properties. The data, which will be obtained during post-irradiation examination work, will support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel&#x2122;. For the three months ended March 31, 2024 and 2023, the Company recorded $0.4 million and $0.2 million in R&amp;amp;D expenses associated with INL, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Romania Feasibility Study&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On October 16, 2023, the Company engaged RATEN ICN in Romania to perform an engineering study to assess the compatibility and suitability of Lightbridge Fuel&#x2122; for use in CANDU reactors. The total price of approximately $0.2 million is payable in three installments, including an advance payment of $0.1 million and an interim milestone payment and final payment totaling approximately $0.1 million. For the three months ended March 31, 2024, the Company recorded $0.1 million in R&amp;amp;D expenses associated with RATEN ICN. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Centrus Energy FEED Study&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 5, 2023, the Company entered into an agreement with Centrus Energy to conduct a FEED study to add a dedicated LPFFF at the American Centrifuge Plant in Piketon, Ohio. As of the date hereof, Centrus Energy has completed the initial phase of the FEED study and issued a preliminary report. For the three months ended March 31, 2024, the Company recorded $0.2 million in R&amp;amp;D expenses associated with this FEED study. After reviewing the preliminary report, the Company will decide whether to proceed to the final phase of the FEED study. If the Company decides to move forward with the final phase of the FEED study, the remaining work is expected to be completed in 2024 at an additional fixed price cost of approximately $0.3 million. &#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following table presents the total R&amp;amp;D expenses for the three months ended March 31, 2024 and 2023 (rounded to millions):&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;INL Project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Romania Feasibility Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Centrus Energy FEED Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Allocated employee compensation and stock-based compensation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other outside R&amp;amp;D expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember"
      decimals="-5"
      id="fid_1396"
      unitRef="USD">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember"
      decimals="-5"
      id="fid_1397"
      unitRef="USD">200000</us-gaap:ResearchAndDevelopmentExpense>
    <ltbr:ResearchAndDevelopmentExpenseAmountForProject
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember"
      decimals="-5"
      id="fid_1399"
      unitRef="USD">200000</ltbr:ResearchAndDevelopmentExpenseAmountForProject>
    <ltbr:AdvancePaymentForResearchAndDevelopmentExpenseAmount
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember"
      decimals="-5"
      id="fid_1400"
      unitRef="USD">100000</ltbr:AdvancePaymentForResearchAndDevelopmentExpenseAmount>
    <ltbr:InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember"
      decimals="-5"
      id="fid_1401"
      unitRef="USD">100000</ltbr:InterimMilestonePaymentFinalPaymentForResearchAndDevelopmentExpenseAmount>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRatenIcnMember"
      decimals="-5"
      id="fid_1398"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember"
      decimals="-5"
      id="fid_1402"
      unitRef="USD">200000</us-gaap:ResearchAndDevelopmentExpense>
    <ltbr:ResearchAndDevelopmentEstimatedExpenses
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseForFeedStudyMember"
      decimals="-5"
      id="fid_1403"
      unitRef="USD">300000</ltbr:ResearchAndDevelopmentEstimatedExpenses>
    <ltbr:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1411">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;INL Project&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Romania Feasibility Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;em&gt;Centrus Energy FEED Study&lt;/em&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Allocated employee compensation and stock-based compensation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.2&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other outside R&amp;amp;D expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.0&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ltbr:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember"
      decimals="-5"
      id="fid_1385"
      unitRef="USD">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseINLMember"
      decimals="-5"
      id="fid_1246"
      unitRef="USD">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember"
      decimals="-5"
      id="fid_1386"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseRomaniaFeasibilityStudyMember"
      decimals="-6"
      id="fid_1387"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember"
      decimals="-5"
      id="fid_1388"
      unitRef="USD">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseCentrusEnergyFEEDStudyMember"
      decimals="-6"
      id="fid_1389"
      unitRef="USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember"
      decimals="-5"
      id="fid_1390"
      unitRef="USD">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseAllocatedEmployeeCompensationStockbasedCompensationMember"
      decimals="-5"
      id="fid_1391"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember"
      decimals="-5"
      id="fid_1392"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_ltbr_ResearchAndDevelopmentExpenseOtherOutsideRandDExpensesMember"
      decimals="-5"
      id="fid_1393"
      unitRef="USD">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_1394"
      unitRef="USD">1000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="fid_1395"
      unitRef="USD">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1110">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 7. Stockholders&#x2019; Equity and Stock-Based Compensation&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2024, the Company had 14,189,780 common shares outstanding (including outstanding RSAs totaling 557,688 shares). Also outstanding were stock options relating to 555,582 shares of common stock (of which 542,972 stock options were vested), all totaling 14,745,362 shares of common stock and all common stock equivalents, potentially outstanding at March 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At December 31, 2023, the Company had 13,698,274 common shares outstanding (including outstanding RSAs totaling 557,688 shares). Also outstanding were stock options relating to 510,787 shares of common stock (of which 498,177 stock options were vested), all totaling 14,209,061 shares of common stock and all common stock equivalents, outstanding at December 31, 2023.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Common Stock Equity Offerings&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;At-the-Market (ATM) Offerings&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On May 28, 2019, the Company entered into an at-the-market equity offering sales agreement with Stifel, Nicolaus &amp;amp; Company, Incorporated (Stifel), which was amended on April 9, 2021 and May 8, 2024 (the &#x201c;ATM Agreement&#x201d;), pursuant to which the Company may issue and sell shares of its common stock from time to time through Stifel as the Company&#x2019;s sales agent. Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party. Sales of the Company&#x2019;s common stock through Stifel, if any, will be made by any method that is deemed to be an &#x201c;at-the-market&#x201d; equity offering as defined in Rule 415 promulgated under the Securities Act of 1933. On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#x2019;s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 29, 2024, the Company filed a new shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#x2019;s securities, which registration statement was declared effective on April 19, 2024. On May 10, 2024, the Company filed a prospectus supplement pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $6.6 million from time to time through its ATM.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company records its ATM sales on a settlement date basis. The Company sold 427,300 shares under the ATM for the three months ended March 31, 2024 resulting in net proceeds of $1.2 million (stock issuance costs were approximately $0.1 million). The Company sold approximately 169,978 shares under the ATM for the three months ended March 31, 2023 resulting in net proceeds of $0.7 million (stock issuance costs were approximately $30,000). &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock-based Compensation&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;2020 Equity Incentive Plan &lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 9, 2020, the Board of Directors adopted the Company&#x2019;s 2020 Omnibus Incentive Plan (the 2020 Plan). On September 3, 2020, the shareholders approved the 2020 Plan to authorize grants of the following types of awards: (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock and Restricted Stock Units, and (d) Other Stock-Based and Cash-Based Awards. The total number of shares of common stock available for issuance under the 2020 Plan is 1,800,000 shares with 758,672 shares available for future issuance at March 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Stock Options&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2024 and 2023, the number of stock options the Company granted to a consultant was 58,309 and 0, respectively. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Common Stock&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Consultants&#x2019; Stock Issuances&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;For the three months ended March 31, 2024 and 2023, the Company issued 3,750 shares (with stock prices at $4.00&#160;per share) to its investor relations firm for services provided during the quarter, recorded to general and administrative expenses. The total stock-based compensation expense recorded for these share issuances was $15,000 for each quarter with a weighted average grant date fair value of $4.00 per share.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;span style="text-decoration:underline"&gt;Directors&#x2019; Stock Issuances&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On November 20, 2023, the Board of Directors approved an equity grant valued at $240,000 in total to its six directors, which resulted in granting a total of 60,456 shares of common stock, valued on the grant date at $3.97 per share, which vested on January 2, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On December 15, 2022, the Board of Directors approved an equity grant valued at $200,000 in total to its five independent directors, recorded in general and administrative expenses, which resulted in granting a total of 52,085 shares of common stock to the five independent directors, valued on the grant date at $3.84 per share, which vested on January 3, 2023. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Restricted Stock Awards&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2024 and December 31, 2023, there were 557,688 restricted stock awards (RSAs) included in the total issued and outstanding common stock. A total of $0.4 million and $0.3 million of compensation expense was recorded for the three months ended March 31, 2024 and 2023, respectively. Compensation expense is recognized in a straight line over the three-year vesting period.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;As of March 31, 2024, total unrecognized compensation cost related to restricted stock units was $2.2 million, which is expected to be recognized over a remaining weighted-average vesting period of 1.9 years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock-Based Compensation Expense&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;Stock Options&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following assumptions were used in the Black-Scholes pricing model to determine the fair value of stock options granted during the three months ended March 31, 2024 and 2023:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;75.36&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk free interest rate &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.54&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected term &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;2 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Closing price per share &#x2013; common stock &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Total non-cash stock-based compensation expense recorded related to options granted and restricted stock awards included in the Company&#x2019;s unaudited condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023 are as follows (rounded in millions):&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total stock-based compensation expense &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1641"
      unitRef="Shares">14189780</us-gaap:CommonStockSharesOutstanding>
    <ltbr:OutstandingRestrictedStockAwards
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1637"
      unitRef="Shares">557688</ltbr:OutstandingRestrictedStockAwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1656"
      unitRef="Shares">555582</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1665"
      unitRef="Shares">542972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <ltbr:CommonStockAndAllCommonStockEquivalents
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1654"
      unitRef="Shares">14745362</ltbr:CommonStockAndAllCommonStockEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1642"
      unitRef="Shares">13698274</us-gaap:CommonStockSharesOutstanding>
    <ltbr:OutstandingRestrictedStockAwards
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1638"
      unitRef="Shares">557688</ltbr:OutstandingRestrictedStockAwards>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="fid_1657"
      unitRef="Shares">510787</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="fid_1666"
      unitRef="Shares">498177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <ltbr:CommonStockAndAllCommonStockEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1655"
      unitRef="Shares">14209061</ltbr:CommonStockAndAllCommonStockEquivalents>
    <ltbr:AtTheMarketOfferingsDisclosureDescription contextRef="From2021-03-01to2021-03-25" id="fid_1658">On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company&#x2019;s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024</ltbr:AtTheMarketOfferingsDisclosureDescription>
    <ltbr:ProceedFromSaleOfAvailableForSaleSecurities
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1680"
      unitRef="USD">75000000.0</ltbr:ProceedFromSaleOfAvailableForSaleSecurities>
    <ltbr:ProceedsFromSaleOfAvailableForSaleSecuritiesB8
      contextRef="AsOf2024-03-31"
      decimals="-5"
      id="fid_1679"
      unitRef="USD">6600000</ltbr:ProceedsFromSaleOfAvailableForSaleSecuritiesB8>
    <ltbr:SharesSoldUnderAtmSettlement
      contextRef="AsOf2024-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1662"
      unitRef="Shares">427300</ltbr:SharesSoldUnderAtmSettlement>
    <ltbr:ProceedsFromSharesSoldUnderTheAtm
      contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1663"
      unitRef="USD">1200000</ltbr:ProceedsFromSharesSoldUnderTheAtm>
    <ltbr:StockIssuedDuringPeriodAmount
      contextRef="From2024-01-01to2024-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1664"
      unitRef="USD">100000</ltbr:StockIssuedDuringPeriodAmount>
    <ltbr:SharesSoldUnderAtmSettlement
      contextRef="AsOf2023-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1667"
      unitRef="Shares">169978</ltbr:SharesSoldUnderAtmSettlement>
    <ltbr:ProceedsFromSharesSoldUnderTheAtm
      contextRef="From2023-01-01to2023-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="-5"
      id="fid_1668"
      unitRef="USD">700000</ltbr:ProceedsFromSharesSoldUnderTheAtm>
    <ltbr:StockIssuedDuringPeriodAmount
      contextRef="From2023-01-01to2023-03-31_ltbr_AvailableForSaleSecuritiesMember"
      decimals="0"
      id="fid_1669"
      unitRef="USD">30000</ltbr:StockIssuedDuringPeriodAmount>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      decimals="0"
      id="fid_1682"
      unitRef="Shares">1800000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <ltbr:FutureIssuanceOfShare
      contextRef="From2024-01-01to2024-03-31_ltbr_TwoThousandTwentyEquityIncentivePlanMember"
      decimals="0"
      id="fid_1648"
      unitRef="Shares">758672</ltbr:FutureIssuanceOfShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-01-01to2024-03-31_ltbr_ConsultantMember"
      decimals="0"
      id="fid_1670"
      unitRef="Shares">58309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2023-01-01to2023-03-31_ltbr_ConsultantMember"
      decimals="0"
      id="fid_1671"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_1672"
      unitRef="Shares">3750</us-gaap:CommonStockSharesIssued>
    <ltbr:StockOptionExercisePrice
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="INF"
      id="fid_1649"
      unitRef="USDPShares">4.00</ltbr:StockOptionExercisePrice>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="0"
      id="fid_1650"
      unitRef="USD">15000</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-03-31_ltbr_CommonShareIssuancesMember"
      decimals="INF"
      id="fid_1651"
      unitRef="USDPShares">4.00</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1639"
      unitRef="USD">240000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:AdditionalCommonShare
      contextRef="AsOf2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1660"
      unitRef="Shares">60456</ltbr:AdditionalCommonShare>
    <ltbr:CommonSharesEquityGrantPricePerShares
      contextRef="From2023-11-01to2023-11-20_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1652"
      unitRef="USDPShares">3.97</ltbr:CommonSharesEquityGrantPricePerShares>
    <ltbr:CommonSharesIssuancesEquityGrant
      contextRef="From2022-12-01to2022-12-15_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1640"
      unitRef="USD">200000</ltbr:CommonSharesIssuancesEquityGrant>
    <ltbr:AdditionalCommonShare
      contextRef="AsOf2022-12-15_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="fid_1661"
      unitRef="Shares">52085</ltbr:AdditionalCommonShare>
    <ltbr:CommonSharesEquityGrantPricePerShares
      contextRef="From2022-12-01to2022-12-15_srt_BoardOfDirectorsChairmanMember"
      decimals="INF"
      id="fid_1653"
      unitRef="USDPShares">3.84</ltbr:CommonSharesEquityGrantPricePerShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-03-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="0"
      id="fid_1673"
      unitRef="Shares">557688</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="-5"
      id="fid_1677"
      unitRef="USD">400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-01to2023-03-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="-5"
      id="fid_1678"
      unitRef="USD">300000</us-gaap:ShareBasedCompensation>
    <ltbr:UnrecongnizedCompensationCostRestrictedStockUnit
      contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember"
      decimals="-5"
      id="fid_1643"
      unitRef="USD">2200000</ltbr:UnrecongnizedCompensationCostRestrictedStockUnit>
    <us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1
      contextRef="From2024-01-01to2024-03-31_ltbr_RestrictedStockAwardActivityMember"
      id="fid_1659">P1Y10M24D</us-gaap:NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1135">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;75.36&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk free interest rate &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.54&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected term &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;2 years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Closing price per share &#x2013; common stock &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_1629"
      unitRef="Pure">0.7536</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_1627"
      unitRef="Pure">0.0454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:OtherInterestAndDividendIncome
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1621"
      unitRef="USD">0</us-gaap:OtherInterestAndDividendIncome>
    <us-gaap:OtherInterestAndDividendIncome
      contextRef="From2023-01-01to2023-03-31"
      decimals="0"
      id="fid_1622"
      unitRef="USD">0</us-gaap:OtherInterestAndDividendIncome>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2024-01-01to2024-03-31" id="fid_1623">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharePrice
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="fid_1625"
      unitRef="USDPShares">2.62</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-31"
      decimals="INF"
      id="fid_1626"
      unitRef="USDPShares">0</us-gaap:SharePrice>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_1140">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Three Months Ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2023&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Research and development expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.1&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.4&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total stock-based compensation expense &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.5&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.3&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1631"
      unitRef="USD">100000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2023-01-01to2023-03-31"
      decimals="-6"
      id="fid_1632"
      unitRef="USD">0</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1633"
      unitRef="USD">400000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-03-31"
      decimals="-5"
      id="fid_1634"
      unitRef="USD">300000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:DividendsSharebasedCompensationStock
      contextRef="From2024-01-01to2024-03-31"
      decimals="-5"
      id="fid_1635"
      unitRef="USD">500000</us-gaap:DividendsSharebasedCompensationStock>
    <us-gaap:DividendsSharebasedCompensationStock
      contextRef="From2023-01-01to2023-03-31"
      decimals="-5"
      id="fid_1636"
      unitRef="USD">300000</us-gaap:DividendsSharebasedCompensationStock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-03-31" id="fid_297">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 8. Subsequent Events&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Amendment to At-the-Market Equity Offering Sales Agreement&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On May 8, 2024, the Company entered into an amendment (the "Amendment") to its&#160;at-the-market equity offering sales agreement, dated May 28, 2019 and as amended on April 9, 2021, with Stifel, Nicolaus &amp;amp; Company, Incorporated (&#x201c;Stifel&#x201d;) to (i) replace certain references to the Company&#x2019;s expired shelf registration statement on Form S-3 (File No. 333-254702) filed on March 25, 2021 with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and declared effective April 5, 2021, with reference to the Company&#x2019;s effective shelf registration statement on Form S-3 (File No. 333-278388), filed on March 29, 2024 with the SEC and declared effective on April 19, 2024 (the &#x201c;Registration Statement&#x201d;), (ii) update public float calculations included therein and (iii) reduce the commission rate for fees owed to Stifel from 4.0% of the gross sales price per share sold to 3.0% of the gross sales price per share sold.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;&lt;strong&gt;ATM Sales&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Sales of common stock under the ATM from April 1, 2024 to May 10, 2024 amounted to approximately 0.2 million shares, which resulted in total net proceeds of approximately $0.7 million.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Amendment to 2020 Equity Incentive Plan&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On February 27, 2024, the Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Equity Incentive Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#x2019; annual meeting on April 19, 2024.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ltbr:CommissionRateDescription
      contextRef="From2024-05-01to2024-05-08_us-gaap_SubsequentEventMember"
      id="fid_1404">reduce the commission rate for fees owed to Stifel from 4.0% of the gross sales price per share sold to 3.0% of the gross sales price per share sold</ltbr:CommissionRateDescription>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_1407"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2024-04-01to2024-05-10_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="fid_1406"
      unitRef="USD">700000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <ltbr:EquityIncentivePlanDescription
      contextRef="From2024-04-01to2024-04-19_us-gaap_SubsequentEventMember"
      id="fid_1410">Board of Directors approved an increase of 700,000 shares to the authorized number of shares under the 2020 Equity Incentive Plan, increasing the total authorized number of shares from 1,800,000 shares to 2,500,000 shares. This increase was approved by the stockholders at the shareholders&#x2019; annual meeting on April 19, 2024</ltbr:EquityIncentivePlanDescription>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
